data_1fzt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fzt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.467 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.661 0.267 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 152' ' ' ILE . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD21 ' CE2' ' A' ' 54' ' ' TYR . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.43 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.465 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 7.4 t30 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' NZ ' ' CG ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 48' ' ' ARG . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' A' ' 74' ' ' ILE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.607 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CG2' ' CG1' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 159' ' ' LEU . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.486 HD11 ' CE1' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.473 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' N ' HG21 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.53 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.425 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.501 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.469 HD21 ' CH2' ' A' ' 111' ' ' TRP . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.473 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 32.8 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 107' ' ' ALA . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 105' ' ' ASP . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.428 ' N ' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.434 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.469 ' CH2' HD21 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.445 ' NH1' ' NH2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.479 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.455 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.486 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.451 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' CD1' ' CZ ' ' A' ' 168' ' ' ARG . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 136' ' ' THR . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.509 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.478 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.521 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.536 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 6.1 p-80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.521 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.607 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.496 ' CG1' ' CG2' ' A' ' 58' ' ' ILE . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.437 HD12 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.489 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 6.3 m-70 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CG2' ' A' ' 136' ' ' THR . 8.4 t30 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.445 ' NH2' ' NH1' ' A' ' 121' ' ' ARG . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.44 HG21 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 171' ' ' ILE . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.511 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.478 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.485 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.415 ' CB ' ' HG2' ' A' ' 121' ' ' ARG . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.471 ' CG ' ' OG ' ' A' ' 205' ' ' SER . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 203' ' ' TYR . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' ASP . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.439 ' N ' HD21 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' HG3' ' CD1' ' A' ' 195' ' ' TYR . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.496 ' CA ' ' HB3' ' A' ' 199' ' ' LYS . . . . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 120.774 0.321 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD11 ' CG2' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.527 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 ' CD2' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 13' ' ' THR . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.483 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 41' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CD2' ' HE2' ' A' ' 157' ' ' LYS . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.491 HG13 ' CD2' ' A' ' 151' ' ' HIS . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' GLU . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD1' ' OG1' ' A' ' 85' ' ' THR . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' ILE . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.409 ' OG1' ' CD1' ' A' ' 75' ' ' LEU . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.533 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.433 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD2' ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.441 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.51 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.485 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.432 ' CB ' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.536 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.536 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.542 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.451 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.624 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.479 ' CG1' ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.557 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.459 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.7 m-70 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 172' ' ' MET . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 202' ' ' LYS . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.457 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.434 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.438 ' NH2' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.438 ' CD2' ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG22 ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.421 HG22 ' CB ' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.437 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.431 HD12 ' CG ' ' A' ' 207' ' ' GLU . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.435 ' CG2' HD11 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.441 ' CE1' ' OE2' ' A' ' 207' ' ' GLU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' N ' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.496 ' HB3' ' CA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.433 ' CA ' HD22 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.441 ' OE2' ' CE1' ' A' ' 195' ' ' TYR . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 210' ' ' ASP . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.62 0.248 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' ND2' ' HA2' ' A' ' 155' ' ' GLY . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 54' ' ' TYR . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CG2' ' A' ' 13' ' ' THR . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 20.2 t30 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.486 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 41' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' CB ' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.431 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CZ ' ' CG2' ' A' ' 58' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.467 ' CG2' ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 163' ' ' HIS . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.8 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.445 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 77' ' ' GLU . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 4.5 t-20 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CH2' ' CD2' ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.501 ' HA ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.47 ' CG1' ' NE ' ' A' ' 120' ' ' ARG . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG2' ' N ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.432 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.482 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.434 ' CD1' HD13 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' NE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.43 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.412 ' CB ' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 136' ' ' THR . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.483 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.491 HG22 ' CE2' ' A' ' 60' ' ' PHE . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.643 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.484 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 200' ' ' ASP . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.432 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.537 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.465 ' C ' ' NZ ' ' A' ' 157' ' ' LYS . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.422 ' N ' ' CD2' ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.464 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.489 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.468 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.458 ' HE1' ' CE1' ' A' ' 123' ' ' TYR . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 172' ' ' MET . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 170' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.47 ' CG2' ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.482 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.47 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 ' HB3' ' A' ' 172' ' ' MET . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.468 ' CD ' HG22 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' HB2' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 208' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.458 ' N ' ' CG2' ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.424 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 8' ' ' ASN . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' LEU . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.425 ' N ' HD11 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' HB3' HG11 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 192' ' ' PRO . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HB2' ' CD2' ' A' ' 196' ' ' HIS . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' HD21 ' A' ' 197' ' ' LEU . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 195' ' ' TYR . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.548 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 ' CG2' HD23 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' CD ' ' CZ3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CB ' ' HE2' ' A' ' 69' ' ' LYS . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 73' ' ' ILE . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.548 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CD2' ' CE1' ' A' ' 143' ' ' TYR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD13 ' CE1' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 19.3 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.424 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.424 ' CG2' HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.498 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 59' ' ' ALA . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 75' ' ' LEU . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.508 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.505 ' CD1' ' CE2' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.435 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.479 HD13 ' CH2' ' A' ' 111' ' ' TRP . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.538 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.437 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.49 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' CG ' ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.448 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.49 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.405 ' N ' ' OG ' ' A' ' 132' ' ' SER . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 141' ' ' LEU . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.542 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.539 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.452 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.423 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.618 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.442 ' CD1' HG13 ' A' ' 152' ' ' ILE . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.434 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 ' CD2' ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.0 m-70 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 7.5 t30 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 172' ' ' MET . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 172' ' ' MET . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 168' ' ' ARG . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.49 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 172' ' ' MET . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 191' ' ' VAL . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.447 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.502 HG13 ' CZ ' ' A' ' 54' ' ' TYR . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.512 ' CE1' ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.49 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.613 0.244 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 197' ' ' LEU . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 54' ' ' TYR . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 ' CG2' ' CD2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.531 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.531 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.48 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' CD1' ' A' ' 73' ' ' ILE . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' NH1' ' OG ' ' A' ' 51' ' ' SER . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.476 HG21 ' CG2' ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CE2' ' CD1' ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.6 OUTLIER -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' CG2' ' HG2' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CG1' ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.433 ' O ' ' CE ' ' A' ' 50' ' ' LYS . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.546 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.436 ' CG2' HD12 ' A' ' 75' ' ' LEU . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.407 ' NH2' ' OH ' ' A' ' 96' ' ' TYR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.54 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.483 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.516 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' GLN . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.449 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.48 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 136' ' ' THR . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.513 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 7.4 p-80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.523 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.508 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.476 ' CG2' HG21 ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.443 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 6.2 m-70 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.46 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.48 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 181' ' ' GLN . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.472 ' CG2' ' CB ' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.472 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH2' ' CG ' ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.454 ' CG ' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.41 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.43 ' CG ' HD11 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.527 ' CG2' ' CE1' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.475 HG12 ' CE2' ' A' ' 54' ' ' TYR . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.427 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.401 ' HB2' HD13 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.479 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.646 0.26 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 156' ' ' GLU . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.52 HG23 ' CE2' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.434 HG21 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD2' ' CD2' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.522 ' CE2' ' CE ' ' A' ' 157' ' ' LYS . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HA ' ' HD3' ' A' ' 157' ' ' LYS . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB1' ' CD1' ' A' ' 83' ' ' LEU . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CE2' HG13 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.417 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD13 ' CE1' ' A' ' 163' ' ' HIS . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.434 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.427 ' CG2' ' HG2' ' A' ' 43' ' ' LYS . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 85' ' ' THR . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' N ' HD23 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 75' ' ' LEU . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.494 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 1.7 t-20 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.487 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.459 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.419 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.506 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.473 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.428 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.434 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 146' ' ' SER . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 32.3 p-80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' VAL . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.511 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 6.5 m-70 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.463 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.429 ' CB ' HD12 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.431 ' CG ' HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.472 ' CG2' ' CG ' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.472 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' NH2' ' HB3' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.431 HG22 ' CB ' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.456 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 208' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 54' ' ' TYR . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 HD11 ' CG ' ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.429 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.525 ' CG2' ' CD2' ' A' ' 196' ' ' HIS . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' CA ' ' HB3' ' A' ' 199' ' ' LYS . . . . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' CD1' ' CD1' ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 54' ' ' TYR . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HD3' ' CG2' ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.478 ' CD2' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' CD1' ' O ' ' A' ' 19' ' ' GLU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' NH2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.437 ' CB ' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HD3' ' CG ' ' A' ' 77' ' ' GLU . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 83' ' ' LEU . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 86' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HD2' ' CD2' ' A' ' 15' ' ' HIS . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 2.1 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' CE ' ' CB ' ' A' ' 34' ' ' LEU . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.488 ' CG1' ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 ' CG2' HG12 ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 59' ' ' ALA . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.462 ' N ' ' CD1' ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 ' CE2' ' A' ' 60' ' ' PHE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 139' ' ' ARG . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.449 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.481 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 120' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.481 ' HD1' ' O ' ' A' ' 115' ' ' GLN . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HA ' ' NH1' ' A' ' 121' ' ' ARG . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' CB ' ' A' ' 122' ' ' SER . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.481 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 131' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 136' ' ' THR . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' N ' ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.526 ' CE1' ' CG2' ' A' ' 147' ' ' THR . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.523 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.523 ' CG1' ' HA ' ' A' ' 144' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 3.9 p-80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.526 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 152' ' ' ILE . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.517 ' CG2' ' CD2' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.645 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.473 ' CD1' ' CD1' ' A' ' 10' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 172' ' ' MET . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.445 ' CB ' HG12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 172' ' ' MET . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.48 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.44 HD21 ' CG ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.445 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.475 ' CZ ' ' CD1' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.475 ' CD1' ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.434 ' CG2' ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 209' ' ' ILE . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.438 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.441 ' CD1' ' CA ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.523 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 2.7 t-160 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.485 ' HB3' ' CA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.523 ' CG2' ' CD2' ' A' ' 196' ' ' HIS . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.482 ' CG ' ' CE2' ' A' ' 195' ' ' TYR . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' CA ' ' CD1' ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.435 ' ND2' ' CG1' ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.492 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 197' ' ' LEU . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 195' ' ' TYR . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 1.3 t30 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.424 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 41' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 11' ' ' VAL . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 163' ' ' HIS . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.408 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' N ' HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' N ' ' CD2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 94' ' ' ARG . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.506 ' CD1' ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.493 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.405 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.506 ' CH2' ' CD1' ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.445 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 122' ' ' SER . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.506 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.422 ' CD2' ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.444 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 148' ' ' ILE . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.426 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 11.4 p-80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.52 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.554 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 10.8 m-70 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.444 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 121' ' ' ARG . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.466 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 172' ' ' MET . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.476 HD22 ' CE1' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.491 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.422 HG11 ' CG ' ' A' ' 121' ' ' ARG . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 186' ' ' GLU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.461 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.505 ' CG2' ' CE2' ' A' ' 195' ' ' TYR . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 54' ' ' TYR . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.436 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 196' ' ' HIS . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.474 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.436 0.16 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 13' ' ' THR . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.407 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.473 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.8 t30 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HD3' ' CE3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.571 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE2' ' CG1' ' A' ' 148' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.438 ' CG2' ' HB2' ' A' ' 71' ' ' CYS . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.507 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' CD1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' O ' ' NH1' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.483 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.449 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 111' ' ' TRP . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.489 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.442 ' CD1' HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 HD23 ' NH1' ' A' ' 168' ' ' ARG . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.446 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.548 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.503 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.429 ' N ' HG13 ' A' ' 152' ' ' ILE . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.477 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.474 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 6.2 m-70 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.402 ' CB ' ' OE2' ' A' ' 93' ' ' GLU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' GLY . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' HA ' ' CE ' ' A' ' 172' ' ' MET . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.426 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.45 ' CE ' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.49 ' CG ' ' HB ' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.49 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.436 HG23 ' CG ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.428 ' N ' ' HG3' ' A' ' 184' ' ' LYS . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 193' ' ' ILE . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.467 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.467 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 207' ' ' GLU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.467 ' CD2' ' HB2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 174' ' ' LEU . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.417 ' N ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.482 ' CD1' ' HG2' ' A' ' 175' ' ' GLU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 209' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 192' ' ' PRO . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.655 0.264 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD23 ' CE2' ' A' ' 54' ' ' TYR . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 195' ' ' TYR . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' CD2' ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.479 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HD3' ' NZ ' ' A' ' 30' ' ' LYS . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.583 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 148' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 12.4 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.448 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' N ' HG23 ' A' ' 74' ' ' ILE . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' ILE . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' ALA . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 131' ' ' GLU . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.487 ' CD2' ' CZ3' ' A' ' 111' ' ' TRP . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.437 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.487 ' CZ3' ' CD2' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.448 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.424 ' CB ' HG21 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.418 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.48 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.521 HG22 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.57 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.521 ' CE1' HG22 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 151' ' ' HIS . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 153' ' ' LEU . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.583 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.462 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.482 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 4.2 m-70 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.401 ' CB ' ' OE2' ' A' ' 93' ' ' GLU . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.449 ' CE ' ' CG2' ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.435 ' CB ' HD12 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.472 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.494 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.449 ' CG2' ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 182' ' ' ILE . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.534 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.474 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 194' ' ' VAL . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 54' ' ' TYR . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.476 ' CD1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' N ' ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.4 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.423 ' N ' HD22 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.428 ' CG ' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.428 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 12' ' ' LEU . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' A' ' 54' ' ' TYR . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' CB ' HD21 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' OE2' ' CB ' ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.423 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' CD1' HD12 ' A' ' 73' ' ' ILE . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD11 ' CE1' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' CG2' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 ' CG2' ' CB ' ' A' ' 71' ' ' CYS . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD11 ' NH2' ' A' ' 66' ' ' ARG . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 39' ' ' ILE . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 HG13 ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.503 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.428 ' OG1' ' CD1' ' A' ' 75' ' ' LEU . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' NZ ' ' CG2' ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.449 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.566 ' CD2' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.505 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.566 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.473 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.424 ' HB3' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.491 ' CE1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.427 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.534 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.546 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.413 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 136' ' ' THR . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.532 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.477 ' CG2' HG22 ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.446 ' HB ' HD23 ' A' ' 12' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 13' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.43 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 82.9 m-20 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.476 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 202' ' ' LYS . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH2' ' CD2' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.446 ' CD2' ' NH2' ' A' ' 185' ' ' ARG . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.439 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 209' ' ' ILE . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.439 ' O ' ' CG1' ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 203' ' ' TYR . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' A' ' 206' ' ' LYS . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.584 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 197' ' ' LEU . 32.8 m-20 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.627 HG23 ' CZ ' ' A' ' 54' ' ' TYR . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.556 ' HG3' ' CD1' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 30.1 p80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.458 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.431 ' N ' HG21 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD21 ' OG1' ' A' ' 70' ' ' THR . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' C ' HD13 ' A' ' 39' ' ' ILE . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CZ ' HG23 ' A' ' 11' ' ' VAL . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.699 ' CE1' ' CB ' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.669 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.58 ' CG2' ' CB ' ' A' ' 71' ' ' CYS . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 29' ' ' TRP . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 27' ' ' THR . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.2 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' HD21 ' A' ' 34' ' ' LEU . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.58 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 26.2 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 77' ' ' GLU . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' ILE . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.661 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HE2' ' OG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.653 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 143' ' ' TYR . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.49 ' CD1' ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.725 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.582 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.725 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.685 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.572 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.723 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.523 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.534 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.572 ' CD1' ' CD1' ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.463 ' N ' ' OG ' ' A' ' 132' ' ' SER . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.525 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.719 ' O ' ' N ' ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 136' ' ' THR . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.653 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.657 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.513 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 147' ' ' THR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.681 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.698 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.681 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.499 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.596 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.561 HG23 ' NE2' ' A' ' 151' ' ' HIS . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.699 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.555 ' CD1' HD23 ' A' ' 10' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 4.1 t30 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' CD1' ' HG3' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.61 ' CD ' ' NH1' ' A' ' 185' ' ' ARG . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 172' ' ' MET . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' ' 141' ' ' LEU . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.522 ' N ' ' SD ' ' A' ' 172' ' ' MET . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HG ' ' CD1' ' A' ' 182' ' ' ILE . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.534 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.517 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.61 ' NH1' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.544 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.574 ' CG1' ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.491 ' O ' ' CD1' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.479 ' C ' ' CG1' ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 8' ' ' ASN . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 197' ' ' LEU . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.528 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.445 0.165 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 54' ' ' TYR . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 159' ' ' LEU . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.42 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.473 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' CD ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HB ' ' CG1' ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 HD11 ' CE1' ' A' ' 163' ' ' HIS . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 1.4 pp0? -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' HD2' ' ND1' ' A' ' 15' ' ' HIS . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.458 HD13 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 85' ' ' THR . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' N ' HD21 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 75' ' ' LEU . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.508 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.468 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 HD13 ' CE2' ' A' ' 26' ' ' PHE . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 41.8 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 107' ' ' ALA . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 9.0 t-20 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.451 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.422 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.421 ' CB ' HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 ' CB ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.41 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.434 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.501 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.501 ' CG1' ' HA ' ' A' ' 137' ' ' ALA . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.524 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.531 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.531 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 8.5 p-80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.48 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.2 m-70 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.473 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HA ' ' CG2' ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.415 ' HB2' ' CB ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.447 ' CG2' ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.446 ' HG3' ' N ' ' A' ' 173' ' ' ASP . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 172' ' ' MET . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.481 HD22 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.441 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.423 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.447 ' CD ' ' CG2' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.475 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.475 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.429 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 12' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.425 ' O ' ' CG2' ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 203' ' ' TYR . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 202' ' ' LYS . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.431 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.416 ' CG ' HD12 ' A' ' 193' ' ' ILE . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.435 HD11 ' CG2' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.433 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.421 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 197' ' ' LEU . 0.3 OUTLIER -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 54' ' ' TYR . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.493 ' CE3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.493 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' CD1' HD13 ' A' ' 73' ' ' ILE . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.482 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.533 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.48 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.519 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 39' ' ' ILE . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' N ' HG21 ' A' ' 74' ' ' ILE . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.502 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD21 ' N ' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.423 ' N ' HD21 ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.459 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.43 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.43 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' THR . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.465 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 8.6 p-80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.535 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.427 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.538 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 10' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.47 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.47 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 174' ' ' LEU . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.446 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 172' ' ' MET . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' LEU . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.471 ' NE ' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 191' ' ' VAL . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.408 ' CG ' ' HB2' ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.488 HG13 ' CE2' ' A' ' 54' ' ' TYR . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.476 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 174' ' ' LEU . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.429 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.476 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 3.4 t30 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' A' ' 160' ' ' ILE . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 195' ' ' TYR . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.429 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.499 ' CE3' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t30 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' ' CE3' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.499 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 69' ' ' LYS . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 73' ' ' ILE . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ARG . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 44' ' ' LEU . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.46 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.443 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' CYS . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 10.4 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' N ' HG23 ' A' ' 74' ' ' ILE . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.502 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 75' ' ' LEU . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.436 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 108' ' ' ARG . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.427 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.478 ' CD1' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.455 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.512 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.523 ' CE1' ' CE ' ' A' ' 172' ' ' MET . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.478 ' CG2' ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.447 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 88' ' ' SER . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 148' ' ' ILE . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.433 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.516 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 1.6 p-80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.453 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' VAL . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 182' ' ' ILE . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 172' ' ' MET . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.475 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.43 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.438 HD13 ' CD2' ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.433 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.433 HG23 ' CB ' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.449 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 12' ' ' LEU . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.0 OUTLIER -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 8' ' ' ASN . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.416 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' HIS . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.566 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 197' ' ' LEU . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 160' ' ' ILE . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.509 ' O ' ' CG2' ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.418 ' CE3' ' NZ ' ' A' ' 30' ' ' LYS . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 2.0 t30 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 69' ' ' LYS . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.701 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 35' ' ' SER . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.701 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' HE3' ' OE1' ' A' ' 77' ' ' GLU . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 54' ' ' TYR . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 1.7 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 22.2 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 42' ' ' ALA . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 74' ' ' ILE . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.693 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.544 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.512 HG23 ' NZ ' ' A' ' 87' ' ' LYS . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.604 ' N ' ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.566 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.578 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.546 ' CB ' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD1' ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' C ' ' CD1' ' A' ' 102' ' ' LEU . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 109' ' ' LYS . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.519 ' N ' HD13 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.513 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 108' ' ' ARG . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.491 ' CA ' HG23 ' A' ' 116' ' ' VAL . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.562 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' ARG . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.6 ' O ' ' CB ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.622 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 123' ' ' TYR . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.561 ' HB3' ' O ' ' A' ' 122' ' ' SER . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.622 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.504 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.44 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 140' ' ' VAL . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 141' ' ' LEU . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 136' ' ' THR . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.574 ' CD1' HG21 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.635 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 199' ' ' LYS . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.666 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.61 ' CG2' ' NE2' ' A' ' 151' ' ' HIS . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.546 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 171' ' ' ILE . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.518 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.527 ' HG3' ' CD1' ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 179' ' ' GLY . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.525 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.499 ' CG1' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.477 ' NH1' ' OH ' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.539 ' CD2' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.525 HG23 ' CB ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.481 ' C ' ' CD1' ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.569 ' CE1' HD11 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 205' ' ' SER . 2.3 t60 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.454 ' O ' HD21 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 202' ' ' LYS . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.475 HD21 ' N ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 3.6 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.752 0.311 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.514 ' N ' HD11 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 54' ' ' TYR . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HG ' ' CE2' ' A' ' 195' ' ' TYR . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.507 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 16' ' ' GLY . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.512 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.707 ' CH2' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 2.3 t30 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.67 ' CG2' ' CH2' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' CA ' ' HB2' ' A' ' 96' ' ' TYR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.521 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.707 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 41' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 ' N ' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' NH1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.61 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.611 ' CG2' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 163' ' ' HIS . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HG2' ' CB ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 61' ' ' THR . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 3.7 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 66' ' ' ARG . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' A' ' 69' ' ' LYS . 34.6 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD1' HD12 ' A' ' 83' ' ' LEU . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.73 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.73 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.516 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.504 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HB2' ' CG2' ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.526 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 120' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.575 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.541 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.515 ' CB ' HG21 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.536 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.497 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.558 ' CG ' ' N ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.525 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.542 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.542 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.688 ' O ' ' N ' ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.578 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.688 ' N ' ' O ' ' A' ' 136' ' ' THR . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.66 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.607 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.697 ' CG1' ' CZ ' ' A' ' 60' ' ' PHE . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.66 ' CE1' ' CG2' ' A' ' 148' ' ' ILE . 0.9 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.605 ' OE1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.611 HG22 ' CG2' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.758 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.492 ' CD1' HD23 ' A' ' 12' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.525 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.502 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 2.4 m120 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.433 ' CB ' ' HB1' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.473 HD11 ' HA2' ' A' ' 164' ' ' GLY . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.511 ' HB1' ' N ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.518 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.576 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.536 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.553 ' HD2' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.489 HD23 ' CG2' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.485 ' HG2' HD12 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.49 ' O ' ' CD1' ' A' ' 195' ' ' TYR . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.566 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.49 ' O ' ' CG2' ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' ASN . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 6' ' ' ALA . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ASP . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 202' ' ' LYS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.454 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 198' ' ' ASP . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.437 ' OD1' ' CD2' ' A' ' 197' ' ' LEU . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 ' CD1' ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' CE1' ' A' ' 54' ' ' TYR . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.436 HD12 ' CE1' ' A' ' 195' ' ' TYR . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.429 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.409 HD12 ' CD2' ' A' ' 34' ' ' LEU . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' LEU . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.439 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 84' ' ' GLU . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 158' ' ' VAL . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.464 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.415 ' HA ' HG22 ' A' ' 74' ' ' ILE . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 77' ' ' GLU . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 74' ' ' ILE . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.503 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.536 ' CD2' ' CZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.426 ' N ' HD13 ' A' ' 102' ' ' LEU . 5.8 t-20 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.428 ' CA ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.577 ' CD1' ' CG1' ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.571 ' CB ' ' CD1' ' A' ' 119' ' ' TRP . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 15.1 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.47 ' CZ ' ' NH1' ' A' ' 120' ' ' ARG . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CE1' ' HE2' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.436 ' CD1' HD13 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.458 ' O ' ' CZ3' ' A' ' 119' ' ' TRP . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 137' ' ' ALA . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.598 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.427 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.53 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 144' ' ' TYR . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 15.5 p-80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.518 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.539 HG12 ' CE2' ' A' ' 60' ' ' PHE . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.458 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.434 ' HB3' ' N ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.481 ' HE2' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.435 ' NH2' ' HB3' ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD2' HG23 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.474 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.474 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.452 ' O ' ' CD1' ' A' ' 209' ' ' ILE . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 208' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.45 ' CG2' HG21 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.436 ' CE1' HD12 ' A' ' 12' ' ' LEU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.487 ' CE1' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 174' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.432 HG21 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 194' ' ' VAL . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' ILE . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.509 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.541 0.21 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.3 OUTLIER -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.423 HG23 ' CD1' ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 190' ' ' GLY . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.461 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' ND2' ' HE3' ' A' ' 104' ' ' LYS . 8.9 t-20 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.466 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' GLU . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 73' ' ' ILE . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 73' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CD1' ' NZ ' ' A' ' 157' ' ' LYS . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' CA ' HD22 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 60' ' ' PHE . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HG23 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD13 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.489 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.489 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' HG21 ' A' ' 74' ' ' ILE . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.434 HG21 ' NZ ' ' A' ' 43' ' ' LYS . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' N ' HG23 ' A' ' 74' ' ' ILE . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD22 ' CA ' ' A' ' 57' ' ' ASP . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.447 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 33.5 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HE3' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.44 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.472 ' CD1' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.496 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.437 ' CE2' ' CE ' ' A' ' 172' ' ' MET . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.472 ' CG2' ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.427 ' N ' HG22 ' A' ' 125' ' ' ILE . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.457 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 136' ' ' THR . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 146' ' ' SER . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 143' ' ' TYR . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.5 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.463 HG21 ' CD2' ' A' ' 151' ' ' HIS . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.579 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' VAL . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.486 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 168' ' ' ARG . 79.9 m-20 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CG ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 178' ' ' THR . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.44 HD13 ' CG ' ' A' ' 185' ' ' ARG . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.448 ' CZ ' HG23 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.405 HD13 ' HD2' ' A' ' 14' ' ' ARG . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.417 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.469 ' CD1' HG12 ' A' ' 209' ' ' ILE . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 54' ' ' TYR . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.48 ' CE1' HD12 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 10' ' ' LEU . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.431 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.46 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.488 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.541 0.21 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 54' ' ' TYR . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.486 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.432 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' CD2' HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 73' ' ' ILE . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' CG ' ' CA ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD23 ' CD ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 11' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.519 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.486 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.459 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.444 ' O ' ' N ' ' A' ' 77' ' ' GLU . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' CB ' ' ND2' ' A' ' 165' ' ' ASN . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.447 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.443 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.495 ' CD1' ' CH2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.524 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.445 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.5 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.435 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 132' ' ' SER . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.426 HD13 ' CB ' ' A' ' 168' ' ' ARG . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.463 ' N ' ' CE ' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.42 ' O ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 136' ' ' THR . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.456 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.519 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 148' ' ' ILE . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.453 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.439 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 15' ' ' HIS . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.462 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 4.1 t30 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.435 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.431 ' CD2' HG21 ' A' ' 160' ' ' ILE . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.517 ' CG1' ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.486 HD13 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' O ' ' CE1' ' A' ' 203' ' ' TYR . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.475 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.44 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.471 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.432 ' N ' ' CG2' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.49 ' CD ' ' CG2' ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 188' ' ' ALA . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.436 ' CA ' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 207' ' ' GLU . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.517 ' CE2' ' CG1' ' A' ' 171' ' ' ILE . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.477 ' CD2' ' HB2' ' A' ' 7' ' ' PRO . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.438 HD21 ' N ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.438 ' N ' HD21 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.444 ' HB2' HG13 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 193' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.615 0.245 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 152' ' ' ILE . 2.1 m120 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 196' ' ' HIS . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 197' ' ' LEU . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.477 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.524 ' CE3' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' CG ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' O ' ' CE3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.413 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 41' ' ' GLU . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.4 HD12 ' CD1' ' A' ' 73' ' ' ILE . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' CD1' ' CB ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD11 ' CE1' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 69' ' ' LYS . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.46 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.47 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' ALA . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.46 ' CG2' ' CD1' ' A' ' 75' ' ' LEU . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 139' ' ' ARG . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD23 ' CB ' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.441 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 111' ' ' TRP . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.529 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 117' ' ' GLN . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.45 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.495 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.529 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.431 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.529 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.536 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CE1' HG21 ' A' ' 148' ' ' ILE . 15.9 p-80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.469 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.436 ' CD2' HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.41 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 60' ' ' PHE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.46 ' CE1' HD11 ' A' ' 64' ' ' LEU . 5.5 m-70 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 4.0 t30 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.453 ' O ' ' CB ' ' A' ' 172' ' ' MET . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 172' ' ' MET . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.42 ' CD1' HD23 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.424 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 168' ' ' ARG . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.461 HD12 ' CZ ' ' A' ' 144' ' ' TYR . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HG2' ' CE1' ' A' ' 203' ' ' TYR . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.424 ' CD ' HG22 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 209' ' ' ILE . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.444 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 207' ' ' GLU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.411 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 195' ' ' TYR . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.411 ' OD1' ' NE ' ' A' ' 48' ' ' ARG . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' CB ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.767 0.317 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 t -62.0 164.56 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -93.58 164.52 13.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -65.38 129.71 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.55 38.07 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -136.74 179.19 1.43 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 152' ' ' ILE . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD21 ' CE2' ' A' ' 54' ' ' TYR . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.437 ' CD2' HD12 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.43 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.465 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 7.4 t30 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' NZ ' ' CG ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 48' ' ' ARG . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' A' ' 74' ' ' ILE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.607 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CG2' ' CG1' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 159' ' ' LEU . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.486 HD11 ' CE1' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.473 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' N ' HG21 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.53 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.425 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.501 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.519 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.469 HD21 ' CH2' ' A' ' 111' ' ' TRP . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.473 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 32.8 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 107' ' ' ALA . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 105' ' ' ASP . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.428 ' N ' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.434 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.469 ' CH2' HD21 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.445 ' NH1' ' NH2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.479 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.455 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.486 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.451 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' CD1' ' CZ ' ' A' ' 168' ' ' ARG . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 136' ' ' THR . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.509 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.478 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.521 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.536 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.521 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 6.1 p-80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.521 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.607 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.496 ' CG1' ' CG2' ' A' ' 58' ' ' ILE . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.437 HD12 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.489 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 6.3 m-70 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CG2' ' A' ' 136' ' ' THR . 8.4 t30 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.441 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.445 ' NH2' ' NH1' ' A' ' 121' ' ' ARG . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.44 HG21 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 171' ' ' ILE . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.511 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.478 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.485 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.415 ' CB ' ' HG2' ' A' ' 121' ' ' ARG . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.471 ' CG ' ' OG ' ' A' ' 205' ' ' SER . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 203' ' ' TYR . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' ASP . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.439 ' N ' HD21 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' HG3' ' CD1' ' A' ' 195' ' ' TYR . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 15.2 ttt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 156' ' ' GLU . 7.5 t -49.64 -25.86 3.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.084 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 2' ' ' THR . 13.2 t 46.28 38.38 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.833 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 8.7 tt0 60.26 125.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.992 0.425 . . . . 0.0 111.412 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 165.36 -79.07 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.308 0.575 . . . . 0.0 111.058 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.496 ' CA ' ' HB3' ' A' ' 199' ' ' LYS . . . -173.47 -64.11 0.0 OUTLIER Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.707 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD11 ' CG2' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD11 ' CD2' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 13' ' ' THR . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.409 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.483 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 41' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CD2' ' HE2' ' A' ' 157' ' ' LYS . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.491 HG13 ' CD2' ' A' ' 151' ' ' HIS . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' GLU . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD1' ' OG1' ' A' ' 85' ' ' THR . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' ILE . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.409 ' OG1' ' CD1' ' A' ' 75' ' ' LEU . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.533 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.433 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD2' ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.51 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.441 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.441 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.51 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.485 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.432 ' CB ' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.536 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.536 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.542 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 4' ' ' GLU . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 2' ' ' THR . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.624 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.479 ' CG1' ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.459 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.7 m-70 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 172' ' ' MET . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 202' ' ' LYS . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.457 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.434 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.438 ' NH2' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.424 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.438 ' CD2' ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG22 ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.421 HG22 ' CB ' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.437 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.431 HD12 ' CG ' ' A' ' 207' ' ' GLU . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.435 ' CG2' HD11 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.441 ' CE1' ' OE2' ' A' ' 207' ' ' GLU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' N ' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.496 ' HB3' ' CA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.433 ' CA ' HD22 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.441 ' OE2' ' CE1' ' A' ' 195' ' ' TYR . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 210' ' ' ASP . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.744 0.307 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 8' ' ' ASN . 70.9 p -42.69 142.12 0.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 t -166.18 -43.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -16.18 63.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 74.57 52.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.992 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -167.7 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HA ' ' CG2' ' A' ' 2' ' ' THR . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' CD1' ' CB ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 54' ' ' TYR . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CG2' ' A' ' 13' ' ' THR . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 20.2 t30 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.486 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 41' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' CB ' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.431 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CZ ' ' CG2' ' A' ' 58' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' CG2' ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 163' ' ' HIS . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.424 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.8 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 77' ' ' GLU . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.487 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 4.5 t-20 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.431 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CH2' ' CD2' ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.501 ' HA ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.47 ' CG1' ' NE ' ' A' ' 120' ' ' ARG . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.501 HG22 ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG2' ' N ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.432 ' CB ' HG22 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.482 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.434 ' CD1' HD13 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' NE ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.43 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 140' ' ' VAL . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.412 ' CB ' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 136' ' ' THR . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.491 HG22 ' CE2' ' A' ' 60' ' ' PHE . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.643 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.484 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 200' ' ' ASP . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.537 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.465 ' C ' ' NZ ' ' A' ' 157' ' ' LYS . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.55 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.422 ' N ' ' CD2' ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.464 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.489 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.468 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.458 ' HE1' ' CE1' ' A' ' 123' ' ' TYR . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 172' ' ' MET . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 170' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.47 ' CG2' ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.482 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.47 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 ' HB3' ' A' ' 172' ' ' MET . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.468 ' CD ' HG22 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' HB2' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 208' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.458 ' N ' ' CG2' ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.424 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 8' ' ' ASN . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' LEU . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.425 ' N ' HD11 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' HB3' HG11 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 192' ' ' PRO . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.334 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' CB ' ' A' ' 8' ' ' ASN . 3.6 m -47.84 167.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.25 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -157.84 169.23 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -49.92 108.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.89 49.15 20.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -137.39 177.93 1.94 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.315 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HB2' ' CD2' ' A' ' 196' ' ' HIS . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.449 ' CB ' ' CG2' ' A' ' 2' ' ' THR . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 195' ' ' TYR . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.548 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' CG2' HD23 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' OE1' ' CG2' ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.408 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' CD ' ' CZ3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CB ' ' HE2' ' A' ' 69' ' ' LYS . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 73' ' ' ILE . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.548 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CD2' ' CE1' ' A' ' 143' ' ' TYR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD13 ' CE1' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 19.3 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.424 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.424 ' CG2' HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.498 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 59' ' ' ALA . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.434 ' CG2' ' CD1' ' A' ' 75' ' ' LEU . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.508 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.505 ' CD1' ' CE2' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.435 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.479 HD13 ' CH2' ' A' ' 111' ' ' TRP . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.445 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.538 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.437 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.49 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' CG ' ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.448 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.49 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.485 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.405 ' N ' ' OG ' ' A' ' 132' ' ' SER . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 141' ' ' LEU . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.542 ' CE1' ' CD2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.539 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.452 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.423 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.618 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.442 ' CD1' HG13 ' A' ' 152' ' ' ILE . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 ' CD2' ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.0 m-70 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 7.5 t30 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 172' ' ' MET . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 172' ' ' MET . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 168' ' ' ARG . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.49 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.429 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 172' ' ' MET . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 191' ' ' VAL . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.447 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.502 HG13 ' CZ ' ' A' ' 54' ' ' TYR . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.512 ' CE1' ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.49 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.236 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 9' ' ' LEU . 7.1 p -51.08 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ALA . 3.3 m -139.51 68.87 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.016 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.85 -84.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.03 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -120.86 80.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.466 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -170.02 -179.86 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 2' ' ' THR . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.494 HG21 ' CE1' ' A' ' 54' ' ' TYR . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 ' CG2' ' CD2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.531 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.531 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.48 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.423 HD13 ' CD1' ' A' ' 73' ' ' ILE . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' NH1' ' OG ' ' A' ' 51' ' ' SER . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.476 HG21 ' CG2' ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CE2' ' CD1' ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.6 OUTLIER -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' CG2' ' HG2' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CG1' ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.433 ' O ' ' CE ' ' A' ' 50' ' ' LYS . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.546 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 59' ' ' ALA . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.436 ' CG2' HD12 ' A' ' 75' ' ' LEU . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.407 ' NH2' ' OH ' ' A' ' 96' ' ' TYR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.54 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.483 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.516 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' GLN . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.449 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.48 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 136' ' ' THR . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.513 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 7.4 p-80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.523 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.508 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.476 ' CG2' HG21 ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.443 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 6.2 m-70 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.46 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.48 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.424 ' CD1' ' HG2' ' A' ' 181' ' ' GLN . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.472 ' CG2' ' CB ' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.472 ' CB ' ' CG2' ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH2' ' CG ' ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.454 ' CG ' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.41 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.43 ' CG ' HD11 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.527 ' CG2' ' CE1' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.475 HG12 ' CE2' ' A' ' 54' ' ' TYR . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.427 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.401 ' HB2' HD13 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HA ' ' CB ' ' A' ' 57' ' ' ASP . 2.2 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.789 0.328 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.42 ' N ' ' HB2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -75.6 81.08 2.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.639 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 4' ' ' GLU . 13.5 t -42.26 -47.49 4.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.397 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 3' ' ' THR . 8.1 tp10 -66.92 111.42 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.55 62.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.194 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.479 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -169.37 -65.9 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.485 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 156' ' ' GLU . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG23 ' CE2' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.434 HG21 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD2' ' CD2' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.522 ' CE2' ' CE ' ' A' ' 157' ' ' LYS . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' O ' ' CD ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HA ' ' HD3' ' A' ' 157' ' ' LYS . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.444 ' HB1' ' CD1' ' A' ' 83' ' ' LEU . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CE2' HG13 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.417 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD13 ' CE1' ' A' ' 163' ' ' HIS . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.434 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.427 ' CG2' ' HG2' ' A' ' 43' ' ' LYS . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 85' ' ' THR . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' N ' HD23 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 75' ' ' LEU . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.494 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 1.7 t-20 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.487 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.459 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.419 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.506 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.473 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' CD1' ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.428 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.434 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 146' ' ' SER . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.514 HG23 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 32.3 p-80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.531 ' CD1' ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' VAL . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.511 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 6.5 m-70 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.477 ' CZ ' ' CD1' ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.463 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.429 ' CB ' HD12 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.431 ' CG ' HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.472 ' CG2' ' CG ' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.472 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' NH2' ' HB3' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.431 HG22 ' CB ' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.456 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 208' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.442 HG22 ' CE1' ' A' ' 54' ' ' TYR . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 HD11 ' CG ' ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.525 ' CG2' ' CD2' ' A' ' 196' ' ' HIS . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 34.1 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.676 0.274 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.484 ' HB ' ' N ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER 44.23 -178.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.481 0.657 . . . . 0.0 112.772 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.478 ' N ' ' OG1' ' A' ' 2' ' ' THR . 92.4 m -38.92 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.394 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 50.59 26.68 2.55 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.269 0.557 . . . . 0.0 109.883 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 162.96 -62.85 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.494 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' CA ' ' HB3' ' A' ' 199' ' ' LYS . . . -168.03 -65.42 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' CD1' ' CD1' ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 54' ' ' TYR . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HD3' ' CG2' ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.478 ' CD2' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' CD1' ' O ' ' A' ' 19' ' ' GLU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' NH2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.437 ' CB ' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.506 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.425 ' HD3' ' CG ' ' A' ' 77' ' ' GLU . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 83' ' ' LEU . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 86' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.408 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HD2' ' CD2' ' A' ' 15' ' ' HIS . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 2.1 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' CE ' ' CB ' ' A' ' 34' ' ' LEU . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 ' CG1' ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 ' CG2' HG12 ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 59' ' ' ALA . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' N ' ' CD1' ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.522 HG12 ' CE2' ' A' ' 60' ' ' PHE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 139' ' ' ARG . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.449 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.481 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 120' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' HD1' ' O ' ' A' ' 115' ' ' GLN . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.491 ' HA ' ' NH1' ' A' ' 121' ' ' ARG . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' CB ' ' A' ' 122' ' ' SER . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.481 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 131' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 136' ' ' THR . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' N ' ' HD2' ' A' ' 142' ' ' PRO . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.526 ' CE1' ' CG2' ' A' ' 147' ' ' THR . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.523 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.523 ' CG1' ' HA ' ' A' ' 144' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.638 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 3.9 p-80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.526 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 152' ' ' ILE . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' C ' ' HB ' ' A' ' 2' ' ' THR . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.517 ' CG2' ' CD2' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.645 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.473 ' CD1' ' CD1' ' A' ' 10' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 172' ' ' MET . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.445 ' CB ' HG12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 172' ' ' MET . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.48 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.44 HD21 ' CG ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.445 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.475 ' CZ ' ' CD1' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.475 ' CD1' ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.434 ' CG2' ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 209' ' ' ILE . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.438 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.441 ' CD1' ' CA ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.523 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 2.7 t-160 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.443 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.485 ' HB3' ' CA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.523 ' CG2' ' CD2' ' A' ' 196' ' ' HIS . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.482 ' CG ' ' CE2' ' A' ' 195' ' ' TYR . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' CA ' ' CD1' ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.435 ' ND2' ' CG1' ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.426 ' CB ' ' HA ' ' A' ' 8' ' ' ASN . 12.4 t -54.37 167.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.034 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 3' ' ' THR . 78.8 m -94.07 23.25 5.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.55 101.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 174.23 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.453 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.492 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -146.03 -69.71 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.299 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 197' ' ' LEU . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 195' ' ' TYR . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.407 ' CE1' ' NH1' ' A' ' 66' ' ' ARG . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 1.3 t30 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.424 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 41' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 11' ' ' VAL . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 HG21 ' CG1' ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 163' ' ' HIS . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.436 ' N ' ' HG3' ' A' ' 65' ' ' GLN . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' N ' HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' N ' ' CD2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.439 ' CE1' ' CZ ' ' A' ' 94' ' ' ARG . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.506 ' CD1' ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.493 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.405 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.506 ' CH2' ' CD1' ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.444 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.445 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 122' ' ' SER . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.506 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.459 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' CD2' ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.444 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 148' ' ' ILE . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.426 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 11.4 p-80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.52 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.554 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.477 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 10.8 m-70 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.444 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 121' ' ' ARG . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.466 ' N ' ' CG2' ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.429 ' N ' ' HG3' ' A' ' 172' ' ' MET . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.476 HD22 ' CE1' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.491 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.422 HG11 ' CG ' ' A' ' 121' ' ' ARG . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 186' ' ' GLU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.461 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.505 ' CG2' ' CE2' ' A' ' 195' ' ' TYR . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 54' ' ' TYR . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.436 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 196' ' ' HIS . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.457 ' OE1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HA ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.83 0.348 . . . . 0.0 111.253 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -52.78 109.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -71.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 0.2 OUTLIER -71.96 -177.54 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.822 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.78 63.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.258 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.474 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -154.61 -67.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.352 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 13' ' ' THR . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.407 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.473 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.8 t30 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HD3' ' CE3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.571 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.519 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CE2' ' CG1' ' A' ' 148' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.438 ' CG2' ' HB2' ' A' ' 71' ' ' CYS . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' N ' HG22 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.507 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' CD1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' O ' ' NH1' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.483 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 HD12 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.449 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 111' ' ' TRP . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.489 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.442 ' CD1' HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.453 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 HD23 ' NH1' ' A' ' 168' ' ' ARG . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.446 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.548 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.503 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.429 ' N ' HG13 ' A' ' 152' ' ' ILE . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.477 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.474 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 6.2 m-70 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.402 ' CB ' ' OE2' ' A' ' 93' ' ' GLU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 164' ' ' GLY . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' HA ' ' CE ' ' A' ' 172' ' ' MET . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.426 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.45 ' CE ' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.49 ' CG ' ' HB ' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.49 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.436 HG23 ' CG ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.428 ' N ' ' HG3' ' A' ' 184' ' ' LYS . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 193' ' ' ILE . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.467 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.467 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 207' ' ' GLU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.467 ' CD2' ' HB2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.439 HD11 ' CD1' ' A' ' 174' ' ' LEU . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.417 ' N ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.482 ' CD1' ' HG2' ' A' ' 175' ' ' GLU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 209' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 192' ' ' PRO . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.423 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.427 ' HB ' ' CA ' ' A' ' 156' ' ' GLU . 1.2 t -39.61 143.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.947 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -168.2 37.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.737 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 72.2 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.64 90.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.02 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . 175.41 179.13 0.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD23 ' CE2' ' A' ' 54' ' ' TYR . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 195' ' ' TYR . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' CD2' ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.479 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HD3' ' NZ ' ' A' ' 30' ' ' LYS . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.583 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 148' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 12.4 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.448 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' N ' HG23 ' A' ' 74' ' ' ILE . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 73' ' ' ILE . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 59' ' ' ALA . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.433 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.504 ' HG ' ' CE2' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 131' ' ' GLU . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.487 ' CD2' ' CZ3' ' A' ' 111' ' ' TRP . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.487 ' CZ3' ' CD2' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.464 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.448 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.424 ' CB ' HG21 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.494 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.522 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.418 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.48 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.504 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.521 HG22 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.57 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.521 ' CE1' HG22 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 151' ' ' HIS . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 153' ' ' LEU . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.427 ' CA ' ' HB ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.583 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.462 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.482 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 4.2 m-70 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.401 ' CB ' ' OE2' ' A' ' 93' ' ' GLU . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.449 ' CE ' ' CG2' ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.435 ' CB ' HD12 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.472 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 182' ' ' ILE . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.494 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.449 ' CG2' ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.439 ' N ' HG22 ' A' ' 182' ' ' ILE . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.534 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.474 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 194' ' ' VAL . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.455 HG22 ' CE2' ' A' ' 54' ' ' TYR . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.476 ' CD1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' N ' ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.4 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.423 ' N ' HD22 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.428 ' CG ' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.428 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 156' ' ' GLU . 48.9 p 45.78 -91.25 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.473 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 166.6 -64.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.842 0.353 . . . . 0.0 110.733 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -131.05 -74.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.34 35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.373 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . -158.12 -56.33 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.494 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 12' ' ' LEU . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' A' ' 54' ' ' TYR . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' CB ' HD21 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' OE2' ' CB ' ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.423 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.425 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' CD1' HD12 ' A' ' 73' ' ' ILE . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD11 ' CE1' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' CG2' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 ' CG2' ' CB ' ' A' ' 71' ' ' CYS . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD11 ' NH2' ' A' ' 66' ' ' ARG . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.551 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 39' ' ' ILE . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 HG13 ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.503 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.428 ' OG1' ' CD1' ' A' ' 75' ' ' LEU . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' NZ ' ' CG2' ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.449 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.566 ' CD2' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.505 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.566 ' CZ2' ' CD2' ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.473 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.424 ' HB3' HG12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.491 ' CE1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.427 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.534 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.546 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.413 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 136' ' ' THR . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.533 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.532 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.477 ' CG2' HG22 ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.446 ' HB ' HD23 ' A' ' 12' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 13' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.43 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 82.9 m-20 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.476 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 202' ' ' LYS . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH2' ' CD2' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HD3' ' A' ' 185' ' ' ARG . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.446 ' CD2' ' NH2' ' A' ' 185' ' ' ARG . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.439 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 209' ' ' ILE . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 208' ' ' LEU . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.439 ' O ' ' CG1' ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 203' ' ' TYR . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' A' ' 206' ' ' LYS . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HA ' ' HG2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.37 0.128 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -64.33 -53.79 43.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.164 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 2' ' ' THR . 0.5 OUTLIER 58.32 144.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.79 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 73.76 155.25 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.44 ' HB3' HD23 ' A' ' 153' ' ' LEU . . . -90.54 64.72 5.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.375 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.584 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . -155.08 -73.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 197' ' ' LEU . 32.8 m-20 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.627 HG23 ' CZ ' ' A' ' 54' ' ' TYR . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.556 ' HG3' ' CD1' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 30.1 p80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.458 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HE2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.431 ' N ' HG21 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD21 ' OG1' ' A' ' 70' ' ' THR . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' C ' HD13 ' A' ' 39' ' ' ILE . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 42' ' ' ALA . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 39' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CZ ' HG23 ' A' ' 11' ' ' VAL . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.699 ' CE1' ' CB ' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.669 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.58 ' CG2' ' CB ' ' A' ' 71' ' ' CYS . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 29' ' ' TRP . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' CZ ' HG22 ' A' ' 27' ' ' THR . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.2 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' HD21 ' A' ' 34' ' ' LEU . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.58 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 26.2 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 77' ' ' GLU . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' ILE . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.661 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HE2' ' OG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.653 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 143' ' ' TYR . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.551 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' CD1' ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.725 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.582 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.725 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.685 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.572 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.723 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.523 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.534 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.572 ' CD1' ' CD1' ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.723 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.463 ' N ' ' OG ' ' A' ' 132' ' ' SER . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.525 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.719 ' O ' ' N ' ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.509 ' CB ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.719 ' N ' ' O ' ' A' ' 136' ' ' THR . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.631 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.653 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.657 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.513 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 147' ' ' THR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.681 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.698 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.681 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.499 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.596 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.561 HG23 ' NE2' ' A' ' 151' ' ' HIS . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.699 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.555 ' CD1' HD23 ' A' ' 10' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 4.1 t30 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' CD1' ' HG3' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.61 ' CD ' ' NH1' ' A' ' 185' ' ' ARG . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 172' ' ' MET . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' A' ' 141' ' ' LEU . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.522 ' N ' ' SD ' ' A' ' 172' ' ' MET . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HG ' ' CD1' ' A' ' 182' ' ' ILE . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.534 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.517 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.61 ' NH1' ' CD ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.544 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.559 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.559 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.574 ' CG1' ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.491 ' O ' ' CD1' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.479 ' C ' ' CG1' ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 8' ' ' ASN . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.473 ' C ' ' CD2' ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 197' ' ' LEU . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.528 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' CB ' ' HG2' ' A' ' 157' ' ' LYS . 11.0 tpt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.507 0.194 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.446 ' CB ' ' HA ' ' A' ' 8' ' ' ASN . 1.6 t -57.7 86.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.833 0.349 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.5 t -94.31 -28.42 15.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.008 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.46 -21.98 11.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.043 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 74.56 33.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -150.3 -70.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.42 HD13 ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 54' ' ' TYR . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 159' ' ' LEU . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.42 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.473 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' CD ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HB ' ' CG1' ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 HD11 ' CE1' ' A' ' 163' ' ' HIS . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 1.4 pp0? -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' HD2' ' ND1' ' A' ' 15' ' ' HIS . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.458 HD13 ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 85' ' ' THR . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' N ' HD21 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 75' ' ' LEU . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG12 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.468 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 HD13 ' CE2' ' A' ' 26' ' ' PHE . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 41.8 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 107' ' ' ALA . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 9.0 t-20 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.451 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.422 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.421 ' CB ' HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD13 ' CB ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.434 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.501 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.501 ' CG1' ' HA ' ' A' ' 137' ' ' ALA . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.524 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.531 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.531 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 8.5 p-80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 2' ' ' THR . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' O ' ' CG2' ' A' ' 2' ' ' THR . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.554 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.48 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 5.2 m-70 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.473 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HA ' ' CG2' ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.415 ' HB2' ' CB ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.447 ' CG2' ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.446 ' HG3' ' N ' ' A' ' 173' ' ' ASP . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 172' ' ' MET . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.481 HD22 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.441 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.423 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.447 ' CD ' ' CG2' ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.475 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.475 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.429 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 12' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' O ' ' CG2' ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 203' ' ' TYR . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 202' ' ' LYS . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.431 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.416 ' CG ' HD12 ' A' ' 193' ' ' ILE . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.435 HD11 ' CG2' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.433 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.421 ' HA ' ' NH1' ' A' ' 48' ' ' ARG . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.775 0.321 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.431 ' CB ' ' HA ' ' A' ' 8' ' ' ASN . 3.4 t -68.95 111.33 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -114.43 23.11 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.98 14.53 7.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.285 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.5 26.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.659 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.496 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -131.96 -71.97 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.548 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.431 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 0.3 OUTLIER -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 54' ' ' TYR . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.493 ' CE3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.493 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' CD1' HD13 ' A' ' 73' ' ' ILE . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.482 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.533 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.48 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.519 ' CE2' ' CD1' ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.431 HD13 ' CD1' ' A' ' 39' ' ' ILE . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' N ' HG21 ' A' ' 74' ' ' ILE . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.502 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 84' ' ' GLU . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.444 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD21 ' N ' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.423 ' N ' HD21 ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.459 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.43 ' CB ' ' CG2' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.43 ' CG2' ' CB ' ' A' ' 122' ' ' SER . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' THR . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.465 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 8.6 p-80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.535 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.427 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.538 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 10' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.47 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.47 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 174' ' ' LEU . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.451 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.446 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.423 ' N ' ' HG3' ' A' ' 172' ' ' MET . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 170' ' ' LEU . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.429 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.471 ' NE ' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 191' ' ' VAL . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.408 ' CG ' ' HB2' ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.488 HG13 ' CE2' ' A' ' 54' ' ' TYR . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.476 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.465 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 174' ' ' LEU . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.643 0.259 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 156' ' ' GLU . 3.7 t -43.2 127.78 4.46 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.83 -72.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -68.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.51 -51.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -64.82 -65.61 1.87 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 3.4 t30 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' A' ' 160' ' ' ILE . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' ' CE1' ' A' ' 54' ' ' TYR . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 195' ' ' TYR . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.429 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.499 ' CE3' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 23' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 t30 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' ' CE3' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.499 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 69' ' ' LYS . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 73' ' ' ILE . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ARG . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 44' ' ' LEU . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 192' ' ' PRO . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.443 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' CYS . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 10.4 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' N ' HG23 ' A' ' 74' ' ' ILE . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.502 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 75' ' ' LEU . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.436 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 108' ' ' ARG . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.427 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.478 ' CD1' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.455 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.512 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.523 ' CE1' ' CE ' ' A' ' 172' ' ' MET . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.478 ' CG2' ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 141' ' ' LEU . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.447 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 88' ' ' SER . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 148' ' ' ILE . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.433 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.477 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.516 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 1.6 p-80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.453 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' VAL . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 182' ' ' ILE . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.426 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 172' ' ' MET . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.475 HD23 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.43 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.438 HD13 ' CD2' ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.433 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.433 HG23 ' CB ' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.449 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 12' ' ' LEU . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.0 OUTLIER -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 8' ' ' ASN . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.416 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 196' ' ' HIS . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 8.9 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.761 0.315 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 156' ' ' GLU . 2.6 t -46.11 147.28 1.09 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 t -93.08 -0.29 57.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER 64.0 87.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 4' ' ' GLU . . . 168.27 -58.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.428 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.566 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -144.54 -72.12 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 197' ' ' LEU . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 160' ' ' ILE . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 56' ' ' PHE . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.509 ' O ' ' CG2' ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.418 ' CE3' ' NZ ' ' A' ' 30' ' ' LYS . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 2.0 t30 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' HB3' ' CE ' ' A' ' 69' ' ' LYS . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.701 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 35' ' ' SER . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.701 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' HE3' ' OE1' ' A' ' 77' ' ' GLU . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 54' ' ' TYR . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.561 ' CG2' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 1.7 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 22.2 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 42' ' ' ALA . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 74' ' ' ILE . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.693 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.544 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.512 HG23 ' NZ ' ' A' ' 87' ' ' LYS . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.604 ' N ' ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.566 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.578 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.546 ' CB ' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD1' ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' C ' ' CD1' ' A' ' 102' ' ' LEU . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 109' ' ' LYS . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.519 ' N ' HD13 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.513 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 108' ' ' ARG . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.491 ' CA ' HG23 ' A' ' 116' ' ' VAL . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.562 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 121' ' ' ARG . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.6 ' O ' ' CB ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.622 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 123' ' ' TYR . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.561 ' HB3' ' O ' ' A' ' 122' ' ' SER . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.522 HD13 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.622 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.504 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.44 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 140' ' ' VAL . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 141' ' ' LEU . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 136' ' ' THR . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.574 ' CD1' HG21 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.574 HG21 ' CD1' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.655 ' CG1' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.635 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 199' ' ' LYS . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.666 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.61 ' CG2' ' NE2' ' A' ' 151' ' ' HIS . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.578 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.546 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 171' ' ' ILE . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 121' ' ' ARG . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.523 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.518 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' HG3' ' CD1' ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 179' ' ' GLY . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.525 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.499 ' CG1' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.477 ' NH1' ' OH ' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.539 ' CD2' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.525 HG23 ' CB ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.481 ' C ' ' CD1' ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.569 ' CE1' HD11 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 205' ' ' SER . 2.3 t60 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.454 ' O ' HD21 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 202' ' ' LYS . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.475 HD21 ' N ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 3.6 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' THR . 25.8 mtp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 156' ' ' GLU . 7.2 p 37.24 -153.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.6 m -141.45 -59.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 5' ' ' ALA . 8.7 pt-20 -137.78 22.1 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 4' ' ' GLU . . . 85.98 -53.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.532 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . . . -52.29 -67.75 0.5 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.292 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.514 ' N ' HD11 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 54' ' ' TYR . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HG ' ' CE2' ' A' ' 195' ' ' TYR . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 192' ' ' PRO . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.507 ' CB ' ' HG2' ' A' ' 66' ' ' ARG . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 16' ' ' GLY . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.512 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.707 ' CH2' ' HG2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 2.3 t30 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.67 ' CG2' ' CH2' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' CA ' ' HB2' ' A' ' 96' ' ' TYR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.521 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.707 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 16' ' ' GLY . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 41' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 ' N ' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 HD12 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' NH1' ' ND2' ' A' ' 211' ' ' ASN . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.61 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.758 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.611 ' CG2' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CZ ' ' CG1' ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.458 HD11 ' CE1' ' A' ' 163' ' ' HIS . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HG2' ' CB ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 61' ' ' THR . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 3.7 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 66' ' ' ARG . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' A' ' 69' ' ' LYS . 34.6 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.585 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' CD1' HD12 ' A' ' 83' ' ' LEU . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.73 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.73 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.516 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HB2' ' CG2' ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 120' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.575 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.541 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.515 ' CB ' HG21 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.536 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.497 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.558 ' CG ' ' N ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.525 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.542 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.542 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.688 ' O ' ' N ' ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.578 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.688 ' N ' ' O ' ' A' ' 136' ' ' THR . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.66 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.607 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.697 ' CG1' ' CZ ' ' A' ' 60' ' ' PHE . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.66 ' CE1' ' CG2' ' A' ' 148' ' ' ILE . 0.9 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' HA2' HG23 ' A' ' 2' ' ' THR . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.605 ' OE1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.611 HG22 ' CG2' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.758 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.492 ' CD1' HD23 ' A' ' 12' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.525 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.502 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 2.4 m120 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.433 ' CB ' ' HB1' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.473 HD11 ' HA2' ' A' ' 164' ' ' GLY . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.511 ' HB1' ' N ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.518 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.576 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.536 ' O ' ' CD1' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.553 ' HD2' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.489 HD23 ' CG2' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.485 ' HG2' HD12 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.49 ' O ' ' CD1' ' A' ' 195' ' ' TYR . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.566 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.49 ' O ' ' CG2' ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' ASN . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 6' ' ' ALA . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 198' ' ' ASP . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 202' ' ' LYS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.824 0.345 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 8' ' ' ASN . 6.1 t -48.84 177.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 14.1 t -92.54 21.26 5.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.503 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 3' ' ' THR . 6.8 pm0 56.15 155.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.811 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 40.87 33.23 0.2 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.806 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.454 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -156.4 178.35 1.71 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.192 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 198' ' ' ASP . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 ' CD1' ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG22 ' CE1' ' A' ' 54' ' ' TYR . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 HD12 ' CE1' ' A' ' 195' ' ' TYR . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 192' ' ' PRO . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.429 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.409 HD12 ' CD2' ' A' ' 34' ' ' LEU . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' LEU . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.439 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 84' ' ' GLU . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 158' ' ' VAL . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.464 ' CZ ' ' CG ' ' A' ' 32' ' ' PRO . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.415 ' HA ' HG22 ' A' ' 74' ' ' ILE . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 77' ' ' GLU . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 74' ' ' ILE . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.503 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.48 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.536 ' CD2' ' CZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.426 ' N ' HD13 ' A' ' 102' ' ' LEU . 5.8 t-20 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.428 ' CA ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.577 ' CD1' ' CG1' ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.571 ' CB ' ' CD1' ' A' ' 119' ' ' TRP . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 15.1 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.47 ' CZ ' ' NH1' ' A' ' 120' ' ' ARG . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CE1' ' HE2' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.436 ' CD1' HD13 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.458 ' O ' ' CZ3' ' A' ' 119' ' ' TRP . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.424 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 137' ' ' ALA . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.598 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.427 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.53 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 144' ' ' TYR . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 152' ' ' ILE . 15.5 p-80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.518 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 4' ' ' GLU . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.539 HG12 ' CE2' ' A' ' 60' ' ' PHE . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.458 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CE1' HD11 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.434 ' HB3' ' N ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.481 ' HE2' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' NH2' ' HB3' ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD2' HG23 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.474 ' CB ' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.474 ' CG2' ' CB ' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.452 ' O ' ' CD1' ' A' ' 209' ' ' ILE . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 208' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.45 ' CG2' HG21 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.436 ' CE1' HD12 ' A' ' 12' ' ' LEU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.487 ' CE1' ' CD1' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.424 ' O ' ' CD2' ' A' ' 174' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.432 HG21 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 194' ' ' VAL . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' ILE . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' CZ ' ' A' ' 54' ' ' TYR . 12.3 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.726 0.298 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.0 p -44.86 157.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p -103.18 -81.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.1 -78.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.509 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -162.59 -69.5 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.241 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.3 OUTLIER -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.423 HG23 ' CD1' ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 190' ' ' GLY . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.461 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.427 ' ND2' ' HE3' ' A' ' 104' ' ' LYS . 8.9 t-20 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.466 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.427 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' GLU . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 73' ' ' ILE . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' NZ ' HG21 ' A' ' 73' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.513 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.579 ' CD1' ' NZ ' ' A' ' 157' ' ' LYS . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' CA ' HD22 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 60' ' ' PHE . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HG23 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD13 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.489 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.489 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' HG21 ' A' ' 74' ' ' ILE . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.434 HG21 ' NZ ' ' A' ' 43' ' ' LYS . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' N ' HG23 ' A' ' 74' ' ' ILE . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD22 ' CA ' ' A' ' 57' ' ' ASP . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.447 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 33.5 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HE3' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' CG1' ' A' ' 116' ' ' VAL . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.44 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.472 ' CD1' ' CG2' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.496 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.437 ' CE2' ' CE ' ' A' ' 172' ' ' MET . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.472 ' CG2' ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.427 ' N ' HG22 ' A' ' 125' ' ' ILE . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.444 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.457 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 136' ' ' THR . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 146' ' ' SER . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 143' ' ' TYR . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.5 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.463 HG21 ' CD2' ' A' ' 151' ' ' HIS . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.579 ' NZ ' ' CD1' ' A' ' 56' ' ' PHE . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' VAL . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.486 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 168' ' ' ARG . 79.9 m-20 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CG ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.448 HG23 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.418 ' HG3' ' CG2' ' A' ' 178' ' ' THR . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.44 HD13 ' CG ' ' A' ' 185' ' ' ARG . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.448 ' CZ ' HG23 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.405 HD13 ' HD2' ' A' ' 14' ' ' ARG . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.417 ' HB2' ' CD1' ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.469 ' CD1' HG12 ' A' ' 209' ' ' ILE . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 54' ' ' TYR . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.48 ' CE1' HD12 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 10' ' ' LEU . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.431 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.46 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.757 0.313 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -42.17 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.354 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -108.31 -34.5 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -127.33 -178.18 4.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.685 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.24 47.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.488 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -159.57 -68.4 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.212 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 54' ' ' TYR . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.486 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.502 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.432 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' CD2' HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 73' ' ' ILE . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' CG ' ' CA ' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD23 ' CD ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 11' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.595 ' CD2' ' HE3' ' A' ' 157' ' ' LYS . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.519 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.486 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.459 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.444 ' O ' ' N ' ' A' ' 77' ' ' GLU . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG12 ' CA ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG2' HD12 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' CB ' ' ND2' ' A' ' 165' ' ' ASN . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.447 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.443 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.495 ' CD1' ' CH2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.443 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 102' ' ' LEU . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 113' ' ' ALA . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.524 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.445 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.5 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.435 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG22 ' CB ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 132' ' ' SER . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.426 HD13 ' CB ' ' A' ' 168' ' ' ARG . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.463 ' CE ' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.463 ' N ' ' CE ' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.42 ' O ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 136' ' ' THR . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.484 HG22 ' CD1' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.519 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 148' ' ' ILE . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.453 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.439 ' CD1' ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' A' ' 15' ' ' HIS . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.462 ' ND2' ' CB ' ' A' ' 94' ' ' ARG . 4.1 t30 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.435 ' CB ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.431 ' CD2' HG21 ' A' ' 160' ' ' ILE . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.517 ' CG1' ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.486 HD13 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' O ' ' CE1' ' A' ' 203' ' ' TYR . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.475 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.44 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.471 ' HB ' ' CG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.432 ' N ' ' CG2' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.49 ' CD ' ' CG2' ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 188' ' ' ALA . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.436 ' CA ' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.427 ' HB2' ' CG1' ' A' ' 11' ' ' VAL . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 207' ' ' GLU . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.517 ' CE2' ' CG1' ' A' ' 171' ' ' ILE . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.477 ' CD2' ' HB2' ' A' ' 7' ' ' PRO . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.438 HD21 ' N ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.436 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.438 ' N ' HD21 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.444 ' HB2' HG13 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 193' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 1.2 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 8' ' ' ASN . 1.6 t -80.87 172.69 13.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.402 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -177.8 132.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.94 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.14 56.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.88 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -167.44 178.77 1.08 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 152' ' ' ILE . 2.1 m120 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 196' ' ' HIS . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 197' ' ' LEU . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 167' ' ' LEU . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.477 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.524 ' CE3' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' CG ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' O ' ' CE3' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.413 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' CD1' ' HG2' ' A' ' 66' ' ' ARG . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 41' ' ' GLU . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.4 HD12 ' CD1' ' A' ' 73' ' ' ILE . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' CD1' ' CB ' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' HG3' ' A' ' 157' ' ' LYS . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 159' ' ' LEU . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD11 ' CE1' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 69' ' ' LYS . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.46 ' CD1' ' CG2' ' A' ' 85' ' ' THR . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.47 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 56' ' ' PHE . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' ALA . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.46 ' CG2' ' CD1' ' A' ' 75' ' ' LEU . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 139' ' ' ARG . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD23 ' CB ' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.441 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 111' ' ' TRP . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.529 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 117' ' ' GLN . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.45 ' CB ' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.495 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.529 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.431 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.529 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.536 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CE1' HG21 ' A' ' 148' ' ' ILE . 15.9 p-80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.469 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.436 ' CD2' HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 3' ' ' THR . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 2' ' ' THR . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 60' ' ' PHE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.46 ' CE1' HD11 ' A' ' 64' ' ' LEU . 5.5 m-70 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 4.0 t30 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 12' ' ' LEU . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.453 ' O ' ' CB ' ' A' ' 172' ' ' MET . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 172' ' ' MET . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.42 ' CD1' HD23 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.424 HG22 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.453 ' CB ' ' O ' ' A' ' 168' ' ' ARG . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.461 HD12 ' CZ ' ' A' ' 144' ' ' TYR . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' HG2' ' CE1' ' A' ' 203' ' ' TYR . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.424 ' CD ' HG22 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 209' ' ' ILE . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.444 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 207' ' ' GLU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.411 ' OD2' ' CG1' ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.444 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.484 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 195' ' ' TYR . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.411 ' OD1' ' NE ' ' A' ' 48' ' ' ARG . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.661 0.267 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.878 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 194' ' ' VAL . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD21 HD11 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.88 ' C ' HD23 ' A' ' 12' ' ' LEU . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.88 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' THR . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.441 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CD ' HG21 ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.447 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.401 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 t-20 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 39' ' ' ILE . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.566 HG21 ' CD ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 34' ' ' LEU . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 44' ' ' LEU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.762 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HG21 ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 159' ' ' LEU . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' C ' HD11 ' A' ' 83' ' ' LEU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.972 HG22 HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.626 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.851 ' CD2' HD11 ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.055 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.697 HD12 ' NE2' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 3.1 tt0 -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.46 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.551 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD11 ' C ' ' A' ' 57' ' ' ASP . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.612 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.723 ' HB3' HD12 ' A' ' 91' ' ' LEU . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.719 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.613 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 127' ' ' PRO . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.613 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 54.5 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.634 ' N ' HD23 ' A' ' 102' ' ' LEU . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 102' ' ' LEU . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.783 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.589 ' CH2' HD22 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.845 ' CD1' HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.469 ' CG ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' HG22 ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.942 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' HD11 ' A' ' 99' ' ' LEU . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.687 HD12 ' ND2' ' A' ' 165' ' ' ASN . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.876 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 90' ' ' LYS . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.688 HG21 ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.665 HG23 ' NE2' ' A' ' 151' ' ' HIS . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 158' ' ' VAL . 13.6 p80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 148' ' ' ILE . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.621 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 151' ' ' HIS . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.644 HD11 HD21 ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 1.055 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.762 ' O ' HD12 ' A' ' 167' ' ' LEU . 4.0 m80 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.687 ' ND2' HD12 ' A' ' 133' ' ' LEU . 8.8 t-20 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 181' ' ' GLN . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.954 ' CB ' HG22 ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.549 ' HB ' HD23 ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 122' ' ' SER . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.538 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.515 ' CG2' ' HB1' ' A' ' 188' ' ' ALA . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.472 ' C ' HD11 ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.931 HD12 ' HG2' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.579 HG22 HG22 ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.864 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.586 HD11 HD22 ' A' ' 174' ' ' LEU . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.756 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.754 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.537 ' C ' HD13 ' A' ' 197' ' ' LEU . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 204' ' ' VAL . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.539 ' N ' HD22 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.931 ' HG2' HD12 ' A' ' 193' ' ' ILE . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.718 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 29.3 t30 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.699 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 120.774 0.321 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.699 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD11 ' CG2' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.644 ' C ' HD23 ' A' ' 12' ' ' LEU . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.849 ' CG2' HD21 ' A' ' 159' ' ' LEU . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.406 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CD ' HG21 ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' CB ' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE2' HD23 ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 39' ' ' ILE . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.501 HG21 ' CD ' ' A' ' 17' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 34' ' ' LEU . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.933 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.909 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.81 ' CE1' HD12 ' A' ' 86' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.054 HG22 ' HB3' ' A' ' 161' ' ' ALA . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.7 mt-30 -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 69' ' ' LYS . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.718 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.867 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.75 ' HB3' HD12 ' A' ' 91' ' ' LEU . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.857 ' O ' HG22 ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.641 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.008 HD23 ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 3.8 t30 -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.924 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.497 ' CB ' HG23 ' A' ' 116' ' ' VAL . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 118' ' ' ILE . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.924 HG21 ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.447 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.488 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.633 HD13 ' CG ' ' A' ' 173' ' ' ASP . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.643 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.725 HG21 ' CE1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 60' ' ' PHE . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.554 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.649 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.909 HG13 ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.933 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 170' ' ' LEU . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.722 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.942 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.2 m80 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.801 ' HB3' HD11 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.719 HD21 HG11 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.633 ' CG ' HD13 ' A' ' 141' ' ' LEU . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.643 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.641 ' OE1' HD21 ' A' ' 177' ' ' LEU . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.856 HD12 ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 178' ' ' THR . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.89 ' HB2' HG22 ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 178' ' ' THR . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.746 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.746 HD23 ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.698 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.698 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.499 ' HB2' HG11 ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.583 ' N ' HD11 ' A' ' 209' ' ' ILE . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.648 HD23 ' CA ' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.739 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.84 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.648 ' CA ' HD23 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.448 ' CG ' HD11 ' A' ' 193' ' ' ILE . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 194' ' ' VAL . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 191' ' ' VAL . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.484 ' H ' HG22 ' A' ' 209' ' ' ILE . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.62 0.248 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' ND2' ' HA2' ' A' ' 155' ' ' GLY . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.653 ' C ' HD23 ' A' ' 12' ' ' LEU . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.692 HG22 HD21 ' A' ' 159' ' ' LEU . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.682 HH11 HG22 ' A' ' 189' ' ' THR . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.549 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.63 ' N ' HG22 ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.722 ' OD2' HD23 ' A' ' 64' ' ' LEU . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLU . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.722 ' HB2' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.633 ' CE2' HG21 ' A' ' 11' ' ' VAL . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.732 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.806 ' CZ ' HG23 ' A' ' 148' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.967 HG21 ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.722 HD23 ' OD2' ' A' ' 31' ' ' ASP . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 9.0 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 15' ' ' HIS . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.967 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 43' ' ' LYS . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.727 HD13 HG21 ' A' ' 85' ' ' THR . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 50' ' ' LYS . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.462 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.936 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.872 HD22 ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 105' ' ' ASP . 22.8 t30 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HG2' ' CE ' ' A' ' 109' ' ' LYS . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.872 ' CH2' HD22 ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.501 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 112' ' ' GLY . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.992 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' HG12 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.513 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.503 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.992 HD13 HD11 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HB3' HD11 ' A' ' 99' ' ' LEU . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 133' ' ' LEU . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.425 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 132' ' ' SER . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.925 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 90' ' ' LYS . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.897 ' CE1' HD11 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.989 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.561 HG22 ' HD1' ' A' ' 143' ' ' TYR . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.897 HD11 ' CE1' ' A' ' 143' ' ' TYR . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 145' ' ' LYS . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.592 HG21 ' HE2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 160' ' ' ILE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.897 ' N ' HD23 ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.946 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.728 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.637 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.479 ' N ' HG23 ' A' ' 171' ' ' ILE . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.925 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 197' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.825 HG22 ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.825 ' CB ' HG22 ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 178' ' ' THR . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.424 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.637 ' HD2' HG21 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 187' ' ' LEU . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 193' ' ' ILE . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.887 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.682 HG22 HH11 ' A' ' 14' ' ' ARG . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.887 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.64 ' HG3' HD12 ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 187' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.477 ' N ' HG22 ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.528 ' C ' HD22 ' A' ' 197' ' ' LEU . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 174' ' ' LEU . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.698 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.745 ' C ' HD13 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.592 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.862 ' HB3' HG13 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 194' ' ' VAL . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 211' ' ' ASN . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.522 ' N ' HG22 ' A' ' 209' ' ' ILE . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.595 HD21 HD11 ' A' ' 197' ' ' LEU . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.672 HD11 ' NE2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 HD12 ' A' ' 160' ' ' ILE . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 194' ' ' VAL . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD22 HD23 ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.759 HG21 HD21 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.669 ' HD3' HG22 ' A' ' 189' ' ' THR . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 25' ' ' LEU . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.853 HG23 ' HE2' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.934 HD23 HD13 ' A' ' 39' ' ' ILE . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.578 HG21 ' OE1' ' A' ' 17' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.934 HD13 HD23 ' A' ' 34' ' ' LEU . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HZ3' HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.537 HD11 HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.604 ' CE1' HG21 ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.087 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.812 ' HB ' HG22 ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.681 ' CZ ' HG23 ' A' ' 147' ' ' THR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 HH21 ' A' ' 66' ' ' ARG . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 6.0 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.58 HH21 HD22 ' A' ' 64' ' ' LEU . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 5.1 mt-30 -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.583 HD21 HD23 ' A' ' 83' ' ' LEU . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.528 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.583 HD23 HD21 ' A' ' 75' ' ' LEU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.89 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.915 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.647 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.788 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HG ' HD12 ' A' ' 102' ' ' LEU . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.792 ' CH2' HD11 ' A' ' 99' ' ' LEU . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.841 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.506 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 108' ' ' ARG . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 123' ' ' TYR . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 1.021 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 90' ' ' LYS . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.915 ' CZ ' HD11 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.545 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.445 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.731 ' O ' HD13 ' A' ' 153' ' ' LEU . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' HG23 ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 149' ' ' VAL . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.812 HG22 ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.087 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.86 HD12 HD21 ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.723 ' O ' HD12 ' A' ' 167' ' ' LEU . 2.7 m80 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 136' ' ' THR . 6.3 t-20 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.994 HD23 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.499 ' O ' HG22 ' A' ' 171' ' ' ILE . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.021 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.81 HD13 HG12 ' A' ' 140' ' ' VAL . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 182' ' ' ILE . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.497 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.902 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.839 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 178' ' ' THR . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.902 ' HB3' HD12 ' A' ' 177' ' ' LEU . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 178' ' ' THR . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.819 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.669 HG22 ' HD3' ' A' ' 14' ' ' ARG . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.819 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.904 HD11 ' CB ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 11' ' ' VAL . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.621 ' OH ' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.672 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 t-80 -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.582 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 174' ' ' LEU . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.497 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.904 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.944 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.613 0.244 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.944 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 197' ' ' LEU . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 194' ' ' VAL . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.79 ' CG2' HD21 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' HA ' HG21 ' A' ' 70' ' ' THR . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 189' ' ' THR . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.552 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 25' ' ' LEU . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.552 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.657 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.657 ' N ' HG22 ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.441 HD13 ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HZ3' HG23 ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.767 HD12 ' CG ' ' A' ' 192' ' ' PRO . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.526 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.855 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CE2' HD11 ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' NH2' HG21 ' A' ' 27' ' ' THR . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 4.3 tt0 -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 15' ' ' HIS . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.59 HG23 ' HZ3' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.826 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 74' ' ' ILE . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 56' ' ' PHE . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.621 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.79 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 91' ' ' LEU . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.713 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 ' CH2' ' A' ' 111' ' ' TRP . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 48.0 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.823 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.704 ' CH2' HD11 ' A' ' 99' ' ' LEU . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.494 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.024 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.53 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.588 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.497 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.024 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.472 HD23 ' HD1' ' A' ' 123' ' ' TYR . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 90' ' ' LYS . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.682 ' CD2' HD11 ' A' ' 170' ' ' LEU . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.671 ' HE1' HG21 ' A' ' 158' ' ' VAL . 21.7 p80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.612 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 153' ' ' LEU . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.855 HG13 ' CG2' ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 13' ' ' THR . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 10' ' ' LEU . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 92' ' ' ASN . 3.5 m80 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' ' 136' ' ' THR . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 91' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HG2' ' HD2' ' A' ' 185' ' ' ARG . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.461 ' N ' HG23 ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 197' ' ' LEU . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.481 HD21 ' OE1' ' A' ' 175' ' ' GLU . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.838 HG22 ' HB3' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 178' ' ' THR . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.838 ' HB3' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.502 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 16' ' ' GLY . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.767 ' CG ' HD12 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.895 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 11' ' ' VAL . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 174' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.421 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.47 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.895 ' HB2' HD12 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 194' ' ' VAL . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.868 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.646 0.26 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 156' ' ' GLU . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.778 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.912 ' C ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.838 ' CG2' HD21 ' A' ' 159' ' ' LEU . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.843 ' HD3' HG22 ' A' ' 189' ' ' THR . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.64 ' OE1' HG21 ' A' ' 37' ' ' THR . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.765 HG23 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.765 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 HD13 ' A' ' 39' ' ' ILE . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' OE1' ' A' ' 17' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.661 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 78' ' ' VAL . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.577 ' OH ' HG23 ' A' ' 11' ' ' VAL . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.912 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.768 ' CG2' HG13 ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.469 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.582 HD13 HH21 ' A' ' 66' ' ' ARG . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.582 HH21 HD13 ' A' ' 64' ' ' LEU . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 85' ' ' THR . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 39' ' ' ILE . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.799 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 83' ' ' LEU . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 75' ' ' LEU . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' N ' HD22 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.754 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.841 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t30 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.632 ' HA ' HG11 ' A' ' 116' ' ' VAL . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 112' ' ' GLY . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.05 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.465 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.05 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 132' ' ' SER . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.841 ' CG ' HD22 ' A' ' 99' ' ' LEU . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.628 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.46 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 132' ' ' SER . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.929 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 145' ' ' LYS . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HA ' HD12 ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.507 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.705 HD13 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.912 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.795 HD13 HD23 ' A' ' 170' ' ' LEU . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 93' ' ' GLU . 3.8 m80 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.628 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.795 HD23 HD13 ' A' ' 160' ' ' ILE . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.929 ' OD1' HD21 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.706 ' HB2' HG22 ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 178' ' ' THR . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.472 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.843 HG22 ' HD3' ' A' ' 14' ' ' ARG . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.471 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.635 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 11' ' ' VAL . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.497 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.786 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.945 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 198' ' ' ASP . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.618 ' CG ' HD11 ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 209' ' ' ILE . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.709 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 194' ' ' VAL . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.797 ' C ' HD23 ' A' ' 12' ' ' LEU . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.924 ' HD3' HG22 ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.656 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.642 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.606 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HG3' HG22 ' A' ' 27' ' ' THR . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 39' ' ' ILE . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' OE1' ' A' ' 17' ' ' GLU . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 35' ' ' SER . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.886 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.694 HD13 ' CE1' ' A' ' 56' ' ' PHE . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.73 ' O ' HD23 ' A' ' 83' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.895 HG23 HG13 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.642 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 58' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' NH1' HG21 ' A' ' 27' ' ' THR . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 9.4 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 73' ' ' ILE . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 15' ' ' HIS . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HB2' HG21 ' A' ' 61' ' ' THR . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.886 HG23 ' NZ ' ' A' ' 43' ' ' LYS . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 83' ' ' LEU . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.529 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.966 ' N ' HD13 ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.84 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 140' ' ' VAL . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 88' ' ' SER . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 131' ' ' GLU . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.864 HD12 ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.642 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.788 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.536 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.48 ' O ' ' HD1' ' A' ' 119' ' ' TRP . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.788 HG21 ' HA ' ' A' ' 108' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.698 HG23 ' HD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.698 ' HD1' HG23 ' A' ' 118' ' ' ILE . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.582 HH21 HD22 ' A' ' 133' ' ' LEU . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 118' ' ' ILE . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.864 ' HB3' HD12 ' A' ' 99' ' ' LEU . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.582 HD22 HH21 ' A' ' 121' ' ' ARG . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.755 ' O ' HG23 ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.647 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 90' ' ' LYS . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.916 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 148' ' ' ILE . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.755 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 143' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 145' ' ' LYS . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 1.117 ' CE1' HG21 ' A' ' 158' ' ' VAL . 10.8 p80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 153' ' ' LEU . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.648 HD21 ' O ' ' A' ' 199' ' ' LYS . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' OE2' ' HB2' ' A' ' 151' ' ' HIS . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.117 HG21 ' CE1' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.766 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.942 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.855 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.653 HD12 ' C ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.647 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.554 HD13 HG12 ' A' ' 140' ' ' VAL . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.495 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.916 ' CG ' HD21 ' A' ' 141' ' ' LEU . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.774 HD22 HD11 ' A' ' 197' ' ' LEU . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.862 ' CD ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.431 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.719 ' H ' HG23 ' A' ' 178' ' ' THR . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.814 ' HB2' HG22 ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.926 ' CZ ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.902 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.841 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.924 HG22 ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.841 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.75 HG22 HG22 ' A' ' 11' ' ' VAL . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.613 ' O ' HG22 ' A' ' 204' ' ' VAL . 4.0 t-80 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.774 HD11 HD22 ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.648 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 198' ' ' ASP . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.5 ' HB2' HG23 ' A' ' 193' ' ' ILE . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.662 ' C ' HD13 ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 197' ' ' LEU . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD21 HD11 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.949 ' CG2' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HB3' HD13 ' A' ' 167' ' ' LEU . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.513 ' CG2' HD11 ' A' ' 159' ' ' LEU . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HD2' HD23 ' A' ' 187' ' ' LEU . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' HG21 ' A' ' 70' ' ' THR . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 37' ' ' THR . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.51 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.823 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD11 ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.777 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.418 HG21 ' OE1' ' A' ' 17' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.477 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 40' ' ' LYS . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.834 ' HB3' HD23 ' A' ' 49' ' ' LEU . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.006 HG22 HG13 ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 86' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.67 HD13 HH21 ' A' ' 66' ' ' ARG . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.67 HH21 HD13 ' A' ' 64' ' ' LEU . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 4.6 mt-30 -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 15' ' ' HIS . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.456 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 10.3 mp0 -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.845 HD13 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.798 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.742 ' HB3' HD13 ' A' ' 91' ' ' LEU . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.024 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD11 ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CH2' HD11 ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 108' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.459 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 126' ' ' ALA . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.619 ' HB3' HD13 ' A' ' 99' ' ' LEU . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.511 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.667 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.879 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.717 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.512 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.884 ' HE1' HG21 ' A' ' 158' ' ' VAL . 30.0 p80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.72 HG23 ' CE1' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.701 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.006 HG13 HG22 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.944 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.568 HD11 HD21 ' A' ' 10' ' ' LEU . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.598 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.024 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.654 ' CD2' ' HB2' ' A' ' 93' ' ' GLU . 6.8 m80 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.669 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 171' ' ' ILE . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.718 HD21 HG11 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.472 ' N ' HG23 ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.879 ' OD1' HD21 ' A' ' 141' ' ' LEU . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.717 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.586 ' HB3' HD13 ' A' ' 177' ' ' LEU . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 175' ' ' GLU . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.895 HG22 ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.672 ' H ' HG23 ' A' ' 178' ' ' THR . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.895 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.488 ' HA ' HD23 ' A' ' 177' ' ' LEU . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.794 ' NH1' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.794 HD12 ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.811 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.811 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.949 HG12 ' CG2' ' A' ' 11' ' ' VAL . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 201' ' ' GLY . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.68 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.718 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.683 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 198' ' ' ASP . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.741 ' O ' HD22 ' A' ' 208' ' ' LEU . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 192' ' ' PRO . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 209' ' ' ILE . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.894 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.436 0.16 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.893 ' C ' HD23 ' A' ' 12' ' ' LEU . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.756 ' CG2' HD21 ' A' ' 159' ' ' LEU . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' CD ' HG22 ' A' ' 189' ' ' THR . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.415 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.636 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.714 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' CE ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 34' ' ' LEU . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.744 ' HA2' HD11 ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.784 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.901 ' CE2' HD12 ' A' ' 159' ' ' LEU . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.892 HG22 HG13 ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 86' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.019 HG22 ' HB3' ' A' ' 161' ' ' ALA . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' NE2' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.714 HH12 HG21 ' A' ' 27' ' ' THR . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.9 mt-30 -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.958 ' HB2' HG21 ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.879 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.722 HD22 HG23 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG2' HG12 ' A' ' 78' ' ' VAL . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD11 HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.777 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.564 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 99' ' ' LEU . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 108' ' ' ARG . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.975 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.517 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.975 HD13 HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD12 ' OD1' ' A' ' 165' ' ' ASN . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.467 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.983 ' O ' HG12 ' A' ' 140' ' ' VAL . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.672 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.983 HG12 ' O ' ' A' ' 136' ' ' THR . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.784 ' OH ' HD11 ' A' ' 174' ' ' LEU . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.767 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.721 HD12 ' CD2' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.871 ' O ' HD23 ' A' ' 153' ' ' LEU . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.781 ' NE2' HG21 ' A' ' 158' ' ' VAL . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 149' ' ' VAL . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.581 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.892 HG13 HG22 ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.901 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.921 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.952 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.7 m80 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.471 ' OD1' HD12 ' A' ' 133' ' ' LEU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' OH ' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 183' ' ' VAL . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.819 ' NH2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.819 HD13 ' NH2' ' A' ' 185' ' ' ARG . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.442 HG22 ' CD ' ' A' ' 14' ' ' ARG . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 191' ' ' VAL . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 187' ' ' LEU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.429 ' O ' HD23 ' A' ' 197' ' ' LEU . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' C ' HD22 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 202' ' ' LYS . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.674 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.762 ' C ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.512 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 209' ' ' ILE . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.448 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.655 0.264 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 9.4 p30 -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HB3' HD22 ' A' ' 167' ' ' LEU . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.827 ' CG2' HD21 ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CD ' HG21 ' A' ' 37' ' ' THR . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.468 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 39' ' ' ILE . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.526 HG21 ' CD ' ' A' ' 17' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.71 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.799 HD22 ' HE1' ' A' ' 56' ' ' PHE . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 194' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.876 ' CZ ' HG21 ' A' ' 11' ' ' VAL . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.544 ' C ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.623 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 ' NE2' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 2.5 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.468 HH12 HG21 ' A' ' 27' ' ' THR . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 3.9 mt-30 -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.967 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 81' ' ' PRO . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.697 ' HA ' HD12 ' A' ' 75' ' ' LEU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.902 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.623 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB3' HD12 ' A' ' 91' ' ' LEU . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.948 ' O ' HG12 ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' OH ' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.646 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.672 ' HB2' HG21 ' A' ' 136' ' ' THR . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.502 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.915 ' HA ' HD23 ' A' ' 102' ' ' LEU . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.915 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 24' ' ' ASN . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.693 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.857 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 118' ' ' ILE . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 112' ' ' GLY . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.145 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.515 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.145 HD13 HD11 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 132' ' ' SER . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.436 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.786 ' O ' HG13 ' A' ' 140' ' ' VAL . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 90' ' ' LYS . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.812 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.785 ' HE1' HD11 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.823 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 149' ' ' VAL . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.598 ' O ' HD23 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.996 ' CE1' HG23 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 148' ' ' ILE . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 149' ' ' VAL . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.933 HG21 ' NE2' ' A' ' 151' ' ' HIS . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.792 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.781 ' O ' HD12 ' A' ' 167' ' ' LEU . 2.5 m80 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.487 ' OD1' HG21 ' A' ' 136' ' ' THR . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.503 ' OG ' HD23 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.551 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.812 ' CG ' HD21 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 197' ' ' LEU . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.772 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 180' ' ' ASP . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.707 ' H ' HG23 ' A' ' 178' ' ' THR . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.654 ' HB2' HG22 ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.556 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.735 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.554 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 208' ' ' LEU . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.818 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 174' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.596 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.845 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.902 ' C ' HD23 ' A' ' 12' ' ' LEU . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HA ' HG21 ' A' ' 70' ' ' THR . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.576 ' CD ' HG21 ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.581 ' O ' HD12 ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.786 HG21 HH12 ' A' ' 66' ' ' ARG . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.769 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.601 ' CG ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 HD13 ' A' ' 39' ' ' ILE . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.576 HG21 ' CD ' ' A' ' 17' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 44' ' ' LEU . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' OE1' ' A' ' 77' ' ' GLU . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 9' ' ' LEU . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE2' HD12 ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.868 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.796 ' CD2' HD11 ' A' ' 86' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.92 HG22 ' HB3' ' A' ' 161' ' ' ALA . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD23 ' CG ' ' A' ' 31' ' ' ASP . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' LYS . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.786 HH12 HG21 ' A' ' 27' ' ' THR . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 65' ' ' GLN . 1.3 pt20 -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 15' ' ' HIS . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 70' ' ' THR . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.686 HD21 HD23 ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 78' ' ' VAL . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.686 HD23 HD21 ' A' ' 75' ' ' LEU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 58' ' ' ILE . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.584 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.8 ' HB3' HD12 ' A' ' 91' ' ' LEU . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.444 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.037 HD21 ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 1.048 ' HA ' HG21 ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.048 HG21 ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 1.037 ' CZ2' HD21 ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.659 ' CB ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.803 HD13 HD11 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.662 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.686 ' HD2' HD23 ' A' ' 99' ' ' LEU . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.411 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 133' ' ' LEU . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 90' ' ' LYS . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.599 HD11 ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 153' ' ' LEU . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.964 HD12 ' CE2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.99 HD11 HD11 ' A' ' 10' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.92 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.936 ' C ' HD12 ' A' ' 167' ' ' LEU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.503 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.831 ' HB2' HD13 ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.503 ' HA ' HD11 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.929 ' NH2' HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 187' ' ' LEU . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 193' ' ' ILE . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.787 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.787 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.967 HG13 HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.728 HG13 HG22 ' A' ' 11' ' ' VAL . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.907 ' O ' HG12 ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 174' ' ' LEU . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.458 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.578 ' HA ' HD22 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 204' ' ' VAL . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 191' ' ' VAL . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 209' ' ' ILE . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 1.016 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 152' ' ' ILE . 7.3 m120 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.727 HD11 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' HB ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.071 ' CG2' HG13 ' A' ' 194' ' ' VAL . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 13' ' ' THR . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.936 ' HD3' HD13 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 44.0 p-80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.534 HG21 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.534 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' CA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HG3' HG23 ' A' ' 27' ' ' THR . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' A' ' 66' ' ' ARG . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.029 HG23 HD13 ' A' ' 73' ' ' ILE . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 9' ' ' LEU . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CE2' HD11 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.763 HD13 HH21 ' A' ' 66' ' ' ARG . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.763 HH21 HD13 ' A' ' 64' ' ' LEU . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 7.3 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 74' ' ' ILE . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.641 ' HB3' HG21 ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 76.9 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.029 HD13 HG23 ' A' ' 39' ' ' ILE . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.851 ' N ' HD12 ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 43' ' ' LYS . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.627 HG12 ' OE1' ' A' ' 80' ' ' GLU . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.839 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.707 ' HB2' HD13 ' A' ' 58' ' ' ILE . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.924 HG22 ' HE3' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.675 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.924 ' HE3' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.951 ' O ' HG22 ' A' ' 140' ' ' VAL . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.552 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD13 ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.978 ' HG ' ' HB2' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.978 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.761 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.872 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.761 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.717 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.551 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.092 HD13 HD11 ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.724 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.696 ' HD2' HD13 ' A' ' 99' ' ' LEU . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 136' ' ' THR . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.656 HD13 ' NH2' ' A' ' 168' ' ' ARG . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.764 ' O ' HG23 ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.786 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 90' ' ' LYS . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.989 HD12 ' OD2' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.716 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.433 HG21 ' HE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.695 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 145' ' ' LYS . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 158' ' ' VAL . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.647 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.526 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 58' ' ' ILE . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.843 ' N ' HD12 ' A' ' 159' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.808 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.514 ' CB ' ' OE1' ' A' ' 93' ' ' GLU . 2.2 t-20 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.445 ' OG ' HG11 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.656 ' NH2' HD13 ' A' ' 133' ' ' LEU . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.786 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 140' ' ' VAL . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.599 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.989 ' OD2' HD12 ' A' ' 141' ' ' LEU . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.558 ' CG ' HD21 ' A' ' 197' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.561 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 172' ' ' MET . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' C ' HD12 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.791 HD12 ' HG2' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.791 ' HG2' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.936 HD13 ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.696 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.696 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.071 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.988 ' C ' HG12 ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 201' ' ' GLY . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.566 ' O ' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.977 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.458 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.988 HG12 ' C ' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.806 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.846 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.445 0.165 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.846 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.94 ' CG2' HG13 ' A' ' 194' ' ' VAL . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.741 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 161' ' ' ALA . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.709 ' HD3' HG22 ' A' ' 189' ' ' THR . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.851 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.796 ' O ' HD12 ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.486 HG22 ' OE2' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' OE2' HG22 ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.797 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' HG12 ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.76 ' CE1' HD12 ' A' ' 86' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' HZ2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.79 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 74' ' ' ILE . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.696 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.787 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.76 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.839 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.623 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.504 HD11 ' CZ3' ' A' ' 111' ' ' TRP . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.623 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 41.4 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.637 ' N ' HD23 ' A' ' 102' ' ' LEU . 51.6 t30 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.554 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.773 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.431 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.435 ' H ' HG22 ' A' ' 125' ' ' ILE . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.477 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.423 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 1.017 ' O ' HG12 ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 1.017 HG12 ' O ' ' A' ' 136' ' ' THR . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 147' ' ' THR . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.663 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 60' ' ' PHE . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.667 ' CE1' HG11 ' A' ' 158' ' ' VAL . 24.4 p80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' A' ' 152' ' ' ILE . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.667 HG11 ' CE1' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.737 ' HB ' HD22 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.905 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.839 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 92' ' ' ASN . 2.9 m80 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.4 ' HB2' ' OE2' ' A' ' 93' ' ' GLU . 2.9 t-20 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.648 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.478 ' HB3' HD13 ' A' ' 182' ' ' ILE . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.901 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.638 HD23 ' HA ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.959 ' O ' HG22 ' A' ' 182' ' ' ILE . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.754 ' HB2' HG22 ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 178' ' ' THR . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.809 ' CD ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.742 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.709 HG22 ' HD3' ' A' ' 14' ' ' ARG . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 209' ' ' ILE . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 209' ' ' ILE . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 208' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.94 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.733 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 194' ' ' VAL . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.775 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.462 ' N ' HG22 ' A' ' 209' ' ' ILE . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 2.9 p30 -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 194' ' ' VAL . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.679 ' CG2' HD21 ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' OE2' HG21 ' A' ' 37' ' ' THR . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 25' ' ' LEU . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' GLY . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 28' ' ' GLY . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 66' ' ' ARG . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.618 HG21 ' OE2' ' A' ' 17' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.47 HD13 HD23 ' A' ' 34' ' ' LEU . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' CE1' HG21 ' A' ' 11' ' ' VAL . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' C ' HD11 ' A' ' 83' ' ' LEU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.877 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 HH21 ' A' ' 66' ' ' ARG . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.645 HH21 HD13 ' A' ' 64' ' ' LEU . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.8 mt-30 -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.622 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 76' ' ' GLU . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 85' ' ' THR . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 57' ' ' ASP . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.928 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.73 ' HB3' HD12 ' A' ' 91' ' ' LEU . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.919 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 162' ' ' ALA . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.75 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.455 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.793 HD11 ' HH2' ' A' ' 111' ' ' TRP . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.832 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.911 ' HA ' HG21 ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.793 ' HH2' HD11 ' A' ' 99' ' ' LEU . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.51 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.036 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 183' ' ' VAL . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.508 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.036 HD13 HD11 ' A' ' 118' ' ' ILE . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 90' ' ' LYS . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.526 HD13 ' OD1' ' A' ' 173' ' ' ASP . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.491 ' HE1' HD11 ' A' ' 86' ' ' ILE . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 174' ' ' LEU . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.438 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.566 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.877 ' CE1' HG21 ' A' ' 158' ' ' VAL . 24.2 p80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 153' ' ' LEU . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 159' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.851 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.638 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.496 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 140' ' ' VAL . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.465 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.526 ' OD1' HD13 ' A' ' 141' ' ' LEU . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD11 ' CZ ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.867 ' HB3' HD12 ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 178' ' ' THR . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 121' ' ' ARG . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.705 HH12 HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.742 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 45' ' ' GLY . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.742 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.449 ' HB2' HD12 ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.696 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 11' ' ' VAL . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.794 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.635 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.6 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.731 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 1.1 t-20 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 197' ' ' LEU . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 194' ' ' VAL . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 193' ' ' ILE . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HB2' HD11 ' A' ' 167' ' ' LEU . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.709 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CE3' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.436 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' CG ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 39' ' ' ILE . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 34' ' ' LEU . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 74' ' ' ILE . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.641 ' HE2' HG11 ' A' ' 194' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.849 ' HB ' HG22 ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.642 HH21 HD13 ' A' ' 64' ' ' LEU . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 31.7 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 15' ' ' HIS . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 83' ' ' LEU . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.7 HG13 HD13 ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.715 ' O ' HD22 ' A' ' 83' ' ' LEU . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.504 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.809 ' HB3' HD12 ' A' ' 91' ' ' LEU . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG12 ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 128' ' ' PRO . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 102' ' ' LEU . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 99' ' ' LEU . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.892 ' HA ' HG21 ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.912 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.429 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.636 ' HD1' HD23 ' A' ' 133' ' ' LEU . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.838 HG21 ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.468 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.682 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.779 HD22 HH21 ' A' ' 168' ' ' ARG . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.456 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.805 ' O ' HG13 ' A' ' 140' ' ' VAL . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.724 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.766 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 147' ' ' THR . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.856 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 152' ' ' ILE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 1.154 ' CE1' HG21 ' A' ' 158' ' ' VAL . 1.1 p80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.154 HG21 ' CE1' ' A' ' 151' ' ' HIS . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.545 ' N ' HD23 ' A' ' 159' ' ' LEU . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.779 HH21 HD22 ' A' ' 133' ' ' LEU . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.766 ' CG ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.856 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.536 HD23 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.76 ' HB2' HG22 ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.536 HD13 HD23 ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 187' ' ' LEU . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.877 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.51 ' HG2' HD21 ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.923 ' N ' HD13 ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 193' ' ' ILE . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 204' ' ' VAL . 4.6 t-80 -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 10' ' ' LEU . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.67 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.691 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 197' ' ' LEU . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 198' ' ' ASP . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.755 ' HA ' HD11 ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 209' ' ' ILE . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 197' ' ' LEU . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.864 ' C ' HD23 ' A' ' 12' ' ' LEU . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.864 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 0.7 OUTLIER 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD23 ' CD1' ' A' ' 39' ' ' ILE . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.682 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 39' ' ' ILE . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.682 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.85 ' NZ ' HG22 ' A' ' 73' ' ' ILE . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CZ ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.681 HD21 ' CE1' ' A' ' 56' ' ' PHE . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HB2' HG12 ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.822 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.896 ' CE1' HG21 ' A' ' 86' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 7.9 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.819 ' CD ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 61' ' ' THR . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 41.3 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.986 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HA ' HG22 ' A' ' 78' ' ' VAL . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.78 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.78 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.561 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.793 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.896 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.791 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.968 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 88' ' ' SER . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.611 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.808 HD13 ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 107' ' ' ALA . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.833 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' GLN . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 112' ' ' GLY . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.532 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.623 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 168' ' ' ARG . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' A' ' 133' ' ' LEU . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.632 ' CB ' ' HD2' ' A' ' 128' ' ' PRO . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.808 ' HD2' HD13 ' A' ' 99' ' ' LEU . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.611 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.838 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.838 HG22 ' OE2' ' A' ' 131' ' ' GLU . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.787 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.968 HG22 ' O ' ' A' ' 90' ' ' LYS . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 152' ' ' ILE . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.667 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.822 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.783 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.816 ' HB ' HD22 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.851 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.851 HD12 ' C ' ' A' ' 163' ' ' HIS . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.728 ' HB3' HD11 ' A' ' 133' ' ' LEU . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.787 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.67 HD13 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 180' ' ' ASP . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.633 ' H ' HG23 ' A' ' 178' ' ' THR . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.606 HG12 ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.814 HH21 HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.814 HD12 HH21 ' A' ' 185' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.897 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.606 ' C ' HD11 ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.916 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.696 ' CE1' ' HB2' ' A' ' 7' ' ' PRO . 1.3 t-80 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.536 ' CA ' HD13 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.517 ' HA ' HD22 ' A' ' 197' ' ' LEU . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.715 ' H ' HD23 ' A' ' 208' ' ' LEU . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 29.6 t30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.951 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.752 0.311 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.951 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.986 HD12 ' OH ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.994 ' C ' HD23 ' A' ' 12' ' ' LEU . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 159' ' ' LEU . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.748 ' HA ' HG21 ' A' ' 70' ' ' THR . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.957 ' CZ3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.81 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.957 HG23 ' CZ3' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.748 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD23 ' CD1' ' A' ' 39' ' ' ILE . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.533 HG21 ' OE1' ' A' ' 17' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.893 ' CD1' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.775 ' CD ' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.958 HD13 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.986 ' OH ' HD12 ' A' ' 9' ' ' LEU . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.789 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.813 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CE2' HD11 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 64' ' ' LEU . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.534 HH22 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 65' ' ' GLN . 16.0 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 15' ' ' HIS . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HB3' ' OE2' ' A' ' 76' ' ' GLU . 34.9 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.775 HG23 ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.828 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 81' ' ' PRO . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.768 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.768 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.852 ' C ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.813 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.848 HG21 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.752 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' PHE . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.567 ' CZ3' HD11 ' A' ' 99' ' ' LEU . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 108' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.554 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.686 ' CD ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.529 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.808 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.923 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 90' ' ' LYS . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.806 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.794 ' CE2' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.955 HG23 ' NE2' ' A' ' 151' ' ' HIS . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.955 ' NE2' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.595 HG23 ' CE1' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.585 ' OE1' ' CG ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 159' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.434 ' CG ' ' OE2' ' A' ' 93' ' ' GLU . 1.7 m-80 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 163' ' ' HIS . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.923 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.569 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.541 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.614 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.794 HD21 ' CE2' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.57 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.552 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.569 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.549 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.892 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.892 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.958 ' HG2' HD13 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.549 HG21 HD21 ' A' ' 187' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 9' ' ' LEU . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.561 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.875 ' O ' HG22 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.745 HD11 HD22 ' A' ' 10' ' ' LEU . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.539 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.573 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.638 ' HA ' HD23 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 196' ' ' HIS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.672 ' O ' HD23 ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.778 ' OD1' HD21 ' A' ' 197' ' ' LEU . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 194' ' ' VAL . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 167' ' ' LEU . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.6 ' HB ' ' HB2' ' A' ' 161' ' ' ALA . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.442 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' OE2' HG22 ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.49 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' SER . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.509 HD11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.842 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.842 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.549 HG22 ' OE2' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 73' ' ' ILE . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.702 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.944 ' CE2' HD12 ' A' ' 148' ' ' ILE . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.538 ' HG2' HD12 ' A' ' 34' ' ' LEU . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 9.9 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 39' ' ' ILE . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.421 HD13 ' OG1' ' A' ' 85' ' ' THR . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.753 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.928 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.928 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.517 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.946 ' N ' HD12 ' A' ' 102' ' ' LEU . 12.3 t30 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.519 ' H ' HD21 ' A' ' 103' ' ' ASN . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.817 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.806 ' CD1' HG12 ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 118' ' ' ILE . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.806 HG12 ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 31.8 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 183' ' ' VAL . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.627 ' CE1' ' HE3' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.059 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . 1.022 ' O ' HG12 ' A' ' 140' ' ' VAL . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.836 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 1.022 HG12 ' O ' ' A' ' 136' ' ' THR . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.631 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.774 ' O ' HD13 ' A' ' 148' ' ' ILE . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.944 HD12 ' CE2' ' A' ' 60' ' ' PHE . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.831 ' CE1' HG21 ' A' ' 158' ' ' VAL . 32.9 p80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.604 HG23 ' CE1' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 151' ' ' HIS . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.702 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.794 ' HB3' HD11 ' A' ' 133' ' ' LEU . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.836 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 144' ' ' TYR . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.627 ' HE3' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.931 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 182' ' ' ILE . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.925 ' O ' HG22 ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.418 ' H ' HG23 ' A' ' 178' ' ' THR . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.811 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.925 HG22 ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ARG . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.561 HH22 HD12 ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.857 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 187' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.428 ' CE2' ' CD ' ' A' ' 207' ' ' GLU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.761 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.778 HD21 ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.514 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.406 ' N ' ' HD2' ' A' ' 199' ' ' LYS . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.702 HG22 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.601 ' C ' HD12 ' A' ' 208' ' ' LEU . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 207' ' ' GLU . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.69 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.69 ' N ' HG23 ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 209' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.804 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.541 0.21 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 4.3 p30 -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.753 HG22 ' HB ' ' A' ' 194' ' ' VAL . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.727 HG22 HD11 ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.699 ' HD2' HD12 ' A' ' 187' ' ' LEU . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' HG21 ' A' ' 70' ' ' THR . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 25' ' ' LEU . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' C ' HD23 ' A' ' 25' ' ' LEU . 60.0 t30 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD11 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HZ1' ' A' ' 30' ' ' LYS . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.623 HD23 HD13 ' A' ' 39' ' ' ILE . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG22 ' HD3' ' A' ' 43' ' ' LYS . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 41' ' ' GLU . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 70' ' ' THR . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD3' HG22 ' A' ' 39' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 192' ' ' PRO . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.555 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 192' ' ' PRO . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.605 ' CE1' HG21 ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.015 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.633 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 158' ' ' VAL . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.755 ' CE2' HG21 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.633 HD12 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.643 ' NH1' HG21 ' A' ' 27' ' ' THR . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 4.2 tt0 -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 15' ' ' HIS . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 61' ' ' THR . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 39' ' ' ILE . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.633 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 73' ' ' ILE . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HD13 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 83' ' ' LEU . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.916 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.891 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.9 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.696 HD23 ' CD2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 62' ' ' SER . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' NE2' ' A' ' 100' ' ' GLN . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 57.9 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD13 ' A' ' 102' ' ' LEU . 1.9 t-20 -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.735 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.703 ' HB2' HG13 ' A' ' 116' ' ' VAL . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.966 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 112' ' ' GLY . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.808 ' HD2' HD23 ' A' ' 133' ' ' LEU . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 132' ' ' SER . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.808 HD23 ' HD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.77 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 90' ' ' LYS . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.919 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.605 ' HA ' HD12 ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.523 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 152' ' ' ILE . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 199' ' ' LYS . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.778 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.755 HG21 ' CE2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.015 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 170' ' ' LEU . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.974 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.643 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 168' ' ' ARG . 24.1 m120 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.407 ' HB3' ' HB1' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.645 ' HG3' HD11 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.77 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 160' ' ' ILE . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.919 ' CG ' HD21 ' A' ' 141' ' ' LEU . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 197' ' ' LEU . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 181' ' ' GLN . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.966 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.701 ' CB ' HD12 ' A' ' 177' ' ' LEU . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.966 HG22 ' O ' ' A' ' 178' ' ' THR . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 121' ' ' ARG . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.686 HH21 HD23 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 193' ' ' ILE . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 187' ' ' LEU . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 209' ' ' ILE . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.674 ' HB2' HD13 ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 207' ' ' GLU . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.473 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.68 HD12 ' HA2' ' A' ' 201' ' ' GLY . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.543 ' HB2' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.68 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.764 ' HB2' HD11 ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.673 HD11 ' N ' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.541 0.21 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 194' ' ' VAL . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.458 ' CG2' ' HB2' ' A' ' 161' ' ' ALA . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.741 ' HB2' HD13 ' A' ' 187' ' ' LEU . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.614 ' OE1' HG21 ' A' ' 37' ' ' THR . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.515 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 25' ' ' LEU . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' A' ' 101' ' ' GLY . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG3' HG23 ' A' ' 27' ' ' THR . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.659 HD23 HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HD23 ' A' ' 34' ' ' LEU . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 ' NE ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.907 HD13 ' HG2' ' A' ' 192' ' ' PRO . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' HG11 ' A' ' 194' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 159' ' ' LEU . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.002 HG22 ' HB3' ' A' ' 161' ' ' ALA . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 2.1 tt0 -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 39' ' ' ILE . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.48 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 71' ' ' CYS . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG2' HD13 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.612 ' HG2' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HG2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.912 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.884 ' HB3' HD12 ' A' ' 91' ' ' LEU . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.454 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.633 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.454 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HA ' HG11 ' A' ' 116' ' ' VAL . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HD11 ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.902 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 112' ' ' GLY . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.512 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.716 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.478 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HB2' ' A' ' 126' ' ' ALA . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 165' ' ' ASN . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 90' ' ' LYS . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 137' ' ' ALA . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.499 ' HE1' HD11 ' A' ' 86' ' ' ILE . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CE2' HD11 ' A' ' 174' ' ' LEU . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.563 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.608 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 1.002 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.843 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.922 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.531 ' O ' HD11 ' A' ' 133' ' ' LEU . 1.7 t-20 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.554 HH12 HG12 ' A' ' 183' ' ' VAL . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.533 HD11 ' CD2' ' A' ' 144' ' ' TYR . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 1.024 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.673 ' HB3' HD13 ' A' ' 171' ' ' ILE . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.808 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.808 ' N ' HD22 ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.674 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.554 HG12 HH12 ' A' ' 168' ' ' ARG . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 1.024 ' CD ' HG21 ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.481 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.806 HD21 HH22 ' A' ' 185' ' ' ARG . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.637 HG22 ' HD3' ' A' ' 14' ' ' ARG . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.907 ' HG2' HD13 ' A' ' 49' ' ' LEU . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD13 HG12 ' A' ' 209' ' ' ILE . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 11' ' ' VAL . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 12' ' ' LEU . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.759 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.835 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.445 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.889 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.644 ' N ' HD23 ' A' ' 197' ' ' LEU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CG ' HD11 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 209' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.502 HD11 ' C ' ' A' ' 192' ' ' PRO . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 209' ' ' ILE . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.615 0.245 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 152' ' ' ILE . 1.6 m-80 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 194' ' ' VAL . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.789 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.577 ' CD2' HD12 ' A' ' 160' ' ' ILE . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.899 ' HB2' HD11 ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.53 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 1.037 ' CE3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.037 HG23 ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HZ1' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 39' ' ' ILE . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 34' ' ' LEU . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 44' ' ' LEU . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.796 ' CG2' HG13 ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.756 ' HE1' HD13 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD12 ' NE2' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 3.0 tt0 -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.955 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' SG ' ' A' ' 71' ' ' CYS . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 84' ' ' GLU . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.645 ' N ' HD23 ' A' ' 83' ' ' LEU . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.935 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' OH ' ' A' ' 143' ' ' TYR . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.583 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 165' ' ' ASN . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.784 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.719 ' CH2' HD22 ' A' ' 99' ' ' LEU . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CA ' HG22 ' A' ' 116' ' ' VAL . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 112' ' ' GLY . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.648 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.518 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.6 HG23 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.858 ' HB3' HD11 ' A' ' 99' ' ' LEU . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.408 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.451 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.81 ' OH ' HD11 ' A' ' 86' ' ' ILE . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.699 ' OH ' HD11 ' A' ' 174' ' ' LEU . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 148' ' ' ILE . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.725 ' HE1' HG21 ' A' ' 158' ' ' VAL . 31.0 p80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 153' ' ' LEU . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.796 HG13 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.882 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.929 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.1 m80 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 136' ' ' THR . 12.0 t-20 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.574 ' HB3' HD11 ' A' ' 133' ' ' LEU . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.46 ' HB2' HG12 ' A' ' 182' ' ' ILE . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.919 ' HG ' HD21 ' A' ' 197' ' ' LEU . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 171' ' ' ILE . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' CB ' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.745 ' CB ' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.584 HD13 HD23 ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.475 ' NH2' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.889 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 14' ' ' ARG . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.889 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.75 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.92 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 9' ' ' LEU . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 197' ' ' LEU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.837 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.919 HD21 ' HG ' ' A' ' 174' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.564 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.554 ' N ' HD23 ' A' ' 197' ' ' LEU . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.92 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 192' ' ' PRO . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.426 ' N ' HG22 ' A' ' 209' ' ' ILE . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' CB ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.767 0.317 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 155' ' ' GLY . 3.2 t -62.0 164.56 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -93.58 164.52 13.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.411 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 29.4 mt-10 -65.38 129.71 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.55 38.07 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -136.74 179.19 1.43 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.878 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.578 ' HA ' HG21 ' A' ' 2' ' ' THR . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 194' ' ' VAL . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD21 HD11 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.88 ' C ' HD23 ' A' ' 12' ' ' LEU . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.88 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' THR . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.441 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CD ' HG21 ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.447 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.401 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 t-20 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 39' ' ' ILE . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.566 HG21 ' CD ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 34' ' ' LEU . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 44' ' ' LEU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.762 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HG21 ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 159' ' ' LEU . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' C ' HD11 ' A' ' 83' ' ' LEU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.972 HG22 HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.626 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.851 ' CD2' HD11 ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.055 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.697 HD12 ' NE2' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 3.1 tt0 -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.46 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.551 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD11 ' C ' ' A' ' 57' ' ' ASP . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.612 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.723 ' HB3' HD12 ' A' ' 91' ' ' LEU . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.719 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.613 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 127' ' ' PRO . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.613 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 54.5 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.634 ' N ' HD23 ' A' ' 102' ' ' LEU . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 102' ' ' LEU . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.783 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.589 ' CH2' HD22 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.845 ' CD1' HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' CG ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' HG22 ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.942 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' HD11 ' A' ' 99' ' ' LEU . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.687 HD12 ' ND2' ' A' ' 165' ' ' ASN . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.876 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 90' ' ' LYS . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.688 HG21 ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.665 HG23 ' NE2' ' A' ' 151' ' ' HIS . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 158' ' ' VAL . 13.6 p80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 148' ' ' ILE . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 2' ' ' THR . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.621 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 151' ' ' HIS . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.644 HD11 HD21 ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 1.055 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.762 ' O ' HD12 ' A' ' 167' ' ' LEU . 4.0 m80 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.687 ' ND2' HD12 ' A' ' 133' ' ' LEU . 8.8 t-20 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 181' ' ' GLN . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.954 ' CB ' HG22 ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.549 ' HB ' HD23 ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 122' ' ' SER . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.538 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.515 ' CG2' ' HB1' ' A' ' 188' ' ' ALA . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.472 ' C ' HD11 ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.931 HD12 ' HG2' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.579 HG22 HG22 ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.864 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.586 HD11 HD22 ' A' ' 174' ' ' LEU . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.756 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.754 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.537 ' C ' HD13 ' A' ' 197' ' ' LEU . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 204' ' ' VAL . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.539 ' N ' HD22 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.931 ' HG2' HD12 ' A' ' 193' ' ' ILE . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.718 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 29.3 t30 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 15.2 ttt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 4' ' ' GLU . 7.5 t -49.64 -25.86 3.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.084 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 2' ' ' THR . 13.2 t 46.28 38.38 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.833 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.591 ' H ' HG23 ' A' ' 2' ' ' THR . 8.7 tt0 60.26 125.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.992 0.425 . . . . 0.0 111.412 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 165.36 -79.07 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.308 0.575 . . . . 0.0 111.058 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.699 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -173.47 -64.11 0.0 OUTLIER Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.707 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.699 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD11 ' CG2' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.644 ' C ' HD23 ' A' ' 12' ' ' LEU . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.849 ' CG2' HD21 ' A' ' 159' ' ' LEU . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.406 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CD ' HG21 ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' CB ' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE2' HD23 ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 39' ' ' ILE . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.501 HG21 ' CD ' ' A' ' 17' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 34' ' ' LEU . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.933 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.909 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.81 ' CE1' HD12 ' A' ' 86' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.054 HG22 ' HB3' ' A' ' 161' ' ' ALA . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD12 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.7 mt-30 -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 69' ' ' LYS . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.718 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.867 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.75 ' HB3' HD12 ' A' ' 91' ' ' LEU . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.857 ' O ' HG22 ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.641 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.008 HD23 ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 3.8 t30 -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.924 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.497 ' CB ' HG23 ' A' ' 116' ' ' VAL . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 118' ' ' ILE . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.924 HG21 ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.447 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.488 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.633 HD13 ' CG ' ' A' ' 173' ' ' ASP . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.643 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.725 HG21 ' CE1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 60' ' ' PHE . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.554 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 4' ' ' GLU . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 2' ' ' THR . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.649 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.909 HG13 ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.933 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 170' ' ' LEU . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.722 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.942 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.2 m80 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.801 ' HB3' HD11 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.719 HD21 HG11 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.633 ' CG ' HD13 ' A' ' 141' ' ' LEU . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.643 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.641 ' OE1' HD21 ' A' ' 177' ' ' LEU . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.856 HD12 ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 178' ' ' THR . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.89 ' HB2' HG22 ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 178' ' ' THR . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.746 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.746 HD23 ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.698 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.698 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.499 ' HB2' HG11 ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.583 ' N ' HD11 ' A' ' 209' ' ' ILE . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.648 HD23 ' CA ' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.739 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.84 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.648 ' CA ' HD23 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.448 ' CG ' HD11 ' A' ' 193' ' ' ILE . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 194' ' ' VAL . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 191' ' ' VAL . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.484 ' H ' HG22 ' A' ' 209' ' ' ILE . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.883 ' CB ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.744 0.307 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 8' ' ' ASN . 70.9 p -42.69 142.12 0.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 t -166.18 -43.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.24 -16.18 63.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 74.57 52.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.992 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -167.7 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 2' ' ' THR . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.883 HD13 ' CB ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.653 ' C ' HD23 ' A' ' 12' ' ' LEU . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.692 HG22 HD21 ' A' ' 159' ' ' LEU . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.682 HH11 HG22 ' A' ' 189' ' ' THR . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.549 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.63 ' N ' HG22 ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.722 ' OD2' HD23 ' A' ' 64' ' ' LEU . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLU . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.722 ' HB2' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.633 ' CE2' HG21 ' A' ' 11' ' ' VAL . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.732 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.806 ' CZ ' HG23 ' A' ' 148' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.967 HG21 ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.722 HD23 ' OD2' ' A' ' 31' ' ' ASP . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 9.0 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 15' ' ' HIS . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.967 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 43' ' ' LYS . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.727 HD13 HG21 ' A' ' 85' ' ' THR . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 50' ' ' LYS . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.462 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.936 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.872 HD22 ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 105' ' ' ASP . 22.8 t30 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.502 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HG2' ' CE ' ' A' ' 109' ' ' LYS . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.872 ' CH2' HD22 ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.501 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 112' ' ' GLY . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.992 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' HG12 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.513 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.503 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.992 HD13 HD11 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HB3' HD11 ' A' ' 99' ' ' LEU . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 133' ' ' LEU . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.425 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 132' ' ' SER . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.925 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 90' ' ' LYS . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.897 ' CE1' HD11 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.989 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.561 HG22 ' HD1' ' A' ' 143' ' ' TYR . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.897 HD11 ' CE1' ' A' ' 143' ' ' TYR . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 145' ' ' LYS . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.614 ' C ' HG21 ' A' ' 2' ' ' THR . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.592 HG21 ' HE2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 160' ' ' ILE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.897 ' N ' HD23 ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.946 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.728 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.637 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.479 ' N ' HG23 ' A' ' 171' ' ' ILE . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.925 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 197' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.825 HG22 ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.825 ' CB ' HG22 ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 178' ' ' THR . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.424 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.637 ' HD2' HG21 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 187' ' ' LEU . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 193' ' ' ILE . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.887 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.682 HG22 HH11 ' A' ' 14' ' ' ARG . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.887 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.64 ' HG3' HD12 ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 187' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.477 ' N ' HG22 ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.528 ' C ' HD22 ' A' ' 197' ' ' LEU . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 174' ' ' LEU . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.698 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.745 ' C ' HD13 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.592 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.862 ' HB3' HG13 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 194' ' ' VAL . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 211' ' ' ASN . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.522 ' N ' HG22 ' A' ' 209' ' ' ILE . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.576 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.334 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 8' ' ' ASN . 3.6 m -47.84 167.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.25 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 4.0 m -157.84 169.23 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 3' ' ' THR . 4.4 pm0 -49.92 108.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.89 49.15 20.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -137.39 177.93 1.94 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.315 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.671 ' CB ' HG23 ' A' ' 2' ' ' THR . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD11 ' NE2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 HD12 ' A' ' 160' ' ' ILE . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 194' ' ' VAL . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD22 HD23 ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.759 HG21 HD21 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.669 ' HD3' HG22 ' A' ' 189' ' ' THR . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 25' ' ' LEU . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.853 HG23 ' HE2' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.934 HD23 HD13 ' A' ' 39' ' ' ILE . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.578 HG21 ' OE1' ' A' ' 17' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.934 HD13 HD23 ' A' ' 34' ' ' LEU . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HZ3' HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.537 HD11 HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.604 ' CE1' HG21 ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.087 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.812 ' HB ' HG22 ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.681 ' CZ ' HG23 ' A' ' 147' ' ' THR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 HH21 ' A' ' 66' ' ' ARG . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 6.0 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.58 HH21 HD22 ' A' ' 64' ' ' LEU . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 5.1 mt-30 -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.583 HD21 HD23 ' A' ' 83' ' ' LEU . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.528 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.583 HD23 HD21 ' A' ' 75' ' ' LEU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.89 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.915 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.647 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.788 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HG ' HD12 ' A' ' 102' ' ' LEU . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.792 ' CH2' HD11 ' A' ' 99' ' ' LEU . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.841 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.506 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 108' ' ' ARG . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 123' ' ' TYR . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 1.021 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 90' ' ' LYS . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.915 ' CZ ' HD11 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.545 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.445 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.731 ' O ' HD13 ' A' ' 153' ' ' LEU . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' HG23 ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 149' ' ' VAL . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.812 HG22 ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.087 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.86 HD12 HD21 ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.723 ' O ' HD12 ' A' ' 167' ' ' LEU . 2.7 m80 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 136' ' ' THR . 6.3 t-20 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.994 HD23 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.499 ' O ' HG22 ' A' ' 171' ' ' ILE . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.021 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.81 HD13 HG12 ' A' ' 140' ' ' VAL . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 182' ' ' ILE . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.497 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.902 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.839 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 178' ' ' THR . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.902 ' HB3' HD12 ' A' ' 177' ' ' LEU . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 178' ' ' THR . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.819 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.669 HG22 ' HD3' ' A' ' 14' ' ' ARG . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.819 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.904 HD11 ' CB ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 11' ' ' VAL . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.621 ' OH ' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.672 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 t-80 -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.582 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 174' ' ' LEU . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.497 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.904 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.236 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 8' ' ' ASN . 7.1 p -51.08 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ALA . 3.3 m -139.51 68.87 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.016 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.85 -84.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.03 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -120.86 80.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.944 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -170.02 -179.86 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.944 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 2' ' ' THR . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 194' ' ' VAL . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.79 ' CG2' HD21 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' HA ' HG21 ' A' ' 70' ' ' THR . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 189' ' ' THR . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.552 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 25' ' ' LEU . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.552 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.657 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.657 ' N ' HG22 ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.441 HD13 ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HZ3' HG23 ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.767 HD12 ' CG ' ' A' ' 192' ' ' PRO . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.526 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.855 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CE2' HD11 ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' NH2' HG21 ' A' ' 27' ' ' THR . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 4.3 tt0 -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 15' ' ' HIS . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.59 HG23 ' HZ3' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.826 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 74' ' ' ILE . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 56' ' ' PHE . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.621 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.79 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 91' ' ' LEU . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.713 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 ' CH2' ' A' ' 111' ' ' TRP . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 48.0 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.823 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.704 ' CH2' HD11 ' A' ' 99' ' ' LEU . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.494 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.024 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.53 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.588 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.497 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.024 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.472 HD23 ' HD1' ' A' ' 123' ' ' TYR . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 90' ' ' LYS . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.682 ' CD2' HD11 ' A' ' 170' ' ' LEU . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.671 ' HE1' HG21 ' A' ' 158' ' ' VAL . 21.7 p80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.612 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 153' ' ' LEU . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.855 HG13 ' CG2' ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 13' ' ' THR . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 10' ' ' LEU . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 92' ' ' ASN . 3.5 m80 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' ' 136' ' ' THR . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 91' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HG2' ' HD2' ' A' ' 185' ' ' ARG . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.461 ' N ' HG23 ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 197' ' ' LEU . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.481 HD21 ' OE1' ' A' ' 175' ' ' GLU . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.838 HG22 ' HB3' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 178' ' ' THR . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.838 ' HB3' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 16' ' ' GLY . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.767 ' CG ' HD12 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.895 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 11' ' ' VAL . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 174' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.421 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.47 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.895 ' HB2' HD12 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 194' ' ' VAL . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 57' ' ' ASP . 2.2 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.789 0.328 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.762 HG21 ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -75.6 81.08 2.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.639 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.5 t -42.26 -47.49 4.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.397 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 3' ' ' THR . 8.1 tp10 -66.92 111.42 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.55 62.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.194 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.868 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -169.37 -65.9 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.485 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.762 ' HA ' HG21 ' A' ' 2' ' ' THR . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.778 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.912 ' C ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.838 ' CG2' HD21 ' A' ' 159' ' ' LEU . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.843 ' HD3' HG22 ' A' ' 189' ' ' THR . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' OE1' HG21 ' A' ' 37' ' ' THR . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.765 HG23 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.765 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 HD13 ' A' ' 39' ' ' ILE . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' OE1' ' A' ' 17' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.661 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 78' ' ' VAL . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.577 ' OH ' HG23 ' A' ' 11' ' ' VAL . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.912 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.768 ' CG2' HG13 ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.469 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.582 HD13 HH21 ' A' ' 66' ' ' ARG . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.582 HH21 HD13 ' A' ' 64' ' ' LEU . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 85' ' ' THR . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 39' ' ' ILE . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.799 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 83' ' ' LEU . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 75' ' ' LEU . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' N ' HD22 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.754 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.841 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t30 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.632 ' HA ' HG11 ' A' ' 116' ' ' VAL . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 112' ' ' GLY . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.05 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.465 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.05 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 132' ' ' SER . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.841 ' CG ' HD22 ' A' ' 99' ' ' LEU . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.628 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.46 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 132' ' ' SER . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.929 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 145' ' ' LYS . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HA ' HD12 ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.507 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.705 HD13 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.912 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.795 HD13 HD23 ' A' ' 170' ' ' LEU . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.632 ' CD2' ' HB2' ' A' ' 93' ' ' GLU . 3.8 m80 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.628 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.795 HD23 HD13 ' A' ' 160' ' ' ILE . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.929 ' OD1' HD21 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.706 ' HB2' HG22 ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 178' ' ' THR . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.472 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.843 HG22 ' HD3' ' A' ' 14' ' ' ARG . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.471 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.635 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 11' ' ' VAL . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.497 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.786 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.945 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 198' ' ' ASP . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.618 ' CG ' HD11 ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 209' ' ' ILE . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' THR . 34.1 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.676 0.274 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.478 ' OG1' ' N ' ' A' ' 3' ' ' THR . 0.6 OUTLIER 44.23 -178.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.481 0.657 . . . . 0.0 112.772 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 5' ' ' ALA . 92.4 m -38.92 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.394 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 7.0 mt-10 50.59 26.68 2.55 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.269 0.557 . . . . 0.0 109.883 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.794 ' H ' HG22 ' A' ' 3' ' ' THR . . . 162.96 -62.85 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.494 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -168.03 -65.42 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.709 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 194' ' ' VAL . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.797 ' C ' HD23 ' A' ' 12' ' ' LEU . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.924 ' HD3' HG22 ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.656 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.642 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.606 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HG3' HG22 ' A' ' 27' ' ' THR . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 39' ' ' ILE . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' OE1' ' A' ' 17' ' ' GLU . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 35' ' ' SER . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.886 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.694 HD13 ' CE1' ' A' ' 56' ' ' PHE . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.73 ' O ' HD23 ' A' ' 83' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.895 HG23 HG13 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.642 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 58' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' NH1' HG21 ' A' ' 27' ' ' THR . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 9.4 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 73' ' ' ILE . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 15' ' ' HIS . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HB2' HG21 ' A' ' 61' ' ' THR . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.886 HG23 ' NZ ' ' A' ' 43' ' ' LYS . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 83' ' ' LEU . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.966 ' N ' HD13 ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.84 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 140' ' ' VAL . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 88' ' ' SER . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 131' ' ' GLU . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.864 HD12 ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.642 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.788 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.536 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.48 ' O ' ' HD1' ' A' ' 119' ' ' TRP . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.788 HG21 ' HA ' ' A' ' 108' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.698 HG23 ' HD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.698 ' HD1' HG23 ' A' ' 118' ' ' ILE . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.582 HH21 HD22 ' A' ' 133' ' ' LEU . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 118' ' ' ILE . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.864 ' HB3' HD12 ' A' ' 99' ' ' LEU . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.582 HD22 HH21 ' A' ' 121' ' ' ARG . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.755 ' O ' HG23 ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.647 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 90' ' ' LYS . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.916 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 148' ' ' ILE . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.755 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 143' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 145' ' ' LYS . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 1.117 ' CE1' HG21 ' A' ' 158' ' ' VAL . 10.8 p80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 153' ' ' LEU . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.648 HD21 ' O ' ' A' ' 199' ' ' LYS . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' OE2' ' HB2' ' A' ' 151' ' ' HIS . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.117 HG21 ' CE1' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.766 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.942 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.855 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.653 HD12 ' C ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.647 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.554 HD13 HG12 ' A' ' 140' ' ' VAL . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.495 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.916 ' CG ' HD21 ' A' ' 141' ' ' LEU . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.774 HD22 HD11 ' A' ' 197' ' ' LEU . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.862 ' CD ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.431 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.719 ' H ' HG23 ' A' ' 178' ' ' THR . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.814 ' HB2' HG22 ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.926 ' CZ ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.902 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.841 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.924 HG22 ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.841 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.75 HG22 HG22 ' A' ' 11' ' ' VAL . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.613 ' O ' HG22 ' A' ' 204' ' ' VAL . 4.0 t-80 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.774 HD11 HD22 ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.648 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 198' ' ' ASP . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.5 ' HB2' HG23 ' A' ' 193' ' ' ILE . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.662 ' C ' HD13 ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' A' ' 157' ' ' LYS . 9.3 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 4' ' ' GLU . 12.4 t -54.37 167.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.034 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 3' ' ' THR . 78.8 m -94.07 23.25 5.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 2' ' ' THR . 0.9 OUTLIER 54.55 101.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 174.23 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -146.03 -69.71 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.299 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD21 HD11 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.949 ' CG2' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HB3' HD13 ' A' ' 167' ' ' LEU . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.513 ' CG2' HD11 ' A' ' 159' ' ' LEU . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HD2' HD23 ' A' ' 187' ' ' LEU . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' HG21 ' A' ' 70' ' ' THR . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 37' ' ' THR . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.51 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.823 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD11 ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.777 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.418 HG21 ' OE1' ' A' ' 17' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 40' ' ' LYS . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.834 ' HB3' HD23 ' A' ' 49' ' ' LEU . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.006 HG22 HG13 ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 86' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.67 HD13 HH21 ' A' ' 66' ' ' ARG . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.67 HH21 HD13 ' A' ' 64' ' ' LEU . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 4.6 mt-30 -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 15' ' ' HIS . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.456 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 10.3 mp0 -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.845 HD13 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.798 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.742 ' HB3' HD13 ' A' ' 91' ' ' LEU . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.024 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' HA ' ' HE1' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.511 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD11 ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CH2' HD11 ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 108' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.459 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 126' ' ' ALA . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.619 ' HB3' HD13 ' A' ' 99' ' ' LEU . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.667 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.879 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.717 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.512 HG12 ' CZ ' ' A' ' 60' ' ' PHE . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.884 ' HE1' HG21 ' A' ' 158' ' ' VAL . 30.0 p80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.72 HG23 ' CE1' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.701 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.006 HG13 HG22 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.944 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.568 HD11 HD21 ' A' ' 10' ' ' LEU . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.598 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.024 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.654 ' CD2' ' HB2' ' A' ' 93' ' ' GLU . 6.8 m80 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.669 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 171' ' ' ILE . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.718 HD21 HG11 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.472 ' N ' HG23 ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.879 ' OD1' HD21 ' A' ' 141' ' ' LEU . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.717 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.586 ' HB3' HD13 ' A' ' 177' ' ' LEU . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 175' ' ' GLU . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.895 HG22 ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.672 ' H ' HG23 ' A' ' 178' ' ' THR . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.895 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.488 ' HA ' HD23 ' A' ' 177' ' ' LEU . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.794 ' NH1' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.794 HD12 ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.811 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.811 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.949 HG12 ' CG2' ' A' ' 11' ' ' VAL . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 201' ' ' GLY . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.68 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.718 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.683 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 198' ' ' ASP . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.741 ' O ' HD22 ' A' ' 208' ' ' LEU . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 192' ' ' PRO . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 209' ' ' ILE . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HA ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.83 0.348 . . . . 0.0 111.253 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -52.78 109.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -46.06 -71.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' H ' HG23 ' A' ' 3' ' ' THR . 0.2 OUTLIER -71.96 -177.54 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.822 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.78 63.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.258 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.894 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -154.61 -67.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.352 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.58 ' HA ' HG21 ' A' ' 2' ' ' THR . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.893 ' C ' HD23 ' A' ' 12' ' ' LEU . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.756 ' CG2' HD21 ' A' ' 159' ' ' LEU . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' CD ' HG22 ' A' ' 189' ' ' THR . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.415 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.636 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.7 OUTLIER 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.714 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' CE ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 34' ' ' LEU . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.744 ' HA2' HD11 ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.784 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.901 ' CE2' HD12 ' A' ' 159' ' ' LEU . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.892 HG22 HG13 ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 86' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.019 HG22 ' HB3' ' A' ' 161' ' ' ALA . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' NE2' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.714 HH12 HG21 ' A' ' 27' ' ' THR . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.9 mt-30 -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.958 ' HB2' HG21 ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.879 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.722 HD22 HG23 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG2' HG12 ' A' ' 78' ' ' VAL . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD11 HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.777 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.564 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 99' ' ' LEU . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 108' ' ' ARG . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.975 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.517 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.975 HD13 HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD12 ' OD1' ' A' ' 165' ' ' ASN . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.467 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.983 ' O ' HG12 ' A' ' 140' ' ' VAL . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.672 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.983 HG12 ' O ' ' A' ' 136' ' ' THR . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.784 ' OH ' HD11 ' A' ' 174' ' ' LEU . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.767 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.721 HD12 ' CD2' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.871 ' O ' HD23 ' A' ' 153' ' ' LEU . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.781 ' NE2' HG21 ' A' ' 158' ' ' VAL . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 149' ' ' VAL . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.624 ' O ' HG23 ' A' ' 2' ' ' THR . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.581 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.892 HG13 HG22 ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.901 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.921 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.952 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.7 m80 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.471 ' OD1' HD12 ' A' ' 133' ' ' LEU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' OH ' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 183' ' ' VAL . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.819 ' NH2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.819 HD13 ' NH2' ' A' ' 185' ' ' ARG . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.442 HG22 ' CD ' ' A' ' 14' ' ' ARG . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 191' ' ' VAL . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 187' ' ' LEU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.429 ' O ' HD23 ' A' ' 197' ' ' LEU . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' C ' HD22 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 202' ' ' LYS . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.674 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.762 ' C ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.512 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 209' ' ' ILE . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.448 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 3' ' ' THR . 1.2 t -39.61 143.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.947 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 2' ' ' THR . 0.7 OUTLIER -168.2 37.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.737 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 72.2 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 49.64 90.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.02 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . 175.41 179.13 0.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 198' ' ' ASP . 9.4 p30 -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HB3' HD22 ' A' ' 167' ' ' LEU . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.827 ' CG2' HD21 ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CD ' HG21 ' A' ' 37' ' ' THR . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.468 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 39' ' ' ILE . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.526 HG21 ' CD ' ' A' ' 17' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.71 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.799 HD22 ' HE1' ' A' ' 56' ' ' PHE . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 194' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.876 ' CZ ' HG21 ' A' ' 11' ' ' VAL . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.544 ' C ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.623 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.662 HD12 ' NE2' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 2.5 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.468 HH12 HG21 ' A' ' 27' ' ' THR . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 3.9 mt-30 -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.967 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 81' ' ' PRO . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.697 ' HA ' HD12 ' A' ' 75' ' ' LEU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.902 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.623 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB3' HD12 ' A' ' 91' ' ' LEU . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.948 ' O ' HG12 ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' OH ' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.646 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.672 ' HB2' HG21 ' A' ' 136' ' ' THR . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.502 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.915 ' HA ' HD23 ' A' ' 102' ' ' LEU . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.915 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 24' ' ' ASN . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.693 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.857 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 118' ' ' ILE . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 112' ' ' GLY . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.145 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.515 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.145 HD13 HD11 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 132' ' ' SER . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.436 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.786 ' O ' HG13 ' A' ' 140' ' ' VAL . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 90' ' ' LYS . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.812 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.785 ' HE1' HD11 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.823 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 149' ' ' VAL . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.598 ' O ' HD23 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.996 ' CE1' HG23 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 148' ' ' ILE . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 149' ' ' VAL . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.933 HG21 ' NE2' ' A' ' 151' ' ' HIS . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.792 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.781 ' O ' HD12 ' A' ' 167' ' ' LEU . 2.5 m80 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.487 ' OD1' HG21 ' A' ' 136' ' ' THR . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.503 ' OG ' HD23 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.551 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.812 ' CG ' HD21 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 197' ' ' LEU . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.772 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 180' ' ' ASP . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.707 ' H ' HG23 ' A' ' 178' ' ' THR . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.654 ' HB2' HG22 ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.556 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.735 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.554 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 208' ' ' LEU . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.818 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 174' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.596 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.845 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' N ' ' HG3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 9' ' ' LEU . 48.9 p 45.78 -91.25 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.473 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 2' ' ' THR . 0.0 OUTLIER 166.6 -64.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.842 0.353 . . . . 0.0 110.733 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' H ' HG23 ' A' ' 3' ' ' THR . 1.8 tt0 -131.05 -74.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.34 35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.373 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -158.12 -56.33 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.494 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.902 ' C ' HD23 ' A' ' 12' ' ' LEU . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HA ' HG21 ' A' ' 70' ' ' THR . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.576 ' CD ' HG21 ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.581 ' O ' HD12 ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.786 HG21 HH12 ' A' ' 66' ' ' ARG . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.769 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.601 ' CG ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 HD13 ' A' ' 39' ' ' ILE . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.576 HG21 ' CD ' ' A' ' 17' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 44' ' ' LEU . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' OE1' ' A' ' 77' ' ' GLU . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 9' ' ' LEU . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE2' HD12 ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.868 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.796 ' CD2' HD11 ' A' ' 86' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.92 HG22 ' HB3' ' A' ' 161' ' ' ALA . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD23 ' CG ' ' A' ' 31' ' ' ASP . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' ' CB ' ' A' ' 69' ' ' LYS . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.786 HH12 HG21 ' A' ' 27' ' ' THR . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' A' ' 65' ' ' GLN . 1.3 pt20 -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 15' ' ' HIS . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 70' ' ' THR . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.686 HD21 HD23 ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 78' ' ' VAL . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.686 HD23 HD21 ' A' ' 75' ' ' LEU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 58' ' ' ILE . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.584 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.8 ' HB3' HD12 ' A' ' 91' ' ' LEU . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.444 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.037 HD21 ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 1.048 ' HA ' HG21 ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.048 HG21 ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 1.037 ' CZ2' HD21 ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.659 ' CB ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.803 HD13 HD11 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.662 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.686 ' HD2' HD23 ' A' ' 99' ' ' LEU . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.411 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 133' ' ' LEU . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 90' ' ' LYS . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.599 HD11 ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 153' ' ' LEU . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 2' ' ' THR . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.964 HD12 ' CE2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.99 HD11 HD11 ' A' ' 10' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.92 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.936 ' C ' HD12 ' A' ' 167' ' ' LEU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.503 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.831 ' HB2' HD13 ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.503 ' HA ' HD11 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.929 ' NH2' HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 187' ' ' LEU . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 193' ' ' ILE . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.787 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.787 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.967 HG13 HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.728 HG13 HG22 ' A' ' 11' ' ' VAL . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.907 ' O ' HG12 ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 174' ' ' LEU . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.458 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.578 ' HA ' HD22 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 204' ' ' VAL . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 191' ' ' VAL . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 209' ' ' ILE . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HA ' ' HG2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.37 0.128 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -64.33 -53.79 43.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.164 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 2' ' ' THR . 0.5 OUTLIER 58.32 144.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.79 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 73.76 155.25 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.54 64.72 5.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.375 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 1.016 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -155.08 -73.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 152' ' ' ILE . 7.3 m120 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.727 HD11 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' HB ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.071 ' CG2' HG13 ' A' ' 194' ' ' VAL . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 13' ' ' THR . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.936 ' HD3' HD13 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 44.0 p-80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.534 HG21 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.534 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' CA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HG3' HG23 ' A' ' 27' ' ' THR . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' A' ' 66' ' ' ARG . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.029 HG23 HD13 ' A' ' 73' ' ' ILE . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 9' ' ' LEU . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CE2' HD11 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD13 HH21 ' A' ' 66' ' ' ARG . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.763 HH21 HD13 ' A' ' 64' ' ' LEU . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 7.3 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 74' ' ' ILE . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.641 ' HB3' HG21 ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 76.9 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.029 HD13 HG23 ' A' ' 39' ' ' ILE . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.851 ' N ' HD12 ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 43' ' ' LYS . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.627 HG12 ' OE1' ' A' ' 80' ' ' GLU . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.839 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.707 ' HB2' HD13 ' A' ' 58' ' ' ILE . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.924 HG22 ' HE3' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.675 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.924 ' HE3' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.951 ' O ' HG22 ' A' ' 140' ' ' VAL . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.552 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD13 ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.978 ' HG ' ' HB2' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.978 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.761 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.872 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.761 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.717 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.551 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.092 HD13 HD11 ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.724 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.696 ' HD2' HD13 ' A' ' 99' ' ' LEU . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 136' ' ' THR . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.656 HD13 ' NH2' ' A' ' 168' ' ' ARG . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.764 ' O ' HG23 ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.786 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 90' ' ' LYS . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.989 HD12 ' OD2' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.716 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.433 HG21 ' HE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.695 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 145' ' ' LYS . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 158' ' ' VAL . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.647 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.526 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.646 ' HB3' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 58' ' ' ILE . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.843 ' N ' HD12 ' A' ' 159' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.808 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.514 ' CB ' ' OE1' ' A' ' 93' ' ' GLU . 2.2 t-20 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.445 ' OG ' HG11 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.656 ' NH2' HD13 ' A' ' 133' ' ' LEU . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.786 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 140' ' ' VAL . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.599 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.989 ' OD2' HD12 ' A' ' 141' ' ' LEU . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.558 ' CG ' HD21 ' A' ' 197' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.561 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 172' ' ' MET . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' C ' HD12 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.791 HD12 ' HG2' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.791 ' HG2' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.936 HD13 ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.696 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.696 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.071 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.988 ' C ' HG12 ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 201' ' ' GLY . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.566 ' O ' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.977 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.458 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.988 HG12 ' C ' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.806 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' CB ' ' HG2' ' A' ' 157' ' ' LYS . 11.0 tpt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.507 0.194 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.57 HG23 ' C ' ' A' ' 155' ' ' GLY . 1.6 t -57.7 86.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.833 0.349 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.5 t -94.31 -28.42 15.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.008 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 5.5 mm-40 -54.46 -21.98 11.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.043 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 74.56 33.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.846 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -150.3 -70.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.846 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.94 ' CG2' HG13 ' A' ' 194' ' ' VAL . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.741 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 161' ' ' ALA . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.709 ' HD3' HG22 ' A' ' 189' ' ' THR . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.851 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.796 ' O ' HD12 ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.486 HG22 ' OE2' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' OE2' HG22 ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.797 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' HG12 ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.76 ' CE1' HD12 ' A' ' 86' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' HZ2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.79 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 74' ' ' ILE . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.696 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.787 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.76 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.839 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.611 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.623 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.504 HD11 ' CZ3' ' A' ' 111' ' ' TRP . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.623 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 41.4 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.637 ' N ' HD23 ' A' ' 102' ' ' LEU . 51.6 t30 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.554 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.773 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.431 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.435 ' H ' HG22 ' A' ' 125' ' ' ILE . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.477 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.423 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.017 ' O ' HG12 ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 1.017 HG12 ' O ' ' A' ' 136' ' ' THR . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 147' ' ' THR . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.663 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 60' ' ' PHE . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.667 ' CE1' HG11 ' A' ' 158' ' ' VAL . 24.4 p80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.519 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' A' ' 152' ' ' ILE . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.57 ' C ' HG23 ' A' ' 2' ' ' THR . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 2' ' ' THR . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.667 HG11 ' CE1' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.737 ' HB ' HD22 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.905 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.839 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.611 ' CE1' ' HA ' ' A' ' 92' ' ' ASN . 2.9 m80 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.4 ' HB2' ' OE2' ' A' ' 93' ' ' GLU . 2.9 t-20 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.648 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.478 ' HB3' HD13 ' A' ' 182' ' ' ILE . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.901 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.638 HD23 ' HA ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.959 ' O ' HG22 ' A' ' 182' ' ' ILE . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.754 ' HB2' HG22 ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 178' ' ' THR . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.809 ' CD ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.742 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.709 HG22 ' HD3' ' A' ' 14' ' ' ARG . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 209' ' ' ILE . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 209' ' ' ILE . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 208' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.94 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.733 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 194' ' ' VAL . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.775 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.462 ' N ' HG22 ' A' ' 209' ' ' ILE . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.775 0.321 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.4 t -68.95 111.33 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -114.43 23.11 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.98 14.53 7.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.285 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.5 26.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.659 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -131.96 -71.97 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.548 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' HA ' HG21 ' A' ' 2' ' ' THR . 2.9 p30 -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 194' ' ' VAL . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.679 ' CG2' HD21 ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' OE2' HG21 ' A' ' 37' ' ' THR . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 25' ' ' LEU . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' GLY . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 28' ' ' GLY . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 66' ' ' ARG . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.618 HG21 ' OE2' ' A' ' 17' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.47 HD13 HD23 ' A' ' 34' ' ' LEU . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' CE1' HG21 ' A' ' 11' ' ' VAL . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' C ' HD11 ' A' ' 83' ' ' LEU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.877 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 HH21 ' A' ' 66' ' ' ARG . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.645 HH21 HD13 ' A' ' 64' ' ' LEU . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 2.8 mt-30 -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.622 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 76' ' ' GLU . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 85' ' ' THR . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 57' ' ' ASP . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.928 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.73 ' HB3' HD12 ' A' ' 91' ' ' LEU . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.919 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 162' ' ' ALA . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.75 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.455 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.793 HD11 ' HH2' ' A' ' 111' ' ' TRP . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.832 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.911 ' HA ' HG21 ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.793 ' HH2' HD11 ' A' ' 99' ' ' LEU . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.51 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.036 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 183' ' ' VAL . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.508 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.036 HD13 HD11 ' A' ' 118' ' ' ILE . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 90' ' ' LYS . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.526 HD13 ' OD1' ' A' ' 173' ' ' ASP . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.491 ' HE1' HD11 ' A' ' 86' ' ' ILE . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 174' ' ' LEU . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.438 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.566 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.877 ' CE1' HG21 ' A' ' 158' ' ' VAL . 24.2 p80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 153' ' ' LEU . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 2' ' ' THR . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 159' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.851 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.638 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.496 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 140' ' ' VAL . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.465 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.526 ' OD1' HD13 ' A' ' 141' ' ' LEU . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD11 ' CZ ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.867 ' HB3' HD12 ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 178' ' ' THR . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 121' ' ' ARG . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.705 HH12 HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.742 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 45' ' ' GLY . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.742 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.449 ' HB2' HD12 ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.696 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 11' ' ' VAL . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.794 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.635 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.6 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.731 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.697 ' H3 ' HD22 ' A' ' 9' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.643 0.259 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.542 HG21 ' C ' ' A' ' 155' ' ' GLY . 3.7 t -43.2 127.78 4.46 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.83 -72.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -68.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . . . -151.51 -51.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -64.82 -65.61 1.87 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 3.4 t30 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 ' H3 ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 197' ' ' LEU . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 194' ' ' VAL . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 193' ' ' ILE . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HB2' HD11 ' A' ' 167' ' ' LEU . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.709 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CE3' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.436 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' CG ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 39' ' ' ILE . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 34' ' ' LEU . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 74' ' ' ILE . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.641 ' HE2' HG11 ' A' ' 194' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.849 ' HB ' HG22 ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.642 HH21 HD13 ' A' ' 64' ' ' LEU . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 31.7 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 15' ' ' HIS . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 83' ' ' LEU . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.7 HG13 HD13 ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.715 ' O ' HD22 ' A' ' 83' ' ' LEU . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.504 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.809 ' HB3' HD12 ' A' ' 91' ' ' LEU . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG12 ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 128' ' ' PRO . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 102' ' ' LEU . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 99' ' ' LEU . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.892 ' HA ' HG21 ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.912 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.429 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.636 ' HD1' HD23 ' A' ' 133' ' ' LEU . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.838 HG21 ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.468 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.682 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.779 HD22 HH21 ' A' ' 168' ' ' ARG . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.456 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.805 ' O ' HG13 ' A' ' 140' ' ' VAL . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.724 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.766 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 147' ' ' THR . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.856 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 152' ' ' ILE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 1.154 ' CE1' HG21 ' A' ' 158' ' ' VAL . 1.1 p80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 2' ' ' THR . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.461 ' N ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.154 HG21 ' CE1' ' A' ' 151' ' ' HIS . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.545 ' N ' HD23 ' A' ' 159' ' ' LEU . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.779 HH21 HD22 ' A' ' 133' ' ' LEU . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.766 ' CG ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.856 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.536 HD23 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.76 ' HB2' HG22 ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.536 HD13 HD23 ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 187' ' ' LEU . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.877 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.51 ' HG2' HD21 ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.923 ' N ' HD13 ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 193' ' ' ILE . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 204' ' ' VAL . 4.6 t-80 -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 10' ' ' LEU . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.67 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.691 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 197' ' ' LEU . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 198' ' ' ASP . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.755 ' HA ' HD11 ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 209' ' ' ILE . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 8.9 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.761 0.315 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 156' ' ' GLU . 2.6 t -46.11 147.28 1.09 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 t -93.08 -0.29 57.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 64.0 87.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 168.27 -58.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.428 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -144.54 -72.12 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.864 ' C ' HD23 ' A' ' 12' ' ' LEU . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.864 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 0.7 OUTLIER 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD23 ' CD1' ' A' ' 39' ' ' ILE . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.682 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 39' ' ' ILE . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.682 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.85 ' NZ ' HG22 ' A' ' 73' ' ' ILE . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CZ ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.681 HD21 ' CE1' ' A' ' 56' ' ' PHE . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HB2' HG12 ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.822 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.896 ' CE1' HG21 ' A' ' 86' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 7.9 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.819 ' CD ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 61' ' ' THR . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 41.3 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.986 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HA ' HG22 ' A' ' 78' ' ' VAL . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.78 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.78 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.561 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.793 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.896 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.791 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.968 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 88' ' ' SER . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.611 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.808 HD13 ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 107' ' ' ALA . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.833 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' GLN . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 112' ' ' GLY . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.532 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.623 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 168' ' ' ARG . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' A' ' 133' ' ' LEU . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.632 ' CB ' ' HD2' ' A' ' 128' ' ' PRO . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.808 ' HD2' HD13 ' A' ' 99' ' ' LEU . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.611 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.838 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.838 HG22 ' OE2' ' A' ' 131' ' ' GLU . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.787 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.968 HG22 ' O ' ' A' ' 90' ' ' LYS . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 152' ' ' ILE . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 4' ' ' GLU . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.667 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.822 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.783 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.816 ' HB ' HD22 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.851 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.851 HD12 ' C ' ' A' ' 163' ' ' HIS . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.728 ' HB3' HD11 ' A' ' 133' ' ' LEU . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.787 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.67 HD13 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 180' ' ' ASP . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.633 ' H ' HG23 ' A' ' 178' ' ' THR . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.606 HG12 ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.814 HH21 HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.814 HD12 HH21 ' A' ' 185' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.897 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.606 ' C ' HD11 ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.916 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.696 ' CE1' ' HB2' ' A' ' 7' ' ' PRO . 1.3 t-80 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.536 ' CA ' HD13 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.517 ' HA ' HD22 ' A' ' 197' ' ' LEU . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.715 ' H ' HD23 ' A' ' 208' ' ' LEU . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 29.6 t30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' THR . 25.8 mtp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.615 HG23 ' N ' ' A' ' 156' ' ' GLU . 7.2 p 37.24 -153.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.6 m -141.45 -59.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 8.7 pt-20 -137.78 22.1 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 85.98 -53.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.951 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -52.29 -67.75 0.5 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.292 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.951 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.986 HD12 ' OH ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.994 ' C ' HD23 ' A' ' 12' ' ' LEU . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 159' ' ' LEU . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.748 ' HA ' HG21 ' A' ' 70' ' ' THR . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.957 ' CZ3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.81 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.957 HG23 ' CZ3' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.748 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD23 ' CD1' ' A' ' 39' ' ' ILE . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.533 HG21 ' OE1' ' A' ' 17' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.893 ' CD1' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.775 ' CD ' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.958 HD13 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.986 ' OH ' HD12 ' A' ' 9' ' ' LEU . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.789 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.813 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CE2' HD11 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 64' ' ' LEU . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.534 HH22 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 65' ' ' GLN . 16.0 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 15' ' ' HIS . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HB3' ' OE2' ' A' ' 76' ' ' GLU . 34.9 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.775 HG23 ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.828 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 81' ' ' PRO . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.768 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.768 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.852 ' C ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.813 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.848 HG21 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.752 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' PHE . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.567 ' CZ3' HD11 ' A' ' 99' ' ' LEU . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 108' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.554 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.686 ' CD ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.529 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.808 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.923 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 90' ' ' LYS . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.806 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.794 ' CE2' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.955 HG23 ' NE2' ' A' ' 151' ' ' HIS . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.955 ' NE2' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.595 HG23 ' CE1' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 159' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.434 ' CG ' ' OE2' ' A' ' 93' ' ' GLU . 1.7 m-80 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 163' ' ' HIS . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.923 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.569 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.541 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.614 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.794 HD21 ' CE2' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.57 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.552 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.569 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.549 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.892 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.892 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.958 ' HG2' HD13 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.549 HG21 HD21 ' A' ' 187' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 9' ' ' LEU . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.561 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.875 ' O ' HG22 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.745 HD11 HD22 ' A' ' 10' ' ' LEU . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.539 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.573 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.638 ' HA ' HD23 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 196' ' ' HIS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.672 ' O ' HD23 ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' HG3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.824 0.345 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.574 HG23 ' HA2' ' A' ' 155' ' ' GLY . 6.1 t -48.84 177.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 14.1 t -92.54 21.26 5.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.503 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 155' ' ' GLY . 6.8 pm0 56.15 155.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.811 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 40.87 33.23 0.2 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.806 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -156.4 178.35 1.71 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.192 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.778 ' OD1' HD21 ' A' ' 197' ' ' LEU . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 194' ' ' VAL . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 167' ' ' LEU . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.6 ' HB ' ' HB2' ' A' ' 161' ' ' ALA . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.442 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' OE2' HG22 ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.49 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' SER . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.509 HD11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.842 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.842 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.549 HG22 ' OE2' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 73' ' ' ILE . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.702 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.944 ' CE2' HD12 ' A' ' 148' ' ' ILE . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' HG2' HD12 ' A' ' 34' ' ' LEU . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 9.9 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 39' ' ' ILE . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD13 ' OG1' ' A' ' 85' ' ' THR . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.753 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.928 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.928 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.517 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.946 ' N ' HD12 ' A' ' 102' ' ' LEU . 12.3 t30 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.519 ' H ' HD21 ' A' ' 103' ' ' ASN . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.817 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.806 ' CD1' HG12 ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 118' ' ' ILE . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.806 HG12 ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 31.8 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 183' ' ' VAL . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.627 ' CE1' ' HE3' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.059 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . 1.022 ' O ' HG12 ' A' ' 140' ' ' VAL . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.836 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 1.022 HG12 ' O ' ' A' ' 136' ' ' THR . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.631 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.774 ' O ' HD13 ' A' ' 148' ' ' ILE . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.944 HD12 ' CE2' ' A' ' 60' ' ' PHE . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.831 ' CE1' HG21 ' A' ' 158' ' ' VAL . 32.9 p80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.604 HG23 ' CE1' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 2' ' ' THR . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 151' ' ' HIS . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.702 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.794 ' HB3' HD11 ' A' ' 133' ' ' LEU . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.836 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 144' ' ' TYR . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.627 ' HE3' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.931 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 182' ' ' ILE . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.925 ' O ' HG22 ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.418 ' H ' HG23 ' A' ' 178' ' ' THR . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.811 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.925 HG22 ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ARG . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.561 HH22 HD12 ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.857 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 187' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.428 ' CE2' ' CD ' ' A' ' 207' ' ' GLU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.761 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.778 HD21 ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.514 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.406 ' N ' ' HD2' ' A' ' 199' ' ' LYS . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.702 HG22 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.601 ' C ' HD12 ' A' ' 208' ' ' LEU . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 207' ' ' GLU . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.69 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.69 ' N ' HG23 ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 209' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 157' ' ' LYS . 12.3 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.726 0.298 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 8' ' ' ASN . 3.0 p -44.86 157.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 7' ' ' PRO . 4.3 p -103.18 -81.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.1 -78.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.804 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -162.59 -69.5 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.241 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 2' ' ' THR . 4.3 p30 -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.753 HG22 ' HB ' ' A' ' 194' ' ' VAL . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.727 HG22 HD11 ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.699 ' HD2' HD12 ' A' ' 187' ' ' LEU . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' HG21 ' A' ' 70' ' ' THR . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 25' ' ' LEU . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' C ' HD23 ' A' ' 25' ' ' LEU . 60.0 t30 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD11 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HZ1' ' A' ' 30' ' ' LYS . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.623 HD23 HD13 ' A' ' 39' ' ' ILE . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG22 ' HD3' ' A' ' 43' ' ' LYS . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 41' ' ' GLU . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 70' ' ' THR . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD3' HG22 ' A' ' 39' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 192' ' ' PRO . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.555 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 192' ' ' PRO . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.605 ' CE1' HG21 ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.015 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.633 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 158' ' ' VAL . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.755 ' CE2' HG21 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.633 HD12 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' NH1' HG21 ' A' ' 27' ' ' THR . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 4.2 tt0 -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 15' ' ' HIS . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 61' ' ' THR . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 39' ' ' ILE . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.633 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 73' ' ' ILE . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HD13 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 83' ' ' LEU . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.916 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.891 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.9 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.696 HD23 ' CD2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 62' ' ' SER . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.629 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' NE2' ' A' ' 100' ' ' GLN . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.629 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 57.9 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD13 ' A' ' 102' ' ' LEU . 1.9 t-20 -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.735 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.703 ' HB2' HG13 ' A' ' 116' ' ' VAL . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.966 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 112' ' ' GLY . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.808 ' HD2' HD23 ' A' ' 133' ' ' LEU . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 132' ' ' SER . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.808 HD23 ' HD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.77 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 90' ' ' LYS . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.919 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.605 ' HA ' HD12 ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.523 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 152' ' ' ILE . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 199' ' ' LYS . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.598 ' C ' HG21 ' A' ' 2' ' ' THR . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' N ' HG21 ' A' ' 2' ' ' THR . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.778 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.755 HG21 ' CE2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.015 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 170' ' ' LEU . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.974 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.643 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 168' ' ' ARG . 24.1 m120 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.407 ' HB3' ' HB1' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.645 ' HG3' HD11 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.77 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 160' ' ' ILE . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.919 ' CG ' HD21 ' A' ' 141' ' ' LEU . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 197' ' ' LEU . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 181' ' ' GLN . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.966 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.701 ' CB ' HD12 ' A' ' 177' ' ' LEU . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.966 HG22 ' O ' ' A' ' 178' ' ' THR . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 121' ' ' ARG . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.686 HH21 HD23 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 193' ' ' ILE . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 187' ' ' LEU . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 209' ' ' ILE . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.674 ' HB2' HD13 ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 207' ' ' GLU . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.473 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.68 HD12 ' HA2' ' A' ' 201' ' ' GLY . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.543 ' HB2' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.68 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.764 ' HB2' HD11 ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.673 HD11 ' N ' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 157' ' ' LYS . 1.6 tmt? . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.757 0.313 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -42.17 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.354 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -108.31 -34.5 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -127.33 -178.18 4.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.685 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.24 47.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -159.57 -68.4 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.212 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 194' ' ' VAL . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.458 ' CG2' ' HB2' ' A' ' 161' ' ' ALA . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.741 ' HB2' HD13 ' A' ' 187' ' ' LEU . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.614 ' OE1' HG21 ' A' ' 37' ' ' THR . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.515 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 25' ' ' LEU . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' A' ' 101' ' ' GLY . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG3' HG23 ' A' ' 27' ' ' THR . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.659 HD23 HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HD23 ' A' ' 34' ' ' LEU . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 ' NE ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.907 HD13 ' HG2' ' A' ' 192' ' ' PRO . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' HG11 ' A' ' 194' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 159' ' ' LEU . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.002 HG22 ' HB3' ' A' ' 161' ' ' ALA . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 2.1 tt0 -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 39' ' ' ILE . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.48 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 71' ' ' CYS . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG2' HD13 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.612 ' HG2' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HG2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.912 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.884 ' HB3' HD12 ' A' ' 91' ' ' LEU . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' CG ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.454 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.633 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.454 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HA ' HG11 ' A' ' 116' ' ' VAL . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HD11 ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.902 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 112' ' ' GLY . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.512 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.716 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.478 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HB2' ' A' ' 126' ' ' ALA . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 165' ' ' ASN . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 90' ' ' LYS . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 137' ' ' ALA . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.499 ' HE1' HD11 ' A' ' 86' ' ' ILE . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CE2' HD11 ' A' ' 174' ' ' LEU . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.563 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.608 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 1.002 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.843 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.922 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.531 ' O ' HD11 ' A' ' 133' ' ' LEU . 1.7 t-20 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.554 HH12 HG12 ' A' ' 183' ' ' VAL . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.533 HD11 ' CD2' ' A' ' 144' ' ' TYR . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 1.024 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.673 ' HB3' HD13 ' A' ' 171' ' ' ILE . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.808 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.808 ' N ' HD22 ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.674 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.554 HG12 HH12 ' A' ' 168' ' ' ARG . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 1.024 ' CD ' HG21 ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.481 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.806 HD21 HH22 ' A' ' 185' ' ' ARG . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.637 HG22 ' HD3' ' A' ' 14' ' ' ARG . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.907 ' HG2' HD13 ' A' ' 49' ' ' LEU . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD13 HG12 ' A' ' 209' ' ' ILE . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 11' ' ' VAL . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 12' ' ' LEU . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.759 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.835 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.445 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.889 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.644 ' N ' HD23 ' A' ' 197' ' ' LEU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CG ' HD11 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 209' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.502 HD11 ' C ' ' A' ' 192' ' ' PRO . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 209' ' ' ILE . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 1.2 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.743 HG23 ' N ' ' A' ' 156' ' ' GLU . 1.6 t -80.87 172.69 13.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.427 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -177.8 132.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.94 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.14 56.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.88 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -167.44 178.77 1.08 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.697 ' CG ' HG21 ' A' ' 2' ' ' THR . 1.6 m-80 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 194' ' ' VAL . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.577 ' CD2' HD12 ' A' ' 160' ' ' ILE . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.899 ' HB2' HD11 ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.53 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 1.037 ' CE3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.037 HG23 ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HZ1' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 39' ' ' ILE . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 34' ' ' LEU . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 44' ' ' LEU . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.796 ' CG2' HG13 ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.756 ' HE1' HD13 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD12 ' NE2' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 3.0 tt0 -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.955 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' SG ' ' A' ' 71' ' ' CYS . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 84' ' ' GLU . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.645 ' N ' HD23 ' A' ' 83' ' ' LEU . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.935 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' OH ' ' A' ' 143' ' ' TYR . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.583 ' HA ' ' CE1' ' A' ' 163' ' ' HIS . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 165' ' ' ASN . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.784 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.719 ' CH2' HD22 ' A' ' 99' ' ' LEU . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CA ' HG22 ' A' ' 116' ' ' VAL . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 112' ' ' GLY . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.648 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.518 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.6 HG23 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.858 ' HB3' HD11 ' A' ' 99' ' ' LEU . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.408 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.451 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.81 ' OH ' HD11 ' A' ' 86' ' ' ILE . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.699 ' OH ' HD11 ' A' ' 174' ' ' LEU . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 148' ' ' ILE . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.725 ' HE1' HG21 ' A' ' 158' ' ' VAL . 31.0 p80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 153' ' ' LEU . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 2' ' ' THR . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.796 HG13 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.882 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.929 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.1 m80 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 136' ' ' THR . 12.0 t-20 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.574 ' HB3' HD11 ' A' ' 133' ' ' LEU . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.46 ' HB2' HG12 ' A' ' 182' ' ' ILE . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.919 ' HG ' HD21 ' A' ' 197' ' ' LEU . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 171' ' ' ILE . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' CB ' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.745 ' CB ' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.584 HD13 HD23 ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.475 ' NH2' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.889 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 14' ' ' ARG . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.889 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.75 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.92 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 9' ' ' LEU . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 197' ' ' LEU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.837 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.919 HD21 ' HG ' ' A' ' 174' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.564 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.554 ' N ' HD23 ' A' ' 197' ' ' LEU . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.92 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 192' ' ' PRO . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.426 ' N ' HG22 ' A' ' 209' ' ' ILE . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.661 0.267 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.878 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 194' ' ' VAL . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD21 HD11 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.88 ' C ' HD23 ' A' ' 12' ' ' LEU . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.88 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' THR . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.441 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CD ' HG21 ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.447 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.401 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.4 t30 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 39' ' ' ILE . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.566 HG21 ' CD ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 34' ' ' LEU . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 44' ' ' LEU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.762 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HG21 ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 159' ' ' LEU . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' C ' HD11 ' A' ' 83' ' ' LEU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.972 HG22 HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.626 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.851 ' CD2' HD11 ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.055 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.882 HD12 ' CE1' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.479 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.46 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.551 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD11 ' C ' ' A' ' 57' ' ' ASP . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.612 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.723 ' HB3' HD12 ' A' ' 91' ' ' LEU . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.719 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 127' ' ' PRO . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.473 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 32.8 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.634 ' N ' HD23 ' A' ' 102' ' ' LEU . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 102' ' ' LEU . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.783 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.589 ' CH2' HD22 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.845 ' CD1' HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.469 ' CG ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' HG22 ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.942 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' HD11 ' A' ' 99' ' ' LEU . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.539 HD12 ' OD1' ' A' ' 165' ' ' ASN . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.876 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 90' ' ' LYS . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.688 HG21 ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.865 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.865 ' CE1' HG23 ' A' ' 148' ' ' ILE . 6.1 p-80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 148' ' ' ILE . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.621 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.972 HG22 HG22 ' A' ' 58' ' ' ILE . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.644 HD11 HD21 ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 1.055 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.882 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.3 m-70 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.778 ' ND2' HG21 ' A' ' 136' ' ' THR . 8.4 t30 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 181' ' ' GLN . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.954 ' CB ' HG22 ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.549 ' HB ' HD23 ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 122' ' ' SER . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.538 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.515 ' CG2' ' HB1' ' A' ' 188' ' ' ALA . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.472 ' C ' HD11 ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.931 HD12 ' HG2' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.579 HG22 HG22 ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.864 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.586 HD11 HD22 ' A' ' 174' ' ' LEU . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.756 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.754 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.537 ' C ' HD13 ' A' ' 197' ' ' LEU . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 204' ' ' VAL . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.539 ' N ' HD22 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.931 ' HG2' HD12 ' A' ' 193' ' ' ILE . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.718 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.699 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 120.774 0.321 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.699 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD11 ' CG2' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.644 ' C ' HD23 ' A' ' 12' ' ' LEU . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.849 ' CG2' HD21 ' A' ' 159' ' ' LEU . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.406 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CD ' HG21 ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' CB ' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE2' HD23 ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 39' ' ' ILE . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.501 HG21 ' CD ' ' A' ' 17' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 34' ' ' LEU . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.933 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.909 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.81 ' CE1' HD12 ' A' ' 86' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.054 HG22 ' HB3' ' A' ' 161' ' ' ALA . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 69' ' ' LYS . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.718 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.867 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.75 ' HB3' HD12 ' A' ' 91' ' ' LEU . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.857 ' O ' HG22 ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.533 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.008 HD23 ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.479 HD22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.924 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.497 ' CB ' HG23 ' A' ' 116' ' ' VAL . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 118' ' ' ILE . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.924 HG21 ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.447 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.474 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.488 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.633 HD13 ' CG ' ' A' ' 173' ' ' ASP . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.643 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.725 HG21 ' CE1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 60' ' ' PHE . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.554 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.649 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.909 HG13 ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.933 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 170' ' ' LEU . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.722 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.942 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.7 m-70 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.801 ' HB3' HD11 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.719 HD21 HG11 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.633 ' CG ' HD13 ' A' ' 141' ' ' LEU . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.643 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.641 ' OE1' HD21 ' A' ' 177' ' ' LEU . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.856 HD12 ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 178' ' ' THR . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.89 ' HB2' HG22 ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 178' ' ' THR . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.746 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.746 HD23 ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.698 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.698 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.499 ' HB2' HG11 ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.583 ' N ' HD11 ' A' ' 209' ' ' ILE . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.648 HD23 ' CA ' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.739 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.84 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.648 ' CA ' HD23 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.448 ' CG ' HD11 ' A' ' 193' ' ' ILE . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 194' ' ' VAL . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 191' ' ' VAL . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.484 ' H ' HG22 ' A' ' 209' ' ' ILE . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.62 0.248 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' ND2' ' HA2' ' A' ' 155' ' ' GLY . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.653 ' C ' HD23 ' A' ' 12' ' ' LEU . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.692 HG22 HD21 ' A' ' 159' ' ' LEU . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.682 HH11 HG22 ' A' ' 189' ' ' THR . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.549 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 20.2 t30 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.726 HD23 HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.63 ' N ' HG22 ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.722 ' OD2' HD23 ' A' ' 64' ' ' LEU . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLU . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.722 ' HB2' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.633 ' CE2' HG21 ' A' ' 11' ' ' VAL . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.732 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.806 ' CZ ' HG23 ' A' ' 148' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.967 HG21 ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.722 HD23 ' OD2' ' A' ' 31' ' ' ASP . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.8 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 15' ' ' HIS . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.967 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 43' ' ' LYS . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.727 HD13 HG21 ' A' ' 85' ' ' THR . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 50' ' ' LYS . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.462 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.936 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.872 HD22 ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.726 HD22 HD23 ' A' ' 25' ' ' LEU . 4.5 t-20 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HG2' ' CE ' ' A' ' 109' ' ' LYS . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.872 ' CH2' HD22 ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.501 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 112' ' ' GLY . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.992 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' HG12 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.513 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.503 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.992 HD13 HD11 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HB3' HD11 ' A' ' 99' ' ' LEU . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 133' ' ' LEU . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.425 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 132' ' ' SER . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.925 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 90' ' ' LYS . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.897 ' CE1' HD11 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.989 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.561 HG22 ' HD1' ' A' ' 143' ' ' TYR . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.897 HD11 ' CE1' ' A' ' 143' ' ' TYR . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 145' ' ' LYS . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.592 HG21 ' HE2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 160' ' ' ILE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.897 ' N ' HD23 ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.946 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.728 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.637 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.479 ' N ' HG23 ' A' ' 171' ' ' ILE . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.925 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 197' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.825 HG22 ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.825 ' CB ' HG22 ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 178' ' ' THR . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.424 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.637 ' HD2' HG21 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 187' ' ' LEU . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 193' ' ' ILE . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.887 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.682 HG22 HH11 ' A' ' 14' ' ' ARG . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.887 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.64 ' HG3' HD12 ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 187' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.477 ' N ' HG22 ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.528 ' C ' HD22 ' A' ' 197' ' ' LEU . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 174' ' ' LEU . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.698 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.745 ' C ' HD13 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.592 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.862 ' HB3' HG13 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 194' ' ' VAL . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 211' ' ' ASN . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.522 ' N ' HG22 ' A' ' 209' ' ' ILE . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.595 HD21 HD11 ' A' ' 197' ' ' LEU . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 HD12 ' A' ' 160' ' ' ILE . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 194' ' ' VAL . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD22 HD23 ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.759 HG21 HD21 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.669 ' HD3' HG22 ' A' ' 189' ' ' THR . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 25' ' ' LEU . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.853 HG23 ' HE2' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.934 HD23 HD13 ' A' ' 39' ' ' ILE . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.578 HG21 ' OE1' ' A' ' 17' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.934 HD13 HD23 ' A' ' 34' ' ' LEU . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HZ3' HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.537 HD11 HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.604 ' CE1' HG21 ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.087 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.812 ' HB ' HG22 ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.681 ' CZ ' HG23 ' A' ' 147' ' ' THR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.626 HD13 ' HE1' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 19.3 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.58 HH21 HD22 ' A' ' 64' ' ' LEU . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.583 HD21 HD23 ' A' ' 83' ' ' LEU . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.528 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.583 HD23 HD21 ' A' ' 75' ' ' LEU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.89 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.915 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.788 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HG ' HD12 ' A' ' 102' ' ' LEU . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.792 ' CH2' HD11 ' A' ' 99' ' ' LEU . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.841 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.506 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 108' ' ' ARG . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 123' ' ' TYR . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 1.021 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 90' ' ' LYS . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.915 ' CZ ' HD11 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.545 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.445 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.731 ' O ' HD13 ' A' ' 153' ' ' LEU . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' HG23 ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 149' ' ' VAL . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.812 HG22 ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.087 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.86 HD12 HD21 ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.723 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.0 m-70 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.698 ' ND2' HG21 ' A' ' 136' ' ' THR . 7.5 t30 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.994 HD23 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.499 ' O ' HG22 ' A' ' 171' ' ' ILE . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.021 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.81 HD13 HG12 ' A' ' 140' ' ' VAL . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 182' ' ' ILE . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.497 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.902 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.839 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 178' ' ' THR . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.902 ' HB3' HD12 ' A' ' 177' ' ' LEU . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 178' ' ' THR . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.819 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.669 HG22 ' HD3' ' A' ' 14' ' ' ARG . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.819 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.904 HD11 ' CB ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 11' ' ' VAL . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.621 ' OH ' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.872 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.582 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 174' ' ' LEU . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.497 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.904 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.944 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.613 0.244 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.944 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 197' ' ' LEU . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 194' ' ' VAL . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.79 ' CG2' HD21 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.624 ' HA ' HG21 ' A' ' 70' ' ' THR . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 189' ' ' THR . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.552 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 25' ' ' LEU . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.552 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.657 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.657 ' N ' HG22 ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.441 HD13 ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HZ3' HG23 ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.767 HD12 ' CG ' ' A' ' 192' ' ' PRO . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.526 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.855 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CE2' HD11 ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD12 ' CE1' ' A' ' 163' ' ' HIS . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.453 ' NH2' HG21 ' A' ' 27' ' ' THR . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.6 OUTLIER -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 15' ' ' HIS . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.59 HG23 ' HZ3' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.826 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 74' ' ' ILE . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 56' ' ' PHE . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.621 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.79 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 91' ' ' LEU . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.713 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 ' CH2' ' A' ' 111' ' ' TRP . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 56.9 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.823 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.704 ' CH2' HD11 ' A' ' 99' ' ' LEU . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.494 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.024 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.53 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.588 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.497 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.024 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.472 HD23 ' HD1' ' A' ' 123' ' ' TYR . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 90' ' ' LYS . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.682 ' CD2' HD11 ' A' ' 170' ' ' LEU . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.619 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.619 ' CE1' HG23 ' A' ' 148' ' ' ILE . 7.4 p-80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 153' ' ' LEU . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.855 HG13 ' CG2' ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 13' ' ' THR . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 10' ' ' LEU . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.2 m-70 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' ' 136' ' ' THR . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 91' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HG2' ' HD2' ' A' ' 185' ' ' ARG . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.461 ' N ' HG23 ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 197' ' ' LEU . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.481 HD21 ' OE1' ' A' ' 175' ' ' GLU . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.838 HG22 ' HB3' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 178' ' ' THR . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.838 ' HB3' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.502 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 16' ' ' GLY . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.767 ' CG ' HD12 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.895 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 11' ' ' VAL . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 174' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.421 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.47 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.895 ' HB2' HD12 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 194' ' ' VAL . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.868 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.646 0.26 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 156' ' ' GLU . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.778 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.912 ' C ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.838 ' CG2' HD21 ' A' ' 159' ' ' LEU . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.843 ' HD3' HG22 ' A' ' 189' ' ' THR . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.64 ' OE1' HG21 ' A' ' 37' ' ' THR . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.765 HG23 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.765 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 HD13 ' A' ' 39' ' ' ILE . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' OE1' ' A' ' 17' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.661 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 78' ' ' VAL . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.577 ' OH ' HG23 ' A' ' 11' ' ' VAL . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.912 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.768 ' CG2' HG13 ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.469 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 163' ' ' HIS . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.582 HH21 HD13 ' A' ' 64' ' ' LEU . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 85' ' ' THR . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 39' ' ' ILE . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.799 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 83' ' ' LEU . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 75' ' ' LEU . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' N ' HD22 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.754 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.841 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.516 HD22 HD23 ' A' ' 25' ' ' LEU . 1.7 t-20 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.632 ' HA ' HG11 ' A' ' 116' ' ' VAL . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 112' ' ' GLY . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.05 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.465 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.05 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 132' ' ' SER . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.841 ' CG ' HD22 ' A' ' 99' ' ' LEU . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.628 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.46 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 132' ' ' SER . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.929 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 145' ' ' LYS . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HA ' HD12 ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.507 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.705 HD13 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 32.3 p-80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.912 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.795 HD13 HD23 ' A' ' 170' ' ' LEU . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.765 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.5 m-70 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.628 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.795 HD23 HD13 ' A' ' 160' ' ' ILE . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.929 ' OD1' HD21 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.706 ' HB2' HG22 ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 178' ' ' THR . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.472 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.843 HG22 ' HD3' ' A' ' 14' ' ' ARG . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.471 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.635 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 11' ' ' VAL . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.497 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.786 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.945 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 198' ' ' ASP . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.618 ' CG ' HD11 ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 209' ' ' ILE . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.709 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 194' ' ' VAL . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.797 ' C ' HD23 ' A' ' 12' ' ' LEU . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.924 ' HD3' HG22 ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.656 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.642 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.606 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HG3' HG22 ' A' ' 27' ' ' THR . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 39' ' ' ILE . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' OE1' ' A' ' 17' ' ' GLU . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 35' ' ' SER . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.886 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.694 HD13 ' CE1' ' A' ' 56' ' ' PHE . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.73 ' O ' HD23 ' A' ' 83' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.895 HG23 HG13 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.642 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 58' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' NH1' HG21 ' A' ' 27' ' ' THR . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 2.1 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 73' ' ' ILE . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 15' ' ' HIS . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HB2' HG21 ' A' ' 61' ' ' THR . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.886 HG23 ' NZ ' ' A' ' 43' ' ' LYS . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 83' ' ' LEU . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.529 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.966 ' N ' HD13 ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.84 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 140' ' ' VAL . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 88' ' ' SER . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 131' ' ' GLU . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.864 HD12 ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.642 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.788 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.536 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.48 ' O ' ' HD1' ' A' ' 119' ' ' TRP . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.788 HG21 ' HA ' ' A' ' 108' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.698 HG23 ' HD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.698 ' HD1' HG23 ' A' ' 118' ' ' ILE . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.582 HH21 HD22 ' A' ' 133' ' ' LEU . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 118' ' ' ILE . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.864 ' HB3' HD12 ' A' ' 99' ' ' LEU . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.582 HD22 HH21 ' A' ' 121' ' ' ARG . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.755 ' O ' HG23 ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.647 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 90' ' ' LYS . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.916 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 148' ' ' ILE . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.755 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 143' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 145' ' ' LYS . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.917 ' NE2' HG21 ' A' ' 158' ' ' VAL . 3.9 p-80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.526 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.648 HD21 ' O ' ' A' ' 199' ' ' LYS . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' OE2' ' HB2' ' A' ' 151' ' ' HIS . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.917 HG21 ' NE2' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.766 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.942 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.855 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.653 HD12 ' C ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.647 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.554 HD13 HG12 ' A' ' 140' ' ' VAL . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.495 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.916 ' CG ' HD21 ' A' ' 141' ' ' LEU . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.774 HD22 HD11 ' A' ' 197' ' ' LEU . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.862 ' CD ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.431 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.719 ' H ' HG23 ' A' ' 178' ' ' THR . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.814 ' HB2' HG22 ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.926 ' CZ ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.902 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.841 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.924 HG22 ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.841 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.75 HG22 HG22 ' A' ' 11' ' ' VAL . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.613 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.774 HD11 HD22 ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.648 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 198' ' ' ASP . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.5 ' HB2' HG23 ' A' ' 193' ' ' ILE . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.662 ' C ' HD13 ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 197' ' ' LEU . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD21 HD11 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.949 ' CG2' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HB3' HD13 ' A' ' 167' ' ' LEU . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.513 ' CG2' HD11 ' A' ' 159' ' ' LEU . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HD2' HD23 ' A' ' 187' ' ' LEU . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' HG21 ' A' ' 70' ' ' THR . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 37' ' ' THR . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.51 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 t30 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.823 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD11 ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.777 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.418 HG21 ' OE1' ' A' ' 17' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.477 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 40' ' ' LYS . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.834 ' HB3' HD23 ' A' ' 49' ' ' LEU . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.006 HG22 HG13 ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 86' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.824 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.67 HH21 HD13 ' A' ' 64' ' ' LEU . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 15' ' ' HIS . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.456 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.845 HD13 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.798 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.742 ' HB3' HD13 ' A' ' 91' ' ' LEU . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.024 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD11 ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CH2' HD11 ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 108' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.459 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 126' ' ' ALA . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.619 ' HB3' HD13 ' A' ' 99' ' ' LEU . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.511 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.667 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.879 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.717 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 151' ' ' HIS . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.653 ' NE2' HG21 ' A' ' 158' ' ' VAL . 11.4 p-80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.701 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.006 HG13 HG22 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.944 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.568 HD11 HD21 ' A' ' 10' ' ' LEU . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.598 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.024 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.8 m-70 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.669 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 171' ' ' ILE . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.718 HD21 HG11 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.472 ' N ' HG23 ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.879 ' OD1' HD21 ' A' ' 141' ' ' LEU . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.717 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.586 ' HB3' HD13 ' A' ' 177' ' ' LEU . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 175' ' ' GLU . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.895 HG22 ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.672 ' H ' HG23 ' A' ' 178' ' ' THR . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.895 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.488 ' HA ' HD23 ' A' ' 177' ' ' LEU . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.794 ' NH1' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.794 HD12 ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.811 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.811 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.949 HG12 ' CG2' ' A' ' 11' ' ' VAL . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 201' ' ' GLY . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.68 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.718 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.683 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 198' ' ' ASP . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.741 ' O ' HD22 ' A' ' 208' ' ' LEU . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 192' ' ' PRO . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 209' ' ' ILE . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.894 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.436 0.16 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.893 ' C ' HD23 ' A' ' 12' ' ' LEU . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.756 ' CG2' HD21 ' A' ' 159' ' ' LEU . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' CD ' HG22 ' A' ' 189' ' ' THR . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.415 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.636 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.8 t30 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.714 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' CE ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 34' ' ' LEU . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.744 ' HA2' HD11 ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.784 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.901 ' CE2' HD12 ' A' ' 159' ' ' LEU . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.892 HG22 HG13 ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 86' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.019 HG22 ' HB3' ' A' ' 161' ' ' ALA . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.806 HD12 ' HE1' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.714 HH12 HG21 ' A' ' 27' ' ' THR . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.958 ' HB2' HG21 ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.879 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.722 HD22 HG23 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG2' HG12 ' A' ' 78' ' ' VAL . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD11 HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.777 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.564 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 99' ' ' LEU . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 108' ' ' ARG . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.975 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.517 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.975 HD13 HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD12 ' OD1' ' A' ' 165' ' ' ASN . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.467 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.983 ' O ' HG12 ' A' ' 140' ' ' VAL . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.672 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.983 HG12 ' O ' ' A' ' 136' ' ' THR . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.784 ' OH ' HD11 ' A' ' 174' ' ' LEU . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.767 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.721 HD12 ' CD2' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.871 ' O ' HD23 ' A' ' 153' ' ' LEU . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.781 ' NE2' HG21 ' A' ' 158' ' ' VAL . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 149' ' ' VAL . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.581 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.892 HG13 HG22 ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.901 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.921 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.952 ' O ' HD12 ' A' ' 167' ' ' LEU . 6.2 m-70 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.471 ' OD1' HD12 ' A' ' 133' ' ' LEU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' OH ' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 183' ' ' VAL . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.819 ' NH2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.819 HD13 ' NH2' ' A' ' 185' ' ' ARG . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.442 HG22 ' CD ' ' A' ' 14' ' ' ARG . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 191' ' ' VAL . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 187' ' ' LEU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.429 ' O ' HD23 ' A' ' 197' ' ' LEU . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' C ' HD22 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 202' ' ' LYS . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.674 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.762 ' C ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.512 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 209' ' ' ILE . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.448 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.655 0.264 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HB3' HD22 ' A' ' 167' ' ' LEU . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.827 ' CG2' HD21 ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CD ' HG21 ' A' ' 37' ' ' THR . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 t30 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.468 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 39' ' ' ILE . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.526 HG21 ' CD ' ' A' ' 17' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.71 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.799 HD22 ' HE1' ' A' ' 56' ' ' PHE . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 194' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.876 ' CZ ' HG21 ' A' ' 11' ' ' VAL . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.544 ' C ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.623 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.862 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 12.4 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.468 HH12 HG21 ' A' ' 27' ' ' THR . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.967 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 81' ' ' PRO . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.697 ' HA ' HD12 ' A' ' 75' ' ' LEU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.902 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.623 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB3' HD12 ' A' ' 91' ' ' LEU . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.948 ' O ' HG12 ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' OH ' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.672 ' HB2' HG21 ' A' ' 136' ' ' THR . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.502 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.915 ' HA ' HD23 ' A' ' 102' ' ' LEU . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.915 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 24' ' ' ASN . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.693 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.857 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 118' ' ' ILE . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 112' ' ' GLY . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.145 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.515 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.145 HD13 HD11 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 132' ' ' SER . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.436 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.786 ' O ' HG13 ' A' ' 140' ' ' VAL . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 90' ' ' LYS . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.812 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.785 ' HE1' HD11 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.823 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 149' ' ' VAL . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.598 ' O ' HD23 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.996 ' CE1' HG23 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 148' ' ' ILE . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 149' ' ' VAL . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.933 HG21 ' NE2' ' A' ' 151' ' ' HIS . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.792 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.862 ' CE1' HD12 ' A' ' 64' ' ' LEU . 4.2 m-70 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.487 ' OD1' HG21 ' A' ' 136' ' ' THR . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.503 ' OG ' HD23 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.551 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.812 ' CG ' HD21 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 197' ' ' LEU . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.772 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 180' ' ' ASP . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.707 ' H ' HG23 ' A' ' 178' ' ' THR . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.654 ' HB2' HG22 ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.556 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.735 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.554 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 208' ' ' LEU . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.818 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 174' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.596 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.845 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.902 ' C ' HD23 ' A' ' 12' ' ' LEU . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HA ' HG21 ' A' ' 70' ' ' THR . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.576 ' CD ' HG21 ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.581 ' O ' HD12 ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.786 HG21 HH12 ' A' ' 66' ' ' ARG . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.769 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.601 ' CG ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 HD13 ' A' ' 39' ' ' ILE . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.576 HG21 ' CD ' ' A' ' 17' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 44' ' ' LEU . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' OE1' ' A' ' 77' ' ' GLU . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 9' ' ' LEU . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE2' HD12 ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.868 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.796 ' CD2' HD11 ' A' ' 86' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.92 HG22 ' HB3' ' A' ' 161' ' ' ALA . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD23 ' CG ' ' A' ' 31' ' ' ASP . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.563 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.786 HH12 HG21 ' A' ' 27' ' ' THR . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 15' ' ' HIS . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 70' ' ' THR . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.686 HD21 HD23 ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 78' ' ' VAL . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.686 HD23 HD21 ' A' ' 75' ' ' LEU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 58' ' ' ILE . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.584 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.8 ' HB3' HD12 ' A' ' 91' ' ' LEU . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.037 HD21 ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 1.048 ' HA ' HG21 ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.048 HG21 ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 1.037 ' CZ2' HD21 ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.659 ' CB ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.803 HD13 HD11 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.662 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.686 ' HD2' HD23 ' A' ' 99' ' ' LEU . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.411 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 133' ' ' LEU . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 90' ' ' LYS . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.599 HD11 ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 153' ' ' LEU . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.964 HD12 ' CE2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.99 HD11 HD11 ' A' ' 10' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.92 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.936 ' C ' HD12 ' A' ' 167' ' ' LEU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 82.9 m-20 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.503 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.831 ' HB2' HD13 ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.503 ' HA ' HD11 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.929 ' NH2' HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 187' ' ' LEU . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 193' ' ' ILE . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.787 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.787 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.967 HG13 HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.728 HG13 HG22 ' A' ' 11' ' ' VAL . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.907 ' O ' HG12 ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 174' ' ' LEU . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.458 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.578 ' HA ' HD22 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 204' ' ' VAL . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 191' ' ' VAL . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 209' ' ' ILE . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 1.016 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.232 0.161 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' LEU . 32.8 m-20 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.727 HD11 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' HB ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.071 ' CG2' HG13 ' A' ' 194' ' ' VAL . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 13' ' ' THR . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.936 ' HD3' HD13 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 30.1 p80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.534 HG21 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.534 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' CA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HG3' HG23 ' A' ' 27' ' ' THR . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' A' ' 66' ' ' ARG . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.029 HG23 HD13 ' A' ' 73' ' ' ILE . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 9' ' ' LEU . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CE2' HD11 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.763 HD13 HH21 ' A' ' 66' ' ' ARG . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.763 HH21 HD13 ' A' ' 64' ' ' LEU . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.2 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 74' ' ' ILE . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.641 ' HB3' HG21 ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 26.2 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.029 HD13 HG23 ' A' ' 39' ' ' ILE . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.851 ' N ' HD12 ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 43' ' ' LYS . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.627 HG12 ' OE1' ' A' ' 80' ' ' GLU . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.839 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.707 ' HB2' HD13 ' A' ' 58' ' ' ILE . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.924 HG22 ' HE3' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.675 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.924 ' HE3' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.951 ' O ' HG22 ' A' ' 140' ' ' VAL . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.552 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD13 ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.978 ' HG ' ' HB2' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.978 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.761 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.872 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.761 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.717 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.551 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.092 HD13 HD11 ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.724 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.696 ' HD2' HD13 ' A' ' 99' ' ' LEU . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 136' ' ' THR . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.656 HD13 ' NH2' ' A' ' 168' ' ' ARG . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.764 ' O ' HG23 ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.786 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 90' ' ' LYS . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.989 HD12 ' OD2' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.716 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.433 HG21 ' HE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.695 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 145' ' ' LYS . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 158' ' ' VAL . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.647 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.526 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 58' ' ' ILE . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.843 ' N ' HD12 ' A' ' 159' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.808 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.608 ' ND2' HG21 ' A' ' 136' ' ' THR . 4.1 t30 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.445 ' OG ' HG11 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.656 ' NH2' HD13 ' A' ' 133' ' ' LEU . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.786 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 140' ' ' VAL . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.599 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.989 ' OD2' HD12 ' A' ' 141' ' ' LEU . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.558 ' CG ' HD21 ' A' ' 197' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.561 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 172' ' ' MET . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' C ' HD12 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.791 HD12 ' HG2' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.791 ' HG2' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.936 HD13 ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.696 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.696 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.071 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.988 ' C ' HG12 ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 201' ' ' GLY . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.566 ' O ' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.977 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.458 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.988 HG12 ' C ' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.806 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.846 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.445 0.165 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.846 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.94 ' CG2' HG13 ' A' ' 194' ' ' VAL . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.741 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 161' ' ' ALA . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.709 ' HD3' HG22 ' A' ' 189' ' ' THR . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.851 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.796 ' O ' HD12 ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.486 HG22 ' OE2' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' OE2' HG22 ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.797 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' HG12 ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.76 ' CE1' HD12 ' A' ' 86' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 1.4 pp0? -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' HZ2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.79 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 74' ' ' ILE . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.696 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.787 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.76 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.839 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.468 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.504 HD11 ' CZ3' ' A' ' 111' ' ' TRP . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 41.8 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.716 HD22 HD23 ' A' ' 25' ' ' LEU . 9.0 t-20 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.773 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.431 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.435 ' H ' HG22 ' A' ' 125' ' ' ILE . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.477 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.423 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 1.017 ' O ' HG12 ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 1.017 HG12 ' O ' ' A' ' 136' ' ' THR . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 147' ' ' THR . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.663 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 60' ' ' PHE . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 8.5 p-80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' A' ' 152' ' ' ILE . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.737 ' HB ' HD22 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.905 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.839 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 5.2 m-70 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.402 HD22 HG21 ' A' ' 136' ' ' THR . 6.1 t30 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.648 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.478 ' HB3' HD13 ' A' ' 182' ' ' ILE . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.901 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.638 HD23 ' HA ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.959 ' O ' HG22 ' A' ' 182' ' ' ILE . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.754 ' HB2' HG22 ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 178' ' ' THR . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.809 ' CD ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.742 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.709 HG22 ' HD3' ' A' ' 14' ' ' ARG . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 209' ' ' ILE . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 209' ' ' ILE . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 208' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.94 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.733 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 194' ' ' VAL . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.775 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.462 ' N ' HG22 ' A' ' 209' ' ' ILE . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 197' ' ' LEU . 0.3 OUTLIER -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 194' ' ' VAL . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.679 ' CG2' HD21 ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' OE2' HG21 ' A' ' 37' ' ' THR . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 25' ' ' LEU . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' GLY . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 28' ' ' GLY . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 66' ' ' ARG . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.618 HG21 ' OE2' ' A' ' 17' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.47 HD13 HD23 ' A' ' 34' ' ' LEU . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' CE1' HG21 ' A' ' 11' ' ' VAL . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' C ' HD11 ' A' ' 83' ' ' LEU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.877 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 HH21 ' A' ' 66' ' ' ARG . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.645 HH21 HD13 ' A' ' 64' ' ' LEU . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.622 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 76' ' ' GLU . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 85' ' ' THR . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 57' ' ' ASP . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.928 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.73 ' HB3' HD12 ' A' ' 91' ' ' LEU . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.919 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 162' ' ' ALA . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.75 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.455 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.793 HD11 ' HH2' ' A' ' 111' ' ' TRP . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.832 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.911 ' HA ' HG21 ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.793 ' HH2' HD11 ' A' ' 99' ' ' LEU . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.51 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.036 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 183' ' ' VAL . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.508 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.036 HD13 HD11 ' A' ' 118' ' ' ILE . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 90' ' ' LYS . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.526 HD13 ' OD1' ' A' ' 173' ' ' ASP . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.491 ' HE1' HD11 ' A' ' 86' ' ' ILE . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 174' ' ' LEU . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.438 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.688 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.6 p-80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.535 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 153' ' ' LEU . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 159' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.851 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.638 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.496 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 140' ' ' VAL . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.465 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.526 ' OD1' HD13 ' A' ' 141' ' ' LEU . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD11 ' CZ ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.867 ' HB3' HD12 ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 178' ' ' THR . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 121' ' ' ARG . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.705 HH12 HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.742 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 45' ' ' GLY . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.742 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.449 ' HB2' HD12 ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.696 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 11' ' ' VAL . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.794 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.635 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.6 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.731 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 3.4 t30 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 197' ' ' LEU . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 194' ' ' VAL . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 193' ' ' ILE . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HB2' HD11 ' A' ' 167' ' ' LEU . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.709 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CE3' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 1.8 t30 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.436 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' CG ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 39' ' ' ILE . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 34' ' ' LEU . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 74' ' ' ILE . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.641 ' HE2' HG11 ' A' ' 194' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.849 ' HB ' HG22 ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.642 HH21 HD13 ' A' ' 64' ' ' LEU . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 10.4 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 15' ' ' HIS . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 83' ' ' LEU . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.7 HG13 HD13 ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.715 ' O ' HD22 ' A' ' 83' ' ' LEU . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.504 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.809 ' HB3' HD12 ' A' ' 91' ' ' LEU . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG12 ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 128' ' ' PRO . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 102' ' ' LEU . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 99' ' ' LEU . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.892 ' HA ' HG21 ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.912 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.429 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.636 ' HD1' HD23 ' A' ' 133' ' ' LEU . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.838 HG21 ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.468 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.682 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.779 HD22 HH21 ' A' ' 168' ' ' ARG . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.456 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.805 ' O ' HG13 ' A' ' 140' ' ' VAL . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.724 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.766 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 147' ' ' THR . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.856 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 152' ' ' ILE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.954 ' NE2' HG21 ' A' ' 158' ' ' VAL . 1.6 p-80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.453 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.954 HG21 ' NE2' ' A' ' 151' ' ' HIS . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.545 ' N ' HD23 ' A' ' 159' ' ' LEU . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.779 HH21 HD22 ' A' ' 133' ' ' LEU . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.766 ' CG ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.856 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.536 HD23 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.76 ' HB2' HG22 ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.536 HD13 HD23 ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 187' ' ' LEU . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.877 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.51 ' HG2' HD21 ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.923 ' N ' HD13 ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 193' ' ' ILE . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.534 ' CE1' HD11 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 10' ' ' LEU . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.67 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.691 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 197' ' ' LEU . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 198' ' ' ASP . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.755 ' HA ' HD11 ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 209' ' ' ILE . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 197' ' ' LEU . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.864 ' C ' HD23 ' A' ' 12' ' ' LEU . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.864 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 2.0 t30 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.589 HD23 ' CD1' ' A' ' 39' ' ' ILE . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.682 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 39' ' ' ILE . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.682 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.85 ' NZ ' HG22 ' A' ' 73' ' ' ILE . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CZ ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.681 HD21 ' CE1' ' A' ' 56' ' ' PHE . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HB2' HG12 ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.822 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.896 ' CE1' HG21 ' A' ' 86' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.517 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 1.7 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.819 ' CD ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 61' ' ' THR . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 22.2 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.986 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HA ' HG22 ' A' ' 78' ' ' VAL . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.78 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.78 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.561 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.793 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.896 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.791 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.968 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 88' ' ' SER . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.611 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.808 HD13 ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 107' ' ' ALA . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.833 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' GLN . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 112' ' ' GLY . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.532 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.623 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 168' ' ' ARG . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' A' ' 133' ' ' LEU . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.632 ' CB ' ' HD2' ' A' ' 128' ' ' PRO . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.808 ' HD2' HD13 ' A' ' 99' ' ' LEU . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.611 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.838 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.838 HG22 ' OE2' ' A' ' 131' ' ' GLU . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.787 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.968 HG22 ' O ' ' A' ' 90' ' ' LYS . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 152' ' ' ILE . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.667 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.822 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.783 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.816 ' HB ' HD22 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.851 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.851 HD12 ' C ' ' A' ' 163' ' ' HIS . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.728 ' HB3' HD11 ' A' ' 133' ' ' LEU . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.787 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.67 HD13 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 180' ' ' ASP . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.633 ' H ' HG23 ' A' ' 178' ' ' THR . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.606 HG12 ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.814 HH21 HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.814 HD12 HH21 ' A' ' 185' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.897 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.606 ' C ' HD11 ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.916 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.663 ' O ' HG12 ' A' ' 204' ' ' VAL . 2.3 t60 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.536 ' CA ' HD13 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.517 ' HA ' HD22 ' A' ' 197' ' ' LEU . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.715 ' H ' HD23 ' A' ' 208' ' ' LEU . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 3.6 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.951 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.752 0.311 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.951 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.986 HD12 ' OH ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.994 ' C ' HD23 ' A' ' 12' ' ' LEU . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 159' ' ' LEU . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.748 ' HA ' HG21 ' A' ' 70' ' ' THR . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.957 ' CZ3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 2.3 t30 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.81 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.957 HG23 ' CZ3' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.748 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.893 HD23 ' CD1' ' A' ' 39' ' ' ILE . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.533 HG21 ' OE1' ' A' ' 17' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.893 ' CD1' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.775 ' CD ' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.958 HD13 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.986 ' OH ' HD12 ' A' ' 9' ' ' LEU . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.789 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.813 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CE2' HD11 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 64' ' ' LEU . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.534 HH22 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 3.7 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 15' ' ' HIS . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 69' ' ' LYS . 34.6 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.775 HG23 ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.828 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 81' ' ' PRO . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.768 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.768 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.852 ' C ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.813 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.848 HG21 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.752 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' PHE . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.567 ' CZ3' HD11 ' A' ' 99' ' ' LEU . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 108' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.554 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.686 ' CD ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.529 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.808 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.923 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 90' ' ' LYS . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.806 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.794 ' CE2' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 1.155 HG23 ' CE1' ' A' ' 151' ' ' HIS . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 1.155 ' CE1' HG23 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.605 ' OE1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 159' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.4 m120 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 163' ' ' HIS . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.923 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.569 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.541 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.614 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.794 HD21 ' CE2' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.57 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.552 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.569 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.549 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.892 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.892 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.958 ' HG2' HD13 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.549 HG21 HD21 ' A' ' 187' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 9' ' ' LEU . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.561 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.875 ' O ' HG22 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.745 HD11 HD22 ' A' ' 10' ' ' LEU . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.539 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.573 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.638 ' HA ' HD23 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 196' ' ' HIS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.672 ' O ' HD23 ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.778 ' OD1' HD21 ' A' ' 197' ' ' LEU . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 194' ' ' VAL . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 167' ' ' LEU . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.6 ' HB ' ' HB2' ' A' ' 161' ' ' ALA . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.442 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' OE2' HG22 ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.49 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' SER . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.724 HD23 HD22 ' A' ' 103' ' ' ASN . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.842 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.842 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.549 HG22 ' OE2' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 73' ' ' ILE . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.702 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.944 ' CE2' HD12 ' A' ' 148' ' ' ILE . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.538 ' HG2' HD12 ' A' ' 34' ' ' LEU . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 39' ' ' ILE . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.421 HD13 ' OG1' ' A' ' 85' ' ' THR . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.753 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.928 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.928 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.517 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.946 ' N ' HD12 ' A' ' 102' ' ' LEU . 5.8 t-20 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.817 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.806 ' CD1' HG12 ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 118' ' ' ILE . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.806 HG12 ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 15.1 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 183' ' ' VAL . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.627 ' CE1' ' HE3' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.059 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 1.022 ' O ' HG12 ' A' ' 140' ' ' VAL . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.836 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 1.022 HG12 ' O ' ' A' ' 136' ' ' THR . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.631 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.774 ' O ' HD13 ' A' ' 148' ' ' ILE . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.944 HD12 ' CE2' ' A' ' 60' ' ' PHE . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.64 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.5 p-80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.518 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.772 HG13 ' CG2' ' A' ' 58' ' ' ILE . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.702 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.794 ' HB3' HD11 ' A' ' 133' ' ' LEU . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.836 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 144' ' ' TYR . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.627 ' HE3' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.931 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 182' ' ' ILE . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.925 ' O ' HG22 ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.418 ' H ' HG23 ' A' ' 178' ' ' THR . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.811 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.925 HG22 ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ARG . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.561 HH22 HD12 ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.857 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 187' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.428 ' CE2' ' CD ' ' A' ' 207' ' ' GLU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.761 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.778 HD21 ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.514 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.406 ' N ' ' HD2' ' A' ' 199' ' ' LYS . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.702 HG22 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.601 ' C ' HD12 ' A' ' 208' ' ' LEU . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 207' ' ' GLU . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.69 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.69 ' N ' HG23 ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 209' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.804 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.541 0.21 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.582 HD21 HD11 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.753 HG22 ' HB ' ' A' ' 194' ' ' VAL . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.727 HG22 HD11 ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.699 ' HD2' HD12 ' A' ' 187' ' ' LEU . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' HG21 ' A' ' 70' ' ' THR . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 25' ' ' LEU . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.9 t-20 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD11 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HZ1' ' A' ' 30' ' ' LYS . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.623 HD23 HD13 ' A' ' 39' ' ' ILE . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG22 ' HD3' ' A' ' 43' ' ' LYS . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 41' ' ' GLU . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 70' ' ' THR . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD3' HG22 ' A' ' 39' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 192' ' ' PRO . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.555 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 192' ' ' PRO . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.605 ' CE1' HG21 ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.015 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.633 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 158' ' ' VAL . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.755 ' CE2' HG21 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.633 HD12 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.643 ' NH1' HG21 ' A' ' 27' ' ' THR . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 15' ' ' HIS . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 61' ' ' THR . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 39' ' ' ILE . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.633 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 73' ' ' ILE . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HD13 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 83' ' ' LEU . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.916 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.891 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.9 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.696 HD23 ' CD2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 62' ' ' SER . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.545 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 33.5 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE3' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.735 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.703 ' HB2' HG13 ' A' ' 116' ' ' VAL . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.966 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 112' ' ' GLY . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.808 ' HD2' HD23 ' A' ' 133' ' ' LEU . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 132' ' ' SER . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.808 HD23 ' HD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.77 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 90' ' ' LYS . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.919 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.605 ' HA ' HD12 ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.523 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 152' ' ' ILE . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 199' ' ' LYS . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.778 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.755 HG21 ' CE2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.015 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 170' ' ' LEU . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.974 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.643 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 79.9 m-20 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.407 ' HB3' ' HB1' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.645 ' HG3' HD11 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.77 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 160' ' ' ILE . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.919 ' CG ' HD21 ' A' ' 141' ' ' LEU . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 197' ' ' LEU . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 181' ' ' GLN . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.966 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.701 ' CB ' HD12 ' A' ' 177' ' ' LEU . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.966 HG22 ' O ' ' A' ' 178' ' ' THR . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 121' ' ' ARG . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.686 HH21 HD23 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 193' ' ' ILE . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 187' ' ' LEU . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 209' ' ' ILE . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.674 ' HB2' HD13 ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 207' ' ' GLU . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.473 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.68 HD12 ' HA2' ' A' ' 201' ' ' GLY . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.543 ' HB2' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.68 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.764 ' HB2' HD11 ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.673 HD11 ' N ' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.541 0.21 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 194' ' ' VAL . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.458 ' CG2' ' HB2' ' A' ' 161' ' ' ALA . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.741 ' HB2' HD13 ' A' ' 187' ' ' LEU . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.495 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.614 ' OE1' HG21 ' A' ' 37' ' ' THR . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.515 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 25' ' ' LEU . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' A' ' 101' ' ' GLY . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG3' HG23 ' A' ' 27' ' ' THR . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.659 HD23 HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HD23 ' A' ' 34' ' ' LEU . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 ' NE ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.907 HD13 ' HG2' ' A' ' 192' ' ' PRO . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' HG11 ' A' ' 194' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 159' ' ' LEU . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.002 HG22 ' HB3' ' A' ' 161' ' ' ALA . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 39' ' ' ILE . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.48 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 71' ' ' CYS . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG2' HD13 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.612 ' HG2' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HG2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.912 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.884 ' HB3' HD12 ' A' ' 91' ' ' LEU . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.466 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.454 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.633 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.454 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HA ' HG11 ' A' ' 116' ' ' VAL . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HD11 ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.902 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 112' ' ' GLY . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.512 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.716 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.478 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HB2' ' A' ' 126' ' ' ALA . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 165' ' ' ASN . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 90' ' ' LYS . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 137' ' ' ALA . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.499 ' HE1' HD11 ' A' ' 86' ' ' ILE . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CE2' HD11 ' A' ' 174' ' ' LEU . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.563 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.608 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 1.002 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.843 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.922 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.531 ' O ' HD11 ' A' ' 133' ' ' LEU . 4.1 t30 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.554 HH12 HG12 ' A' ' 183' ' ' VAL . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.533 HD11 ' CD2' ' A' ' 144' ' ' TYR . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 1.024 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.673 ' HB3' HD13 ' A' ' 171' ' ' ILE . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.808 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.808 ' N ' HD22 ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.674 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.554 HG12 HH12 ' A' ' 168' ' ' ARG . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 1.024 ' CD ' HG21 ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.481 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.806 HD21 HH22 ' A' ' 185' ' ' ARG . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.637 HG22 ' HD3' ' A' ' 14' ' ' ARG . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.907 ' HG2' HD13 ' A' ' 49' ' ' LEU . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD13 HG12 ' A' ' 209' ' ' ILE . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 11' ' ' VAL . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 12' ' ' LEU . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.759 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.835 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.445 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.889 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.644 ' N ' HD23 ' A' ' 197' ' ' LEU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CG ' HD11 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 209' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.502 HD11 ' C ' ' A' ' 192' ' ' PRO . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 209' ' ' ILE . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.615 0.245 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 152' ' ' ILE . 2.1 m120 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 194' ' ' VAL . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.789 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.577 ' CD2' HD12 ' A' ' 160' ' ' ILE . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.899 ' HB2' HD11 ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.53 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 1.037 ' CE3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.037 HG23 ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HZ1' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 39' ' ' ILE . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 34' ' ' LEU . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 44' ' ' LEU . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.796 ' CG2' HG13 ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.756 ' HE1' HD13 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.824 HD12 ' CE1' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.955 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' SG ' ' A' ' 71' ' ' CYS . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 84' ' ' GLU . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.645 ' N ' HD23 ' A' ' 83' ' ' LEU . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.935 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' OH ' ' A' ' 143' ' ' TYR . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 165' ' ' ASN . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.784 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.719 ' CH2' HD22 ' A' ' 99' ' ' LEU . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CA ' HG22 ' A' ' 116' ' ' VAL . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 112' ' ' GLY . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.648 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.518 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.6 HG23 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.858 ' HB3' HD11 ' A' ' 99' ' ' LEU . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.408 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.451 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.81 ' OH ' HD11 ' A' ' 86' ' ' ILE . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.699 ' OH ' HD11 ' A' ' 174' ' ' LEU . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 148' ' ' ILE . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 148' ' ' ILE . 15.9 p-80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 153' ' ' LEU . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.796 HG13 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.882 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.929 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.5 m-70 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.729 ' ND2' HG21 ' A' ' 136' ' ' THR . 4.0 t30 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.574 ' HB3' HD11 ' A' ' 133' ' ' LEU . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.46 ' HB2' HG12 ' A' ' 182' ' ' ILE . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.919 ' HG ' HD21 ' A' ' 197' ' ' LEU . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 171' ' ' ILE . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' CB ' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.745 ' CB ' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.584 HD13 HD23 ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.475 ' NH2' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.889 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 14' ' ' ARG . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.889 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.75 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.92 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 9' ' ' LEU . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 197' ' ' LEU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.837 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.919 HD21 ' HG ' ' A' ' 174' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.564 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.554 ' N ' HD23 ' A' ' 197' ' ' LEU . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.92 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 192' ' ' PRO . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.426 ' N ' HG22 ' A' ' 209' ' ' ILE . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' CB ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.767 0.317 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 155' ' ' GLY . 3.2 t -62.0 164.56 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 m -93.58 164.52 13.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.411 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 29.4 mt-10 -65.38 129.71 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.55 38.07 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -136.74 179.19 1.43 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.878 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 72.3 Cg_exo -49.02 100.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.593 2.195 . . . . 0.0 112.272 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.578 ' HA ' HG21 ' A' ' 2' ' ' THR . 2.1 m120 -66.7 143.17 57.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 194' ' ' VAL . 4.8 tp -110.54 125.31 53.21 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.722 0.773 . . . . 0.0 111.42 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD21 HD11 ' A' ' 160' ' ' ILE . 1.8 tp -122.08 114.0 20.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.498 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.88 ' C ' HD23 ' A' ' 12' ' ' LEU . 25.6 t -92.06 131.1 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.29 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.88 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.03 122.97 46.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.855 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' THR . 10.3 t -117.95 111.0 18.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.471 . . . . 0.0 110.962 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -94.16 123.21 37.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.67 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.441 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 11.8 p80 -46.79 139.78 5.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -59.49 -122.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.879 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CD ' HG21 ' A' ' 37' ' ' THR . 15.7 pt-20 -111.2 130.42 55.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.989 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.447 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 2.0 p -90.46 166.15 13.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.74 -53.62 30.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.2 m95 -59.29 -26.14 64.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -45.43 92.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.261 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.257 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.7 -23.92 67.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.401 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.4 t30 75.09 48.66 0.09 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -127.85 152.45 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.783 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 1.7 m-85 -56.78 140.07 48.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -96.18 -84.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.981 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 104.24 -127.2 9.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -97.61 -24.0 15.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.728 0.299 . . . . 0.0 111.139 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.85 150.5 1.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.997 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -104.87 92.2 4.99 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 67.1 Cg_endo -74.61 176.02 10.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.47 2.113 . . . . 0.0 112.284 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.88 117.55 34.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 39' ' ' ILE . 9.5 tp -50.05 159.22 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.725 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.83 177.32 4.69 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.305 0.574 . . . . 0.0 111.627 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 40' ' ' LYS . 2.9 mp0 -53.51 -40.82 65.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.566 HG21 ' CD ' ' A' ' 17' ' ' GLU . 21.2 m -63.08 -44.68 95.09 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.29 -52.18 51.29 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 34' ' ' LEU . 16.5 mm -59.26 -55.84 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 44' ' ' LEU . 14.0 mtpp -54.32 -38.65 66.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.334 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 19.1 mm-40 -66.17 -46.02 78.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.604 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.04 39.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.585 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 mmtt -54.08 -53.53 51.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.519 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.3 mp -54.6 -46.29 73.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.295 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.31 -54.19 37.64 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -55.73 -51.39 55.37 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -57.72 -32.68 67.65 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 44' ' ' LEU . 5.5 mpt_? -72.3 -36.4 68.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.822 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.762 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.4 mt -75.44 -34.66 60.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.094 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.24 -28.21 22.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.213 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.443 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 4.8 m -64.4 -48.22 76.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.339 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' A' ' 51' ' ' SER . 0.0 OUTLIER -65.09 -36.06 83.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.064 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.14 5.07 15.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HG21 ' A' ' 11' ' ' VAL . 13.0 t80 -68.64 114.0 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 110.578 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -96.79 148.82 22.52 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.706 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 159' ' ' LEU . 17.9 m-85 -109.74 143.16 39.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 0.0 112.349 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' C ' HD11 ' A' ' 83' ' ' LEU . 1.5 m-20 -106.17 -41.28 5.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.607 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.972 HG22 HG22 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -146.08 150.54 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.104 179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.626 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -131.9 146.31 52.04 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.794 -0.566 . . . . 0.0 112.359 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.851 ' CD2' HD11 ' A' ' 86' ' ' ILE . 14.1 m-85 -128.26 135.7 50.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.635 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.055 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -135.33 174.78 10.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.319 0.58 . . . . 0.0 110.86 179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -91.84 -179.99 5.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.047 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.36 22.86 4.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 110.94 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.882 HD12 ' CE1' ' A' ' 163' ' ' HIS . 20.1 mt -107.47 142.17 37.75 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 111.173 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.2 pt20 -56.16 -41.17 75.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.644 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HD3' ' CB ' ' A' ' 18' ' ' SER . 12.5 mtm180 -51.29 -51.93 49.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.828 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.56 -38.29 26.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.558 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.479 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -60.47 -31.03 70.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 108.993 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 65' ' ' GLN . 21.4 ttpt -86.61 -53.37 5.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.108 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -49.51 -34.72 17.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.526 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.46 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -66.47 -50.83 61.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.981 0.419 . . . . 0.0 110.534 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 6.8 mt-30 -54.19 -44.14 71.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.339 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 77' ' ' GLU . 30.1 mt -60.25 -58.84 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -58.5 -45.65 90.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.334 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -63.41 -41.19 98.73 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-O 121.023 0.44 . . . . 0.0 110.298 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 54.3 mt-10 -73.55 -25.42 60.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.075 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -80.52 -53.93 6.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.796 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -51.6 -24.75 4.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.83 27.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.551 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.8 tp10 -137.97 52.22 4.79 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 42.4 Cg_exo -58.28 -32.29 95.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.034 1.823 . . . . 0.0 111.864 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -50.76 -26.74 5.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD11 ' C ' ' A' ' 57' ' ' ASP . 11.7 tp -48.26 155.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.659 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.589 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -88.27 94.62 9.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.085 0.469 . . . . 0.0 110.512 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.612 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 m -96.59 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.945 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -91.02 156.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.6 mmpt? -119.76 136.7 54.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.723 ' HB3' HD12 ' A' ' 91' ' ' LEU . 16.1 t -129.89 136.93 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 111.372 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 6.6 pt-20 -78.59 -27.76 45.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.2 mttt -73.3 -15.88 61.39 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -90.95 18.88 6.11 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.039 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -78.13 -173.47 3.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.785 0.326 . . . . 0.0 111.197 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 15.7 tp10 -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.396 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.719 ' HB2' HG21 ' A' ' 136' ' ' THR . 1.4 tmm_? -52.67 121.72 7.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 4.4 t80 -49.46 148.11 2.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -110.74 16.13 21.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.692 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 47.27 -128.77 13.32 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.084 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.46 16.1 6.96 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 127' ' ' PRO . 11.1 mt -90.74 -21.09 21.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.307 . . . . 0.0 110.913 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.473 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 32.8 mt-30 -55.54 108.11 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 112.6 18.08 7.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.867 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -112.47 121.99 46.41 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.386 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.634 ' N ' HD23 ' A' ' 102' ' ' LEU . 12.1 t-20 -59.49 129.47 42.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -38.38 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' LYS . 1.3 t70 -60.15 -55.19 36.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 102' ' ' LEU . 1.6 m-20 -62.76 -45.99 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -55.53 -51.98 65.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.783 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.4 ptp180 -69.89 -29.49 66.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.149 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' ASP . 4.3 mtpp -76.23 -20.53 57.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.028 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -18.36 13.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.688 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.589 ' CH2' HD22 ' A' ' 99' ' ' LEU . 3.0 m0 -124.83 -8.04 7.28 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 54.88 163.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.753 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -51.04 -38.87 54.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.0 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -58.04 -75.97 0.04 OUTLIER 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.313 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.494 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -54.16 -48.85 70.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.005 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.783 HG21 ' HA ' ' A' ' 108' ' ' ARG . 54.5 t -53.87 -46.75 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.021 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 13.4 tt0 -58.71 -64.47 0.92 Allowed 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.845 ' CD1' HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.22 -25.39 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.994 0.426 . . . . 0.0 110.204 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -79.85 -43.38 22.42 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.444 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.427 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 0.6 OUTLIER -89.71 -45.32 9.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' CG ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -98.23 -78.87 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' HG22 ' A' ' 125' ' ' ILE . 8.0 t 47.71 -94.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.704 0.287 . . . . 0.0 110.591 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 4.7 t80 160.8 -50.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.177 0.591 . . . . 0.0 110.56 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -121.83 -23.99 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.942 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.45 144.37 11.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.948 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.942 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -134.34 142.48 43.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' HD11 ' A' ' 99' ' ' LEU . 43.2 Cg_exo -55.88 167.07 2.49 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.48 2.12 . . . . 0.0 111.868 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.1 Cg_exo -45.49 97.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.393 2.062 . . . . 0.0 111.887 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 44.7 t-20 89.3 -26.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.467 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.5 162.17 29.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.689 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -97.31 175.32 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.77 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -126.64 -172.41 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.705 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.539 HD12 ' OD1' ' A' ' 165' ' ' ASN . 2.2 tp -71.55 -57.6 4.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -51.34 -45.14 62.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.24 -62.82 1.55 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.876 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 p -48.12 -54.97 11.44 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.777 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.91 -58.69 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.052 0.453 . . . . 0.0 109.854 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tt0 -47.65 -37.47 12.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.337 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.99 -9.8 35.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.044 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 90' ' ' LYS . 69.6 t -95.22 -40.02 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.31 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.512 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.1 mt -54.4 -42.15 92.83 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.609 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.9 Cg_exo -48.62 -50.86 11.44 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.753 1.636 . . . . 0.0 111.688 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.688 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.7 t80 -56.39 -50.5 71.42 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 7.4 t80 -53.74 -68.67 0.16 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.806 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -51.5 -63.6 1.08 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.85 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 35.0 t -46.22 -70.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.688 HG21 ' CE1' ' A' ' 143' ' ' TYR . 6.5 t -100.69 12.42 37.49 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.865 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.5 mt -131.43 -2.33 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.295 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.634 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.4 p -89.23 -20.16 0.25 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 96.7 Cg_endo -80.35 -37.48 0.39 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.595 1.53 . . . . 0.0 113.427 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.865 ' CE1' HG23 ' A' ' 148' ' ' ILE . 6.1 p-80 -81.96 -39.86 23.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 148' ' ' ILE . 49.5 pt -58.31 -19.17 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 111.189 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.9 mm? -87.25 -32.01 19.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -65.75 -25.21 67.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.642 ' O ' HG23 ' A' ' 2' ' ' THR . . . 105.59 39.09 2.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ASP . 23.6 tt0 -105.03 162.61 13.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.621 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -108.58 140.74 41.52 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.972 HG22 HG22 ' A' ' 58' ' ' ILE . 18.7 t -135.07 149.99 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.7 tt -90.57 153.47 20.31 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.023 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.644 HD11 HD21 ' A' ' 10' ' ' LEU . 5.3 mt -147.99 120.28 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.119 0.485 . . . . 0.0 111.158 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 1.055 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -129.93 106.02 8.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.723 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -141.86 -99.03 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.882 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.3 m-70 -162.36 163.44 27.87 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -44.25 -48.56 8.29 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.931 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.778 ' ND2' HG21 ' A' ' 136' ' ' THR . 8.4 t30 -61.94 -53.28 57.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -60.2 3.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 110.046 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER -58.55 -40.65 83.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.727 179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.2 mtm180 -52.87 -57.44 10.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.59 -44.08 76.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.69 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.0 tp -57.77 -64.83 0.77 Allowed 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.692 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -50.64 -38.44 16.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -53.2 -70.93 0.08 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.407 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 172' ' ' MET . 13.2 t70 -61.45 -29.39 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.387 . . . . 0.0 110.932 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 75.5 mt -72.06 -24.81 61.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -108.95 -16.27 14.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.56 34.77 48.83 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.516 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -49.81 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 112.636 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 181' ' ' GLN . 5.3 t -134.64 146.6 49.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.325 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -38.07 -28.47 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 N-CA-C 114.357 0.503 . . . . 0.0 114.357 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -117.24 26.63 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.34 0.57 . . . . 0.0 112.096 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.954 ' CB ' HG22 ' A' ' 178' ' ' THR . 5.1 tt0 -131.84 -6.0 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.549 ' HB ' HD23 ' A' ' 177' ' ' LEU . 7.4 tp -100.02 -20.11 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.884 0.373 . . . . 0.0 111.104 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 122' ' ' SER . 1.5 m -81.91 5.39 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.411 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -110.78 -21.53 12.02 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.716 0.294 . . . . 0.0 110.887 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.538 ' CZ ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -53.83 -171.31 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.554 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.0 151.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.25 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -129.67 -177.91 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.648 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 191' ' ' VAL . . . -119.09 126.09 50.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.335 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 35.6 p -85.0 134.24 34.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 90.55 -40.49 3.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.459 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.515 ' CG2' ' HB1' ' A' ' 188' ' ' ALA . 24.8 m -103.05 121.99 47.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.472 ' C ' HD11 ' A' ' 209' ' ' ILE . 9.2 Cg_endo -53.25 -171.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.219 1.946 . . . . 0.0 112.561 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.931 HD12 ' HG2' ' A' ' 207' ' ' GLU . 0.3 OUTLIER -168.52 120.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.48 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.579 HG22 HG22 ' A' ' 11' ' ' VAL . 3.4 t -98.68 139.72 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.529 ' CE1' ' CD1' ' A' ' 12' ' ' LEU . 3.4 m-30 -101.6 142.56 32.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.557 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.864 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -99.76 73.25 1.78 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.586 HD11 HD22 ' A' ' 174' ' ' LEU . 3.4 mt -79.0 166.88 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.824 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.756 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -96.33 -173.23 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.216 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.754 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -68.26 -6.42 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.707 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -23.7 13.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.852 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.537 ' C ' HD13 ' A' ' 197' ' ' LEU . . . 112.37 28.8 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 204' ' ' VAL . 14.0 ttmt -123.87 141.62 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.726 0.298 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.539 ' N ' HD22 ' A' ' 197' ' ' LEU . 4.0 p90 -51.18 146.01 7.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.37 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.2 m -142.58 27.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.471 ' OG ' ' CG ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -175.79 -81.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.58 152.42 0.09 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.931 ' HG2' HD12 ' A' ' 193' ' ' ILE . 3.1 tt0 -57.59 174.11 0.24 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.692 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -176.79 161.24 2.0 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.348 0.594 . . . . 0.0 111.937 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.718 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -127.93 -164.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.569 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 209' ' ' ILE . 7.3 m-20 -122.06 -40.05 2.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.621 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.884 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 15.2 ttt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.736 0.303 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 4' ' ' GLU . 7.5 t -49.64 -25.86 3.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.084 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 2' ' ' THR . 13.2 t 46.28 38.38 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.833 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.591 ' H ' HG23 ' A' ' 2' ' ' THR . 8.7 tt0 60.26 125.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.992 0.425 . . . . 0.0 111.412 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 165.36 -79.07 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.308 0.575 . . . . 0.0 111.058 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.699 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -173.47 -64.11 0.0 OUTLIER Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.707 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.699 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.3 Cg_endo -61.22 83.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.044 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 197' ' ' LEU . 8.9 p30 -63.93 141.5 58.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -98.25 145.97 26.1 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.409 0.623 . . . . 0.0 111.121 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD11 ' CG2' ' A' ' 158' ' ' VAL . 0.6 OUTLIER -145.47 123.63 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.94 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.644 ' C ' HD23 ' A' ' 12' ' ' LEU . 85.8 t -105.73 140.1 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.624 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -118.11 122.2 42.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.357 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.849 ' CG2' HD21 ' A' ' 159' ' ' LEU . 9.0 t -131.5 89.63 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.108 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 190' ' ' GLY . 51.9 ttt180 -71.1 134.79 47.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.406 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.4 p80 -44.02 134.14 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.948 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -47.76 -96.71 0.01 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CD ' HG21 ' A' ' 37' ' ' THR . 20.5 pt-20 -146.57 136.48 23.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.426 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -97.0 -172.7 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 111.144 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.72 -35.3 79.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 30' ' ' LYS . 10.2 m95 -67.99 -24.68 65.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.641 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.52 -39.17 77.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -64.18 -48.7 74.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' CB ' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -61.29 -27.73 68.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.278 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 27.1 t30 76.68 62.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.781 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.68 169.83 17.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.016 0.436 . . . . 0.0 110.743 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.008 ' CE2' HD23 ' A' ' 99' ' ' LEU . 2.3 m-85 -70.5 138.05 50.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.702 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -88.14 -85.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.0 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.21 -127.82 9.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.723 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.31 -24.06 15.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.49 147.72 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.257 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.68 96.05 11.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.827 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 88.3 Cg_endo -81.18 -167.76 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -124.02 122.92 39.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 39' ' ' ILE . 12.2 tp -49.04 163.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.98 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.52 177.14 6.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.027 0.441 . . . . 0.0 111.162 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . 2.4 mt-10 -51.98 -44.18 63.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.392 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.501 HG21 ' CD ' ' A' ' 17' ' ' GLU . 45.8 m -62.34 -38.53 89.83 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.09 26.27 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.488 HD13 HD23 ' A' ' 34' ' ' LEU . 17.9 mm -56.6 -50.53 73.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CE ' ' HB3' ' A' ' 36' ' ' GLU . 46.4 mttm -59.42 -36.46 75.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.118 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.3 mm-40 -64.69 -48.21 75.52 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.365 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.94 -56.62 15.59 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.693 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -53.1 -53.74 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.538 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -55.9 -48.17 76.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -52.19 -55.26 22.55 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -58.7 -49.99 71.88 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.218 -0.992 . . . . 0.0 110.908 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -51.4 -58.18 6.95 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -55.34 -54.4 44.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 54' ' ' TYR . 2.3 tm? -43.71 -59.7 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.783 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -65.99 -20.02 66.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.189 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 52' ' ' ARG . 3.0 p -57.6 -65.01 0.7 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.866 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' NH1' ' CB ' ' A' ' 210' ' ' ASP . 1.4 mpp_? -58.39 -36.0 72.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.98 33.26 1.08 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.616 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 t80 -93.14 121.0 34.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 1.6 mmpm? -106.89 157.58 17.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.933 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 27.2 m-85 -115.81 158.55 22.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 15.2 m-20 -123.29 -54.37 1.79 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.934 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.909 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.3 mm -112.04 138.9 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.625 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.58 116.86 23.82 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.225 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.81 ' CE1' HD12 ' A' ' 86' ' ' ILE . 3.7 m-85 -115.91 118.69 33.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.707 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.054 HG22 ' HB3' ' A' ' 161' ' ' ALA . 61.8 p -132.23 159.2 39.74 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.253 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 3.6 p -66.2 146.3 54.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.85 -19.88 13.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.93 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' A' ' 163' ' ' HIS . 83.0 mt -58.17 141.61 49.93 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.319 0.58 . . . . 0.0 111.76 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -51.57 -38.69 55.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.41 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 5.4 mtm180 -50.53 -67.56 0.24 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.964 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -55.88 -37.39 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.542 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.28 -45.65 80.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -71.74 -44.0 64.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.78 178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.5 m -56.58 -31.29 64.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.323 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 61' ' ' THR . 10.7 t -71.25 -65.28 0.77 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.948 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -47.5 -50.22 23.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.315 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 69' ' ' LYS . 12.3 mt -55.41 -66.73 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.065 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -54.34 -45.91 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.824 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 74' ' ' ILE . 14.5 mt -60.57 -46.74 89.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.976 0.417 . . . . 0.0 110.372 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 3.8 mm-40 -71.29 -24.46 62.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 8.7 tp10 -82.44 -37.59 25.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.006 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 74' ' ' ILE . 42.0 t -73.46 -24.84 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.235 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.74 34.79 9.75 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.718 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -149.69 55.62 1.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 5.7 Cg_exo -78.49 -41.09 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.189 1.926 . . . . 0.0 112.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -47.26 -31.2 3.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -51.66 -178.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.614 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -74.02 98.96 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.231 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.867 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 97.3 m -103.17 102.46 12.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.067 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.04 156.7 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.702 0.763 . . . . 0.0 111.066 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -135.89 154.69 51.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.703 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.75 ' HB3' HD12 ' A' ' 91' ' ' LEU . 13.6 t -124.22 144.8 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.005 0.431 . . . . 0.0 111.472 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -76.45 -31.45 57.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.586 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.857 ' O ' HG22 ' A' ' 140' ' ' VAL . 7.3 mtmt -73.32 -15.95 61.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.274 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.3 mt -72.09 -25.33 61.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.891 0.376 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -43.54 162.9 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.384 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.533 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.8 tp10 -66.78 152.22 45.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.144 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 3.7 tmm_? -54.88 139.57 39.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.488 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.9 t80 -69.04 127.43 33.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.369 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.493 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 1.5 m-85 -98.3 25.35 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 44.67 -108.02 0.17 Allowed Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.266 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.4 12.77 36.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.008 HD23 ' CE2' ' A' ' 26' ' ' PHE . 5.5 mp -87.76 -27.27 22.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.529 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.6 mt-30 -46.73 106.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.16 -16.43 17.76 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.891 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -71.18 122.99 21.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.99 0.424 . . . . 0.0 110.959 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.479 HD22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -58.59 127.41 32.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.645 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 11.5 mtmt -47.87 -40.81 22.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.484 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.57 -49.48 68.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.83 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.86 -50.8 72.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -60.87 -49.06 79.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.834 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.924 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.9 mtp85 -69.59 -9.26 53.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.943 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 68.0 mttt -99.1 -41.9 7.32 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.631 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -84.01 -37.32 22.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.497 ' CB ' HG23 ' A' ' 116' ' ' VAL . 2.0 m0 -100.05 -8.18 24.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.516 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 111' ' ' TRP . . . 55.67 159.41 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.641 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -47.15 -37.99 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 118' ' ' ILE . 8.9 mp0 -59.35 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.191 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.9 OUTLIER -53.79 -47.81 70.43 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.775 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.924 HG21 ' HA ' ' A' ' 108' ' ' ARG . 40.0 t -55.08 -42.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.902 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.8 tt0 -59.25 -65.56 0.65 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -50.96 -24.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.489 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 6.0 m95 -83.91 -72.93 0.44 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.448 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -65.51 -31.37 72.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.453 -178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.447 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 16.8 mmt-85 -95.35 -90.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.101 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 45.84 -171.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.529 0.204 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.474 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 36.2 t80 -133.34 -53.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.681 0.276 . . . . 0.0 111.491 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -109.59 -28.71 8.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 111.624 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 118' ' ' ILE . 1.2 pt -88.83 159.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.02 170.18 8.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.57 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.488 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 17.5 Cg_exo -67.43 173.22 9.09 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.99 2.46 . . . . 0.0 112.228 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -44.49 97.49 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.38 2.053 . . . . 0.0 111.56 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 4.9 m120 75.05 142.4 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.179 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 126.59 -148.39 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.86 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 1.3 mt-10 -135.88 175.03 9.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.764 0.316 . . . . 0.0 110.799 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' NH1' ' A' ' 94' ' ' ARG . 12.0 t -124.73 -85.11 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.793 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 168' ' ' ARG . 5.7 tp -148.73 -59.74 0.23 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.185 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -53.74 -35.73 61.55 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 131' ' ' GLU . 17.3 m-20 -68.82 -56.45 7.95 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.043 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 140' ' ' VAL . 47.3 m -49.45 -47.86 47.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.181 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 141' ' ' LEU . . . -65.37 -42.89 92.27 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -57.72 -21.02 38.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.707 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -111.75 -15.84 13.32 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.152 178.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 90' ' ' LYS . 98.9 t -97.59 -49.93 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.988 0.423 . . . . 0.0 110.687 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.633 HD13 ' CG ' ' A' ' 173' ' ' ASP . 20.2 mt -47.6 -45.69 58.9 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.876 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 52.9 Cg_exo -49.97 -49.33 16.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.434 1.423 . . . . 0.0 110.613 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 147' ' ' THR . 4.3 t80 -55.79 -48.91 74.52 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.643 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.67 -72.82 0.06 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.431 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -45.94 -59.25 2.94 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.021 179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 21.3 t -48.84 -69.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.725 HG21 ' CE1' ' A' ' 143' ' ' TYR . 15.2 t -97.63 8.43 44.66 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.766 HD11 ' CD2' ' A' ' 60' ' ' PHE . 17.1 mt -119.1 -11.97 10.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.969 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 5.2 p -75.24 -27.34 0.69 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 72.9 Cg_endo -83.45 -57.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.785 1.657 . . . . 0.0 114.358 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.554 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.9 p-80 -59.96 -15.84 25.4 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.7 pp -84.89 -26.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.6 mt -101.15 22.15 12.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.218 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -110.01 -43.01 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.139 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 4' ' ' GLU . . . 141.65 42.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 2' ' ' THR . 12.3 mp0 -149.57 158.85 44.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.649 ' C ' ' HE3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -102.65 -174.57 2.59 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.115 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.909 HG13 ' CG2' ' A' ' 58' ' ' ILE . 2.1 t -146.38 143.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.933 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.6 tt -94.9 142.01 27.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.875 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 170' ' ' LEU . 53.1 mt -133.75 113.88 19.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.531 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 1.054 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.35 98.79 5.58 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.891 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.722 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -138.3 -99.98 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.942 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.7 m-70 -159.13 161.93 36.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -41.3 -54.68 3.83 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.263 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -57.7 -56.07 26.72 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -51.44 -57.74 8.17 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 163' ' ' HIS . 2.3 mp -55.14 -37.52 67.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.801 ' HB3' HD11 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -55.2 -54.66 40.54 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -54.37 -52.75 60.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.029 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.719 HD21 HG11 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.17 -65.11 0.71 Allowed 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.772 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -43.06 -48.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.233 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 4.9 ptm -66.16 -38.52 88.29 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.633 ' CG ' HD13 ' A' ' 141' ' ' LEU . 36.6 t70 -67.97 -33.98 75.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.643 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 48.8 mt -81.75 -47.15 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.641 ' OE1' HD21 ' A' ' 177' ' ' LEU . 16.2 mt-10 -78.06 -19.15 54.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 73.07 28.11 67.16 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.149 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.856 HD12 ' HB3' ' A' ' 181' ' ' GLN . 1.9 mm? -51.22 -176.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 181' ' ' GLN . 12.2 t -120.58 -159.28 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.813 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.26 -32.73 22.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.881 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 178' ' ' THR . 13.7 m-20 -107.27 22.93 15.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.36 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.89 ' HB2' HG22 ' A' ' 178' ' ' THR . 53.3 mt-30 -125.79 -41.4 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.731 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 178' ' ' THR . 6.9 tp -75.5 -19.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.233 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.4 p -72.91 -2.01 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 181' ' ' GLN . 1.3 pttt -109.78 -21.02 12.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.578 0.228 . . . . 0.0 111.188 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.746 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -49.41 143.85 6.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.848 0.356 . . . . 0.0 110.757 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 7.1 tp10 -160.19 156.89 27.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.746 HD23 ' NH2' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -122.48 -171.35 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.698 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -115.76 29.27 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.38 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' ALA . 69.4 p 34.75 103.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.88 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 109.22 -43.29 1.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.766 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.698 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.2 m -67.56 113.31 13.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.566 0.222 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.499 ' HB2' HG11 ' A' ' 11' ' ' VAL . 54.5 Cg_endo -69.49 98.38 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.496 2.131 . . . . 0.0 112.284 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.583 ' N ' HD11 ' A' ' 209' ' ' ILE . 7.4 tp -81.57 124.99 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.172 0.51 . . . . 0.0 110.972 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 9' ' ' LEU . 2.4 p -88.41 139.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.367 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 36.3 m-85 -130.5 131.91 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.188 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 204' ' ' VAL . 1.1 t60 -85.73 111.34 20.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.648 HD23 ' CA ' ' A' ' 202' ' ' LYS . 0.5 OUTLIER -111.3 145.76 38.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.339 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.739 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -74.53 -178.74 3.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.478 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.84 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.65 -7.58 45.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.466 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -100.3 -22.55 15.06 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.776 0.322 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.73 49.2 0.86 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.648 ' CA ' HD23 ' A' ' 197' ' ' LEU . 2.4 tttt -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.668 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -49.84 140.95 10.99 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.9 m -140.36 17.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.887 0.375 . . . . 0.0 110.965 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.13 -156.94 0.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.22 145.45 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.118 0.485 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.448 ' CG ' HD11 ' A' ' 193' ' ' ILE . 4.9 pm0 -86.77 165.07 16.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.783 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 194' ' ' VAL . 5.3 tt -158.44 146.74 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.301 0.572 . . . . 0.0 111.793 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 191' ' ' VAL . 1.4 mm -115.21 156.62 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.597 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.502 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 1.9 p30 -40.88 -48.8 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.921 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.484 ' H ' HG22 ' A' ' 209' ' ' ILE . 61.4 m-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.158 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.883 ' CB ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.744 0.307 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 8' ' ' ASN . 70.9 p -42.69 142.12 0.92 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 t -166.18 -43.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -70.24 -16.18 63.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.256 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 74.57 52.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.992 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -167.7 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 63.0 Cg_endo -73.18 60.76 3.96 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.534 2.156 . . . . 0.0 112.208 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 2' ' ' THR . 8.7 m120 -55.81 140.65 41.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.324 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.883 HD13 ' CB ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -111.19 136.25 50.52 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.491 0.662 . . . . 0.0 112.103 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -127.11 131.63 50.78 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.085 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.653 ' C ' HD23 ' A' ' 12' ' ' LEU . 1.2 t -118.67 133.66 64.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.402 0.62 . . . . 0.0 111.159 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -110.8 125.46 53.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.026 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.692 HG22 HD21 ' A' ' 159' ' ' LEU . 10.8 t -129.11 103.78 7.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.109 0.481 . . . . 0.0 111.438 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.682 HH11 HG22 ' A' ' 189' ' ' THR . 56.3 ttt-85 -82.95 125.09 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.3 p80 -45.06 146.26 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.23 -129.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.564 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 19.8 pt-20 -114.87 131.97 56.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 0.0 110.754 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.5 p -102.91 175.45 5.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -50.14 -25.6 3.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.549 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.91 -21.14 63.08 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 21.8 t-20 -73.28 -54.12 9.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.622 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -35.99 47.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.5 -32.7 42.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.585 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 20.2 t30 73.55 56.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.206 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.726 HD23 HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -139.87 170.59 15.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CD1' ' CE2' ' A' ' 96' ' ' TYR . 19.3 m-85 -79.47 -172.61 3.32 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.5 m -142.59 -82.02 0.2 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.893 0.377 . . . . 0.0 110.343 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.63 ' N ' HG22 ' A' ' 27' ' ' THR . . . 105.21 -100.98 1.82 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.639 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -111.36 -30.8 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.286 . . . . 0.0 111.178 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -49.03 150.1 1.68 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.002 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.722 ' OD2' HD23 ' A' ' 64' ' ' LEU . 1.8 m-20 -101.63 99.56 11.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 97.7 Cg_endo -78.31 -167.44 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.602 2.201 . . . . 0.0 112.133 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.56 122.78 41.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.27 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.6 tp -56.72 169.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.617 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -127.42 171.25 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 11.9 mt-10 -52.18 -41.84 62.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.37 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 17' ' ' GLU . 41.7 m -63.94 -37.51 87.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.71 -55.68 16.32 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -56.92 -51.6 66.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 36' ' ' GLU . 2.9 tmtt? -56.53 -38.5 71.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.872 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -64.17 -45.87 86.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.269 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.3 -52.2 65.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.636 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.478 ' HG2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -52.22 -57.52 9.43 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.574 178.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -56.35 -42.86 78.44 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.191 178.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' LEU . . . -53.58 -59.37 9.79 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -61.71 -56.81 20.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.086 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 51' ' ' SER . 1.2 mm-40 -47.92 -33.73 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.15 0.5 . . . . 0.0 110.181 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.51 -29.48 25.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.958 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 ' HG3' ' A' ' 192' ' ' PRO . 0.4 OUTLIER -68.75 -54.35 16.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.602 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.722 ' HB2' HG22 ' A' ' 78' ' ' VAL . 8.6 ttmt -76.17 -23.1 54.72 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -52.96 -68.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.151 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.75 36.86 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.748 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.633 ' CE2' HG21 ' A' ' 11' ' ' VAL . 36.3 t80 -102.08 124.23 47.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.652 0.263 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -112.34 173.2 6.48 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.691 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 33.1 m-85 -121.82 164.71 17.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.851 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 157' ' ' LYS . 1.3 m-20 -128.65 -49.28 1.26 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.15 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.732 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 12.7 mm -129.14 150.48 34.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.673 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.57 127.38 46.28 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.364 -0.535 . . . . 0.0 111.536 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.806 ' CZ ' HG23 ' A' ' 148' ' ' ILE . 23.7 m-85 -120.47 105.58 11.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.967 HG21 ' HB3' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -116.59 160.08 21.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 111.255 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 84.4 p -75.1 173.46 10.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.877 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -89.11 19.85 4.01 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.21 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.722 HD23 ' OD2' ' A' ' 31' ' ' ASP . 8.0 mt -99.28 138.72 35.99 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.214 0.531 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.4 pt20 -49.43 -37.44 25.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 8.4 mtm180 -54.71 -58.64 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.51 -35.53 74.34 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.945 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.8 mt-30 -65.89 -35.96 82.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.24 -43.11 61.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.82 179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 15' ' ' HIS . 73.7 m -72.01 -22.41 61.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.045 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.967 ' HB3' HG21 ' A' ' 61' ' ' THR . 4.8 p -82.59 -46.61 13.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.344 . . . . 0.0 111.016 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' N ' ' SG ' ' A' ' 71' ' ' CYS . 1.2 mt-30 -49.59 -70.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.075 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 43' ' ' LYS . 6.5 mt -50.56 -64.98 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.239 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -48.25 -48.01 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.021 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.727 HD13 HG21 ' A' ' 85' ' ' THR . 34.1 mt -64.44 -57.09 10.23 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.267 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 2.4 mt-10 -58.76 -18.27 30.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.8 mm-40 -106.68 -3.06 21.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.884 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 50' ' ' LYS . 55.8 t -163.66 -38.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.222 0.534 . . . . 0.0 112.219 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 75' ' ' LEU . . . -61.86 -15.88 50.17 Favored Glycine 0 CA--C 1.489 -1.574 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.519 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER 63.29 73.14 0.52 Allowed Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.462 ' CG ' ' HA ' ' A' ' 76' ' ' GLU . 24.5 Cg_exo -28.0 -38.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 124.182 3.255 . . . . 0.0 114.16 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 80' ' ' GLU . 11.3 p30 -58.85 -44.48 91.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.491 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -48.99 160.04 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.044 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -70.1 101.74 1.9 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.409 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.936 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 52.2 m -105.14 110.91 23.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.92 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -124.44 166.05 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.672 0.749 . . . . 0.0 111.059 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -146.34 -176.99 5.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.501 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 2.9 t -164.11 155.65 16.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.898 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 17.5 pt-20 -77.77 -30.73 51.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.294 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 140' ' ' VAL . 5.1 mttt -68.2 -20.06 64.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.91 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -77.19 -3.76 41.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.459 179.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 66.6 m-20 -63.16 -178.57 0.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.837 0.351 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 6.1 tp10 -86.74 148.43 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.02 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.0 OUTLIER -50.37 126.69 15.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.41 ' O ' ' CA ' ' A' ' 130' ' ' GLY . 2.2 t80 -51.59 131.69 29.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.58 ' CE2' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -105.25 19.69 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.836 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 38.62 -109.79 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.759 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.01 -8.05 41.02 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.872 HD22 ' CH2' ' A' ' 111' ' ' TRP . 4.1 mt -83.63 6.44 20.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.624 0.249 . . . . 0.0 111.259 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 27' ' ' THR . 26.2 mt-30 -71.16 118.75 14.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 84.64 8.5 82.84 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.395 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -71.44 122.52 20.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.891 0.345 . . . . 0.0 110.471 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.726 HD22 HD23 ' A' ' 25' ' ' LEU . 4.5 t-20 -52.31 114.8 1.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.323 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.5 OUTLIER -42.86 -37.46 1.83 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 110.587 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 6.1 m-20 -65.3 -54.86 22.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.67 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.93 -47.78 83.82 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -58.94 -52.96 63.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.018 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -72.14 -6.28 41.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -96.71 -41.8 8.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HG2' ' CE ' ' A' ' 109' ' ' LYS . 4.0 mmtt -95.3 -33.69 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.55 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.872 ' CH2' HD22 ' A' ' 99' ' ' LEU . 7.5 m0 -104.08 -24.16 13.23 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.568 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 49.54 173.35 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.685 -0.688 . . . . 0.0 113.52 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -46.19 -38.61 8.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.005 0.431 . . . . 0.0 110.4 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' ILE . 4.7 mp0 -53.04 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.29 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.501 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -52.89 -47.86 67.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.17 0.509 . . . . 0.0 110.211 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 112' ' ' GLY . 94.8 t -51.11 -60.33 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' ARG . 16.1 pt20 -56.59 -48.69 76.88 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.279 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.992 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.9 -18.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.449 178.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.3 m95 -88.95 -42.33 11.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.404 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.528 ' NE ' HG12 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -102.23 -34.5 9.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 117' ' ' GLN . 6.1 mmp_? -85.5 -28.91 24.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.513 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.9 p -36.53 155.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.503 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 10.2 t80 -101.78 -43.29 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -116.98 -32.33 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 0.0 111.381 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.992 HD13 HD11 ' A' ' 118' ' ' ILE . 11.3 tt -78.18 139.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -123.99 153.39 67.66 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.608 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.535 ' HB3' HD11 ' A' ' 99' ' ' LEU . 30.2 Cg_endo -65.57 163.53 29.72 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.387 2.058 . . . . 0.0 111.908 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 90.8 Cg_exo -41.8 97.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.55 2.167 . . . . 0.0 112.533 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER 89.84 -32.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.017 0.527 . . . . 0.0 111.771 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 127' ' ' PRO . . . -54.78 -168.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.794 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -121.18 -176.48 3.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.826 ' O ' HG23 ' A' ' 136' ' ' THR . 7.4 t -133.59 -171.58 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 133' ' ' LEU . 2.3 tp -70.58 -58.95 3.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.425 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.43 -42.95 54.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.697 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 8.0 t70 -62.15 -62.24 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.029 0.443 . . . . 0.0 109.841 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 132' ' ' SER . 72.2 p -50.56 -51.91 43.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.987 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.925 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -59.62 -45.23 92.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.969 0.414 . . . . 0.0 110.046 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 4.2 mm-40 -62.44 -34.22 76.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.023 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -92.64 -11.98 32.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.156 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 90' ' ' LYS . 53.9 t -96.34 -34.36 5.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -61.04 -45.54 96.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.15 -179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.1 Cg_exo -46.96 -48.06 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.833 1.689 . . . . 0.0 111.004 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.897 ' CE1' HD11 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -58.05 -53.41 58.52 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.643 ' HA ' HD12 ' A' ' 148' ' ' ILE . 12.2 t80 -49.08 -65.38 0.58 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.716 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.989 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -55.27 -71.1 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.149 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 9.3 t -33.23 -62.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.561 HG22 ' HD1' ' A' ' 143' ' ' TYR . 4.2 t -123.78 26.47 7.67 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.897 HD11 ' CE1' ' A' ' 143' ' ' TYR . 5.2 mt -137.4 -5.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.989 HG22 ' O ' ' A' ' 145' ' ' LYS . 12.5 m -96.23 -2.22 0.1 OUTLIER Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 84.2 Cg_endo -83.77 -43.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 CA-C-N 120.915 1.363 . . . . 0.0 112.82 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CD2' HG13 ' A' ' 58' ' ' ILE . 39.5 p-80 -80.13 -51.32 9.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.67 0.271 . . . . 0.0 111.14 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 149' ' ' VAL . 37.5 pt -50.01 -25.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.902 0.382 . . . . 0.0 110.594 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -87.88 -27.5 22.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.498 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -77.78 -42.65 33.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.081 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA2' ' ND2' ' A' ' 8' ' ' ASN . . . 141.01 48.29 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.615 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.614 ' C ' HG21 ' A' ' 2' ' ' THR . 0.3 OUTLIER -118.61 145.49 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -95.17 153.33 17.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.592 HG21 ' HE2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -147.71 153.81 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -176.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 160' ' ' ILE . 5.1 tt -100.05 148.72 24.23 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.408 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.897 ' N ' HD23 ' A' ' 159' ' ' LEU . 60.0 mt -139.52 106.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.88 0.371 . . . . 0.0 111.45 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.946 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -121.32 104.7 9.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.174 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -147.76 -97.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.675 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.728 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.4 m-70 -160.76 164.95 31.15 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.045 0.45 . . . . 0.0 110.911 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -43.35 -54.15 5.6 Favored Glycine 0 C--O 1.224 -0.486 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.912 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 94' ' ' ARG . 40.8 m-80 -56.39 -51.33 68.75 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -53.51 -61.8 2.06 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 110.704 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -59.28 -44.47 92.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.459 ' NH1' ' NH1' ' A' ' 121' ' ' ARG . 6.3 mtm180 -53.04 -55.48 23.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.26 -47.8 74.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.736 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 tp -59.92 -65.87 0.61 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.657 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.637 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -53.16 -46.87 56.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.649 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.479 ' N ' HG23 ' A' ' 171' ' ' ILE . 15.0 ptm -58.77 -48.82 79.91 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.142 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.925 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 11.8 m-20 -70.28 -26.5 63.84 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.165 0.507 . . . . 0.0 110.158 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.847 HD21 HD11 ' A' ' 197' ' ' LEU . 12.6 tp -76.48 -36.52 57.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 3.0 mt-10 -88.72 -37.03 15.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.656 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.19 23.67 11.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.032 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -65.33 -172.9 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.764 0.316 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.825 HG22 ' CB ' ' A' ' 181' ' ' GLN . 14.7 t -120.57 -159.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.952 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -80.11 -53.1 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.795 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.22 16.14 7.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.576 0.227 . . . . 0.0 111.536 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.825 ' CB ' HG22 ' A' ' 178' ' ' THR . 11.2 tt0 -122.53 -7.37 8.63 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 178' ' ' THR . 7.7 tp -104.62 -35.49 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.696 0.284 . . . . 0.0 110.953 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.424 ' HA ' ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -49.0 -25.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -29.28 69.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.637 ' HD2' HG21 ' A' ' 171' ' ' ILE . 32.6 ttt85 -48.54 165.11 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.921 0.391 . . . . 0.0 110.47 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 187' ' ' LEU . 1.6 tt0 -167.8 164.45 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 193' ' ' ILE . 0.8 OUTLIER -157.11 167.83 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.123 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.887 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -110.6 141.44 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.682 HG22 HH11 ' A' ' 14' ' ' ARG . 32.3 p -82.55 113.13 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 115.25 -32.24 5.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.731 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.887 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.9 m -97.88 104.34 21.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.102 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.64 ' HG3' HD12 ' A' ' 49' ' ' LEU . 53.2 Cg_endo -67.53 116.57 4.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.77 2.313 . . . . 0.0 111.946 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.644 HG21 HD11 ' A' ' 187' ' ' LEU . 6.9 tp -86.06 154.16 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.813 0.339 . . . . 0.0 111.348 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 207' ' ' GLU . 1.6 p -120.1 163.44 17.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.578 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.477 ' N ' HG22 ' A' ' 194' ' ' VAL . 71.4 m-85 -147.97 171.75 15.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.017 0.437 . . . . 0.0 110.88 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.528 ' C ' HD22 ' A' ' 197' ' ' LEU . 1.4 t60 -117.24 119.47 35.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.372 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.847 HD11 HD21 ' A' ' 174' ' ' LEU . 1.4 mm? -117.22 143.98 45.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.167 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -81.92 179.21 7.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.404 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.698 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -60.38 -16.63 37.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.201 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.03 23.09 10.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.065 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 56.65 36.21 70.55 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.584 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.745 ' C ' HD13 ' A' ' 197' ' ' LEU . 46.3 tttt -120.05 140.49 50.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.954 0.406 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.592 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -56.61 127.98 34.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.983 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 198' ' ' ASP . 18.9 m -119.63 7.69 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.02 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 204' ' ' VAL . 1.9 m 162.73 141.45 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' CD ' ' A' ' 206' ' ' LYS . 0.0 OUTLIER -87.73 122.39 31.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.881 0.372 . . . . 0.0 110.435 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.862 ' HB3' HG13 ' A' ' 194' ' ' VAL . 3.7 tp10 -82.45 -147.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.076 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 194' ' ' VAL . 2.2 pt? -159.79 -162.8 1.06 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.468 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 211' ' ' ASN . 12.5 mm -98.22 152.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -71.76 -40.58 69.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.567 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.522 ' N ' HG22 ' A' ' 209' ' ' ILE . 43.6 t30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.956 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.576 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.334 . . . . 0.0 111.219 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 8' ' ' ASN . 3.6 m -47.84 167.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.25 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 4.0 m -157.84 169.23 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 3' ' ' THR . 4.4 pm0 -49.92 108.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.89 49.15 20.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -137.39 177.93 1.94 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.315 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 46.8 Cg_exo -56.56 110.87 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.794 2.329 . . . . 0.0 112.651 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.671 ' CB ' HG23 ' A' ' 2' ' ' THR . 1.9 p-10 -84.42 157.04 21.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.759 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -112.09 124.95 53.53 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.095 0.474 . . . . 0.0 111.566 -179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.86 HD21 HD12 ' A' ' 160' ' ' ILE . 1.3 tp -117.87 124.99 49.65 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.184 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 194' ' ' VAL . 46.1 t -100.43 145.43 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.471 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD22 HD23 ' A' ' 167' ' ' LEU . 83.1 mt -123.72 118.18 26.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.385 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.759 HG21 HD21 ' A' ' 159' ' ' LEU . 0.7 OUTLIER -121.7 71.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.126 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.669 ' HD3' HG22 ' A' ' 189' ' ' THR . 22.9 ttt-85 -54.39 119.73 5.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.494 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -42.42 148.48 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.14 -129.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.546 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.2 pt-20 -112.43 140.49 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.918 0.39 . . . . 0.0 110.962 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.411 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -100.02 168.4 9.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -52.39 -43.95 65.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.711 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' CZ3' ' CD ' ' A' ' 30' ' ' LYS . 6.4 m0 -60.64 -26.53 67.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.385 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.55 -39.19 93.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.14 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -63.88 -43.1 97.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.192 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD23 HD11 ' A' ' 25' ' ' LEU . 10.4 mp -63.47 -23.53 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.466 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 t30 76.03 50.28 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.259 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD11 HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -131.08 144.85 51.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.587 179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -48.67 159.97 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.146 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.853 HG23 ' HE2' ' A' ' 30' ' ' LYS . 54.9 m -103.53 -83.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.04 -123.64 7.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.486 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 95' ' ' TYR . 2.9 m0 -103.48 -20.31 14.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.645 0.26 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.853 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -46.23 154.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.338 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.72 92.25 16.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 93.6 Cg_endo -86.9 -168.17 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.915 2.41 . . . . 0.0 112.458 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.52 151.53 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.934 HD23 HD13 ' A' ' 39' ' ' ILE . 10.6 tp -80.84 166.79 20.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.4 p -123.33 171.77 9.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 111.379 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -44.14 62.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.578 HG21 ' OE1' ' A' ' 17' ' ' GLU . 39.2 m -62.32 -35.32 78.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.96 -56.27 11.34 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.934 HD13 HD23 ' A' ' 34' ' ' LEU . 32.9 mm -56.33 -48.54 79.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.06 80.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.935 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' THR . 2.0 mm-40 -62.03 -54.92 34.79 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.33 82.88 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HZ3' HG22 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -54.2 -59.87 4.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.394 178.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -57.3 -39.96 76.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.298 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.52 -59.4 10.83 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.346 -0.93 . . . . 0.0 110.896 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.16 -51.33 58.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.214 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.97 -40.21 63.56 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.08 0.467 . . . . 0.0 109.847 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 1.7 mmp_? -73.95 -39.2 63.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.734 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.537 HD11 HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -61.74 -43.01 99.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.295 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 16.7 ttpt -76.8 -39.27 52.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.81 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' NH1' ' A' ' 52' ' ' ARG . 8.8 m -43.05 -68.12 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' NH1' ' CB ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -48.5 -41.1 28.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.225 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.42 33.99 0.98 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.604 ' CE1' HG21 ' A' ' 11' ' ' VAL . 43.1 t80 -96.4 111.28 23.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.704 0.288 . . . . 0.0 110.838 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -96.27 153.23 17.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.087 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.4 m-85 -112.71 157.5 21.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 4.9 m-20 -121.88 -40.23 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.448 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.812 ' HB ' HG22 ' A' ' 158' ' ' VAL . 11.8 mm -128.11 151.52 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.072 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.05 128.49 36.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.681 ' CZ ' HG23 ' A' ' 147' ' ' THR . 5.4 m-85 -124.56 122.86 38.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.08 0.467 . . . . 0.0 111.857 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -125.48 165.76 17.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 111.582 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.5 p -78.75 178.07 8.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -92.04 24.32 3.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.964 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.626 HD13 ' HE1' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -103.79 139.44 39.01 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.308 0.575 . . . . 0.0 111.344 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 19.3 pt20 -48.48 -42.53 33.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.679 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.58 HH21 HD22 ' A' ' 64' ' ' LEU . 7.6 mtm180 -50.83 -59.35 4.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.01 77.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.86 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -61.47 -41.34 97.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HE2' ' CB ' ' A' ' 34' ' ' LEU . 4.7 ttpm? -68.39 -53.67 22.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.539 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.3 m -54.0 -37.78 64.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.517 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -59.68 -66.46 0.51 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 6.6 mt-30 -47.65 -48.84 28.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 39' ' ' ILE . 23.6 mt -59.77 -67.14 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.733 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -49.95 -47.41 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.738 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.583 HD21 HD23 ' A' ' 83' ' ' LEU . 20.2 mt -62.28 -59.5 4.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 2.7 mm-40 -55.09 -23.12 18.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -83.46 -43.75 15.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.845 179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 74' ' ' ILE . 79.3 t -60.15 -26.07 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.501 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 17.45 51.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.139 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.528 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 3.3 mt-10 -127.96 43.98 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 117.009 0.404 . . . . 0.0 111.967 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 91.8 Cg_exo -44.12 -44.32 12.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.021 1.814 . . . . 0.0 112.226 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -56.52 -22.57 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.972 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.583 HD23 HD21 ' A' ' 75' ' ' LEU . 1.8 tp -46.17 145.06 1.73 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 1.5 mt-10 -62.82 96.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 110.564 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.89 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 8.5 m -98.47 110.95 23.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -125.16 165.84 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.906 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -155.86 172.61 18.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.989 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.615 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -152.67 159.77 43.18 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.259 0.552 . . . . 0.0 112.149 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 15.1 tt0 -79.47 -27.99 41.57 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.4 mtmt -68.53 -12.81 61.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.539 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.915 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 0.5 OUTLIER -92.97 21.51 5.68 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.612 0.244 . . . . 0.0 111.156 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.2 m-20 -91.47 146.98 23.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.758 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.9 tp10 -52.15 139.61 23.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.788 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.6 OUTLIER -47.95 133.55 14.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.645 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 2.4 t80 -67.73 126.35 29.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 94' ' ' ARG . 8.2 m-85 -90.4 19.37 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.721 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 49.71 -100.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.47 1.12 37.83 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HG ' HD12 ' A' ' 102' ' ' LEU . 3.3 mp -88.48 13.15 12.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.559 0.218 . . . . 0.0 111.328 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -75.26 120.6 20.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.5 3.55 89.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.07 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HG ' ' A' ' 99' ' ' LEU . 1.8 mt -67.77 115.41 7.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.992 0.396 . . . . 0.0 111.167 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -56.55 119.03 5.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.299 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -42.84 -37.35 1.78 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.938 0.399 . . . . 0.0 110.748 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 4.0 m-20 -64.27 -52.59 57.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.482 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.15 -47.21 87.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -57.53 -58.5 8.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.056 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.343 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 4.7 ttmt -73.32 -51.99 15.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -106.74 71.94 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.632 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.792 ' CH2' HD11 ' A' ' 99' ' ' LEU . 3.6 m0 157.14 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.279 0.632 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.841 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.97 171.96 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.872 -0.603 . . . . 0.0 113.124 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -43.92 -46.73 8.25 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 118' ' ' ILE . 6.3 mt-10 -52.14 -77.57 0.02 OUTLIER 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.506 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -55.64 -50.26 70.67 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.972 -178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 108' ' ' ARG . 16.5 m -55.52 -36.71 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.241 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.485 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 27.5 tt0 -62.06 -62.46 1.76 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -55.65 -20.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.388 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.494 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 6.2 m95 -89.67 -33.57 16.58 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.1 OUTLIER -91.99 -38.53 12.19 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 8.6 mmp_? -97.12 -81.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.226 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER 40.35 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 67.4 t80 -56.99 -47.01 81.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.533 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.21 -29.39 3.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.759 HG13 HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -75.7 82.15 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' CA ' ' HB2' ' A' ' 132' ' ' SER . . . -63.85 139.67 97.69 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.164 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 44.2 Cg_exo -57.24 -178.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.588 2.192 . . . . 0.0 112.517 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 33.5 Cg_exo -57.56 93.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 111.987 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 9.9 m-80 79.3 141.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.9 -126.25 7.27 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.781 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.5 OUTLIER -148.18 -175.85 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.894 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -129.08 -86.21 0.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.543 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 123' ' ' TYR . 11.1 tp -149.27 -57.68 0.2 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.834 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -55.01 -38.27 67.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.841 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.3 m-20 -63.57 -62.01 1.95 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 140' ' ' VAL . 80.6 p -49.67 -51.63 36.75 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.171 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 1.021 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -52.36 -61.79 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 1.8 tm-20 -42.97 -39.57 2.66 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.286 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -94.74 -6.32 43.38 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 90' ' ' LYS . 79.1 t -100.04 -25.28 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -80.79 -31.7 0.63 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.501 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -52.13 -47.88 24.51 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.439 1.426 . . . . 0.0 110.679 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.915 ' CZ ' HD11 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -54.94 -48.09 73.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 148' ' ' ILE . 22.2 t80 -56.16 -72.23 0.08 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.552 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.545 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -46.73 -59.01 3.31 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.013 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.445 ' N ' ' HE3' ' A' ' 145' ' ' LYS . 47.2 t -53.78 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.3 t -93.31 9.53 35.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 144' ' ' TYR . 3.7 mt -128.53 -7.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.361 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.731 ' O ' HD13 ' A' ' 153' ' ' LEU . 4.0 p -85.57 -6.79 0.11 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -89.77 -46.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 121.27 1.489 . . . . 0.0 113.302 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' HG23 ' A' ' 152' ' ' ILE . 13.9 p-80 -73.48 -45.88 51.39 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.519 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 151' ' ' HIS . 18.6 pt -56.3 -20.8 10.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.854 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 149' ' ' VAL . 5.0 mp -80.19 -20.39 44.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.712 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -86.64 -39.6 15.94 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.394 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.73 47.58 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.974 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -129.07 148.67 51.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.524 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.28 161.04 14.63 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.812 HG22 ' HB ' ' A' ' 58' ' ' ILE . 6.4 t -132.97 156.54 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.087 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -103.81 147.38 27.36 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.897 176.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.86 HD12 HD21 ' A' ' 10' ' ' LEU . 8.7 mt -139.7 128.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.218 0.532 . . . . 0.0 111.49 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.7 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -137.87 106.8 5.97 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.138 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -140.6 -97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.723 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.0 m-70 -159.97 161.28 34.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 168' ' ' ARG . . . -43.12 -51.73 6.05 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.853 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.698 ' ND2' HG21 ' A' ' 136' ' ' THR . 7.5 t30 -59.53 -56.93 15.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.744 0.307 . . . . 0.0 110.56 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.46 -58.86 4.78 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.015 0.436 . . . . 0.0 110.811 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.994 HD23 HD22 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -63.16 -35.12 79.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.194 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.499 ' O ' HG22 ' A' ' 171' ' ' ILE . 7.5 mtm180 -57.22 -56.95 15.15 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.021 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -55.68 -51.57 66.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.694 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.81 HD13 HG12 ' A' ' 140' ' ' VAL . 1.2 tp -59.41 -52.99 63.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.58 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -60.4 -43.23 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.644 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 182' ' ' ILE . 1.8 ptt? -55.92 -45.45 78.73 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.481 ' CB ' ' CD2' ' A' ' 141' ' ' LEU . 1.7 t70 -75.84 -28.46 58.24 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.059 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -70.97 -34.89 71.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.27 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.497 ' HG2' ' CG ' ' A' ' 203' ' ' TYR . 19.2 mt-10 -97.31 -26.22 14.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 92.52 27.54 14.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.301 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.902 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.7 mm? -58.16 -176.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.368 . . . . 0.0 111.022 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.839 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.7 t -124.72 -159.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.795 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.31 -31.8 24.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 178' ' ' THR . 17.1 m-20 -105.24 24.0 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 111.125 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.902 ' HB3' HD12 ' A' ' 177' ' ' LEU . 41.9 mt-30 -128.01 -60.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.726 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 178' ' ' THR . 6.5 tp -51.22 -28.71 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.18 -20.16 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.38 16.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.628 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.9 121.46 4.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 0.0 110.785 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -129.5 126.93 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 185' ' ' ARG . 4.4 tt -111.97 117.62 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.819 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -52.07 -177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.669 HG22 ' HD3' ' A' ' 14' ' ' ARG . 73.0 p -121.69 112.83 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.82 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.56 -20.2 35.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.502 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.819 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -93.59 101.1 5.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 36.0 Cg_endo -65.33 99.84 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.461 2.107 . . . . 0.0 112.39 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.904 HD11 ' CB ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -90.1 135.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 11' ' ' VAL . 20.0 t -116.31 149.33 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.621 ' OH ' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -135.76 144.01 45.57 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 178.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.872 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -90.87 106.93 18.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.431 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -114.88 173.07 6.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.404 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -89.31 173.63 8.28 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.795 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 199' ' ' LYS . 0.0 OUTLIER -66.18 -13.66 60.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.996 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.93 -24.99 26.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.863 0.363 . . . . 0.0 110.596 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.582 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 112.18 20.5 6.67 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 174' ' ' LEU . 8.0 tttt -113.33 139.23 49.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 0.0 110.509 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.497 ' CG ' ' HG2' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -61.8 134.63 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.823 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 196' ' ' HIS . 10.1 m -120.26 -5.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 4.7 p -142.92 -155.98 0.64 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.567 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.77 166.36 10.87 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.053 0.454 . . . . 0.0 111.584 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.904 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -57.97 -177.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.213 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 121.43 2.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.089 0.471 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 11.2 mm -134.78 162.0 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.342 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 9.6 m-20 -86.22 -44.7 11.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.82 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.892 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.236 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 8' ' ' ASN . 7.1 p -51.08 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.921 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' ALA . 3.3 m -139.51 68.87 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.016 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.85 -84.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.03 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -120.86 80.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.944 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -170.02 -179.86 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.913 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.944 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.0 Cg_exo -44.73 94.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.416 2.078 . . . . 0.0 112.236 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.57 ' HA ' HG22 ' A' ' 2' ' ' THR . 11.5 p30 -59.38 -165.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.763 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' N ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -152.09 119.79 6.11 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.559 0.695 . . . . 0.0 111.427 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.8 118.11 27.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.949 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 194' ' ' VAL . 2.3 t -102.83 135.55 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.062 0.458 . . . . 0.0 110.678 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.57 119.62 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.42 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.79 ' CG2' HD21 ' A' ' 159' ' ' LEU . 0.3 OUTLIER -116.71 102.79 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.899 0.381 . . . . 0.0 111.263 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -83.61 123.65 30.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.578 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.624 ' HA ' HG21 ' A' ' 70' ' ' THR . 10.6 p80 -45.06 148.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.105 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 189' ' ' THR . . . -61.93 -128.71 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.204 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' CG ' ' HB ' ' A' ' 37' ' ' THR . 9.7 pt-20 -115.07 139.92 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.717 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.6 p -107.02 173.53 6.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.57 -26.28 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.678 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.552 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -58.94 -20.08 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.837 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 28.9 t-20 -74.62 -51.36 14.71 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -52.79 -35.39 56.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 25' ' ' LEU . 6.9 mp -84.12 -25.65 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.573 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 21.9 t30 65.28 62.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.047 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -142.73 174.95 10.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.552 ' HA ' ' CZ3' ' A' ' 20' ' ' TRP . 7.1 m-85 -82.61 -172.21 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.477 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.657 HG22 ' N ' ' A' ' 28' ' ' GLY . 1.4 m -141.57 -83.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 110.417 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.657 ' N ' HG22 ' A' ' 27' ' ' THR . . . 117.91 -115.77 3.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.515 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -105.94 -25.18 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 111.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -50.91 176.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -122.74 96.64 45.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 73.8 Cg_endo -75.36 172.52 16.19 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.635 2.223 . . . . 0.0 112.287 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.47 134.42 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.349 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.441 HD13 ' HG2' ' A' ' 66' ' ' ARG . 4.7 tp -72.96 166.35 23.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.93 175.06 7.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.058 0.456 . . . . 0.0 111.493 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.79 -43.36 63.02 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.404 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' GLU . 94.0 m -62.23 -38.07 87.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.11 17.72 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.25 -51.32 64.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -59.17 -35.78 74.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.063 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.9 mm-40 -65.04 -47.66 76.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.178 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.32 58.74 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.397 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HZ3' HG23 ' A' ' 73' ' ' ILE . 7.4 mttm -55.31 -49.29 72.54 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 -41.73 83.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -64.74 3.85 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -52.08 -46.21 56.29 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.135 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 34.8 mt-10 -59.47 -43.35 93.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 6.7 mmt85 -67.51 -32.77 73.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.749 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.767 HD12 ' CG ' ' A' ' 192' ' ' PRO . 1.4 tt -71.05 -56.69 5.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.915 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.49 -51.87 63.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.177 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 62.0 p -40.95 -30.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.836 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.1 mmp_? -85.65 -41.94 14.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.94 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.52 11.24 5.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.225 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.526 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 38.9 t80 -79.02 110.69 14.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -97.97 160.06 14.54 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.001 0.429 . . . . 0.0 110.596 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 159' ' ' LEU . 35.0 m-85 -113.53 155.91 24.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.495 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 156' ' ' GLU . 68.9 m-20 -116.55 -43.22 2.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.791 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.855 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.5 OUTLIER -138.77 146.62 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.653 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -125.8 143.16 51.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CE2' HD11 ' A' ' 86' ' ' ILE . 26.9 m-85 -133.8 126.17 30.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.906 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -123.92 178.34 5.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.467 0.651 . . . . 0.0 111.132 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 82.8 p -89.81 175.8 7.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.79 25.06 2.48 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.119 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD12 ' CE1' ' A' ' 163' ' ' HIS . 42.9 mt -114.16 146.09 40.79 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.165 0.507 . . . . 0.0 111.472 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 19.1 pt20 -50.65 -49.18 57.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.355 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.453 ' NH2' HG21 ' A' ' 27' ' ' THR . 26.5 mtm180 -42.8 -51.69 5.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -80.35 -41.4 24.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.52 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.6 OUTLIER -56.92 -27.52 60.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.554 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -94.44 -53.21 4.0 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.477 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 15' ' ' HIS . 30.0 m -49.62 -34.41 17.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.553 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.602 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.8 t -65.87 -53.27 41.86 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.003 0.43 . . . . 0.0 110.41 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -52.06 -50.49 61.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.435 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.59 HG23 ' HZ3' ' A' ' 43' ' ' LYS . 78.5 mt -50.46 -67.32 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.41 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.34 -42.2 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.118 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.826 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.3 mt -56.66 -67.16 0.33 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 11.9 pt-20 -56.91 -27.95 61.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.114 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -72.5 -41.65 65.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.682 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 74' ' ' ILE . 33.0 m -75.93 -2.09 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.688 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.34 30.52 75.43 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.271 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 6.4 mm-40 -138.82 53.26 5.15 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.918 0.359 . . . . 0.0 111.815 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.5 Cg_exo -65.43 -41.69 14.91 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.145 1.896 . . . . 0.0 111.886 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 83' ' ' LEU . 53.4 p-10 -49.68 -27.72 5.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 56' ' ' PHE . 2.2 tt -49.09 151.04 1.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.621 ' O ' HD13 ' A' ' 58' ' ' ILE . 95.5 mt-10 -74.75 100.76 4.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.967 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 94.0 m -107.44 120.65 42.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.79 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -121.84 177.71 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.185 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -147.85 162.53 39.07 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.934 ' HB3' HD12 ' A' ' 91' ' ' LEU . 1.5 t -139.93 150.01 44.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.104 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 2.9 tp10 -79.43 -28.57 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.554 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -78.27 -12.57 60.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.225 178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.7 mt -82.62 -1.92 52.38 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.582 0.23 . . . . 0.0 110.918 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -65.64 -178.82 0.59 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.786 0.326 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 21.9 tp10 -82.34 147.63 28.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.713 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -50.84 126.06 14.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -53.32 122.39 9.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.962 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 3.9 m-85 -98.3 30.72 3.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' CA ' ' OD1' ' A' ' 129' ' ' ASN . . . 31.41 -125.35 0.2 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 114.321 0.488 . . . . 0.0 114.321 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -76.95 -2.07 31.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.704 HD11 ' CH2' ' A' ' 111' ' ' TRP . 8.0 mp -88.81 14.16 10.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.656 0.265 . . . . 0.0 111.33 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 56.9 mt-30 -74.76 116.88 15.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.264 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 83.88 5.59 87.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.143 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -65.59 119.16 10.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.923 0.361 . . . . 0.0 110.326 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 106' ' ' ASP . 2.2 t-20 -53.9 111.29 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -40.79 -35.99 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.854 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 7.3 t0 -63.58 -50.73 68.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.607 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.6 t70 -68.6 -43.7 75.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -60.21 -42.1 94.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.184 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.823 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.9 ptp180 -79.89 -27.88 39.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.974 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 5.3 ttmt -72.09 -48.71 42.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.492 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -103.81 70.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.492 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.704 ' CH2' HD11 ' A' ' 99' ' ' LEU . 4.0 m0 155.16 -21.95 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.933 0.77 . . . . 0.0 110.41 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.31 165.19 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.963 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -49.36 -33.98 14.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.769 0.319 . . . . 0.0 110.42 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.33 -75.59 0.07 Allowed 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.494 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.2 OUTLIER -54.06 -45.25 71.66 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.6 t -55.35 -46.49 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 121' ' ' ARG . 5.1 tt0 -55.44 -59.3 5.01 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.024 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.98 -15.62 14.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.405 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.505 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.6 m95 -88.91 -41.41 12.44 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -113.03 -31.13 6.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.53 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.7 mmt-85 -91.08 -18.01 25.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.588 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.15 157.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.497 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 32.6 t80 -93.77 -54.23 3.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.834 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -112.96 -31.81 6.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 110.848 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.024 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -76.55 142.13 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.21 161.8 54.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.484 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 46.8 Cg_endo -71.82 172.63 14.13 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.085 . . . . 0.0 112.264 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -38.31 90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.935 2.424 . . . . 0.0 112.265 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER 73.14 152.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.304 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.07 -149.71 18.83 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.843 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.3 178.75 5.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.732 0.301 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 2.4 p -129.83 -87.27 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.472 HD23 ' HD1' ' A' ' 123' ' ' TYR . 8.6 tp -145.6 -61.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.001 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -53.4 -39.95 64.68 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -63.64 -55.58 22.48 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.777 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.1 p -51.8 -45.96 64.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.234 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 141' ' ' LEU . . . -63.34 -48.43 78.02 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.07 -29.83 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.857 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -100.51 -14.74 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.597 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 90' ' ' LYS . 76.2 t -97.56 -21.39 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.665 0.269 . . . . 0.0 110.92 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 mt -75.69 -44.4 4.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 50.6 Cg_exo -52.44 -48.7 20.48 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.776 1.651 . . . . 0.0 111.13 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 19.4 t80 -58.77 -48.64 80.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.682 ' CD2' HD11 ' A' ' 170' ' ' LEU . 23.8 t80 -52.41 -68.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.665 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.535 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.39 -66.68 0.35 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.803 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.9 t -46.88 -65.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.528 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.7 t -100.29 10.13 41.68 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.619 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.1 mt -132.65 -0.44 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.709 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.641 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.0 OUTLIER -93.0 -15.16 0.21 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.9 Cg_endo -79.24 -50.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.518 1.479 . . . . 0.0 113.51 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.619 ' CE1' HG23 ' A' ' 148' ' ' ILE . 7.4 p-80 -65.62 -42.11 91.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.641 0.258 . . . . 0.0 111.681 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.556 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -55.65 -21.77 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 111.335 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 153' ' ' LEU . 5.1 mt -96.5 -16.55 21.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -46.95 58.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.797 0.332 . . . . 0.0 110.981 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.86 42.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 57' ' ' ASP . 12.9 mp0 -137.6 152.84 49.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 0.0 110.591 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.55 161.91 13.29 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.855 HG13 ' CG2' ' A' ' 58' ' ' ILE . 5.1 t -129.98 155.59 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.79 HD21 ' CG2' ' A' ' 13' ' ' THR . 7.0 tt -104.99 139.67 39.34 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.469 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.629 HD11 HD21 ' A' ' 10' ' ' LEU . 10.0 mt -137.2 112.23 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.663 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.837 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -119.77 108.9 14.96 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.357 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.5 -97.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.447 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.2 m-70 -159.82 164.41 33.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.38 19.0 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.168 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' ' 136' ' ' THR . 5.7 t30 -66.97 -58.38 5.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 91' ' ' LEU . 1.8 t -52.98 -45.78 67.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.16 -46.57 88.36 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.801 178.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HG2' ' HD2' ' A' ' 185' ' ' ARG . 9.8 mtm180 -56.8 -55.61 32.1 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 172' ' ' MET . . . -53.78 -57.54 10.51 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.03 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 144' ' ' TYR . 2.3 tp -56.2 -64.16 0.95 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.485 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 172' ' ' MET . 0.1 OUTLIER -48.35 -51.67 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.221 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.461 ' N ' HG23 ' A' ' 171' ' ' ILE . 5.9 ptm -58.55 -39.68 80.89 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 172' ' ' MET . 19.0 t70 -70.35 -38.05 74.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 197' ' ' LEU . 48.8 mt -72.21 -39.79 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 19.5 mt-10 -85.05 -21.67 29.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 79.79 25.11 58.91 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.238 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.481 HD21 ' OE1' ' A' ' 175' ' ' GLU . 2.8 mm? -50.72 -178.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.339 . . . . 0.0 110.847 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.838 HG22 ' HB3' ' A' ' 181' ' ' GLN . 9.1 t -117.1 -158.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.497 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -85.59 -23.26 47.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.917 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.562 ' H ' HG23 ' A' ' 178' ' ' THR . 3.1 m-20 -123.82 22.86 8.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.838 ' HB3' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -127.71 -3.05 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.818 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 172' ' ' MET . 5.9 tp -103.82 -34.5 3.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.779 0.324 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -48.17 -26.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -30.82 57.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -53.95 121.1 7.31 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.663 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.54 160.5 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -146.74 140.33 25.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.967 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -78.33 163.82 25.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 16' ' ' GLY . 9.5 p -102.43 115.27 30.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.88 -33.29 6.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 18.4 m -81.85 115.66 58.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.384 0.135 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.767 ' CG ' HD12 ' A' ' 49' ' ' LEU . 59.8 Cg_endo -72.83 101.6 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 112.702 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.895 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.6 OUTLIER -67.52 153.65 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.264 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 11' ' ' VAL . 2.1 t -125.1 120.15 57.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.175 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 193' ' ' ILE . 21.9 m-30 -107.0 116.95 32.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.236 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.836 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.2 t60 -82.12 98.58 8.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 174' ' ' LEU . 1.1 mp -100.61 155.47 17.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.48 0.657 . . . . 0.0 112.42 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.421 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -79.29 -174.79 4.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.473 179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -5.67 30.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.801 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.5 -21.77 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 109.95 28.04 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.307 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.47 ' CA ' HD23 ' A' ' 197' ' ' LEU . 11.0 tttm -121.93 142.64 50.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.776 0.322 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.6 p90 -50.32 145.12 6.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 196' ' ' HIS . 16.1 m -133.17 3.52 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.93 -84.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.032 0.444 . . . . 0.0 110.966 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.03 171.31 0.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.895 ' HB2' HD12 ' A' ' 193' ' ' ILE . 1.6 pt-20 -77.37 169.19 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.823 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 194' ' ' VAL . 0.5 OUTLIER -174.04 136.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.741 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.5 mm -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.376 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.3 m-20 -56.15 -58.6 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.8 p30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.94 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' CB ' ' A' ' 57' ' ' ASP . 2.2 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.789 0.328 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.762 HG21 ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -75.6 81.08 2.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.639 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.5 t -42.26 -47.49 4.77 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.397 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 3' ' ' THR . 8.1 tp10 -66.92 111.42 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.55 62.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.194 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.868 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -169.37 -65.9 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.485 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 87.5 Cg_endo -78.56 65.45 8.62 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.595 2.197 . . . . 0.0 112.959 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.762 ' HA ' HG21 ' A' ' 2' ' ' THR . 14.3 m-80 -55.54 143.59 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 157' ' ' LYS . 8.5 tp -115.61 131.68 56.86 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.447 0.642 . . . . 0.0 111.216 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.778 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -127.7 129.37 47.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.261 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.912 ' C ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -114.11 146.76 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.197 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -120.88 120.3 35.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.747 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.838 ' CG2' HD21 ' A' ' 159' ' ' LEU . 3.3 t -127.47 95.96 4.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.961 0.41 . . . . 0.0 111.302 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.843 ' HD3' HG22 ' A' ' 189' ' ' THR . 0.4 OUTLIER -74.6 125.59 28.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.507 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -42.99 152.57 0.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -61.78 -130.4 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.412 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' OE1' HG21 ' A' ' 37' ' ' THR . 12.7 pt-20 -108.85 139.76 43.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 0.0 111.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -99.59 163.87 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.761 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -48.0 -39.93 21.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 10.8 m95 -60.67 -26.04 66.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.46 -37.34 86.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -48.82 75.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.21 -25.84 68.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.391 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 10.1 t30 80.05 61.13 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.96 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -139.48 167.04 23.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.612 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -70.6 147.94 48.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.765 HG23 ' CE ' ' A' ' 30' ' ' LYS . 69.4 m -80.91 -81.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.077 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -137.89 14.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -20.79 18.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.765 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.68 151.21 1.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.077 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.31 97.9 20.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.8 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 94.7 Cg_endo -87.67 -168.07 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.811 2.341 . . . . 0.0 112.381 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.9 117.67 26.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.247 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.539 HD23 HD13 ' A' ' 39' ' ' ILE . 19.8 tp -49.21 161.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.922 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.4 177.35 5.23 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.505 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.95 -44.26 63.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' OE1' ' A' ' 17' ' ' GLU . 24.3 m -61.81 -36.9 82.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -65.7 -55.9 17.65 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.8 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.558 HG23 HD13 ' A' ' 73' ' ' ILE . 18.1 mm -57.5 -51.16 73.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -57.23 -35.62 69.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.054 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 37' ' ' THR . 4.2 mm-40 -67.47 -47.95 68.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.443 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.61 55.38 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 mttm -51.98 -53.89 36.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.471 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.4 tp -56.62 -49.32 75.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.14 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -51.56 -59.46 8.46 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.125 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.45 -46.22 88.0 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.039 -1.077 . . . . 0.0 110.737 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 51' ' ' SER . 3.5 tt0 -52.28 -57.1 10.76 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.2 OUTLIER -59.43 -40.2 86.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.623 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.661 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -56.0 -57.05 13.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HB2' HG13 ' A' ' 78' ' ' VAL . 2.0 tmmt? -80.98 -21.68 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.7 t -65.92 -61.83 1.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.758 0.313 . . . . 0.0 111.767 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' NH1' ' HB3' ' A' ' 210' ' ' ASP . 24.3 mtm-85 -59.57 -17.2 30.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.52 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.21 57.36 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.408 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.577 ' OH ' HG23 ' A' ' 11' ' ' VAL . 20.4 t80 -124.31 124.41 42.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.764 0.316 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -109.16 168.18 9.57 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.912 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 35.8 m-85 -135.72 140.38 44.34 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' OD2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -106.53 -28.63 10.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.768 ' CG2' HG13 ' A' ' 158' ' ' VAL . 10.9 mm -142.14 153.64 18.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.475 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -136.17 124.21 22.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 0.0 111.3 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 158' ' ' VAL . 18.5 m-85 -112.63 114.5 27.14 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.533 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.469 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.0 OUTLIER -117.75 167.53 11.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.322 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 78.5 p -83.68 169.9 14.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -86.45 16.28 4.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.49 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 163' ' ' HIS . 41.2 mt -95.46 141.41 29.03 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.08 0.467 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 20.1 pt20 -47.22 -46.29 24.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.668 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.582 HH21 HD13 ' A' ' 64' ' ' LEU . 7.7 mtm180 -48.16 -63.0 1.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.106 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -57.24 -38.06 73.24 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.705 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -57.02 -53.71 54.93 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -44.65 92.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.729 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.3 m -56.68 -34.37 67.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.35 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 85' ' ' THR . 0.3 OUTLIER -65.17 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -49.39 -49.8 43.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 39' ' ' ILE . 73.4 mt -58.87 -65.93 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.675 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.799 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -50.25 -45.81 24.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.666 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 83' ' ' LEU . 4.1 mt -63.45 -62.41 1.69 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.017 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 79.5 mt-10 -53.84 -24.48 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.216 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 tp10 -81.31 -45.93 15.46 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 74' ' ' ILE . 53.4 t -56.55 -21.58 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.379 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.51 19.79 67.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.338 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.51 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 9.7 tp10 -133.35 44.48 1.3 Allowed Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 77.5 Cg_exo -42.79 -44.69 8.92 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.252 1.968 . . . . 0.0 112.283 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -50.56 -25.9 4.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 75' ' ' LEU . 1.4 tm? -45.61 126.51 6.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' N ' HD22 ' A' ' 83' ' ' LEU . 25.1 mt-10 -49.88 100.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.966 0.412 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.78 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 61.1 m -103.77 120.03 40.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -135.46 165.34 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.484 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -152.3 179.03 8.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.055 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 4.8 t -155.23 156.4 35.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.25 0.548 . . . . 0.0 112.081 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 10.5 pt-20 -79.26 -32.64 43.82 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.407 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 9.8 mtmt -70.67 -13.91 62.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.33 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.754 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 3.6 tp -89.9 18.11 6.05 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 111.161 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 52.3 m-20 -82.03 179.51 7.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 tp10 -74.46 150.04 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -53.85 117.56 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.768 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.6 t80 -47.87 116.82 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.151 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' A' ' 100' ' ' GLN . 4.0 m-85 -106.37 64.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -34.08 -82.1 0.01 OUTLIER Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.152 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -10.75 59.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.841 HD22 ' CG ' ' A' ' 127' ' ' PRO . 8.1 mp -98.53 5.37 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' TYR . 2.5 mt-30 -76.1 114.75 15.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.859 0.361 . . . . 0.0 111.128 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.21 -4.13 82.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.163 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mt -63.22 127.75 32.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.963 0.381 . . . . 0.0 111.179 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.516 HD22 HD23 ' A' ' 25' ' ' LEU . 1.7 t-20 -70.16 120.68 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.089 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -41.37 -38.27 1.18 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.916 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' LYS . 44.7 m-20 -63.61 -52.64 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.927 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -44.82 89.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -59.14 -49.69 76.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.049 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.632 ' HA ' HG11 ' A' ' 116' ' ' VAL . 8.3 ptm180 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.32 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.8 mttt -74.29 -44.83 51.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.443 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 1.9 tttp -108.47 70.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.542 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 4.0 m0 154.59 -22.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.936 0.773 . . . . 0.0 110.175 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.36 164.88 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.749 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.481 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.21 -43.47 10.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.697 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.0 mt-10 -55.47 -76.1 0.03 OUTLIER 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.289 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -53.59 -49.89 66.79 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.916 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 112' ' ' GLY . 17.8 m -56.72 -39.2 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.93 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 15.2 tt0 -61.24 -62.81 1.57 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.05 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -56.37 -20.28 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.242 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.0 m95 -82.79 -52.38 6.8 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -82.31 -39.38 22.97 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.4 mmp_? -89.5 -89.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.4 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.465 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER 47.49 -174.27 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 16.8 t80 -118.54 -54.78 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.71 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 19.9 p-10 -119.04 -27.42 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.05 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 tt -71.65 149.13 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 132' ' ' SER . . . -140.47 158.75 65.49 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.841 ' CG ' HD22 ' A' ' 99' ' ' LEU . 18.9 Cg_exo -65.15 166.81 17.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.64 2.226 . . . . 0.0 111.927 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.85 93.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.293 1.995 . . . . 0.0 111.213 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' PRO . 6.0 m-20 78.9 139.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.981 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 131.5 -149.74 19.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.578 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.3 OUTLIER -131.81 176.37 8.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.306 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.745 ' O ' HG23 ' A' ' 136' ' ' THR . 27.9 t -139.73 -159.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.173 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.628 HD13 ' CZ ' ' A' ' 168' ' ' ARG . 2.1 tp -74.12 -60.03 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 111.227 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HE2' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.83 -42.48 47.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.46 ' N ' ' HE2' ' A' ' 134' ' ' LYS . 3.2 m-20 -63.52 -62.96 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 132' ' ' SER . 76.6 p -48.59 -50.32 33.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.076 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -62.45 -44.22 96.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.094 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 1.3 mm-40 -63.07 -33.1 74.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.082 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.5 OUTLIER -93.13 -17.9 23.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.138 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 136' ' ' THR . 54.6 t -90.96 -33.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.961 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.929 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -61.99 -49.73 83.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 145' ' ' LYS . 87.2 Cg_exo -44.84 -50.96 7.95 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.109 1.873 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.2 OUTLIER -55.0 -50.23 69.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HA ' HD12 ' A' ' 148' ' ' ILE . 8.9 t80 -54.23 -71.54 0.08 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.925 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.475 ' HG3' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -48.04 -55.45 10.1 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.864 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 47.3 t -47.06 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.507 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.8 t -104.1 17.86 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.705 HD13 ' CE2' ' A' ' 60' ' ' PHE . 14.2 mt -128.03 -2.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.92 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.4 p -88.44 -16.84 0.22 Allowed Pre-proline 0 CA--C 1.549 0.914 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 69.8 Cg_endo -77.83 -41.27 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 121.399 1.4 . . . . 0.0 114.072 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 32.3 p-80 -84.86 -47.13 10.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 148' ' ' ILE . 18.6 pt -55.61 -20.99 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.945 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.1 mm? -84.99 -45.09 12.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -63.71 -24.03 67.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.15 41.93 0.57 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -96.83 154.27 17.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.945 0.402 . . . . 0.0 111.237 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.84 137.2 42.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 60' ' ' PHE . 3.1 t -139.55 153.39 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.912 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 5.6 tt -102.4 156.07 17.84 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.624 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.795 HD13 HD23 ' A' ' 170' ' ' LEU . 59.7 mt -143.64 113.14 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.909 0.385 . . . . 0.0 111.647 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -128.0 103.3 7.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.294 0.569 . . . . 0.0 111.235 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -143.62 -93.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.765 ' CE1' HD12 ' A' ' 64' ' ' LEU . 6.5 m-70 -159.64 163.89 34.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.912 0.387 . . . . 0.0 110.944 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -47.2 -38.76 12.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.568 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -66.27 -56.45 11.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -53.58 -44.38 69.31 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -63.89 -45.8 87.73 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.656 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.628 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 18.2 mtm180 -57.65 -50.93 71.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.16 -60.79 3.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.331 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.795 HD23 HD13 ' A' ' 160' ' ' ILE . 3.2 tp -54.63 -51.88 64.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 195' ' ' TYR . 0.1 OUTLIER -60.64 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.026 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 169' ' ' ALA . 5.6 ptm -54.85 -40.17 69.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.929 ' OD1' HD21 ' A' ' 141' ' ' LEU . 25.0 t70 -71.93 -29.72 64.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.647 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 197' ' ' LEU . 1.6 tp -72.9 -54.01 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.455 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 20.2 mt-10 -79.23 -24.22 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.971 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 82.47 27.17 44.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.39 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -54.0 -171.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.801 0.334 . . . . 0.0 110.758 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 181' ' ' GLN . 5.2 t -125.5 174.06 8.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . -66.96 -9.35 53.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.102 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -125.19 15.51 8.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.978 0.389 . . . . 0.0 111.606 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.706 ' HB2' HG22 ' A' ' 178' ' ' THR . 20.6 mm-40 -138.57 8.28 2.6 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 178' ' ' THR . 6.0 tp -108.44 -33.08 2.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.653 0.263 . . . . 0.0 111.233 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.2 OUTLIER -51.14 -24.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -71.62 -38.38 70.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.688 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.472 ' NH2' HD23 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -51.1 140.96 15.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.645 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.52 168.18 24.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -153.23 138.06 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -79.11 156.07 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.843 HG22 ' HD3' ' A' ' 14' ' ' ARG . 67.1 p -87.39 113.38 23.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.8 20.46 14.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 188' ' ' ALA . 26.4 m -130.46 111.52 16.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.576 0.227 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.471 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 72.3 Cg_endo -76.4 99.06 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.681 2.254 . . . . 0.0 112.596 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.635 HG23 ' HG ' ' A' ' 12' ' ' LEU . 8.1 tp -82.54 152.12 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.725 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.715 HG22 ' CG2' ' A' ' 11' ' ' VAL . 9.9 t -111.74 148.47 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.617 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.497 ' CZ ' HG13 ' A' ' 171' ' ' ILE . 23.5 m-85 -135.32 105.55 6.32 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' CD2' ' CG2' ' A' ' 204' ' ' VAL . 3.4 t-160 -60.24 106.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 174' ' ' LEU . 6.2 mt -105.83 153.22 22.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.362 0.601 . . . . 0.0 111.988 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.786 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -90.47 -170.61 2.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.911 178.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.945 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.79 -0.13 10.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.63 24.09 11.09 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 60.13 35.58 88.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.405 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 2.9 tttm -122.99 139.78 53.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -56.37 145.27 27.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' A' ' 198' ' ' ASP . 34.7 m -146.35 23.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -173.45 -156.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.206 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 176.23 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 111.145 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.618 ' CG ' HD11 ' A' ' 193' ' ' ILE . 24.1 pm0 -107.57 153.58 22.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.212 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 193' ' ' ILE . 1.5 mp -135.26 142.06 45.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.254 0.55 . . . . 0.0 111.697 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -120.37 175.68 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.246 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 209' ' ' ILE . 31.3 p30 -75.11 -44.79 45.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 209' ' ' ILE . 10.1 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' THR . 34.1 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.676 0.274 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.478 ' OG1' ' N ' ' A' ' 3' ' ' THR . 0.6 OUTLIER 44.23 -178.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.481 0.657 . . . . 0.0 112.772 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 5' ' ' ALA . 92.4 m -38.92 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.394 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 7.0 mt-10 50.59 26.68 2.55 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.269 0.557 . . . . 0.0 109.883 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.794 ' H ' HG22 ' A' ' 3' ' ' THR . . . 162.96 -62.85 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.494 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -168.03 -65.42 0.01 OUTLIER Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.709 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 22.0 Cg_endo -61.35 101.51 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.815 2.343 . . . . 0.0 112.853 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.451 ' HA ' ' N ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -84.08 178.48 7.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.159 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 194' ' ' VAL . 0.2 OUTLIER -133.91 140.33 46.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.115 0.483 . . . . 0.0 111.132 -179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 160' ' ' ILE . 10.7 tp -131.6 116.61 17.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.689 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.797 ' C ' HD23 ' A' ' 12' ' ' LEU . 79.8 t -100.23 128.01 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.676 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -110.97 127.25 55.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.601 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.7 OUTLIER -114.42 80.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.958 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.924 ' HD3' HG22 ' A' ' 189' ' ' THR . 19.7 ttt-85 -65.39 115.65 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.656 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.5 p80 -42.28 140.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.79 -122.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.514 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 37' ' ' THR . 11.0 pt-20 -114.35 113.48 24.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.903 0.382 . . . . 0.0 110.685 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 6.2 p -82.26 177.8 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -49.14 -47.8 45.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 30' ' ' LYS . 13.3 m95 -69.53 -28.98 66.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -59.96 -60.47 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.654 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -51.76 -45.45 63.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.3 mp -55.53 -22.67 22.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.807 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.83 37.48 0.22 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.652 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.642 HD23 ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -118.13 164.84 14.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 96' ' ' TYR . 4.8 m-30 -76.98 121.99 24.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.173 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.606 HG22 ' NZ ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -63.44 -85.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.788 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.25 -112.02 3.08 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.832 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.82 -26.31 6.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' NZ ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.37 160.12 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HB2' ' CG ' ' A' ' 65' ' ' GLN . 3.1 p-10 -101.84 106.58 47.9 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.341 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.499 ' HG3' HG22 ' A' ' 27' ' ' THR . 85.3 Cg_endo -93.72 114.59 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.865 2.377 . . . . 0.0 112.539 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.81 111.14 0.43 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.851 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 69' ' ' LYS . 2.3 tp -44.56 151.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 39' ' ' ILE . 23.4 p -98.15 176.54 5.7 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 24.4 tt0 -51.88 -51.32 57.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.353 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' OE1' ' A' ' 17' ' ' GLU . 22.6 m -54.03 -41.87 68.52 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -62.0 -48.62 82.22 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 35' ' ' SER . 20.8 mm -57.14 -59.98 2.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.9 -37.79 71.91 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 7.1 mm-40 -61.41 -49.24 77.67 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 -53.27 57.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.439 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.886 ' NZ ' HG23 ' A' ' 73' ' ' ILE . 22.9 mmtt -52.58 -47.43 66.87 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.314 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 40' ' ' LYS . 8.1 mp -61.0 -50.71 72.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.0 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.59 -53.16 22.1 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.444 -0.884 . . . . 0.0 110.997 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' CA ' ' CG1' ' A' ' 74' ' ' ILE . . . -63.61 -53.43 38.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.273 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -50.73 -37.64 42.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.998 0.427 . . . . 0.0 109.992 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 211' ' ' ASN . 27.0 mmt180 -75.38 -54.24 7.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.527 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.694 HD13 ' CE1' ' A' ' 56' ' ' PHE . 1.3 mt -50.46 -30.96 13.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.087 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -67.48 -73.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.899 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.4 t -52.46 -24.76 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' CG ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -54.45 -20.97 8.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.06 21.5 45.62 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.251 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.681 ' CE2' HG21 ' A' ' 11' ' ' VAL . 21.2 t80 -111.35 121.07 44.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -111.48 128.09 55.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.73 ' O ' HD23 ' A' ' 83' ' ' LEU . 46.7 m-85 -85.48 134.18 34.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -99.14 -37.94 9.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.216 177.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.895 HG23 HG13 ' A' ' 158' ' ' VAL . 0.4 OUTLIER -143.35 145.03 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.682 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.642 ' H ' HD13 ' A' ' 58' ' ' ILE . . . -126.91 147.96 50.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 58' ' ' ILE . 15.2 m-85 -133.04 118.6 18.99 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.062 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.6 p -122.95 163.5 20.26 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.99 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 58.0 p -85.45 -179.84 7.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -72.78 -19.05 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.401 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 12.8 mt -70.79 122.15 19.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' CG ' ' HB2' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -48.42 -31.8 6.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' NH1' HG21 ' A' ' 27' ' ' THR . 1.5 ttm180 -44.72 -61.65 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -66.53 -31.09 71.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HG2' ' CD ' ' A' ' 87' ' ' LYS . 2.1 mt-30 -66.82 -40.84 88.15 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.777 0.798 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 73' ' ' ILE . 4.8 ttpp -75.01 -37.61 61.76 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.054 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 15' ' ' HIS . 56.0 m -69.8 -26.93 64.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.633 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' HB2' HG21 ' A' ' 61' ' ' THR . 3.5 t -85.13 -47.12 10.46 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.941 0.4 . . . . 0.0 110.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -51.97 -52.0 53.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.132 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.886 HG23 ' NZ ' ' A' ' 43' ' ' LYS . 52.8 mt -53.33 -64.06 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.3 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.76 -42.04 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 83' ' ' LEU . 11.7 mt -64.06 -45.76 87.35 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.701 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -74.82 -21.99 58.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.792 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' CG ' ' HD3' ' A' ' 43' ' ' LYS . 2.2 mm-40 -85.69 -40.42 16.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.027 0.441 . . . . 0.0 110.108 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 74' ' ' ILE . 54.3 t -63.03 -25.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.344 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.66 19.23 35.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 1.7 mt-10 -121.78 38.19 0.34 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.5 Cg_exo -43.5 -45.74 10.28 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.799 1.666 . . . . 0.0 112.104 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -49.44 -26.67 3.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.966 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -47.29 147.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.695 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.966 ' N ' HD13 ' A' ' 83' ' ' LEU . 5.0 pt-20 -98.38 116.06 29.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.3 t -114.21 119.19 36.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 86' ' ' ILE . 1.4 pp -90.39 159.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.032 0.444 . . . . 0.0 111.679 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CD ' ' HG2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -121.92 117.05 25.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.376 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.84 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -115.63 139.0 50.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.227 0.537 . . . . 0.0 111.698 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 11.9 mt-10 -80.37 -15.96 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.326 177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 140' ' ' VAL . 18.4 mttt -81.16 -15.89 54.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD12 ' CB ' ' A' ' 88' ' ' SER . 1.5 mt -93.23 10.13 33.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.07 151.01 45.98 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.724 0.297 . . . . 0.0 110.702 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -54.84 150.54 9.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.978 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 4.9 tmm_? -59.24 141.85 53.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 131' ' ' GLU . 2.1 t80 -73.36 128.14 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -101.3 22.57 12.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.571 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 42.27 -129.43 4.67 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.15 -6.46 34.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.864 HD12 ' HB3' ' A' ' 127' ' ' PRO . 30.8 mt -89.14 16.51 7.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.494 0.187 . . . . 0.0 111.365 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -71.64 85.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 117.25 10.97 9.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.927 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.787 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -76.72 130.71 38.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.642 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -69.32 120.86 15.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.037 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -40.97 2.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.723 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.6 m-20 -62.98 -60.07 3.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.089 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.55 -48.51 74.61 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -57.93 -51.59 69.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.365 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.788 ' HA ' HG21 ' A' ' 116' ' ' VAL . 8.8 ptp180 -75.94 -3.25 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.086 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' ASP . 11.8 ttmt -99.42 -44.53 6.16 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.919 0.39 . . . . 0.0 110.769 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -80.21 -25.89 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.536 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 4.6 m-90 -116.44 -7.99 11.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 111.723 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.81 152.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.372 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.97 -46.4 43.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -65.11 0.61 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.187 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.48 ' O ' ' HD1' ' A' ' 119' ' ' TRP . 3.0 tt0 -64.63 -42.89 95.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.023 0.44 . . . . 0.0 110.371 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.788 HG21 ' HA ' ' A' ' 108' ' ' ARG . 19.0 t -59.99 -60.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.875 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 121' ' ' ARG . 6.1 tt0 -32.53 -65.1 0.16 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.199 0.312 . . . . 0.0 111.821 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.698 HG23 ' HD1' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -50.98 -47.01 30.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.294 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.698 ' HD1' HG23 ' A' ' 118' ' ' ILE . 21.6 m95 -67.32 -27.65 67.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.73 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.62 -74.93 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.669 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.582 HH21 HD22 ' A' ' 133' ' ' LEU . 2.8 mmm180 -87.34 -72.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.489 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.8 p 48.28 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.019 0.438 . . . . 0.0 110.669 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -115.06 -56.03 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.59 -30.66 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.896 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG12 HD11 ' A' ' 118' ' ' ILE . 7.2 tp -74.76 134.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -128.58 172.45 6.97 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.864 ' HB3' HD12 ' A' ' 99' ' ' LEU . 66.5 Cg_exo -52.38 -171.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.832 2.355 . . . . 0.0 112.46 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 84.7 Cg_endo -88.99 74.6 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.895 2.396 . . . . 0.0 112.109 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 74.1 m-20 129.53 -27.87 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 0.0 110.074 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.64 -179.48 38.81 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.719 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' HG3' ' CB ' ' A' ' 135' ' ' ASP . 1.3 tt0 -110.02 166.64 10.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.417 -0.391 . . . . 0.0 110.128 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 25.1 t -110.83 -164.93 0.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.892 0.377 . . . . 0.0 111.175 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.582 HD22 HH21 ' A' ' 121' ' ' ARG . 10.3 tp -75.25 -57.36 3.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.024 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -48.22 -44.16 32.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.603 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 138' ' ' GLU . 4.1 m-20 -62.95 -57.85 9.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.755 ' O ' HG23 ' A' ' 140' ' ' VAL . 36.1 m -48.42 -46.22 37.2 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.357 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.647 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -65.12 -45.43 85.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.993 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -55.98 -34.36 65.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.121 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 0.9 OUTLIER -96.13 -27.04 15.25 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.285 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 90' ' ' LYS . 55.2 t -78.12 -31.13 16.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.573 0.225 . . . . 0.0 111.094 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.916 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -68.04 -54.2 16.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 141' ' ' LEU . 1.2 Cg_endo -45.61 -45.66 15.93 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.699 1.599 . . . . 0.0 110.84 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 148' ' ' ILE . 27.1 t80 -62.55 -46.78 86.8 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.755 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 50.4 t80 -49.45 -64.24 0.87 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.558 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.51 -54.58 44.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 26.6 t -46.67 -61.69 1.72 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.526 ' CG2' ' CE1' ' A' ' 143' ' ' TYR . 9.7 t -125.01 27.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 143' ' ' TYR . 2.2 mt -134.19 -10.08 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.6 -0.84 . . . . 0.0 112.973 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 145' ' ' LYS . 27.2 m -97.75 -10.58 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 95.8 Cg_endo -79.42 -26.99 4.54 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.266 1.311 . . . . 0.0 112.754 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.917 ' NE2' HG21 ' A' ' 158' ' ' VAL . 3.9 p-80 -82.15 -40.94 21.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.156 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.526 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.9 pp -55.78 -44.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.92 0.39 . . . . 0.0 109.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.648 HD21 ' O ' ' A' ' 199' ' ' LYS . 13.2 mt -70.58 -23.94 62.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.798 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -69.07 -40.91 78.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.174 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 122.07 31.69 1.07 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' OE2' ' HB2' ' A' ' 151' ' ' HIS . 1.2 pt-20 -123.23 142.49 50.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -84.3 156.67 21.81 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.917 HG21 ' NE2' ' A' ' 151' ' ' HIS . 21.5 t -135.36 146.19 30.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 3.8 tp -96.35 143.16 27.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.312 176.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.766 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.7 mp -135.32 117.75 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.173 0.511 . . . . 0.0 110.038 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.942 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.67 88.44 2.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.804 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -122.49 -98.68 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.855 ' CE1' HD12 ' A' ' 64' ' ' LEU . 2.8 m-70 -161.25 166.75 27.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.07 -48.08 39.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.579 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -60.93 -54.63 42.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.4 t -53.76 -57.32 11.28 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.13 0.491 . . . . 0.0 109.721 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.653 HD12 ' C ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -56.48 -37.63 70.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.315 178.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HA ' HG22 ' A' ' 171' ' ' ILE . 20.3 mtm-85 -61.08 -52.37 65.2 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.647 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -59.18 -37.64 77.89 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.554 HD13 HG12 ' A' ' 140' ' ' VAL . 3.9 tp -69.47 -57.36 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.322 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -56.33 -46.71 81.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.495 ' N ' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.55 -40.93 53.36 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.863 0.363 . . . . 0.0 110.727 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.916 ' CG ' HD21 ' A' ' 141' ' ' LEU . 16.2 t70 -84.38 -41.71 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.319 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.774 HD22 HD11 ' A' ' 197' ' ' LEU . 31.0 mt -57.48 -37.6 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.132 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.862 ' CD ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -101.64 -31.1 10.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.607 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.21 45.03 6.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.788 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.47 -165.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.461 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 181' ' ' GLN . 8.6 t -119.12 -159.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.377 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.431 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -94.63 2.69 67.5 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.139 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.719 ' H ' HG23 ' A' ' 178' ' ' THR . 0.9 OUTLIER -142.26 14.81 2.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.008 0.404 . . . . 0.0 111.535 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.814 ' HB2' HG22 ' A' ' 178' ' ' THR . 26.8 mm100 -127.18 -3.03 6.33 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.443 HG12 ' CB ' ' A' ' 172' ' ' MET . 4.7 tp -103.98 -12.92 9.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 121' ' ' ARG . 2.9 m -87.8 15.34 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.43 -36.78 2.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.926 ' CZ ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -50.5 151.85 2.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.689 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.902 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.5 pt-20 -171.93 159.76 5.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.737 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -119.34 -173.46 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 111.292 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.841 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -106.38 102.41 11.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.924 HG22 ' HD3' ' A' ' 14' ' ' ARG . 60.3 p -51.49 112.5 0.76 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.205 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 120.26 -27.33 6.71 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.278 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.841 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 11.4 m -107.68 118.45 53.11 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.834 0.317 . . . . 0.0 111.048 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 34.0 Cg_endo -63.95 105.66 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.766 2.311 . . . . 0.0 112.364 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 208' ' ' LEU . 0.5 OUTLIER -77.28 155.73 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.581 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.75 HG22 HG22 ' A' ' 11' ' ' VAL . 2.8 t -125.45 124.09 66.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.266 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.482 ' CE2' ' CG ' ' A' ' 207' ' ' GLU . 66.0 m-85 -103.07 139.29 38.8 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.801 0.334 . . . . 0.0 111.27 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.613 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.7 t-160 -92.67 101.39 13.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.774 HD11 HD22 ' A' ' 174' ' ' LEU . 5.2 mt -100.56 153.9 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.266 0.555 . . . . 0.0 111.952 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -85.27 -172.13 3.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.835 179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.648 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -70.02 -3.17 15.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.64 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.98 21.57 12.74 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.684 0.278 . . . . 0.0 111.294 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.02 91.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.851 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -121.5 140.51 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.311 . . . . 0.0 110.743 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -52.86 142.18 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 198' ' ' ASP . 29.9 m -139.39 18.1 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.605 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.12 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.236 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.51 167.39 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.094 0.473 . . . . 0.0 111.0 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.5 ' HB2' HG23 ' A' ' 193' ' ' ILE . 2.2 pm0 -115.56 122.08 44.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.133 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.662 ' C ' HD13 ' A' ' 193' ' ' ILE . 1.8 mt -143.06 175.52 9.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.316 0.579 . . . . 0.0 111.592 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.477 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.2 mm -103.97 162.88 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.532 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.523 ' CB ' ' CG ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -115.1 -21.48 9.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.4 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.454 ' ND2' HG11 ' A' ' 191' ' ' VAL . 42.8 p-10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.397 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HB2' ' A' ' 157' ' ' LYS . 9.3 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 4' ' ' GLU . 12.4 t -54.37 167.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.034 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 3' ' ' THR . 78.8 m -94.07 23.25 5.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 2' ' ' THR . 0.9 OUTLIER 54.55 101.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 174.23 -71.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.453 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . . . -146.03 -69.71 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.299 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 6' ' ' ALA . 26.6 Cg_endo -62.33 68.22 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.386 2.057 . . . . 0.0 112.82 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 15.5 p-10 -59.78 168.88 1.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.36 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -118.89 134.46 55.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.359 0.6 . . . . 0.0 111.444 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD21 HD11 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.04 109.52 11.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.291 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.949 ' CG2' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER -99.96 123.83 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.199 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HB3' HD13 ' A' ' 167' ' ' LEU . 3.7 mt -102.71 118.31 36.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.513 ' CG2' HD11 ' A' ' 159' ' ' LEU . 11.8 t -122.12 118.64 29.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.029 0.442 . . . . 0.0 111.288 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HD2' HD23 ' A' ' 187' ' ' LEU . 7.1 ttt180 -86.46 135.53 33.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.644 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' HG21 ' A' ' 70' ' ' THR . 8.4 p80 -48.73 176.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.566 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -75.52 -124.4 0.16 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.388 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 37' ' ' THR . 14.5 pt-20 -132.65 121.85 23.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.586 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -72.99 164.22 27.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -50.24 65.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.505 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.3 m0 -59.55 -25.46 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -60.18 -41.12 92.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.329 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -68.48 -40.43 80.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.281 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 23' ' ' LEU . 2.6 mm? -60.01 -21.17 60.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.843 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.51 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.3 t30 78.72 48.38 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -136.39 146.15 46.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.663 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.25 154.61 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.132 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 ' HE2' ' A' ' 30' ' ' LYS . 90.3 m -104.07 -77.72 0.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.801 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.9 -115.39 5.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.776 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -26.64 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.757 0.313 . . . . 0.0 111.153 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.823 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -56.64 112.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -59.77 109.19 1.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.0 Cg_endo -83.07 -168.25 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.588 2.192 . . . . 0.0 112.363 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.65 118.05 29.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.131 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD11 ' HA3' ' A' ' 38' ' ' GLY . 15.8 tp -61.72 152.62 30.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.971 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.777 ' O ' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -113.8 172.35 7.04 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.32 -40.58 35.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.322 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.418 HG21 ' OE1' ' A' ' 17' ' ' GLU . 58.6 m -62.39 -36.08 81.18 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.83 -53.69 18.3 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.777 HD12 ' O ' ' A' ' 35' ' ' SER . 4.5 mp -56.01 -50.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.47 -38.05 79.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.027 178.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.4 mm-40 -64.52 -46.86 81.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.514 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.71 -52.13 64.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -53.26 -53.19 54.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.521 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HG2' ' A' ' 40' ' ' LYS . 3.8 mm? -59.7 -42.51 93.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.34 -65.03 3.86 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.945 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.37 -47.61 86.71 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.116 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.0 tp10 -52.64 -49.92 64.19 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 45.1 mmt-85 -66.57 -38.32 86.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.632 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 54' ' ' TYR . 1.5 tt -59.13 -51.24 70.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.567 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -45.38 21.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.506 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 45.7 t -45.81 -59.95 2.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.502 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -48.86 -30.44 5.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.164 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.66 16.06 3.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.241 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.834 ' HB3' HD23 ' A' ' 49' ' ' LEU . 10.6 t80 -92.58 119.08 31.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.888 0.344 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -110.12 156.8 20.11 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.189 0.518 . . . . 0.0 111.219 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 9.5 m-30 -107.88 155.37 20.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -126.31 -42.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.811 177.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.006 HG22 HG13 ' A' ' 158' ' ' VAL . 7.6 mm -126.11 149.01 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.829 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.29 126.35 31.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.026 0.441 . . . . 0.0 112.178 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 86' ' ' ILE . 21.6 m-85 -128.52 114.22 16.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.359 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -115.07 170.58 8.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.091 0.472 . . . . 0.0 111.066 179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.17 176.85 7.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -89.47 23.02 2.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.506 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.824 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.7 mt -100.97 139.39 36.72 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 14.0 pt20 -49.65 -38.38 32.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.462 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.67 HH21 HD13 ' A' ' 64' ' ' LEU . 13.3 mtm180 -56.65 -53.07 61.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.16 88.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -61.73 -49.03 78.06 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -60.89 -52.9 63.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.208 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 15' ' ' HIS . 19.6 m -53.75 -37.43 63.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.284 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.456 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.02 -70.44 0.2 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -44.03 -52.17 7.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 77' ' ' GLU . 70.6 mt -59.69 -64.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.0 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.845 HD13 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.11 -48.1 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -65.01 -46.63 80.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.883 0.373 . . . . 0.0 110.052 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 4.0 mm-40 -64.78 -22.6 67.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.332 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tm-20 -87.51 -44.28 11.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 74' ' ' ILE . 78.1 t -58.25 -35.28 52.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.352 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.24 18.64 23.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.659 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -129.54 43.11 1.02 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -48.17 -53.65 6.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 121.919 1.746 . . . . 0.0 112.523 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -51.03 -24.44 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.537 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 84' ' ' GLU . 8.3 tt -46.97 159.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.218 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.798 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -66.82 95.25 0.35 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 26.4 m -103.12 118.24 36.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.283 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -134.99 167.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.596 -179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -148.62 158.97 44.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.825 0.345 . . . . 0.0 111.417 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.742 ' HB3' HD13 ' A' ' 91' ' ' LEU . 8.5 t -124.82 149.93 46.91 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.344 0.592 . . . . 0.0 112.039 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -79.79 -32.11 40.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.724 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 140' ' ' VAL . 1.6 mttt -77.39 -10.1 59.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.319 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.024 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -78.68 -13.63 59.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.198 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -52.41 176.48 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.875 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 5.6 tp10 -78.67 150.22 32.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.383 . . . . 0.0 111.363 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 2.1 tmm_? -53.7 124.92 16.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.511 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.4 t80 -61.15 132.59 54.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 7.5 m-85 -97.42 14.46 26.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 47.19 -99.37 0.02 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.987 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -109.34 19.41 19.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD11 ' CH2' ' A' ' 111' ' ' TRP . 0.8 OUTLIER -94.46 -24.34 17.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.571 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 96' ' ' TYR . 10.8 mt-30 -50.91 116.85 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 98.42 18.48 25.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.814 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.1 OUTLIER -98.5 106.08 18.31 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.818 0.342 . . . . 0.0 110.327 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 4.3 t-20 -48.49 121.59 4.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.534 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -45.12 -33.58 2.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -65.74 -55.11 19.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.489 178.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.57 -48.59 81.08 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -55.78 -55.4 32.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -69.89 -9.02 53.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 2.9 ttmt -95.94 -25.9 15.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.21 -23.56 11.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.231 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CH2' HD11 ' A' ' 99' ' ' LEU . 15.3 m0 -113.31 -20.7 11.28 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 111.142 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 54.24 165.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.593 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.02 -42.98 8.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.03 -80.64 0.02 OUTLIER 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.16 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tp60 -50.38 -46.98 56.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.143 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' A' ' 108' ' ' ARG . 53.5 t -54.46 -53.99 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 22.2 tt0 -49.38 -60.54 2.74 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -61.22 -16.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.601 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 4.2 m95 -86.45 -65.28 1.03 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.889 0.376 . . . . 0.0 111.366 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -72.84 -24.09 60.84 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.459 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -108.05 -82.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.492 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.1 OUTLIER 44.3 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.314 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.525 ' CG ' ' CA ' ' A' ' 179' ' ' GLY . 10.3 t80 -124.62 -53.7 1.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 110.081 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -116.85 -31.53 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.722 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 126' ' ' ALA . 2.6 tp -80.22 127.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.806 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 125' ' ' ILE . . . -122.57 168.61 11.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.619 ' HB3' HD13 ' A' ' 99' ' ' LEU . 20.1 Cg_exo -65.66 172.23 8.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.743 2.295 . . . . 0.0 111.963 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 2.0 Cg_endo -45.32 98.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 111.279 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 71.92 150.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.173 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.33 -147.98 18.92 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.666 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 135' ' ' ASP . 0.8 OUTLIER -131.9 179.71 5.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.92 -84.31 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.652 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 tp -146.98 -59.56 0.28 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.43 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -54.23 -36.03 63.08 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 6.0 m-20 -65.43 -59.44 4.0 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.667 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.8 p -53.98 -52.55 60.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.396 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.667 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.23 -42.52 81.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.84 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 21.1 mm-40 -63.23 -44.89 93.97 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -81.63 -15.33 54.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 90' ' ' LYS . 73.4 t -95.57 -38.53 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.732 0.301 . . . . 0.0 111.478 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.879 HD21 ' OD1' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -51.37 -53.34 50.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 75.6 Cg_exo -47.6 -49.21 13.81 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 121.484 1.456 . . . . 0.0 111.041 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 88' ' ' SER . 1.0 OUTLIER -59.32 -47.14 86.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.717 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.2 t80 -55.08 -68.25 0.21 Allowed 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.446 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.49 -65.34 0.57 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.032 0.444 . . . . 0.0 110.99 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.1 t -49.61 -59.71 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.34 -0.54 49.32 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 151' ' ' HIS . 3.6 mt -127.47 -1.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -94.01 -13.81 0.19 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 75.8 Cg_endo -79.32 -40.56 0.26 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.425 1.417 . . . . 0.0 113.334 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.653 ' NE2' HG21 ' A' ' 158' ' ' VAL . 11.4 p-80 -78.64 -46.65 18.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.608 0.242 . . . . 0.0 111.491 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.631 HG23 ' CD2' ' A' ' 151' ' ' HIS . 47.4 pt -56.02 -20.99 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 199' ' ' LYS . 1.8 mm? -85.23 -15.06 44.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.346 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.58 17.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.787 0.327 . . . . 0.0 111.088 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.84 51.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.437 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.51 172.75 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.764 0.316 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.701 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -108.22 145.62 34.0 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.006 HG13 HG22 ' A' ' 58' ' ' ILE . 21.3 t -128.8 135.98 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.944 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 8.3 tp -95.31 133.08 39.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.401 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.568 HD11 HD21 ' A' ' 10' ' ' LEU . 18.3 mt -129.68 123.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.483 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.598 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -131.27 108.81 9.94 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.383 0.611 . . . . 0.0 111.55 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.024 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -145.01 -94.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.632 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.824 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.8 m-70 -162.5 169.2 20.73 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -50.69 -42.44 45.09 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -62.08 -56.8 15.2 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 1.9 t -51.11 -53.99 29.2 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.669 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -54.46 -54.37 41.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.746 178.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 171' ' ' ILE . 18.3 mtm180 -50.03 -44.59 51.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.432 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -59.21 -62.53 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.826 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.718 HD21 HG11 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -57.76 -60.26 3.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.916 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -45.8 -50.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.337 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.472 ' N ' HG23 ' A' ' 171' ' ' ILE . 13.3 ptm -65.9 -42.63 89.99 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.109 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.879 ' OD1' HD21 ' A' ' 141' ' ' LEU . 33.3 t70 -62.94 -36.4 83.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.717 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 2.1 mt -80.83 -49.74 10.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.55 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.586 ' HB3' HD13 ' A' ' 177' ' ' LEU . 9.5 mt-10 -68.59 -24.68 64.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.852 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 81.43 20.63 63.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.284 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 175' ' ' GLU . 1.1 mp -55.65 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.895 HG22 ' HB2' ' A' ' 181' ' ' GLN . 7.2 t -130.47 163.72 26.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.525 ' CA ' ' CG ' ' A' ' 123' ' ' TYR . . . -51.47 -22.51 7.84 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.862 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.672 ' H ' HG23 ' A' ' 178' ' ' THR . 1.8 m-20 -112.14 17.45 19.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.895 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -140.0 11.59 2.42 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.488 ' HA ' HD23 ' A' ' 177' ' ' LEU . 5.7 tp -115.3 -40.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.799 0.333 . . . . 0.0 110.56 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.23 -25.01 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.438 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.77 -31.03 71.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.58 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.794 ' NH1' HD12 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -52.33 165.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.463 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.473 ' N ' ' CG ' ' A' ' 185' ' ' ARG . 13.4 tt0 -173.14 133.85 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.443 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.794 HD12 ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -126.73 -179.31 4.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 0.0 111.302 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.811 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -120.8 -171.99 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 22.1 p -108.66 114.19 27.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.73 -49.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.324 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.811 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 32.8 m -61.07 110.07 2.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.513 0.197 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.3 Cg_endo -82.64 125.55 4.37 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.735 2.29 . . . . 0.0 112.74 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 207' ' ' GLU . 0.5 OUTLIER -91.67 150.24 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.972 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.949 HG12 ' CG2' ' A' ' 11' ' ' VAL . 1.3 m -117.32 121.34 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.193 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 193' ' ' ILE . 32.3 m-85 -110.86 133.35 53.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.055 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.6 t60 -86.42 108.99 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 201' ' ' GLY . 0.6 OUTLIER -102.59 145.33 29.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 0.0 111.721 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.68 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -77.72 -176.68 4.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.794 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.718 ' O ' HD13 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -62.01 -14.42 35.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.568 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.34 -28.89 13.09 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.683 ' C ' HD12 ' A' ' 197' ' ' LEU . . . 116.77 31.86 1.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.203 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -120.77 144.95 48.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.66 0.267 . . . . 0.0 110.673 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.503 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.7 OUTLIER -51.6 141.05 17.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 198' ' ' ASP . 35.1 m -141.1 22.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.07 0.462 . . . . 0.0 110.797 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.94 -157.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.971 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 173.43 6.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.741 ' O ' HD22 ' A' ' 208' ' ' LEU . 6.0 pm0 -125.1 153.47 42.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.286 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -150.15 172.81 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.331 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 192' ' ' PRO . 18.9 mm -108.36 158.28 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.252 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 52' ' ' ARG . 7.7 m-20 -78.92 -46.28 18.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 209' ' ' ILE . 37.9 t30 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.887 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HA ' ' CB ' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.83 0.348 . . . . 0.0 111.253 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 155' ' ' GLY . 0.5 OUTLIER -52.78 109.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -46.06 -71.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' H ' HG23 ' A' ' 3' ' ' THR . 0.2 OUTLIER -71.96 -177.54 2.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.822 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.78 63.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.258 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.894 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -154.61 -67.96 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.352 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 97.9 Cg_endo -80.91 71.44 7.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.462 2.108 . . . . 0.0 112.55 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.58 ' HA ' HG21 ' A' ' 2' ' ' THR . 0.4 OUTLIER -54.9 143.32 26.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.709 0.29 . . . . 0.0 110.416 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.513 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -99.71 134.31 42.79 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.204 0.526 . . . . 0.0 111.023 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.772 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.5 tp -129.26 116.25 18.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.399 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.893 ' C ' HD23 ' A' ' 12' ' ' LEU . 48.7 t -94.65 140.29 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.703 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -119.27 114.23 22.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.26 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.756 ' CG2' HD21 ' A' ' 159' ' ' LEU . 6.2 t -118.66 108.79 15.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' CD ' HG22 ' A' ' 189' ' ' THR . 26.6 ttm180 -88.63 117.41 27.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.233 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.415 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 10.7 p80 -41.4 124.04 2.28 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.936 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -37.42 -97.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.815 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -147.09 136.73 22.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.13 170.93 9.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.02 -43.39 66.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.1 m0 -62.96 -27.64 69.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 110.265 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -61.99 -40.15 94.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.078 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -43.57 98.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.988 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 3.8 mm? -60.69 -25.66 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.636 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.8 t30 80.4 45.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.383 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.22 147.78 51.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.908 0.385 . . . . 0.0 110.819 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 3.1 m-85 -49.95 148.75 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.714 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -89.04 -83.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 95.67 -158.24 22.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.38 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -72.86 -16.87 61.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.575 0.226 . . . . 0.0 111.363 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' CE ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -58.34 148.03 29.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 111.206 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.76 102.19 25.31 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 95.9 Cg_endo -86.08 -168.45 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.737 2.291 . . . . 0.0 112.507 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.71 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 34' ' ' LEU . 12.2 tp -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 177.38 6.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.132 0.492 . . . . 0.0 111.242 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -40.57 62.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.367 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 41' ' ' GLU . 53.5 m -63.88 -40.12 95.78 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.13 -55.49 21.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mm -56.85 -50.95 73.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -56.04 -41.55 75.19 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.092 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.9 mm-40 -61.75 -50.33 72.82 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.623 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.82 -54.34 48.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.95 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -51.39 -57.85 7.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.015 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 1.5 mm? -55.42 -52.62 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.461 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -48.33 -57.84 7.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.495 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.744 ' HA2' HD11 ' A' ' 74' ' ' ILE . . . -59.66 -46.93 93.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.085 -1.055 . . . . 0.0 110.974 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 0.8 OUTLIER -53.53 -42.08 67.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -75.96 -36.92 59.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.903 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.784 HD22 ' HE1' ' A' ' 56' ' ' PHE . 5.2 mt -62.35 -44.82 95.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.677 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 tmmt? -83.93 -20.76 32.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.405 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 9.0 t -78.89 -60.48 2.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.727 0.298 . . . . 0.0 111.357 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HG3' ' CB ' ' A' ' 210' ' ' ASP . 59.4 mmt-85 -46.11 -27.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.64 52.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.399 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 27.4 t80 -129.77 125.35 35.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 110.471 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -104.59 152.08 22.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 111.066 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.901 ' CE2' HD12 ' A' ' 159' ' ' LEU . 21.8 m-85 -118.23 138.65 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.428 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' OD1' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -114.07 -41.23 3.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.892 HG22 HG13 ' A' ' 158' ' ' VAL . 1.2 mm -121.04 145.24 27.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.067 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 86' ' ' ILE . . . -133.32 104.76 6.6 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.006 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 86' ' ' ILE . 4.0 m-85 -94.3 124.71 38.49 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.941 0.4 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.019 HG22 ' HB3' ' A' ' 161' ' ' ALA . 17.5 p -133.03 159.92 38.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.825 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.42 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 92.0 p -73.75 177.91 5.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -88.67 18.7 4.46 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.336 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.806 HD12 ' HE1' ' A' ' 163' ' ' HIS . 19.1 mt -100.13 139.63 35.51 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.259 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -49.15 -37.85 23.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.636 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.714 HH12 HG21 ' A' ' 27' ' ' THR . 12.9 mtm180 -51.51 -68.22 0.19 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.884 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.4 68.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.551 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -56.27 -48.56 76.34 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -67.66 -44.01 78.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.443 178.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 m -58.55 -24.08 59.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.302 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.958 ' HB2' HG21 ' A' ' 61' ' ' THR . 14.1 t -82.85 -66.68 0.86 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.973 0.415 . . . . 0.0 111.108 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 9.1 mt-30 -43.26 -52.14 5.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.274 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' GLU . 47.7 mt -59.66 -66.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.879 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -49.64 -48.13 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.722 HD22 HG23 ' A' ' 74' ' ' ILE . 4.3 mm? -64.12 -52.15 60.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.392 . . . . 0.0 110.254 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 44.2 mm-40 -60.76 -23.99 65.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.131 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.1 tm-20 -83.6 -40.12 19.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.788 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 74' ' ' ILE . 84.7 t -58.87 -27.75 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.143 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.07 21.22 46.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.644 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG2' HG12 ' A' ' 78' ' ' VAL . 11.8 mm-40 -139.68 54.0 5.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 23.7 Cg_exo -63.91 -22.09 68.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.027 1.818 . . . . 0.0 112.09 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -58.58 -27.01 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD11 HD11 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -52.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.705 0.288 . . . . 0.0 110.692 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 5.0 mm-40 -87.92 100.34 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.485 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.508 HG22 ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -83.26 87.74 6.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.777 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.1 mm -95.53 139.98 17.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 112.202 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -133.15 149.57 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.233 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 19.2 t -136.68 144.78 44.13 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.309 0.576 . . . . 0.0 112.15 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -80.49 -30.35 37.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.64 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 12.6 mttt -74.2 -6.88 50.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.641 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -90.52 11.23 22.46 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.164 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.39 160.37 27.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 19.9 tp10 -64.12 148.71 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.036 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' A' ' 132' ' ' SER . 2.8 tmm_? -61.69 128.11 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.7 OUTLIER -51.09 132.17 27.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.51 21.77 14.66 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 41.93 -95.67 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.578 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -5.38 15.39 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 111' ' ' TRP . 4.9 mp -78.89 0.01 28.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.486 0.184 . . . . 0.0 111.084 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 6.0 mt-30 -74.64 119.43 18.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.784 0.326 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 96.3 -2.66 63.38 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.855 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.521 HD13 ' HA ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -72.78 125.84 28.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 7.8 t-20 -63.04 125.66 24.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 3.4 mtmt -44.77 -38.23 4.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.02 -57.65 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.021 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.38 -48.15 77.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 111' ' ' TRP . . . -61.13 -49.59 76.64 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.564 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -75.83 -2.82 31.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.149 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 105' ' ' ASP . 5.1 mtpm? -105.58 -34.84 7.63 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.687 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.33 -24.23 16.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.152 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 99' ' ' LEU . 10.8 m0 -118.28 -12.87 9.88 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.536 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 53.93 162.66 0.01 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.358 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.49 -36.4 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.404 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -60.94 -77.68 0.04 OUTLIER 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.837 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.6 tp60 -53.38 -44.23 68.46 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 108' ' ' ARG . 55.6 t -54.65 -50.97 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 121' ' ' ARG . 25.2 tt0 -52.61 -56.71 13.43 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.975 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -66.45 -15.48 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.363 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.5 ' CD1' ' O ' ' A' ' 115' ' ' GLN . 3.8 m95 -86.91 -39.59 15.63 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -114.84 -33.21 5.54 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.56 ' O ' HG23 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -91.45 -13.81 31.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.517 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -40.11 159.94 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.584 0.231 . . . . 0.0 111.21 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 1.7 t80 -100.88 -50.13 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.9 p30 -112.04 -32.8 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 110.751 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.975 HD13 HD11 ' A' ' 118' ' ' ILE . 8.6 tt -80.16 137.86 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 127' ' ' PRO . . . -120.09 161.28 39.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 61.5 Cg_endo -74.94 170.11 21.13 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.486 2.124 . . . . 0.0 112.514 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' CZ3' ' A' ' 119' ' ' TRP . 90.7 Cg_exo -42.61 95.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.526 2.151 . . . . 0.0 111.731 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.2 OUTLIER 76.81 156.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.146 -179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 115.7 -145.53 18.7 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.831 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 132' ' ' SER . 16.2 tt0 -135.28 167.0 21.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 110.57 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -123.24 166.58 15.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.851 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD12 ' OD1' ' A' ' 165' ' ' ASN . 3.7 tp -50.24 -54.17 23.05 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.032 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.99 -53.22 20.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.494 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.467 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.3 m-20 -54.77 -50.79 67.59 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.983 ' O ' HG12 ' A' ' 140' ' ' VAL . 54.5 m -51.54 -67.01 0.29 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.201 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.672 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -45.86 -54.0 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.591 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 2.0 tp10 -58.07 -27.36 63.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -93.21 -32.77 14.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.983 HG12 ' O ' ' A' ' 136' ' ' THR . 2.0 p -86.74 -33.84 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.588 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -53.61 -46.15 98.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 59.7 Cg_exo -49.58 -44.88 33.56 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 121.792 1.661 . . . . 0.0 110.846 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.0 t80 -60.51 -55.52 32.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.784 ' OH ' HD11 ' A' ' 174' ' ' LEU . 30.1 t80 -49.52 -58.28 5.49 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.767 ' O ' HG22 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -59.44 -81.63 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.169 -1.013 . . . . 0.0 109.644 179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -51.17 2.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.3 m -85.6 -40.99 15.65 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.721 HD12 ' CD2' ' A' ' 144' ' ' TYR . 53.8 mt -91.77 -1.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.871 ' O ' HD23 ' A' ' 153' ' ' LEU . 30.9 m -86.48 -18.97 0.25 Allowed Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.6 Cg_endo -80.33 -48.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.453 1.435 . . . . 0.0 113.566 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.781 ' NE2' HG21 ' A' ' 158' ' ' VAL . 5.6 p-80 -70.55 -35.35 73.06 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.559 HG23 ' CD2' ' A' ' 151' ' ' HIS . 26.9 pt -69.56 -42.5 80.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.876 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 149' ' ' VAL . 1.1 mm? -56.36 -25.71 50.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -26.53 22.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.624 ' O ' HG23 ' A' ' 2' ' ' THR . . . 108.98 50.84 0.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.595 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.77 164.38 13.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 110.625 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.581 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -114.95 147.42 40.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.892 HG13 HG22 ' A' ' 58' ' ' ILE . 5.7 t -139.77 147.82 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.901 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.6 tt -88.71 157.61 18.47 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.703 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.772 HD11 ' CD2' ' A' ' 10' ' ' LEU . 90.0 mt -144.25 111.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.026 0.441 . . . . 0.0 111.32 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -125.67 103.04 7.62 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.219 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.921 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -141.61 -100.2 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.839 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.952 ' O ' HD12 ' A' ' 167' ' ' LEU . 6.2 m-70 -160.94 160.18 30.5 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.993 0.425 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.2 -40.05 7.32 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.402 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.471 ' OD1' HD12 ' A' ' 133' ' ' LEU . 4.6 t30 -64.17 -59.76 4.04 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -52.35 41.74 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.941 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.9 mp -63.84 -35.81 81.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.963 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 171' ' ' ILE . 8.1 mtm180 -58.85 -54.26 49.06 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.94 -46.54 88.88 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.953 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.9 tp -56.06 -56.59 18.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -58.16 -39.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -51.04 -55.07 19.32 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.23 -34.44 72.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.748 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' OH ' ' A' ' 144' ' ' TYR . 1.7 tp -66.0 -35.36 80.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.1 OUTLIER -109.27 3.49 21.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.68 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 49.96 51.52 29.4 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.013 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.23 -172.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.281 . . . . 0.0 111.327 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -121.61 -40.42 2.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.398 0.618 . . . . 0.0 111.488 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 155.15 -46.67 0.53 Allowed Glycine 0 C--N 1.309 -0.961 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.168 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 183' ' ' VAL . 36.1 t70 -90.62 -20.85 22.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 110.775 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.9 OUTLIER -81.99 -24.97 35.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.868 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -80.9 -42.33 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 110.844 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 121' ' ' ARG . 7.8 p -56.96 -19.75 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.222 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 185' ' ' ARG . 9.2 pttt -92.77 -35.34 13.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.819 ' NH2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -49.16 146.76 3.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.853 0.359 . . . . 0.0 110.824 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -158.58 156.09 29.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.819 HD13 ' NH2' ' A' ' 185' ' ' ARG . 0.7 OUTLIER -125.41 178.31 5.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.033 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.58 155.39 18.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.442 HG22 ' CD ' ' A' ' 14' ' ' ARG . 7.6 p -100.28 114.45 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 192' ' ' PRO . . . 106.61 -51.66 0.72 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 191' ' ' VAL . 32.9 m -77.46 108.92 7.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.582 0.229 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 48.1 Cg_endo -67.36 114.08 3.12 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.763 HG21 HD11 ' A' ' 187' ' ' LEU . 6.6 tp -90.71 129.2 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 11' ' ' VAL . 21.8 t -89.55 142.98 12.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.868 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.429 ' O ' HD23 ' A' ' 197' ' ' LEU . 9.7 m-85 -130.7 134.95 47.35 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.743 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' C ' HD22 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -84.55 116.7 23.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.762 HD13 ' C ' ' A' ' 202' ' ' LYS . 1.1 mm? -114.63 156.55 24.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.708 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.674 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.2 OUTLIER -88.63 -178.93 5.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.548 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -72.89 -4.34 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.716 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -103.39 -16.63 15.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.593 0.235 . . . . 0.0 111.393 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.52 47.95 1.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.174 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.762 ' C ' HD13 ' A' ' 197' ' ' LEU . 14.1 tttt -145.62 146.76 31.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.806 0.336 . . . . 0.0 110.777 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 197' ' ' LEU . 1.5 p90 -54.0 142.26 25.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.226 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 198' ' ' ASP . 16.3 m -138.36 13.44 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.309 . . . . 0.0 111.379 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.65 -158.22 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.09 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.57 157.32 18.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.957 0.408 . . . . 0.0 110.843 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.512 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -87.0 169.85 12.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.939 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.576 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.4 tp -169.59 142.03 2.48 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.798 0.809 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 209' ' ' ILE . 1.6 tp -100.16 171.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.782 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.448 ' CB ' ' HG3' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -71.97 -41.31 67.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.678 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.851 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 3' ' ' THR . 1.2 t -39.61 143.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.947 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 2' ' ' THR . 0.7 OUTLIER -168.2 37.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.737 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 72.2 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 49.64 90.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.02 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.915 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . 175.41 179.13 0.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 76.9 Cg_exo -42.8 102.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.664 2.242 . . . . 0.0 112.517 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -75.41 144.56 42.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.683 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.9 tp -101.12 135.34 42.74 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.235 0.54 . . . . 0.0 111.21 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD21 ' CD1' ' A' ' 160' ' ' ILE . 4.6 tp -125.81 112.64 16.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.421 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.876 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 87.2 t -87.23 131.92 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.034 0.445 . . . . 0.0 110.92 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HB3' HD22 ' A' ' 167' ' ' LEU . 10.1 mt -110.73 104.71 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.608 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.827 ' CG2' HD21 ' A' ' 159' ' ' LEU . 1.9 t -118.67 81.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.352 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 12.3 ttt180 -71.85 127.95 34.2 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.287 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' GLY . 8.9 p80 -43.0 138.05 2.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.629 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -49.69 -104.36 0.01 OUTLIER Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.167 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' CD ' HG21 ' A' ' 37' ' ' THR . 4.0 pt-20 -135.98 130.79 34.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.91 0.386 . . . . 0.0 111.174 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 24.8 p -81.38 157.01 25.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.563 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -50.98 -31.57 18.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -63.9 -29.43 70.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.254 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.38 -40.98 96.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.051 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -60.55 -46.39 90.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.032 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -23.31 63.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.574 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' C ' HD23 ' A' ' 25' ' ' LEU . 1.5 t30 77.87 44.85 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -129.49 145.6 51.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 110.735 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -51.79 155.41 1.72 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.906 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.468 HG21 HH12 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -88.25 -84.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.033 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.7 -122.72 7.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.474 ' HB2' ' CD1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -117.8 -16.04 10.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.507 0.194 . . . . 0.0 111.517 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' NZ ' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -56.55 159.7 3.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.988 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.37 94.75 19.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.786 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 95.2 Cg_endo -79.99 -171.28 1.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.706 2.271 . . . . 0.0 112.238 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.58 122.72 48.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.71 HD23 HD13 ' A' ' 39' ' ' ILE . 13.3 tp -49.48 150.32 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 p -103.92 172.32 6.86 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -41.27 65.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.526 HG21 ' CD ' ' A' ' 17' ' ' GLU . 98.9 m -63.54 -38.38 90.89 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -66.17 -55.61 17.97 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.71 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -56.97 -49.03 80.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.74 -36.7 74.75 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.848 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' THR . 9.2 mm-40 -66.98 -43.55 82.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.444 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.85 -59.49 4.14 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.923 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' HG2' ' CG2' ' A' ' 73' ' ' ILE . 7.3 mmtt -53.15 -62.7 1.48 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.831 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 48' ' ' ARG . 15.2 tp -53.6 -41.32 66.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.58 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.2 -58.29 15.37 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.12 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.63 -52.36 53.54 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.088 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' N ' ' HG3' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -54.84 -34.99 63.49 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.143 0.497 . . . . 0.0 109.744 178.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -78.93 -29.03 43.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.155 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.799 HD22 ' HE1' ' A' ' 56' ' ' PHE . 1.1 mt -73.69 -42.14 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.454 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -83.18 -49.17 9.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.727 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 19.1 m -41.55 -34.27 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.749 0.309 . . . . 0.0 111.785 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -77.36 -47.1 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.49 2.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.023 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.653 ' HE2' HG21 ' A' ' 194' ' ' VAL . 8.1 t80 -59.59 110.22 1.08 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.783 0.325 . . . . 0.0 110.697 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -96.33 152.24 18.78 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.876 ' CZ ' HG21 ' A' ' 11' ' ' VAL . 20.7 m-85 -116.66 142.94 46.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.544 ' C ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.04 -51.76 2.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.499 178.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.829 ' HB ' HG22 ' A' ' 158' ' ' VAL . 1.3 mm -113.65 153.18 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.702 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -139.96 133.45 30.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.018 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.623 ' CZ ' HG21 ' A' ' 86' ' ' ILE . 2.4 m-85 -125.53 121.31 33.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.739 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -125.23 162.12 25.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.303 0.573 . . . . 0.0 111.55 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 67' ' ' ALA . 89.3 p -77.47 174.11 11.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -89.94 19.9 4.56 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.284 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.862 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.1 mt -101.06 142.1 33.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.128 0.49 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 12.4 pt20 -49.07 -46.42 44.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.864 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.468 HH12 HG21 ' A' ' 27' ' ' THR . 8.8 mtm180 -48.55 -59.1 3.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' OG ' ' A' ' 62' ' ' SER . . . -60.02 -39.38 85.62 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.662 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -56.91 -53.68 55.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -61.96 -43.84 98.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.558 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -62.23 -24.53 67.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.347 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 44.3 t -75.32 -68.42 0.56 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.206 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -44.41 -48.34 9.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' GLU . 45.3 mt -55.81 -62.44 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.062 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.967 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -60.55 -47.17 93.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.025 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 81' ' ' PRO . 3.0 mm? -60.06 -43.29 95.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.877 0.37 . . . . 0.0 110.424 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 8.7 mm-40 -75.26 -27.5 59.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.821 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 6.9 tp10 -73.19 -56.34 5.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.244 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 74' ' ' ILE . 2.0 m -54.05 -27.48 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.023 0.439 . . . . 0.0 110.367 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.04 32.45 14.34 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.056 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 3.8 mm-40 -147.7 57.09 3.1 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.898 0.349 . . . . 0.0 111.878 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.697 ' HA ' HD12 ' A' ' 75' ' ' LEU . 3.4 Cg_exo -78.74 -32.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.3 2.0 . . . . 0.0 111.993 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -48.7 -34.35 11.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.131 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -53.13 -174.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.515 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.3 mm-40 -79.02 94.6 5.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.902 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.6 m -92.36 75.94 5.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.725 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.623 HG21 ' CZ ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -88.17 168.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -160.61 -178.29 6.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.162 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB3' HD12 ' A' ' 91' ' ' LEU . 3.8 t -166.83 159.47 13.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.44 0.638 . . . . 0.0 112.449 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 mt-10 -79.57 -32.57 42.06 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.772 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.948 ' O ' HG12 ' A' ' 140' ' ' VAL . 13.8 mttt -66.7 -12.16 57.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD21 ' OH ' ' A' ' 143' ' ' TYR . 5.2 mt -90.73 18.19 6.75 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.459 0.171 . . . . 0.0 111.151 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 28.1 m-20 -90.1 152.8 20.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 16.1 tp10 -56.78 146.86 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.672 ' HB2' HG21 ' A' ' 136' ' ' THR . 4.2 tmm_? -59.65 128.45 37.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.502 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 3.8 t80 -57.21 145.14 32.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.222 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.11 17.77 21.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 45.18 -106.6 0.12 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.433 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.27 -4.51 55.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.915 ' HA ' HD23 ' A' ' 102' ' ' LEU . 93.3 mt -90.62 20.35 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.688 0.28 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -74.67 106.6 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.87 16.43 61.38 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.915 HD23 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -72.1 119.9 16.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 105' ' ' ASP . 3.7 t-20 -56.0 117.06 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.16 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 24' ' ' ASN . 7.7 mtmt -42.52 -38.06 1.83 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.9 0.381 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.3 m-20 -65.25 -55.4 18.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.064 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.81 -47.66 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.25 74.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -72.34 -12.0 60.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.815 179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 105' ' ' ASP . 46.9 mttt -94.57 -36.46 11.8 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.791 0.329 . . . . 0.0 110.825 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -14.93 28.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.815 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.693 ' CZ3' HD21 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -128.38 -2.43 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.857 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 54.29 160.86 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.317 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.68 -40.48 28.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 110.364 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 118' ' ' ILE . 20.1 tt0 -57.94 -73.62 0.07 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.653 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.5 OUTLIER -55.84 -48.4 75.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.608 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 112' ' ' GLY . 21.7 m -58.18 -34.42 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.992 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 12.0 tt0 -64.48 -61.46 2.2 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.145 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.09 -19.11 15.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.106 178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -85.91 -43.01 13.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 111.283 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' NE ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -87.74 -24.81 23.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.271 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NE ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -113.77 -80.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.662 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 121' ' ' ARG . 0.3 OUTLIER 44.72 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.832 0.348 . . . . 0.0 111.151 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.515 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 17.7 t80 -123.15 -53.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 3.9 p30 -118.28 -28.09 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.235 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.145 HD13 HD11 ' A' ' 118' ' ' ILE . 12.0 tt -75.8 140.43 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 132' ' ' SER . . . -127.55 157.71 72.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 16.8 Cg_exo -67.15 167.65 19.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.726 2.284 . . . . 0.0 112.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 90.9 Cg_exo -42.5 96.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.342 2.028 . . . . 0.0 111.322 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 73.7 150.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.869 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 124.63 -148.34 16.73 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.687 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' CB ' ' HG2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -126.37 176.51 7.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.615 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -141.76 166.61 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 123' ' ' TYR . 1.6 tp -49.9 -59.6 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.33 -47.49 66.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.805 0.335 . . . . 0.0 110.508 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.436 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -59.4 -63.11 1.42 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 110.013 179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.786 ' O ' HG13 ' A' ' 140' ' ' VAL . 43.3 p -50.24 -48.83 54.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.793 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.75 -47.43 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.66 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -22.01 64.28 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.453 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -97.34 -25.69 15.15 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.947 0.403 . . . . 0.0 110.42 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.948 HG12 ' O ' ' A' ' 90' ' ' LYS . 18.2 m -86.92 -42.53 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.395 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.812 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -48.0 -46.57 64.7 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.8 Cg_exo -48.07 -45.85 24.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.833 1.689 . . . . 0.0 110.612 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.785 ' HE1' HD11 ' A' ' 148' ' ' ILE . 0.0 OUTLIER -59.63 -49.71 76.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.823 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 5.7 t80 -54.25 -67.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.473 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 149' ' ' VAL . 2.4 ptmt -50.54 -59.68 3.79 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.73 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 11.8 t -51.44 -64.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 143' ' ' TYR . 9.8 t -96.82 4.03 51.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' A' ' 151' ' ' HIS . 10.5 mt -123.15 -17.44 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.24 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.598 ' O ' HD23 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -73.88 -26.92 0.75 Allowed Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -81.17 -18.87 8.42 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.466 1.444 . . . . 0.0 113.374 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.996 ' CE1' HG23 ' A' ' 148' ' ' ILE . 1.8 p-80 -100.66 -27.23 13.49 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.835 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.448 HG23 HG22 ' A' ' 148' ' ' ILE . 1.1 pp -71.86 -29.57 34.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.008 0.433 . . . . 0.0 110.198 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 149' ' ' VAL . 2.1 mm? -62.95 -29.32 70.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.021 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -80.26 -22.85 41.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.739 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 103.66 -13.45 53.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.917 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -41.06 151.72 0.06 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.787 0.327 . . . . 0.0 111.374 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.61 140.62 34.63 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.933 HG21 ' NE2' ' A' ' 151' ' ' HIS . 6.9 t -133.65 148.59 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 116.264 1.949 . . . . 0.0 116.264 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.5 tt -89.96 155.16 19.3 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.888 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.649 ' CD1' HD21 ' A' ' 10' ' ' LEU . 13.0 mt -148.65 112.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.245 0.545 . . . . 0.0 111.502 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.792 ' HB2' HG23 ' A' ' 13' ' ' THR . . . -129.08 103.33 6.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.903 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -139.49 -94.88 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.862 ' CE1' HD12 ' A' ' 64' ' ' LEU . 4.2 m-70 -161.84 162.54 29.4 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.22 -54.05 6.42 Favored Glycine 0 C--O 1.22 -0.73 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.487 ' OD1' HG21 ' A' ' 136' ' ' THR . 3.7 t30 -52.75 -55.24 24.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.503 ' OG ' HD23 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -49.66 -63.94 0.96 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.831 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.3 OUTLIER -60.41 -34.23 73.63 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.342 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.485 ' CD ' ' CZ ' ' A' ' 185' ' ' ARG . 18.8 mtm180 -57.48 -58.72 7.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -57.71 -42.67 84.26 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.551 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.8 tp -57.57 -64.27 0.95 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.779 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.772 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -53.68 -39.98 40.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.839 ' CE ' HG21 ' A' ' 182' ' ' ILE . 3.9 tpp -52.7 -56.06 18.23 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.276 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.812 ' CG ' HD21 ' A' ' 141' ' ' LEU . 17.5 t0 -67.53 -51.83 46.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.572 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 197' ' ' LEU . 8.6 mt -50.69 -52.1 43.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.772 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -78.78 -22.37 46.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.885 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 71.1 32.41 65.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -56.28 -170.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.371 . . . . 0.0 110.778 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 180' ' ' ASP . 8.9 t -115.92 -157.0 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.493 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.515 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -104.06 11.47 52.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.069 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.707 ' H ' HG23 ' A' ' 178' ' ' THR . 3.6 p-10 -145.83 15.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.745 0.272 . . . . 0.0 111.407 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.654 ' HB2' HG22 ' A' ' 178' ' ' THR . 7.2 mm100 -138.24 7.1 2.62 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 ' CE ' ' A' ' 172' ' ' MET . 8.7 tp -108.97 -27.65 2.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 183' ' ' VAL . 0.5 OUTLIER -59.88 -16.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.367 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -33.59 26.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 186' ' ' GLU . 0.0 OUTLIER -46.19 158.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.556 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 34.1 tt0 -164.8 138.87 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.289 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.735 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -126.92 41.06 3.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.312 . . . . 0.0 111.386 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.554 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . 39.33 -161.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.044 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 56.9 p -144.06 111.35 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.36 -36.79 4.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.229 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.554 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 21.5 m -68.54 122.17 83.58 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.52 0.2 . . . . 0.0 110.654 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.485 ' CG ' ' HG ' ' A' ' 49' ' ' LEU . 60.6 Cg_endo -72.09 84.3 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.627 2.218 . . . . 0.0 112.552 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.845 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.7 OUTLIER -65.08 164.49 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.233 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 208' ' ' LEU . 5.1 p -145.2 118.82 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.161 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 12' ' ' LEU . 13.3 m-85 -103.58 132.86 49.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.939 0.4 . . . . 0.0 111.222 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.818 ' O ' HG22 ' A' ' 204' ' ' VAL . 2.0 t60 -85.45 98.97 10.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.602 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 174' ' ' LEU . 0.9 OUTLIER -102.08 155.87 17.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.953 -178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.443 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -84.25 -177.13 6.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.015 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.596 ' O ' HD22 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -71.68 -5.8 36.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.713 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -101.37 -19.03 15.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 111.366 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.423 ' CA ' HD13 ' A' ' 152' ' ' ILE . . . 106.46 29.92 4.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.191 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.666 ' C ' HD23 ' A' ' 197' ' ' LEU . 3.6 ttmt -123.82 146.22 48.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.855 0.36 . . . . 0.0 110.797 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 2.9 p90 -59.07 146.11 39.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.261 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 196' ' ' HIS . 28.0 m -138.41 13.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.008 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 206' ' ' LYS . 1.5 p -167.05 -153.39 0.15 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.685 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.413 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -120.77 146.77 46.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 111.188 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.845 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -50.55 168.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -162.6 148.67 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 111.529 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 1.8 mm -123.82 162.45 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.692 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 68.7 m-20 -92.51 -37.07 12.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.741 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 48' ' ' ARG . 1.4 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.003 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' N ' ' HG3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 9' ' ' LEU . 48.9 p 45.78 -91.25 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.473 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 2' ' ' THR . 0.0 OUTLIER 166.6 -64.69 0.0 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.842 0.353 . . . . 0.0 110.733 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.552 ' H ' HG23 ' A' ' 3' ' ' THR . 1.8 tt0 -131.05 -74.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.34 35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.373 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -158.12 -56.33 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.494 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.9 Cg_exo -76.54 54.13 4.26 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.598 2.199 . . . . 0.0 112.432 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.9 OUTLIER -51.65 144.79 10.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 110.488 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -109.22 138.89 44.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 111.507 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -131.14 123.91 29.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.939 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.902 ' C ' HD23 ' A' ' 12' ' ' LEU . 89.4 t -114.31 139.35 40.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 121.032 0.444 . . . . 0.0 110.863 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -124.46 127.14 47.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -99.21 102.02 13.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -84.63 108.53 17.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HA ' HG21 ' A' ' 70' ' ' THR . 23.3 p80 -41.76 123.01 2.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -40.65 -95.35 0.01 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.234 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.576 ' CD ' HG21 ' A' ' 37' ' ' THR . 6.9 pt-20 -144.77 125.58 14.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.942 0.401 . . . . 0.0 111.24 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -85.75 170.08 12.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.412 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -48.47 -49.87 33.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.581 ' O ' HD12 ' A' ' 25' ' ' LEU . 7.0 m0 -62.02 -37.99 86.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' SER . 1.5 m120 -55.74 -46.47 77.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.401 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -54.41 -46.33 73.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.276 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 HD21 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -63.76 -20.38 65.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.983 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 77.36 43.85 0.1 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.711 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -117.27 152.29 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.526 179.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.58 134.56 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.786 HG21 HH12 ' A' ' 66' ' ' ARG . 51.2 m -78.88 -86.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 100' ' ' GLN . . . 97.46 -141.68 15.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.538 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 1.4 m0 -92.22 -18.75 23.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.573 0.225 . . . . 0.0 111.387 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.769 ' CE ' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -50.64 155.48 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.978 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.601 ' CG ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -106.08 94.88 10.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 86.8 Cg_endo -80.87 -168.0 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.71 2.274 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.55 117.87 23.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.058 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD23 HD13 ' A' ' 39' ' ' ILE . 17.7 tp -49.92 158.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.0 p -116.93 171.89 7.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.137 0.494 . . . . 0.0 111.477 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -51.3 -39.84 57.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.25 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.576 HG21 ' CD ' ' A' ' 17' ' ' GLU . 43.4 m -63.0 -43.36 99.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -62.2 -53.52 41.74 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD13 HD23 ' A' ' 34' ' ' LEU . 17.8 mm -58.47 -55.49 22.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.2 mtpm? -54.92 -36.8 65.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.395 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' CA ' ' A' ' 190' ' ' GLY . 11.6 mm-40 -67.06 -47.36 71.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.491 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.98 -53.22 60.83 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -53.41 -54.17 40.6 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.612 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 44' ' ' LEU . 6.2 mt -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.306 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.44 -57.6 17.86 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HG13 ' A' ' 74' ' ' ILE . . . -57.47 -46.12 92.29 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.168 -1.015 . . . . 0.0 111.042 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' OE1' ' A' ' 77' ' ' GLU . 45.9 mt-10 -58.19 -40.57 81.87 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 3.7 mmm-85 -74.71 -31.9 61.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.088 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 11' ' ' VAL . 0.4 OUTLIER -75.71 -31.17 59.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 78' ' ' VAL . 17.3 ttpp -85.12 -57.5 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -47.36 -30.73 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.317 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' NE ' ' OXT' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -69.03 -23.54 64.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.25 18.05 27.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.354 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 9' ' ' LEU . 16.7 t80 -96.56 107.63 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.864 0.364 . . . . 0.0 110.54 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -89.37 162.73 15.64 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.546 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE2' HD12 ' A' ' 159' ' ' LEU . 23.6 m-85 -123.87 140.51 52.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.478 0.656 . . . . 0.0 112.506 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -102.7 -40.88 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.068 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.868 ' CG2' HG13 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -135.46 149.89 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.9 0.381 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.633 ' HB2' ' CD2' ' A' ' 83' ' ' LEU . . . -132.51 144.36 50.38 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.796 ' CD2' HD11 ' A' ' 86' ' ' ILE . 9.4 m-85 -130.52 125.32 33.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.92 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.92 HG22 ' HB3' ' A' ' 161' ' ' ALA . 12.1 p -126.34 159.2 33.84 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 110.833 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 88' ' ' SER . 13.9 p -88.4 158.99 18.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -52.37 -23.32 5.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 0.0 111.081 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD23 ' CG ' ' A' ' 31' ' ' ASP . 14.9 mt -67.94 139.46 56.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.563 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 9.5 pt20 -63.93 -31.71 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.748 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.786 HH12 HG21 ' A' ' 27' ' ' THR . 2.0 mtm180 -48.83 -59.38 3.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.218 0.533 . . . . 0.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -71.69 -37.42 70.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.311 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -66.97 -36.15 81.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 25.2 ttpt -76.18 -47.91 22.4 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.931 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 15' ' ' HIS . 46.1 m -59.15 -38.16 79.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.071 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.473 ' CB ' ' CG2' ' A' ' 61' ' ' THR . 18.6 t -73.08 -42.87 62.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.354 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -56.2 -46.96 79.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.281 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 70' ' ' THR . 10.7 mt -59.2 -60.87 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.936 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -53.94 -43.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.054 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.686 HD21 HD23 ' A' ' 83' ' ' LEU . 9.8 mt -62.21 -47.71 83.25 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.85 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 31.7 mt-10 -66.85 -24.7 66.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.976 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.9 tm-20 -83.15 -36.4 24.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.822 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 74' ' ' ILE . 93.6 t -63.07 -27.58 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.288 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.14 42.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.834 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 78' ' ' VAL . 7.7 mm-40 -137.73 43.72 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 82.2 Cg_exo -45.5 -32.6 8.32 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.904 1.736 . . . . 0.0 112.082 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -53.63 -22.79 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.686 HD23 HD21 ' A' ' 75' ' ' LEU . 10.0 tp -45.44 152.57 0.29 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.97 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 58' ' ' ILE . 5.3 mm-40 -82.39 90.66 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.024 0.44 . . . . 0.0 110.527 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' NZ ' ' A' ' 87' ' ' LYS . 20.7 m -99.36 106.67 18.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.946 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 60' ' ' PHE . 1.3 pp -90.18 155.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.741 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.584 ' NZ ' HG22 ' A' ' 85' ' ' THR . 1.7 mmpt? -120.69 116.84 26.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.221 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.8 ' HB3' HD12 ' A' ' 91' ' ' LEU . 4.9 t -114.48 135.07 54.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.128 0.49 . . . . 0.0 111.482 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -78.51 -23.26 46.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.722 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 140' ' ' VAL . 15.2 mtmt -77.08 -13.27 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.025 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -87.68 -8.99 55.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 10.4 m-20 -48.88 176.23 0.01 OUTLIER 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 4.7 tp10 -80.03 150.8 30.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.772 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.448 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -54.08 122.52 10.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CA ' ' CD1' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -61.38 116.98 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.048 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -93.67 37.88 1.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 37.89 -116.97 0.5 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.477 -0.392 . . . . 0.0 113.626 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.45 6.29 49.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.037 HD21 ' CZ2' ' A' ' 119' ' ' TRP . 3.9 mm? -81.0 -20.39 41.9 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 33.8 mt-30 -48.88 90.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 118.34 32.02 1.43 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.945 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.01 113.07 19.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.819 0.342 . . . . 0.0 110.479 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.68 129.08 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.714 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -49.86 -32.53 14.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.338 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -64.34 -53.13 53.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 110' ' ' LYS . 3.2 m-20 -63.03 -48.59 78.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.43 82.39 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.733 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 1.048 ' HA ' HG21 ' A' ' 116' ' ' VAL . 35.6 mtp85 -71.3 -26.28 62.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.784 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 105' ' ' ASP . 13.7 tttp -82.7 -22.31 34.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.884 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 106' ' ' ASP . 53.6 mttp -80.6 -78.47 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.533 ' CH2' ' CZ2' ' A' ' 119' ' ' TRP . 4.1 m-90 -88.51 15.85 7.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.13 162.68 0.01 OUTLIER Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.91 -44.13 49.98 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.898 0.38 . . . . 0.0 111.067 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.72 -72.92 0.05 OUTLIER 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.69 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -62.77 -47.01 85.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.048 HG21 ' HA ' ' A' ' 108' ' ' ARG . 14.7 t -44.72 -59.6 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -41.87 -49.87 4.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.763 0.316 . . . . 0.0 111.763 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.803 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -84.05 -14.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.423 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 1.037 ' CZ2' HD21 ' A' ' 99' ' ' LEU . 1.3 t-105 -91.08 -20.84 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.02 0.528 . . . . 0.0 111.255 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -113.4 -42.36 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.007 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.659 ' CB ' HG12 ' A' ' 183' ' ' VAL . 0.0 OUTLIER -90.85 -74.81 0.49 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.733 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 125' ' ' ILE . 0.1 OUTLIER 44.34 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.156 0.503 . . . . 0.0 111.79 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' OG1' ' A' ' 178' ' ' THR . 2.4 t80 -133.06 -53.88 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.479 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 125' ' ' ILE . 2.7 p30 -108.03 -36.77 6.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 109.987 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.803 HD13 HD11 ' A' ' 118' ' ' ILE . 9.2 tt -77.42 155.0 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.112 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -145.68 174.63 3.28 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.662 ' CD ' ' HB1' ' A' ' 126' ' ' ALA . 21.5 Cg_exo -64.65 -164.52 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.152 2.568 . . . . 0.0 110.708 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.686 ' HD2' HD23 ' A' ' 99' ' ' LEU . 2.9 Cg_exo -76.02 98.62 1.21 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.763 2.309 . . . . 0.0 111.279 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.411 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 1.0 OUTLIER 74.04 163.95 0.27 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.658 -179.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.72 -104.8 1.52 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.061 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 132' ' ' SER . 15.5 tt0 -178.72 155.89 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.358 . . . . 0.0 110.582 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -109.42 -169.08 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 133' ' ' LEU . 5.5 tp -74.44 -54.73 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.223 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -50.93 -42.61 59.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 1.1 m-20 -65.95 -48.44 71.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 140' ' ' VAL . 27.5 m -52.55 -45.93 66.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.143 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.19 -42.25 84.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.615 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -62.17 -27.98 69.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.888 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 136' ' ' THR . 1.3 ppt_? -99.63 -20.91 16.09 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.05 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 90' ' ' LYS . 70.3 t -90.79 -44.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 3.3 mt -52.59 -44.3 94.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.233 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 74.8 Cg_exo -47.6 -49.31 13.61 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 121.842 1.695 . . . . 0.0 110.988 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.523 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 3.2 t80 -56.6 -46.13 81.03 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HA ' ' CG1' ' A' ' 148' ' ' ILE . 0.1 OUTLIER -56.46 -70.59 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.809 178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 2.6 ptpt -54.58 -47.98 72.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.822 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 7.5 t -64.77 -61.61 2.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.523 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -106.24 11.1 31.52 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.599 HD11 ' CE2' ' A' ' 60' ' ' PHE . 3.8 mt -127.87 -5.52 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.563 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.9 OUTLIER -85.51 -21.01 0.27 Allowed Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.76 -60.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.371 1.381 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.2 p-80 -56.63 -43.63 80.42 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.321 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 153' ' ' LEU . 2.9 pp -54.92 -22.06 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -84.65 -22.78 29.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -77.02 -50.01 14.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.301 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 2' ' ' THR . . . 139.86 42.16 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.551 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.467 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -126.06 148.36 49.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -97.2 165.55 11.99 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 58' ' ' ILE . 25.3 t -134.08 142.68 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.964 HD12 ' CE2' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -91.73 142.7 27.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.975 176.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.99 HD11 HD11 ' A' ' 10' ' ' LEU . 10.2 mt -139.49 110.72 4.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.92 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -105.25 93.79 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.924 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -130.01 -115.15 0.25 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.936 ' C ' HD12 ' A' ' 167' ' ' LEU . 13.5 m-70 -156.34 170.0 23.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 122.064 -0.397 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -50.55 -47.14 45.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.79 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 82.9 m-20 -62.25 -58.12 8.91 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -49.97 64.79 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.0 HD23 HD12 ' A' ' 12' ' ' LEU . 1.1 mt -53.96 -48.66 70.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.281 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' CZ ' ' NH2' ' A' ' 121' ' ' ARG . 20.3 mtm180 -56.39 -56.25 23.43 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.361 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -50.93 -32.59 21.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 170' ' ' LEU . 2.3 tp -76.74 -61.23 2.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.145 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.82 -50.76 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.909 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.503 ' HA ' ' HG ' ' A' ' 177' ' ' LEU . 5.0 ppp? -54.25 -40.65 67.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.99 -63.07 1.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.155 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.755 HD13 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -51.56 -54.13 30.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.077 0.465 . . . . 0.0 110.265 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.831 ' HB2' HD13 ' A' ' 171' ' ' ILE . 1.0 OUTLIER -69.8 -28.54 65.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.655 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.44 22.45 53.97 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.108 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -96.25 -179.74 4.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.93 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 177' ' ' LEU . 15.1 t 132.67 -169.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.623 1.202 . . . . 0.0 111.111 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 180' ' ' ASP . . . 64.82 6.91 26.46 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.429 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 179' ' ' GLY . 1.0 OUTLIER 158.02 -25.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.131 0.465 . . . . 0.0 111.022 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.402 ' C ' ' CD1' ' A' ' 177' ' ' LEU . 63.2 mt-30 -96.14 -16.35 21.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.503 ' HA ' HD11 ' A' ' 177' ' ' LEU . 5.7 tp -89.17 11.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.659 HG12 ' CB ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -107.33 17.59 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.498 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.68 -42.32 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.929 ' NH2' HD21 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -44.95 152.08 0.26 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.831 0.348 . . . . 0.0 111.113 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 187' ' ' LEU . 8.7 pt-20 -170.88 -178.65 2.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 193' ' ' ILE . 1.6 mt -141.7 -170.01 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.014 0.435 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.787 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.05 96.39 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.642 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 47.4 p -47.75 110.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 111.011 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 41' ' ' GLU . . . 124.88 -46.7 1.07 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.787 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 27.9 m -91.01 122.27 66.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 12.9 Cg_endo -56.49 113.36 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.504 2.136 . . . . 0.0 112.552 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.967 HG13 HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.18 139.76 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.728 HG13 HG22 ' A' ' 11' ' ' VAL . 9.2 t -111.21 159.27 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.472 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.527 ' CE1' HD11 ' A' ' 193' ' ' ILE . 11.1 m-85 -144.95 160.12 41.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.35 0.595 . . . . 0.0 111.448 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.907 ' O ' HG12 ' A' ' 204' ' ' VAL . 1.5 t60 -115.88 97.43 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.755 HD11 HD13 ' A' ' 174' ' ' LEU . 3.9 mt -105.24 162.39 13.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.708 0.766 . . . . 0.0 112.54 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -81.15 -172.02 3.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -70.95 -2.4 15.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.458 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 39.8 t0 -114.7 20.35 15.32 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.689 0.28 . . . . 0.0 111.448 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 61.35 50.42 67.06 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.767 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 13.1 tttp -141.06 142.11 34.2 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.578 ' HA ' HD22 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -41.32 128.61 3.0 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.496 0.665 . . . . 0.0 110.477 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 196' ' ' HIS . 1.4 p -121.36 13.02 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.645 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 204' ' ' VAL . 10.3 t 168.4 -90.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -172.83 147.56 1.73 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 208' ' ' LEU . 0.9 OUTLIER 172.29 151.16 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.083 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 193' ' ' ILE . 0.4 OUTLIER -172.47 20.57 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 191' ' ' VAL . 0.0 OUTLIER 169.86 162.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.542 0.686 . . . . 0.0 111.553 177.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 209' ' ' ILE . 2.4 p30 -115.89 -32.71 5.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.414 ' OXT' ' NE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.852 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HA ' ' HG2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.37 0.128 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -64.33 -53.79 43.19 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.164 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 2' ' ' THR . 0.5 OUTLIER 58.32 144.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.79 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 73.76 155.25 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.54 64.72 5.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.375 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 1.016 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -155.08 -73.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 50.8 Cg_endo -86.17 69.62 4.64 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.486 2.124 . . . . 0.0 113.309 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' LEU . 32.8 m-20 -72.72 171.26 12.91 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.727 HD11 ' OH ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -161.76 160.14 28.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.824 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HG ' ' HB ' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -144.85 142.16 29.7 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.071 ' CG2' HG13 ' A' ' 194' ' ' VAL . 25.5 t -114.68 140.02 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.267 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.5 OUTLIER -123.0 122.13 37.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.388 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 13' ' ' THR . 12.7 t -109.41 99.15 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.286 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.936 ' HD3' HD13 ' A' ' 187' ' ' LEU . 0.7 OUTLIER -72.84 111.94 8.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.424 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 30.1 p80 -46.94 133.04 11.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 15' ' ' HIS . . . -54.36 -118.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.033 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.37 132.75 54.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ASN . 25.9 p -92.02 161.01 14.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -36.92 -52.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 8.2 m0 -63.99 -34.46 78.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.4 t-20 -61.8 -30.94 71.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.897 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.1 ttpt -71.7 -58.68 3.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.345 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -40.5 -76.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER 155.61 35.76 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.05 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -123.94 175.0 7.21 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.217 0.532 . . . . 0.0 111.773 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -87.78 157.89 18.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.903 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.534 HG21 ' CZ ' ' A' ' 66' ' ' ARG . 56.9 m -93.65 -107.56 0.12 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 27' ' ' THR . . . 120.42 -160.41 14.96 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.011 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.534 ' O ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -66.73 -12.15 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 111.36 -179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -72.25 169.24 16.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.165 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' CA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -119.95 109.71 37.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.787 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HG3' HG23 ' A' ' 27' ' ' THR . 55.4 Cg_endo -97.52 158.32 0.97 Allowed 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.579 2.852 . . . . 0.0 112.404 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -84.63 104.94 15.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.552 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' A' ' 66' ' ' ARG . 5.5 tp -40.39 164.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 p -118.19 177.82 4.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.632 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.72 -63.08 1.19 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.062 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 2.4 m -45.36 -44.03 11.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -60.53 -62.48 5.94 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.584 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.029 HG23 HD13 ' A' ' 73' ' ' ILE . 1.5 mt -55.95 -55.37 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -47.47 -43.6 24.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 2.5 mm-40 -63.3 -39.43 94.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.851 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -63.88 -56.15 17.47 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -53.81 -51.38 63.69 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 2.1 mt -61.26 -41.32 96.72 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -57.66 -61.41 7.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.12 -43.67 98.1 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.961 -1.114 . . . . 0.0 110.61 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.8 mm-40 -56.16 -46.47 79.29 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.1 mmp_? -67.17 -34.1 76.82 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -63.1 -57.35 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.215 178.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 51' ' ' SER . 3.9 ttmt -74.03 -46.0 46.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.233 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 27.5 t -37.26 -38.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.145 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' CG ' ' HB3' ' A' ' 210' ' ' ASP . 6.7 mmp_? -78.1 -47.73 17.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.934 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.49 31.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.415 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' HD11 ' A' ' 9' ' ' LEU . 11.9 t80 -96.83 105.49 17.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.755 0.312 . . . . 0.0 110.339 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.04 154.2 20.67 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.905 -179.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 28.8 m-85 -119.11 153.56 34.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -120.69 -33.0 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.553 177.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.891 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.2 mm -126.62 138.92 53.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.702 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -123.71 120.19 32.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.462 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CE2' HD11 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -112.18 110.11 20.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.221 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 161' ' ' ALA . 22.0 p -122.75 156.44 34.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.411 0.624 . . . . 0.0 111.407 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 88' ' ' SER . 59.6 p -77.87 164.24 25.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.984 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -67.92 -7.2 26.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD13 HH21 ' A' ' 66' ' ' ARG . 83.9 mt -88.13 128.71 35.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.018 0.437 . . . . 0.0 110.92 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' GLN . 20.7 pt20 -38.96 -52.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.354 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.763 HH21 HD13 ' A' ' 64' ' ' LEU . 1.2 ttm180 -26.82 -71.46 0.03 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.282 0.563 . . . . 0.0 111.421 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -59.04 -32.23 69.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.666 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.2 mt-30 -70.43 -63.26 1.12 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -45.43 -43.57 11.45 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.518 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 74' ' ' ILE . 53.1 m -64.48 -57.11 10.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.503 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.641 ' HB3' HG21 ' A' ' 61' ' ' THR . 41.3 t -60.34 -55.23 36.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' GLN . 26.2 mt-30 -42.18 -50.91 4.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.015 0.436 . . . . 0.0 110.041 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.029 HD13 HG23 ' A' ' 39' ' ' ILE . 50.1 mt -60.57 -69.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.726 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.851 HD12 ' N ' ' A' ' 75' ' ' LEU . 1.1 pp -46.04 -43.52 4.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.851 ' N ' HD12 ' A' ' 74' ' ' ILE . 9.0 mt -63.19 -49.29 74.82 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.747 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 85.6 mt-10 -66.56 -22.72 66.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.874 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 43' ' ' LYS . 3.4 tp10 -86.45 -36.53 19.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.941 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.627 HG12 ' OE1' ' A' ' 80' ' ' GLU . 22.7 t -71.75 -39.74 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.126 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 81' ' ' PRO . . . 98.71 12.66 43.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.09 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.839 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -110.19 21.06 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 50.8 Cg_exo -50.35 -45.18 35.36 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.368 1.379 . . . . 0.0 111.767 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -46.3 -31.01 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.4 OUTLIER -53.53 -178.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.576 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.707 ' HB2' HD13 ' A' ' 58' ' ' ILE . 73.2 mm-40 -75.14 98.74 3.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.928 0.394 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.924 HG22 ' HE3' ' A' ' 87' ' ' LYS . 27.5 m -95.63 124.69 39.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.018 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.675 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -126.27 140.8 47.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.377 0.608 . . . . 0.0 112.491 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.924 ' HE3' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.15 109.01 11.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.87 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 0.6 OUTLIER -117.55 146.81 43.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.977 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 3.3 pm0 -80.47 -13.38 59.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.951 ' O ' HG22 ' A' ' 140' ' ' VAL . 8.2 mtmm -75.93 -13.28 60.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.068 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -94.77 20.76 8.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 89' ' ' GLU . 46.2 m-20 -80.25 153.52 28.46 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.588 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.4 tp10 -67.23 150.37 49.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.582 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -47.15 121.55 3.84 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.841 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.552 ' HB3' ' CA ' ' A' ' 130' ' ' GLY . 0.6 OUTLIER -49.5 122.89 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.279 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -93.12 54.06 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.38 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . 4.86 -113.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.675 0 O-C-N 123.656 0.597 . . . . 0.0 114.239 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.84 -8.4 59.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.601 0.238 . . . . 0.0 111.261 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD13 ' HD2' ' A' ' 128' ' ' PRO . 11.1 mp -82.35 8.08 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.853 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 62.1 mt-30 -71.94 105.93 4.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 93.32 1.82 66.34 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.978 ' HG ' ' HB2' ' A' ' 107' ' ' ALA . 7.1 tp -67.56 130.62 43.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.053 0.454 . . . . 0.0 111.355 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 7.9 m120 -62.94 112.32 2.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.927 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 24' ' ' ASN . 10.1 mttt -34.3 -46.13 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.071 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.8 t0 -63.82 -59.47 4.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.98 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 103' ' ' ASN . 1.5 t70 -52.91 -49.67 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.978 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -59.63 -47.17 86.63 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.212 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -86.18 11.27 12.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -112.41 -48.19 3.04 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.493 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.589 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 12.4 tptt -96.2 37.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.344 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.761 ' HB3' ' CG ' ' A' ' 115' ' ' GLN . 0.8 OUTLIER 172.53 -32.73 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 -178.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.26 -165.38 3.5 Favored Glycine 0 C--O 1.247 0.936 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.61 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -48.37 -56.59 7.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.367 -1.417 . . . . 0.0 111.623 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.872 ' O ' HG22 ' A' ' 118' ' ' ILE . 7.8 tp10 -35.6 -48.09 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.761 ' CG ' ' HB3' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -78.43 -67.92 0.69 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.484 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.717 ' N ' ' HG3' ' A' ' 115' ' ' GLN . 22.1 m -48.11 -40.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.91 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 113' ' ' ALA . 32.1 tt0 -59.88 -70.92 0.14 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 109.968 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -52.01 -18.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.155 179.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 6.3 m95 -91.62 -64.88 1.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.652 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.773 -179.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 12.9 mmt-85 -94.12 -94.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 125' ' ' ILE . 0.4 OUTLIER 37.12 -163.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.585 0.231 . . . . 0.0 110.943 -179.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.551 ' CD1' ' HA2' ' A' ' 179' ' ' GLY . 44.4 t80 -144.4 -34.32 0.38 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.63 -9.03 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.092 HD13 HD11 ' A' ' 118' ' ' ILE . 6.6 tt -104.99 162.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 121.129 -0.229 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -143.21 155.61 61.55 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.724 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 5.9 Cg_endo -49.92 178.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.222 2.615 . . . . 0.0 112.169 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.696 ' HD2' HD13 ' A' ' 99' ' ' LEU . 9.9 Cg_endo -51.44 86.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.096 1.864 . . . . 0.0 111.434 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' PRO . 0.7 OUTLIER 78.39 154.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.513 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 121.2 -122.63 5.25 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.814 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 136' ' ' THR . 0.8 OUTLIER -148.43 166.24 28.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.303 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 25.3 t -116.71 -126.33 0.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.302 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.656 HD13 ' NH2' ' A' ' 168' ' ' ARG . 7.7 tp -110.22 -65.47 1.15 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.708 0.29 . . . . 0.0 110.477 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -48.49 -40.91 28.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.469 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.527 ' N ' ' HG3' ' A' ' 134' ' ' LYS . 21.7 m-20 -61.76 -69.52 0.24 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.764 ' O ' HG23 ' A' ' 140' ' ' VAL . 24.0 p -47.44 -41.06 19.53 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.418 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.786 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -60.16 -53.58 56.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 3.3 tt0 -66.93 -13.04 61.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.895 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' O ' ' CD ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -113.03 -0.24 14.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.529 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 90' ' ' LYS . 46.2 t -122.15 -24.43 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.989 HD12 ' OD2' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -96.27 -8.33 0.13 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 21.5 Cg_endo -63.08 -47.17 8.75 Favored 'Trans proline' 0 C--N 1.367 1.504 0 CA-C-N 120.663 1.272 . . . . 0.0 109.107 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 88' ' ' SER . 1.6 t80 -52.18 -47.51 65.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 176.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -53.51 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.436 177.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.716 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.4 OUTLIER -44.17 -47.85 9.17 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.305 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.534 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 37.5 t -58.64 -66.59 0.47 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.433 HG21 ' HE1' ' A' ' 143' ' ' TYR . 0.7 OUTLIER -99.05 -3.02 35.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.695 ' HA ' ' CE1' ' A' ' 151' ' ' HIS . 9.3 mt -101.0 -26.02 3.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.36 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 145' ' ' LYS . 4.2 p -77.17 -16.6 0.26 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 60.6 Cg_endo -86.98 -31.31 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.787 1.658 . . . . 0.0 113.021 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 158' ' ' VAL . 2.9 p-80 -90.72 -39.64 12.31 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.89 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.647 HG23 ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -63.74 -27.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.148 0.499 . . . . 0.0 109.85 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 199' ' ' LYS . 0.3 OUTLIER -80.62 -26.74 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.016 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -22.87 61.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.007 0.432 . . . . 0.0 110.525 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . 116.89 42.35 0.67 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.296 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.526 ' HG2' ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -127.48 158.95 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.646 ' HB3' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -108.67 159.58 16.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 58' ' ' ILE . 44.6 t -134.59 158.58 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -116.83 141.93 47.59 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.218 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.843 ' N ' HD12 ' A' ' 159' ' ' LEU . 11.0 mt -131.43 132.79 62.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.484 0.659 . . . . 0.0 111.678 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.808 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -135.26 83.26 2.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.713 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -119.82 -97.34 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.376 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 93' ' ' GLU . 7.4 m-70 -165.96 159.68 15.95 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.856 0.36 . . . . 0.0 111.103 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.09 -55.7 4.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.608 ' ND2' HG21 ' A' ' 136' ' ' THR . 4.1 t30 -53.23 -65.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.627 0.251 . . . . 0.0 110.561 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.445 ' OG ' HG11 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -44.58 -53.6 6.94 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.39 0.614 . . . . 0.0 109.368 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 14' ' ' ARG . 4.2 mt -56.33 -66.06 0.5 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.745 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.656 ' NH2' HD13 ' A' ' 133' ' ' LEU . 34.3 mtm180 -40.72 -54.76 2.55 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.786 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -53.85 -40.95 66.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.468 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 140' ' ' VAL . 1.5 tp -74.38 -55.61 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.686 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -56.78 -46.12 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.599 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -51.71 -43.9 62.98 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.989 ' OD2' HD12 ' A' ' 141' ' ' LEU . 4.1 t70 -76.33 -35.1 58.94 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.74 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.558 ' CG ' HD21 ' A' ' 197' ' ' LEU . 7.5 tp -68.73 -31.81 71.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.001 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.561 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -104.15 -20.85 13.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.739 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 80.59 38.24 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.361 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 172' ' ' MET . 3.7 mm? -50.09 -177.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.691 0.281 . . . . 0.0 110.61 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.87 12.88 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.349 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 123' ' ' TYR . . . 87.66 -42.89 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.855 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -86.75 -23.19 25.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' C ' HD12 ' A' ' 177' ' ' LEU . 20.1 mm-40 -102.15 4.83 39.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.791 HD12 ' HG2' ' A' ' 185' ' ' ARG . 7.5 tp -102.96 -18.88 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 179' ' ' GLY . 0.0 OUTLIER -83.54 7.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.727 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 1.5 tptt -128.86 -1.58 5.31 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.791 ' HG2' HD12 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.47 -15.11 48.02 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.718 0.771 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 185' ' ' ARG . 4.3 pt-20 41.98 177.21 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 113.471 -1.695 . . . . 0.0 111.302 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.936 HD13 ' HD3' ' A' ' 14' ' ' ARG . 3.3 pp -148.73 -174.36 4.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.341 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.696 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -141.33 93.28 2.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.783 0.325 . . . . 0.0 111.172 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 14' ' ' ARG . 29.3 p -50.79 110.68 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.35 -66.34 0.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.278 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.696 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 9.8 m -59.24 130.5 87.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 0.0 111.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 Cg_endo -85.36 104.8 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.008 2.472 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 207' ' ' GLU . 5.1 tp -77.39 149.35 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 111.318 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.071 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.2 t -124.6 131.29 72.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -119.91 126.17 50.26 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.786 177.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.988 ' C ' HG12 ' A' ' 204' ' ' VAL . 2.5 t60 -81.32 123.25 28.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 201' ' ' GLY . 7.9 mp -119.64 162.7 18.54 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 113.31 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 199' ' ' LYS . 0.1 OUTLIER -80.29 -171.58 3.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.566 ' O ' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -69.38 -4.57 18.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.141 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.7 19.37 18.11 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.72 0.295 . . . . 0.0 111.081 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.977 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 59.55 40.96 96.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.349 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 197' ' ' LEU . 29.5 tttt -125.61 145.02 50.33 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.458 ' HB3' ' HG2' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -37.05 133.13 0.65 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.523 0.678 . . . . 0.0 109.568 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.988 HG12 ' C ' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -137.83 3.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.08 -177.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 206' ' ' LYS . 12.9 t -162.44 -127.26 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.514 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.521 ' CE ' ' O ' ' A' ' 205' ' ' SER . 2.3 mmpt? -136.16 157.18 47.43 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.447 . . . . 0.0 111.452 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.806 ' HB2' HD11 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -79.82 150.27 30.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.073 -179.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.35 144.85 14.39 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 0.7 OUTLIER -104.18 166.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.833 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.559 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 43.8 m-20 -75.49 -52.72 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.613 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.443 ' OD1' ' OXT' ' A' ' 211' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.948 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' CB ' ' HG2' ' A' ' 157' ' ' LYS . 11.0 tpt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.507 0.194 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.57 HG23 ' C ' ' A' ' 155' ' ' GLY . 1.6 t -57.7 86.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.833 0.349 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.5 t -94.31 -28.42 15.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.008 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 5.5 mm-40 -54.46 -21.98 11.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.043 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 74.56 33.34 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.846 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -150.3 -70.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.846 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 72.3 Cg_endo -75.55 74.89 4.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.108 1.872 . . . . 0.0 112.48 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 0.5 OUTLIER -55.93 141.51 39.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.43 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -102.46 118.8 37.64 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.597 0.713 . . . . 0.0 111.205 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.58 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.7 OUTLIER -123.11 119.39 30.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.835 -178.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.94 ' CG2' HG13 ' A' ' 194' ' ' VAL . 6.7 t -108.93 131.11 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.318 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.741 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -107.9 154.3 21.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.586 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.779 HG23 ' HB2' ' A' ' 161' ' ' ALA . 2.2 t -154.69 115.18 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.446 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.709 ' HD3' HG22 ' A' ' 189' ' ' THR . 38.5 ttt180 -84.95 127.87 34.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.481 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.8 p80 -44.42 168.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.163 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -69.46 -137.53 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -117.78 112.34 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.685 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -62.52 167.25 4.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.994 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -44.97 96.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 1.5 m0 -59.4 -28.03 66.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.417 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -35.95 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.86 -44.79 76.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.342 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.9 -21.03 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.778 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 104' ' ' LYS . 2.6 t30 77.4 50.55 0.04 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.268 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -135.55 141.98 45.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.758 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 1.7 m-85 -52.77 147.47 8.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.851 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -109.27 -84.38 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.017 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.82 -157.36 22.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.627 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -52.25 -23.75 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 111.175 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -47.23 160.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.23 93.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 85.3 Cg_endo -82.14 -167.65 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.723 2.282 . . . . 0.0 112.189 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.75 128.91 52.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.176 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.7 156.79 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.813 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.796 ' O ' HD12 ' A' ' 39' ' ' ILE . 52.4 p -110.69 163.72 13.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.08 0.467 . . . . 0.0 111.461 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.09 -38.97 18.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.482 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.486 HG22 ' OE2' ' A' ' 41' ' ' GLU . 26.1 m -63.42 -40.46 97.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -65.7 -53.45 31.29 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 35' ' ' SER . 4.6 mp -55.31 -51.5 55.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -54.82 -38.42 67.34 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.798 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' OE2' HG22 ' A' ' 37' ' ' THR . 9.3 mt-10 -65.64 -43.06 90.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.066 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -54.99 38.44 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.615 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' CD ' ' CG2' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -54.04 -51.24 64.65 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 17.6 tp -56.68 -46.46 81.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.484 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.56 -64.13 4.66 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.38 -0.915 . . . . 0.0 111.179 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.55 -52.0 48.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.456 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -56.08 -42.08 76.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.866 0.365 . . . . 0.0 110.272 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -66.83 -57.24 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.249 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -55.48 -44.14 76.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.105 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.56 -44.7 73.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' NH1' ' A' ' 52' ' ' ARG . 6.1 t -46.86 -50.36 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.369 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -60.33 -33.17 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.88 15.97 7.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.73 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 157' ' ' LYS . 47.8 t80 -81.82 107.28 14.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -93.41 159.97 15.01 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.8 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 31.1 m-85 -118.25 147.9 42.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.797 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -114.43 -35.95 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.106 178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' HG12 ' A' ' 158' ' ' VAL . 6.6 mm -127.6 130.93 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.213 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.69 111.05 20.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.76 ' CE1' HD12 ' A' ' 86' ' ' ILE . 1.8 m-85 -111.94 126.93 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.7 OUTLIER -132.87 176.79 8.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.489 . . . . 0.0 110.977 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 87.1 p -85.13 172.02 11.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -87.82 23.16 2.09 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.168 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 163' ' ' HIS . 14.1 mt -105.19 139.52 39.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.318 0.58 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 69' ' ' LYS . 1.4 pp0? -49.82 -34.4 19.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.169 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' NE ' ' HG2' ' A' ' 32' ' ' PRO . 11.6 mtm180 -58.59 -46.35 87.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.15 64.74 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.354 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' HZ2' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -64.18 -34.67 78.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 65' ' ' GLN . 1.6 tttp -75.31 -48.76 21.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.454 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.79 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.2 m -68.94 -9.62 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.153 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 48.6 t -89.04 -61.15 1.77 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.069 0.461 . . . . 0.0 110.896 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.9 -52.46 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' CG2' ' CD ' ' A' ' 43' ' ' LYS . 78.1 mt -48.61 -69.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.843 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.04 -45.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.403 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.8 mt -55.09 -44.16 74.62 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.242 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 73' ' ' ILE . 4.8 pt-20 -76.7 -29.43 56.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.041 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CG ' ' HE3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -68.65 -51.68 39.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 74' ' ' ILE . 27.4 m -60.42 -25.46 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.22 32.84 22.0 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.012 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.696 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.1 tp10 -151.44 57.6 2.41 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -81.82 -23.25 4.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.331 2.02 . . . . 0.0 111.77 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -50.75 -28.24 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -63.4 146.34 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.8 mt-10 -45.48 109.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.883 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.787 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 92.0 m -114.05 107.24 15.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.231 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.76 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -127.07 159.57 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.334 0.587 . . . . 0.0 110.382 -178.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -132.32 154.68 49.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.852 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 143' ' ' TYR . 10.0 t -121.9 143.43 49.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.568 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 50.6 mt-10 -79.28 -29.45 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.599 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 11.9 mttt -74.7 -14.41 60.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.153 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.839 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -86.88 12.52 10.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.129 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 22.5 m-20 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 26.6 tp10 -68.48 143.06 55.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.43 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -49.32 136.73 15.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.35 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.468 ' CE1' ' OE1' ' A' ' 100' ' ' GLN . 2.8 t80 -64.48 133.99 53.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.61 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 4.4 m-85 -95.65 19.4 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' CA ' ' HB3' ' A' ' 129' ' ' ASN . . . 44.45 -113.53 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.229 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -98.13 16.06 22.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.504 HD11 ' CZ3' ' A' ' 111' ' ' TRP . 2.4 mm? -91.49 -24.0 19.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.368 . . . . 0.0 110.729 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 41.8 mt-30 -54.04 119.75 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.944 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 92.84 24.12 23.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.681 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -111.58 122.6 48.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.954 0.407 . . . . 0.0 110.327 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.716 HD22 HD23 ' A' ' 25' ' ' LEU . 9.0 t-20 -60.43 127.85 33.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.437 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -46.43 -37.42 7.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.795 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.409 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -60.68 -49.19 78.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.15 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.73 -45.31 68.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.6 ' HB2' HD22 ' A' ' 102' ' ' LEU . . . -58.73 -40.18 83.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.773 ' HA ' HG21 ' A' ' 116' ' ' VAL . 11.5 ptm180 -80.93 -37.65 29.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.212 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 105' ' ' ASP . 23.6 mtpt -65.38 -36.86 85.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.297 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 8.8 mmtt -112.21 66.9 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' A' ' 110' ' ' LYS . 2.4 m0 152.07 -18.69 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.677 0.791 . . . . 0.0 110.737 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 55.68 161.71 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.207 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.26 -32.51 7.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 110.379 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.63 -75.25 0.08 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.674 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 0.4 OUTLIER -55.32 -41.91 73.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 108' ' ' ARG . 74.4 t -58.96 -48.49 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.703 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.48 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 23.4 tt0 -55.89 -62.15 1.89 Allowed 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -54.3 -22.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.199 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 2.7 m95 -81.59 -67.52 0.77 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.881 0.372 . . . . 0.0 111.1 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' NH1' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -71.16 -35.75 71.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.331 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.431 ' NH1' ' HD3' ' A' ' 120' ' ' ARG . 14.3 mmt-85 -91.97 -89.95 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.29 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.35 -173.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.846 0.355 . . . . 0.0 110.903 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.52 ' CD2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 t80 -133.21 -54.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.809 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -105.83 -30.08 9.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.482 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.91 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.443 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.435 ' H ' HG22 ' A' ' 125' ' ' ILE . . . -154.96 157.56 31.96 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.507 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 18.3 Cg_exo -65.91 154.96 71.78 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.73 2.286 . . . . 0.0 111.784 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 85.9 Cg_exo -45.61 106.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.42 2.08 . . . . 0.0 112.111 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.477 ' HB3' ' CA ' ' A' ' 97' ' ' GLY . 59.3 t30 91.51 -26.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.139 0.575 . . . . 0.0 111.388 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.423 ' N ' ' HA3' ' A' ' 97' ' ' GLY . . . -75.36 175.11 51.56 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.39 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 2.5 pt-20 -108.69 177.7 4.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.682 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -117.87 -165.62 1.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.39 -54.32 6.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.732 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.441 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.44 -45.7 66.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.177 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.441 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 3.8 t70 -55.89 -56.31 22.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.017 ' O ' HG12 ' A' ' 140' ' ' VAL . 29.6 m -53.94 -65.48 0.56 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.243 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HB1' ' OD2' ' A' ' 173' ' ' ASP . . . -43.6 -42.68 5.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.518 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' OE1' ' CA ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.82 -45.72 73.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.2 OUTLIER -79.74 -8.93 59.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.809 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 1.017 HG12 ' O ' ' A' ' 136' ' ' THR . 2.8 p -107.52 -34.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -48.44 -47.34 69.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.744 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HA ' ' CD ' ' A' ' 145' ' ' LYS . 71.9 Cg_exo -48.94 -48.73 17.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.698 1.599 . . . . 0.0 110.708 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 147' ' ' THR . 2.0 t80 -57.47 -48.44 79.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.663 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.7 t80 -55.58 -69.6 0.13 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.36 178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.8 OUTLIER -51.25 -66.4 0.39 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.174 179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 142' ' ' PRO . 8.0 t -51.14 -59.25 4.38 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -95.95 5.91 50.1 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 60' ' ' PHE . 4.7 mt -131.98 -3.18 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 119.694 -0.802 . . . . 0.0 113.016 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.5 p -91.58 -16.48 0.21 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 71.6 Cg_endo -80.03 -52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 121.599 1.533 . . . . 0.0 113.717 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 8.5 p-80 -66.74 -43.76 83.3 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 2.7 pp -51.12 -24.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HG ' HD12 ' A' ' 152' ' ' ILE . 11.0 mt -87.21 -26.53 23.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -31.74 73.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.073 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.57 ' C ' HG23 ' A' ' 2' ' ' THR . . . 116.85 36.14 1.08 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.541 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 2' ' ' THR . 1.1 mp0 -122.47 154.3 37.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.652 0.263 . . . . 0.0 110.749 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -105.11 158.31 16.66 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -137.0 168.35 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.8 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 7.0 tp -112.07 140.56 46.65 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.961 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.737 ' HB ' HD22 ' A' ' 12' ' ' LEU . 21.4 mt -132.53 114.32 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.68 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.905 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -126.55 110.22 13.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.259 0.552 . . . . 0.0 111.578 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.839 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.59 -92.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.232 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 93' ' ' GLU . 5.2 m-70 -160.85 161.5 31.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -47.44 -44.42 21.62 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.779 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.402 HD22 HG21 ' A' ' 136' ' ' THR . 6.1 t30 -61.61 -55.62 28.73 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -53.01 -52.31 58.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.648 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -55.14 -47.03 75.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.584 178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 171' ' ' ILE . 19.0 mtm180 -56.58 -47.53 79.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -54.27 -58.57 6.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.558 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.68 ' N ' HD23 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -64.23 -63.09 1.24 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.014 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -43.64 -39.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.612 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.478 ' HB3' HD13 ' A' ' 182' ' ' ILE . 12.7 ptm -77.78 -48.33 16.83 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.238 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.901 ' OD2' ' HB1' ' A' ' 137' ' ' ALA . 5.2 m-20 -61.69 -24.68 66.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 4.4 mt -94.56 -54.38 3.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB2' HD13 ' A' ' 171' ' ' ILE . 0.9 OUTLIER -64.5 -27.91 69.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.791 0.329 . . . . 0.0 110.397 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.06 43.46 5.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.605 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.638 HD23 ' HA ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -80.02 -172.87 3.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.324 . . . . 0.0 110.746 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.959 ' O ' HG22 ' A' ' 182' ' ' ILE . 12.9 t -131.02 -178.6 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.815 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.52 ' CA ' ' CD2' ' A' ' 123' ' ' TYR . . . -64.46 -40.85 98.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.993 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.45 21.26 5.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.626 0.25 . . . . 0.0 111.431 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.754 ' HB2' HG22 ' A' ' 178' ' ' THR . 1.4 mm-40 -130.19 -59.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.959 HG22 ' O ' ' A' ' 178' ' ' THR . 4.0 tp -53.0 -30.12 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.066 0.46 . . . . 0.0 110.441 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 183' ' ' VAL . 7.7 p -69.33 -7.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.437 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 -20.99 13.17 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.494 0.187 . . . . 0.0 111.454 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.809 ' CD ' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -50.71 179.04 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 2.4 tm-20 -166.94 160.98 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.742 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.2 -178.43 5.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.829 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -118.8 149.34 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.189 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.709 HG22 ' HD3' ' A' ' 14' ' ' ARG . 71.5 p -98.27 112.59 24.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.74 -41.64 2.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.566 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.775 ' HB ' HD12 ' A' ' 209' ' ' ILE . 27.4 m -91.61 130.38 39.32 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.535 0.207 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 209' ' ' ILE . 86.3 Cg_endo -83.82 125.1 3.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.65 2.234 . . . . 0.0 112.779 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 208' ' ' LEU . 9.0 tp -90.98 148.37 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.94 HG13 ' CG2' ' A' ' 11' ' ' VAL . 1.7 t -111.5 131.2 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 111.952 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.518 ' CE2' ' CD1' ' A' ' 12' ' ' LEU . 18.8 m-30 -116.77 126.04 52.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.55 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.773 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -87.75 85.85 7.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 4.3 mt -87.23 164.22 16.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.252 0.549 . . . . 0.0 111.593 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.733 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -95.32 -172.95 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.415 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -76.71 1.27 17.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.663 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 36.8 t70 -116.81 11.01 14.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 121.24 -0.184 . . . . 0.0 111.402 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.03 43.34 22.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.617 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -136.28 143.9 44.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.9 p90 -60.26 140.1 57.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 196' ' ' HIS . 34.4 m -140.42 25.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -177.27 -159.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.294 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 166.35 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.007 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 194' ' ' VAL . 10.0 pm0 -111.94 168.52 9.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.304 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 193' ' ' ILE . 1.5 pt? -177.69 162.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.096 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.775 HD12 ' HB ' ' A' ' 191' ' ' VAL . 15.9 mm -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.37 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 52' ' ' ARG . 3.8 m-20 -67.5 -45.85 74.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.462 ' N ' HG22 ' A' ' 209' ' ' ILE . 16.6 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.307 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.775 0.321 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.4 t -68.95 111.33 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -114.43 23.11 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.981 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.98 14.53 7.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.285 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.5 26.51 0.51 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.659 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -131.96 -71.97 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.548 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 85.4 Cg_endo -79.34 75.92 4.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.036 1.824 . . . . 0.0 112.472 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' HA ' HG21 ' A' ' 2' ' ' THR . 0.3 OUTLIER -61.78 136.76 58.12 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.622 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CG1' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -98.65 124.86 43.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.289 0.566 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 160' ' ' ILE . 1.2 tp -122.11 118.08 27.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.983 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 194' ' ' VAL . 3.0 t -103.94 118.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.863 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 12' ' ' LEU . 2.0 mt -98.08 129.54 44.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.289 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.679 ' CG2' HD21 ' A' ' 159' ' ' LEU . 15.0 t -134.18 99.96 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 0.0 111.295 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 163' ' ' HIS . 19.4 ttt180 -79.32 127.6 32.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.579 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -42.99 144.71 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -53.17 -105.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.82 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' OE2' HG21 ' A' ' 37' ' ' THR . 7.7 pt-20 -138.97 140.67 38.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.869 0.366 . . . . 0.0 110.935 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.96 167.29 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -50.7 -25.07 3.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.485 ' CZ3' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -60.23 -25.47 65.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.64 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -64.48 -34.73 78.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.294 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.09 64.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.474 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 25' ' ' LEU . 3.4 mm? -70.12 -25.37 63.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.744 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 70.03 51.86 0.4 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.394 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.64 -173.89 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.65 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' GLY . 11.6 m-85 -93.89 178.52 5.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.54 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 28' ' ' GLY . 8.3 m -118.68 -84.76 0.65 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.813 0.339 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.37 -104.99 3.11 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.36 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.07 -31.99 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.135 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -48.08 150.0 1.29 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -103.71 97.46 10.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 78.4 Cg_endo -78.5 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.589 2.193 . . . . 0.0 112.261 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 150.7 30.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.358 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 66' ' ' ARG . 10.7 tp -86.34 168.09 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.548 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -126.5 172.23 10.39 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.163 0.506 . . . . 0.0 111.388 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -51.57 -42.28 61.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.618 HG21 ' OE2' ' A' ' 17' ' ' GLU . 75.0 m -63.27 -36.3 83.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -67.74 -56.42 11.3 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.47 HD13 HD23 ' A' ' 34' ' ' LEU . 20.3 mm -56.31 -50.51 71.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -56.88 -42.26 79.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.843 178.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' THR . 7.0 mm-40 -59.61 -50.69 72.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.408 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.27 66.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.645 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -54.05 -58.3 7.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.801 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -54.79 -40.68 69.71 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -59.05 -61.28 7.52 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -56.89 -51.25 58.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.105 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 51' ' ' SER . 8.1 tp10 -55.26 -38.19 68.23 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -69.11 -48.58 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.743 178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 56' ' ' PHE . 7.8 tt -59.7 -63.83 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.899 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -52.61 -39.06 61.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.884 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 1.6 m -50.05 -63.65 1.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -49.84 -25.9 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.65 32.22 4.25 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.577 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' CE1' HG21 ' A' ' 11' ' ' VAL . 42.8 t80 -97.87 109.16 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -93.71 161.04 14.5 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.9 m-85 -115.11 154.72 28.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' C ' HD11 ' A' ' 83' ' ' LEU . 5.1 m-20 -119.64 -42.64 2.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.323 177.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 158' ' ' VAL . 15.8 mm -129.93 151.31 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.979 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -137.36 131.2 31.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 148' ' ' ILE . 5.8 m-85 -125.61 119.59 28.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.526 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.877 HG22 ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -118.14 171.1 8.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.26 0.553 . . . . 0.0 110.903 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 162' ' ' ALA . 39.8 p -81.22 174.02 11.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -90.16 30.31 1.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.27 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 HH21 ' A' ' 66' ' ' ARG . 83.8 mt -115.84 145.58 42.72 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.279 0.561 . . . . 0.0 111.329 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 68' ' ' GLN . 11.8 pt20 -49.78 -44.59 48.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.645 HH21 HD13 ' A' ' 64' ' ' LEU . 3.8 mtm180 -47.3 -63.1 1.13 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.99 -37.88 77.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.82 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -56.79 -53.34 58.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -47.86 78.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.706 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.8 m -54.52 -35.26 62.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.622 ' C ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -71.18 -56.75 5.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.766 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.39 -51.19 56.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HA ' ' HG2' ' A' ' 76' ' ' GLU . 26.4 mt -56.47 -65.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.577 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.02 -42.19 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.517 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.893 HD11 HG21 ' A' ' 85' ' ' THR . 4.2 mt -63.48 -58.31 7.43 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 13.0 pt-20 -61.85 -23.65 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.516 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.31 -53.23 6.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.008 0.432 . . . . 0.0 110.073 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 74' ' ' ILE . 24.3 t -52.78 -25.98 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.199 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.58 20.49 47.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.86 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 8.6 tp10 -135.74 56.58 15.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 31.9 Cg_exo -59.98 -39.97 66.05 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.294 1.996 . . . . 0.0 112.091 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -50.15 -25.51 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 57' ' ' ASP . 13.2 tp -45.7 151.82 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.051 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 66.8 mm-40 -74.86 92.95 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 110.61 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.928 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.9 m -98.46 114.59 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.389 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -123.47 169.15 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.76 161.23 37.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.862 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.73 ' HB3' HD12 ' A' ' 91' ' ' LEU . 12.1 t -134.47 147.65 50.42 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.146 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 pt-20 -77.86 -33.75 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.226 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.919 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mtmt -77.54 -10.02 59.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 162' ' ' ALA . 3.9 mt -78.59 -15.34 58.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.591 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -54.46 -171.95 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -85.88 169.17 13.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.983 0.42 . . . . 0.0 110.975 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.75 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.9 OUTLIER -73.79 122.68 22.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.555 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.69 131.66 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.472 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.455 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 1.5 m-85 -103.81 19.91 19.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.361 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 129' ' ' ASN . . . 49.58 -126.94 21.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.64 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.42 16.92 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.793 HD11 ' HH2' ' A' ' 111' ' ' TRP . 4.5 mp -104.09 -32.93 8.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.85 0.357 . . . . 0.0 110.979 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -42.49 136.0 2.57 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.502 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 80.09 0.88 86.98 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.498 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.832 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.9 tt -81.7 149.67 28.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.199 0.5 . . . . 0.0 110.534 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -65.23 118.23 8.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 13.8 mttt -47.56 -47.77 28.13 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.146 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -59.42 -40.03 85.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.433 ' HB2' ' CB ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -60.95 -53.38 58.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.832 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -56.55 -56.62 19.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.535 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.911 ' HA ' HG21 ' A' ' 116' ' ' VAL . 21.6 mtp180 -59.58 -20.38 55.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.706 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -84.36 -59.92 2.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.163 179.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -93.34 69.46 4.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.793 ' HH2' HD11 ' A' ' 99' ' ' LEU . 2.6 m0 156.93 -21.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 55.92 162.73 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.972 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -45.42 -35.31 3.61 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.849 0.356 . . . . 0.0 110.52 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -59.45 -78.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.758 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.51 ' HG2' ' CD1' ' A' ' 111' ' ' TRP . 1.6 tp60 -52.76 -46.12 67.37 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.91 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.911 HG21 ' HA ' ' A' ' 108' ' ' ARG . 13.3 t -55.34 -48.44 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.861 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 30.6 tt0 -54.33 -56.04 22.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.036 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -64.54 -13.83 14.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.549 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -92.45 -36.59 13.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.581 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -111.0 -37.44 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 183' ' ' VAL . 2.7 mmp_? -89.41 -17.12 29.4 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -37.45 150.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.671 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.508 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 11.7 t80 -98.21 -45.93 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -112.9 -35.23 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.022 0.439 . . . . 0.0 110.909 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.036 HD13 HD11 ' A' ' 118' ' ' ILE . 17.7 tt -76.69 150.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 131' ' ' GLU . . . -138.6 151.53 69.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.624 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 36.8 Cg_exo -57.69 160.76 13.8 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.604 2.203 . . . . 0.0 112.029 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 69.3 Cg_exo -50.18 104.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.177 1.918 . . . . 0.0 111.218 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 1.6 m-20 90.85 -23.25 0.09 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.649 0.593 . . . . 0.0 111.043 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -68.77 -173.3 8.33 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.084 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -123.82 173.35 8.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.775 0.322 . . . . 0.0 110.758 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 136' ' ' THR . 35.7 t -122.54 -162.24 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 133' ' ' LEU . 2.3 tp -79.35 -59.45 2.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -47.95 -39.79 20.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.927 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -65.13 -68.24 0.38 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 140' ' ' VAL . 55.7 p -44.37 -50.66 9.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.892 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -60.08 -54.1 49.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 134' ' ' LYS . 5.8 mm-40 -48.56 -25.93 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.079 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.1 OUTLIER -105.31 -14.16 15.44 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.308 179.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 90' ' ' LYS . 85.8 t -95.15 -21.86 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.709 0.29 . . . . 0.0 110.783 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.526 HD13 ' OD1' ' A' ' 173' ' ' ASP . 20.2 mt -76.09 -45.21 3.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 54.1 Cg_exo -49.92 -48.88 17.75 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.521 1.481 . . . . 0.0 110.805 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.491 ' HE1' HD11 ' A' ' 86' ' ' ILE . 1.6 t80 -57.54 -45.91 84.5 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.853 ' CZ ' HD11 ' A' ' 174' ' ' LEU . 20.9 t80 -55.76 -67.49 0.28 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.522 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.536 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -53.55 -63.42 1.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.027 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.8 t -51.58 -60.96 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.438 ' OG1' ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -96.77 7.4 46.68 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 151' ' ' HIS . 2.2 mt -135.47 -1.5 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.337 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.656 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -92.41 -14.83 0.2 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 178.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.656 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 98.0 Cg_endo -80.66 -48.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 121.615 1.543 . . . . 0.0 113.488 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.688 ' NE2' HG21 ' A' ' 158' ' ' VAL . 8.6 p-80 -67.96 -43.26 79.44 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.535 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 9.9 pt -51.87 -24.3 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 153' ' ' LEU . 13.5 mt -87.85 -16.09 34.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.229 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -79.65 -35.52 39.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 111.143 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 120.95 48.05 0.3 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 2' ' ' THR . 1.7 mp0 -132.95 158.44 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 0.0 110.634 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.32 156.86 18.92 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 58' ' ' ILE . 11.5 t -132.46 153.45 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 4.2 tt -99.34 147.44 25.21 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.768 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 159' ' ' LEU . 21.4 mt -142.72 107.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.883 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.668 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -116.49 106.2 13.33 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.971 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.851 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -137.22 -99.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.957 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.638 ' CE1' HD12 ' A' ' 64' ' ' LEU . 10.2 m-70 -161.87 177.07 10.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.269 0.557 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.65 -49.13 58.97 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.302 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.449 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.6 m-80 -62.39 -57.07 12.63 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 121.069 -0.253 . . . . 0.0 110.804 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -51.82 -46.52 64.32 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -60.0 -50.67 72.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.868 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.496 ' HG2' ' NE ' ' A' ' 185' ' ' ARG . 26.2 mtm180 -54.86 -53.22 58.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.547 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -56.67 -59.59 4.78 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.528 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.612 HD13 HG12 ' A' ' 140' ' ' VAL . 2.1 tp -54.03 -54.9 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.465 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -59.22 -49.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.064 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 10.9 ptm -57.05 -42.62 80.85 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.722 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.526 ' OD1' HD13 ' A' ' 141' ' ' LEU . 22.7 t70 -72.25 -29.27 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD11 ' CZ ' ' A' ' 144' ' ' TYR . 0.7 OUTLIER -75.83 -39.15 57.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.963 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 7.4 mp0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.166 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 84.05 26.15 42.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.88 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 181' ' ' GLN . 2.3 mm? -51.87 -174.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 182' ' ' ILE . 11.8 t -125.75 -157.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.657 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -88.17 -28.55 22.56 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.728 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 178' ' ' THR . 0.3 OUTLIER -107.35 22.01 16.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.192 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.867 ' HB3' HD12 ' A' ' 177' ' ' LEU . 62.2 mt-30 -125.15 -61.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.468 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 178' ' ' THR . 5.4 tp -51.12 -39.65 20.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 121' ' ' ARG . 9.5 p -53.47 -21.77 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.964 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -88.8 -27.69 20.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.251 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.705 HH12 HD13 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -48.72 146.01 3.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 1.2 tt0 -146.07 136.04 23.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -121.5 175.57 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.742 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -102.6 -164.2 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.975 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 69.2 p -137.06 112.64 9.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 45' ' ' GLY . . . 101.15 -25.19 29.16 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.606 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.742 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 24.5 m -88.49 105.28 9.15 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.712 0.291 . . . . 0.0 111.126 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.449 ' HB2' HD12 ' A' ' 49' ' ' LEU . 37.8 Cg_endo -66.57 107.09 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.585 2.19 . . . . 0.0 112.376 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.696 HD12 ' CE2' ' A' ' 195' ' ' TYR . 0.0 OUTLIER -86.78 135.92 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.81 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 11' ' ' VAL . 1.5 t -99.5 122.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.758 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 193' ' ' ILE . 17.6 m-85 -111.09 116.61 31.42 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.532 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.794 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -71.74 97.09 1.7 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 mt -96.1 157.89 15.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.329 0.585 . . . . 0.0 111.796 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.635 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.6 OUTLIER -94.83 -171.34 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.87 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ALA . 2.3 pptp? -67.67 -4.72 12.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -116.33 30.33 7.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.713 0.292 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 54.78 25.6 37.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.257 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -108.28 140.97 40.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 0.0 110.939 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -57.83 147.27 28.9 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.79 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 196' ' ' HIS . 27.6 m -145.74 18.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 3.6 m -167.32 -152.15 0.12 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.771 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -122.54 155.08 36.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.436 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.6 ' CB ' HD11 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -49.18 171.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.048 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.731 ' O ' HG23 ' A' ' 194' ' ' VAL . 1.5 tp -160.8 112.2 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.318 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 20.8 mm -115.06 161.91 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.235 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 8.5 m-20 -73.0 -53.96 9.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.894 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.697 ' H3 ' HD22 ' A' ' 9' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.643 0.259 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.542 HG21 ' C ' ' A' ' 155' ' ' GLY . 3.7 t -43.2 127.78 4.46 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.183 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.83 -72.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -68.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.013 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . . . -151.51 -51.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -64.82 -65.61 1.87 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 47.0 Cg_endo -68.55 70.27 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.52 2.147 . . . . 0.0 112.202 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 197' ' ' LEU . 3.4 t30 -68.75 161.67 27.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 ' H3 ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -119.27 152.92 35.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.387 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 197' ' ' LEU . 1.6 tp -147.21 125.66 12.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.897 HG22 HG22 ' A' ' 194' ' ' VAL . 48.8 t -96.26 119.19 43.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.36 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 193' ' ' ILE . 22.8 mt -100.7 131.35 46.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 6.9 t -144.91 158.27 43.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HB2' HD11 ' A' ' 167' ' ' LEU . 77.6 ttt180 -131.97 135.84 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.709 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.2 p80 -42.07 121.93 1.97 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' CB ' ' A' ' 41' ' ' GLU . . . -38.25 -58.72 1.6 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.797 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.22 151.32 1.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.877 0.37 . . . . 0.0 111.174 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -122.9 166.52 14.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.702 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.44 -25.48 6.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.854 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.48 ' CE3' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -62.81 -25.14 68.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.613 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -68.22 -52.63 32.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.5 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -52.33 -40.47 61.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' HB3' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -77.37 -25.2 50.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.713 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 1.8 t30 68.19 53.54 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.974 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -135.87 166.1 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.049 0.452 . . . . 0.0 111.068 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 m-85 -72.75 158.33 35.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.766 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.436 ' OG1' ' CE3' ' A' ' 20' ' ' TRP . 1.5 m -121.03 -69.29 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.72 -132.59 11.21 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.087 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -47.51 60.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.625 0.25 . . . . 0.0 111.534 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HE2' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -43.32 138.4 2.33 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.261 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' CG ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -91.37 106.77 17.61 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.234 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 92.3 Cg_endo -78.53 -166.98 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.535 2.157 . . . . 0.0 112.127 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.18 119.88 32.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.898 0.38 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 39' ' ' ILE . 5.4 tp -49.52 172.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 175.93 9.13 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 5.5 mt-10 -51.99 -40.91 61.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.368 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 94.5 m -62.46 -42.29 99.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.99 -56.31 16.96 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 34' ' ' LEU . 30.9 mm -54.79 -54.39 23.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 3.8 mtpm? -55.89 -41.78 74.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.131 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' CB ' ' HA3' ' A' ' 16' ' ' GLY . 6.4 mm-40 -58.9 -49.0 79.45 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.255 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.84 63.88 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.714 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -53.18 -56.75 13.95 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.734 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.72 -43.75 76.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.72 -49.59 69.25 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.386 -0.911 . . . . 0.0 110.878 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -63.45 -53.55 38.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.032 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 51' ' ' SER . 16.9 tt0 -55.51 -32.57 63.0 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.3 mmt85 -75.36 -45.25 40.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.961 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 74' ' ' ILE . 12.4 mt -62.46 -47.94 81.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.556 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -35.88 65.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.529 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.3 t -47.99 -64.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' CZ ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -52.88 -68.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.047 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.2 50.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.42 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.641 ' HE2' HG11 ' A' ' 194' ' ' VAL . 35.4 t80 -116.13 113.02 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.682 0.277 . . . . 0.0 110.657 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -98.5 150.93 21.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.389 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 159' ' ' LEU . 29.5 m-85 -111.75 153.59 26.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' CB ' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -117.94 -32.05 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.879 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.849 ' HB ' HG22 ' A' ' 158' ' ' VAL . 2.2 mt -144.04 155.08 15.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -133.88 128.0 33.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.085 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' CZ ' HG12 ' A' ' 148' ' ' ILE . 4.3 m-85 -112.6 113.2 25.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 161' ' ' ALA . 0.8 OUTLIER -118.92 164.76 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.312 0.577 . . . . 0.0 111.813 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 p -88.08 156.77 19.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.263 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.6 -23.49 4.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 55.7 mt -67.9 133.89 49.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 111.361 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 8.8 pt20 -53.67 -37.32 63.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.481 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.642 HH21 HD13 ' A' ' 64' ' ' LEU . 7.1 mtm180 -40.31 -66.4 0.32 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -57.32 -38.06 73.45 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.413 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 10.4 mt-30 -59.19 -48.66 80.81 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -66.43 -47.54 72.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.466 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 15' ' ' HIS . 11.0 m -61.84 -24.46 66.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.414 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 61' ' ' THR . 35.0 t -82.96 -52.84 6.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -48.66 64.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.0 110.399 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 77' ' ' GLU . 51.0 mt -57.98 -60.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.806 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -56.72 -46.49 83.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.789 0.328 . . . . 0.0 110.381 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 83' ' ' LEU . 10.1 mt -60.24 -62.95 1.49 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 5.6 mm-40 -55.34 -25.91 37.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.795 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.9 mm-40 -73.1 -55.68 6.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.483 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.7 HG13 HD13 ' A' ' 74' ' ' ILE . 13.5 m -54.84 -28.79 20.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.929 0.395 . . . . 0.0 110.591 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 34.06 7.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.004 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.715 ' O ' HD22 ' A' ' 83' ' ' LEU . 5.1 mm-40 -147.84 57.1 3.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 12.0 Cg_exo -70.78 -21.27 28.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.352 2.035 . . . . 0.0 112.15 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -54.03 -31.28 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.538 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.9 OUTLIER -48.73 176.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.949 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -83.35 99.22 9.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 6.8 m -90.96 103.63 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.504 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -123.95 160.96 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.397 0.618 . . . . 0.0 111.027 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -145.57 168.05 21.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.96 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.809 ' HB3' HD12 ' A' ' 91' ' ' LEU . 29.8 t -138.7 151.39 47.12 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.579 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -77.61 -32.7 53.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.909 ' O ' HG12 ' A' ' 140' ' ' VAL . 11.1 mtmt -73.59 -11.98 60.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.493 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 88' ' ' SER . 5.2 mt -84.04 7.76 17.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.457 0.17 . . . . 0.0 111.397 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -74.19 163.07 28.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.2 tp10 -65.84 144.65 56.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.771 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.3 tmm_? -50.62 143.31 9.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' CE1' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -66.99 131.25 45.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.226 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 26' ' ' PHE . 2.5 m-85 -109.52 34.84 3.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 128' ' ' PRO . . . 38.62 -119.97 0.94 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.598 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -95.34 12.95 27.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.568 0.223 . . . . 0.0 111.564 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.033 HD13 HD12 ' A' ' 102' ' ' LEU . 2.4 mm? -87.19 -24.54 24.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' NE2' ' CE1' ' A' ' 95' ' ' TYR . 65.3 mt-30 -49.32 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.003 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 122.47 -22.36 7.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.139 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.033 HD12 HD13 ' A' ' 99' ' ' LEU . 3.1 mt -63.55 134.9 56.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 111.074 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -74.09 128.72 36.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.311 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -44.29 -34.12 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -65.8 -58.62 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.895 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -61.33 -41.32 96.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.807 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 116' ' ' VAL . . . -64.81 -46.65 81.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.197 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.892 ' HA ' HG21 ' A' ' 116' ' ' VAL . 2.2 ptm180 -76.84 -12.96 60.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.737 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASP . 12.1 mtpp -95.76 -34.71 11.81 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -61.43 2.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.0 m-90 -87.71 2.78 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 116' ' ' VAL . . . 60.14 147.26 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.742 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -52.31 -34.51 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.945 0.402 . . . . 0.0 110.134 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.35 -57.65 10.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG3' ' NE1' ' A' ' 119' ' ' TRP . 1.5 tp60 -73.85 -46.78 42.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.045 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 108' ' ' ARG . 73.9 t -51.47 -47.97 35.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.471 ' NE2' ' CB ' ' A' ' 121' ' ' ARG . 34.2 tp60 -50.41 -76.36 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.405 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.912 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.2 -27.6 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.593 178.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 2.2 m95 -69.1 -46.82 66.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.691 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.3 OUTLIER -105.75 -7.34 18.44 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 3.2 mmp_? -107.91 -37.19 6.16 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.429 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 45.5 t -39.89 160.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.874 0.369 . . . . 0.0 111.875 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.636 ' HD1' HD23 ' A' ' 133' ' ' LEU . 9.4 t80 -89.15 -43.84 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.908 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -105.43 -37.02 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.701 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.838 HG21 ' CD1' ' A' ' 118' ' ' ILE . 8.7 mm -62.4 147.0 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.127 0.489 . . . . 0.0 111.001 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.447 ' HB1' ' O ' ' A' ' 131' ' ' GLU . . . -137.69 143.6 41.15 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.686 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.468 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 51.5 Cg_exo -54.32 171.77 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.495 2.13 . . . . 0.0 112.229 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 78.5 Cg_exo -47.44 95.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.52 2.147 . . . . 0.0 111.991 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.02 155.63 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 118.71 -125.06 6.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.862 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.682 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.0 OUTLIER -151.17 177.79 9.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.584 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -132.73 176.0 8.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.779 HD22 HH21 ' A' ' 168' ' ' ARG . 9.9 tp -57.1 -48.59 78.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' CE ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.83 -48.39 59.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.456 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 6.5 t70 -61.59 -53.69 52.97 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.805 ' O ' HG13 ' A' ' 140' ' ' VAL . 52.1 p -52.69 -54.61 31.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.62 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.724 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . . . -57.88 -50.25 73.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.79 -20.06 66.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.62 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -101.05 -30.1 11.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.482 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 90' ' ' LYS . 15.3 m -83.12 -32.38 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.73 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.766 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -58.6 -49.56 92.79 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 83.2 Cg_exo -46.38 -48.93 12.53 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.083 1.855 . . . . 0.0 111.01 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 147' ' ' THR . 5.2 t80 -59.46 -40.02 85.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.856 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 3.2 t80 -64.3 -68.46 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.774 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -51.61 -42.51 62.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.197 179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 4.7 t -74.31 -58.34 3.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.99 5.28 50.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 152' ' ' ILE . 32.1 mt -124.24 -14.23 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.609 -0.836 . . . . 0.0 112.767 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 2.3 p -76.66 -27.33 0.61 Allowed Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 86.3 Cg_endo -82.11 -40.45 0.14 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.762 1.641 . . . . 0.0 113.862 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.954 ' NE2' HG21 ' A' ' 158' ' ' VAL . 1.6 p-80 -77.39 -18.41 57.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 148' ' ' ILE . 2.0 pp -79.88 -23.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.126 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 199' ' ' LYS . 6.8 mt -91.07 -22.59 20.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -64.17 -23.92 67.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.19 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 2' ' ' THR . . . 107.04 38.89 2.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.276 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.461 ' N ' HG21 ' A' ' 2' ' ' THR . 0.0 OUTLIER -128.38 160.26 32.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.599 0.237 . . . . 0.0 110.661 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.522 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -110.59 160.1 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.954 HG21 ' NE2' ' A' ' 151' ' ' HIS . 23.5 t -140.87 154.84 21.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 1.1 tt -97.75 155.89 16.81 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.812 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.545 ' N ' HD23 ' A' ' 159' ' ' LEU . 13.6 mt -144.62 104.03 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -114.93 98.36 6.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 163' ' ' HIS . . . -132.27 -97.33 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 7.1 m-70 -160.46 172.52 17.08 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -51.48 -54.56 23.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.569 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 81.9 m-20 -58.81 -49.66 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.673 0.273 . . . . 0.0 110.28 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -57.28 11.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.4 mt -57.38 -36.41 71.22 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.71 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.779 HH21 HD22 ' A' ' 133' ' ' LEU . 52.5 mtp85 -61.92 -62.45 1.78 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.724 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -52.15 -37.06 53.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.298 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 144' ' ' TYR . 1.4 tp -72.31 -68.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -49.83 -47.2 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.449 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.523 ' CE ' ' CE1' ' A' ' 123' ' ' TYR . 19.5 ptm -53.34 -50.79 64.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 110.383 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.766 ' CG ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -71.45 -34.51 70.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.339 179.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.856 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 81.0 mt -66.91 -36.84 83.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.244 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -86.64 -51.21 6.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 115.58 19.97 5.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.533 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.536 HD23 HD13 ' A' ' 182' ' ' ILE . 0.3 OUTLIER -65.83 -174.18 0.21 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.786 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 181' ' ' GLN . 13.5 t -130.17 171.55 12.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.06 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -58.92 -32.26 70.07 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.436 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.78 18.99 14.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.658 0.266 . . . . 0.0 111.114 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.76 ' HB2' HG22 ' A' ' 178' ' ' THR . 37.2 mm-40 -145.92 17.05 1.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.312 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.536 HD13 HD23 ' A' ' 177' ' ' LEU . 8.0 tp -134.59 33.26 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.37 20.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.181 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 23.67 1.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -96.07 25.27 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -51.24 137.63 22.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.927 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 187' ' ' LEU . 2.5 pt? -116.93 -171.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -101.32 147.49 26.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 8.0 p -81.75 113.5 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.61 -66.4 0.24 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.666 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.877 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 31.1 m -48.34 104.8 0.44 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.71 0.291 . . . . 0.0 111.304 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.51 ' HG2' HD21 ' A' ' 49' ' ' LEU . 73.6 Cg_endo -75.74 116.34 4.42 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.684 2.256 . . . . 0.0 111.934 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -90.18 144.12 9.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.114 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.923 ' N ' HD13 ' A' ' 193' ' ' ILE . 25.2 t -106.09 117.26 51.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.335 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.632 ' CD2' HD12 ' A' ' 193' ' ' ILE . 19.1 m-85 -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 111.324 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.534 ' CE1' HD11 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -82.84 121.47 26.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 10' ' ' LEU . 1.8 mp -119.56 157.49 28.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.383 0.611 . . . . 0.0 111.786 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.67 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.4 OUTLIER -91.47 -177.07 4.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.716 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.606 ' HB2' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.83 -12.89 53.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.456 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 10.7 t0 -104.4 23.45 13.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 111.08 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.691 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.22 38.95 91.65 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.654 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.441 ' N ' HD23 ' A' ' 197' ' ' LEU . 7.0 ttpt -125.75 140.2 52.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.313 . . . . 0.0 110.743 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 1.2 p90 -49.52 148.1 3.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.67 HG11 ' HB3' ' A' ' 198' ' ' ASP . 7.8 m -149.09 20.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -169.24 -155.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.292 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 165.67 13.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.436 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.755 ' HA ' HD11 ' A' ' 193' ' ' ILE . 5.2 pt-20 -60.97 173.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.26 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.6 tp -166.63 106.52 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.662 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 210' ' ' ASP . 10.0 mm -108.39 161.6 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.329 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 40.3 m-20 -79.17 -47.85 15.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 209' ' ' ILE . 60.2 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' N ' ' HG2' ' A' ' 157' ' ' LYS . 8.9 ttp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.761 0.315 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' N ' ' A' ' 156' ' ' GLU . 2.6 t -46.11 147.28 1.09 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 t -93.08 -0.29 57.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 64.0 87.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . 168.27 -58.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.428 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -144.54 -72.12 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 90.3 Cg_endo -79.23 85.27 1.88 Allowed 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.471 2.114 . . . . 0.0 113.898 -178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 2' ' ' THR . 1.8 p30 -67.42 -171.72 0.19 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -144.72 126.02 14.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.345 0.593 . . . . 0.0 111.825 -179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.46 131.4 46.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.944 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.864 ' C ' HD23 ' A' ' 12' ' ' LEU . 18.9 t -115.24 135.01 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.084 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.864 HD23 ' C ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER -114.17 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.711 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 13' ' ' THR . 6.6 t -129.71 103.71 6.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HD3' ' CD2' ' A' ' 187' ' ' LEU . 0.0 OUTLIER -70.42 164.77 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.526 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.6 p80 -91.3 129.7 37.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.432 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -35.94 -93.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.632 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 37' ' ' THR . 8.4 pt-20 -157.57 140.6 15.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.49 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -86.22 160.94 19.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -47.41 -49.13 25.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -59.05 -28.53 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.987 0.423 . . . . 0.0 110.287 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -59.84 -41.05 90.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.224 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.75 -48.39 77.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.449 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.4 OUTLIER -61.95 -22.74 65.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.535 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 104' ' ' LYS . 2.0 t30 86.99 51.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.951 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -130.7 157.25 43.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.631 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 22.2 m-85 -78.34 154.0 31.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.0 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.563 ' CG2' ' HE2' ' A' ' 30' ' ' LYS . 3.5 m -104.83 -71.78 0.73 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.836 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.08 -119.56 6.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.551 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -101.62 -30.25 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.554 0.216 . . . . 0.0 111.253 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HE2' ' CG2' ' A' ' 27' ' ' THR . 0.0 OUTLIER -60.08 121.01 10.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.994 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 4.3 p30 -66.77 124.21 87.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CG ' ' NE ' ' A' ' 66' ' ' ARG . 85.7 Cg_endo -95.19 -168.48 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.249 2.632 . . . . 0.0 112.652 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 34' ' ' LEU . . . -120.62 103.98 9.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.464 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.589 HD23 ' CD1' ' A' ' 39' ' ' ILE . 14.5 tp -38.27 162.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.028 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 39' ' ' ILE . 86.7 p -124.6 179.69 4.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -44.97 -65.86 0.47 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.762 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.682 ' HA ' ' CG ' ' A' ' 40' ' ' LYS . 29.8 m -44.53 -44.98 9.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' HG ' ' A' ' 34' ' ' LEU . . . -58.89 -54.6 36.65 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 39' ' ' ILE . 2.2 mm -57.1 -59.11 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.682 ' CG ' ' HA ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -57.09 -30.88 64.7 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.824 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' THR . 5.6 mm-40 -70.06 -52.06 26.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -59.26 -53.96 52.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.255 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.85 ' NZ ' HG22 ' A' ' 73' ' ' ILE . 1.9 mmtm -50.89 -53.14 35.16 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.452 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.611 HD11 ' CZ ' ' A' ' 48' ' ' ARG . 41.9 tp -57.74 -49.54 76.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.702 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.73 22.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.658 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -56.24 -54.44 35.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.39 -0.909 . . . . 0.0 110.994 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' SER . 54.6 mt-10 -56.75 -36.18 69.48 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 40.1 mmt-85 -67.4 -49.67 62.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.677 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.681 HD21 ' CE1' ' A' ' 56' ' ' PHE . 1.2 tp -66.04 -43.64 86.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.497 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HB2' HG12 ' A' ' 78' ' ' VAL . 13.9 tptp -62.88 -52.66 62.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.849 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.52 ' OG ' ' CZ ' ' A' ' 52' ' ' ARG . 6.9 p -56.03 -49.63 73.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.733 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' CD ' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -52.13 -44.56 64.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.4 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.21 25.4 3.83 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.366 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.692 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 4.2 t80 -96.0 118.81 33.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.159 0.479 . . . . 0.0 110.4 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 mmpt? -102.82 160.23 14.78 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.021 0.438 . . . . 0.0 110.71 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE2' ' HB2' ' A' ' 159' ' ' LEU . 53.0 m-85 -133.07 142.57 48.82 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OE1' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -108.47 -27.47 9.9 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.877 -1.51 . . . . 0.0 109.405 177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.822 ' HB ' HG22 ' A' ' 158' ' ' VAL . 3.1 mm -129.54 125.61 61.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.754 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -114.06 113.64 25.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.284 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.896 ' CE1' HG21 ' A' ' 86' ' ' ILE . 1.3 m-85 -104.35 111.89 24.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.699 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 71' ' ' CYS . 0.9 OUTLIER -121.24 160.62 23.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 111.037 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.2 p -85.04 147.42 26.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.691 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' SER . . . -43.39 -26.57 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.971 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD12 ' HE1' ' A' ' 163' ' ' HIS . 14.9 mt -65.33 126.38 28.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.092 0.472 . . . . 0.0 111.107 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 66' ' ' ARG . 5.9 pt20 -47.97 -42.43 27.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.376 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' NE ' ' CG ' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -32.42 -65.88 0.14 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.016 0.436 . . . . 0.0 111.222 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.33 -35.8 81.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.517 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 1.7 mt-30 -63.25 -53.26 55.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.819 ' CD ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -58.49 -53.68 55.63 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.879 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -52.01 -57.52 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.017 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 61' ' ' THR . 4.2 p -58.37 -42.86 87.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.337 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 22.2 mt-30 -53.95 -48.34 70.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.789 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.72 -65.36 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.177 179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.986 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.2 pp -52.25 -42.46 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.657 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' HA ' HG22 ' A' ' 78' ' ' VAL . 82.1 mt -67.76 -52.97 31.11 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 16.3 mm-40 -62.1 -24.87 67.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.826 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 73' ' ' ILE . 4.8 tp10 -82.55 -48.05 11.44 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.331 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 74' ' ' ILE . 5.2 m -71.99 -12.88 16.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.73 34.99 37.28 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.066 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.78 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -109.18 11.49 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 72.8 Cg_exo -47.28 -55.43 3.93 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.295 1.33 . . . . 0.0 112.216 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 81' ' ' PRO . 2.8 p-10 -35.98 -42.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.757 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.78 HD22 ' O ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -49.03 172.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.555 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.561 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 2.4 mp0 -78.3 101.15 7.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 111.246 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.793 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 2.9 m -81.9 91.44 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.896 HG21 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -98.48 130.97 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.256 -178.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.791 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -124.34 153.4 41.85 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.781 178.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.833 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.9 t -149.98 143.36 25.16 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.437 -0.505 . . . . 0.0 112.302 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.06 -27.54 43.08 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.968 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.7 mttp -67.95 -15.76 63.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.929 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.833 HD12 ' HB3' ' A' ' 88' ' ' SER . 8.3 mt -95.68 10.38 37.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -75.68 149.29 38.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 11.7 tp10 -55.45 146.15 20.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.3 OUTLIER -45.17 137.35 4.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.611 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -63.63 122.22 15.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.565 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.4 m-85 -88.37 38.11 0.85 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.586 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 23.12 -93.34 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.16 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -105.89 -9.36 17.18 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.808 HD13 ' HD2' ' A' ' 128' ' ' PRO . 3.8 mp -76.72 -7.63 55.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 110.35 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.584 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 13.4 mt-30 -60.27 105.37 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 26' ' ' PHE . . . 88.75 37.17 7.49 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.774 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 107' ' ' ALA . 1.1 tm? -111.45 124.43 52.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.833 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -47.2 107.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.224 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 24' ' ' ASN . 28.2 mttt -39.49 -43.52 1.27 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 12.1 t0 -59.31 -52.63 64.83 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.405 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 109' ' ' LYS . 4.7 t0 -59.65 -48.96 79.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -53.81 -56.75 14.72 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.048 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 2.0 ptm180 -68.53 -16.35 63.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.234 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 46.7 mttt -81.38 -44.4 17.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.228 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -87.88 -41.56 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 115' ' ' GLN . 2.3 m-90 -98.31 -40.61 8.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.21 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.72 170.46 0.61 Allowed Glycine 0 N--CA 1.454 -0.118 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.58 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' GLN . . . -36.74 -65.67 0.27 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.279 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -33.43 -58.87 0.39 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -81.48 -53.76 6.01 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 112' ' ' GLY . 14.7 m -55.62 -47.47 78.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.992 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.532 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.5 pt20 -56.74 -54.2 49.02 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -64.58 -25.34 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.623 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.7 m95 -77.92 -33.02 51.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.27 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -40.33 7.09 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 168' ' ' ARG . 68.2 mmt-85 -104.15 -9.99 18.28 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 118' ' ' ILE . 2.1 t -36.26 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.833 0.742 . . . . 0.0 112.354 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.601 ' CD1' HD22 ' A' ' 133' ' ' LEU . 8.4 t80 77.42 -52.83 0.54 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.568 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -38.89 11.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' CD1' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -99.19 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.933 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -130.67 172.63 6.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 112.015 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.632 ' CB ' ' HD2' ' A' ' 128' ' ' PRO . 12.8 Cg_exo -70.64 -173.05 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.447 2.765 . . . . 0.0 111.324 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.808 ' HD2' HD13 ' A' ' 99' ' ' LEU . 8.2 Cg_endo -50.22 86.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.876 1.717 . . . . 0.0 111.416 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' PRO . 0.5 OUTLIER 79.19 165.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.567 -179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.611 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 112.48 -131.93 10.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.961 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.838 ' OE2' HG22 ' A' ' 136' ' ' THR . 0.2 OUTLIER -144.79 170.87 15.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 0.0 111.028 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -122.59 174.76 6.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.366 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 168' ' ' ARG . 1.3 tt -55.68 -58.24 8.65 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.211 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -48.3 -45.61 35.12 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.381 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -58.56 -58.99 6.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.838 HG22 ' OE2' ' A' ' 131' ' ' GLU . 41.2 p -47.2 -63.34 1.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.787 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -41.43 -66.65 0.32 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.66 -51.98 5.04 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.454 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.511 ' NH2' ' OE1' ' A' ' 131' ' ' GLU . 3.6 ppt_? -93.89 27.05 2.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.678 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.968 HG22 ' O ' ' A' ' 90' ' ' LYS . 11.2 t -128.54 -40.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 0.0 OUTLIER -77.34 -14.1 0.22 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.681 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 53.0 Cg_exo -56.62 -55.82 2.46 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 120.968 1.112 . . . . 0.0 110.634 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.559 ' O ' HG23 ' A' ' 147' ' ' THR . 2.3 t80 -49.77 -45.25 49.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -58.84 -77.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.656 178.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.626 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -43.03 -44.47 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.1 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 41.3 t -63.05 -71.94 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -97.98 7.26 46.61 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.881 HD11 ' CE2' ' A' ' 60' ' ' PHE . 27.3 mt -115.95 -24.08 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.675 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -77.63 -26.08 0.51 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 85.9 Cg_endo -80.9 -37.98 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.769 1.646 . . . . 0.0 113.119 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 3.8 p-80 -73.9 -43.91 56.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.606 0.241 . . . . 0.0 111.048 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.596 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -50.69 -24.36 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.714 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 152' ' ' ILE . 13.5 mt -86.3 -15.94 39.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.063 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -85.22 -7.07 59.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 4' ' ' GLU . . . 90.43 47.7 3.7 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.505 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.543 ' OE2' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -137.11 160.52 38.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.667 ' CE ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -113.44 171.66 7.43 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.484 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.822 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.4 t -133.31 150.46 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.783 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -111.08 109.08 19.0 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.816 ' HB ' HD22 ' A' ' 12' ' ' LEU . 97.0 mt -99.67 124.96 53.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.278 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.451 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -131.5 84.86 2.21 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.417 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -122.31 -93.72 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.292 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.851 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.7 m-70 -164.18 159.01 19.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.23 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -44.19 -44.85 7.82 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.323 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 94' ' ' ARG . 11.0 t-20 -63.74 -60.04 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -49.26 -54.85 14.83 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.851 HD12 ' C ' ' A' ' 163' ' ' HIS . 2.0 mt -56.33 -51.05 69.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.628 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.728 ' HB3' HD11 ' A' ' 133' ' ' LEU . 16.2 mtm180 -50.87 -60.02 3.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.787 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -51.95 -51.49 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.352 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.67 HD13 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -59.2 -66.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.858 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -47.74 -37.19 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.385 0.612 . . . . 0.0 109.367 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -57.1 -62.02 2.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.153 178.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 172' ' ' MET . 4.4 t70 -67.5 -27.56 67.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 202' ' ' LYS . 25.1 mt -74.0 -40.63 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.402 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' HD11 ' A' ' 171' ' ' ILE . 4.1 mm-40 -89.92 -24.25 21.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.658 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 93.68 0.37 66.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.043 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -45.35 176.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 111.127 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 180' ' ' ASP . 4.7 t -116.66 -151.71 0.49 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.639 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 178' ' ' THR . . . -96.8 0.85 61.11 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.058 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.633 ' H ' HG23 ' A' ' 178' ' ' THR . 14.4 m-20 -123.86 -22.58 4.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 111.509 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.63 -3.14 33.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.038 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.565 HG13 ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -101.15 -45.2 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.818 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.606 HG12 ' NH1' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -51.49 -20.21 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -77.05 -37.37 54.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.792 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.814 HH21 HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -56.33 127.79 32.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.232 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -131.98 158.38 41.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.814 HD12 HH21 ' A' ' 185' ' ' ARG . 0.0 OUTLIER -121.75 -177.41 3.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.894 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.897 ' O ' HG22 ' A' ' 191' ' ' VAL . . . -127.68 102.76 6.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -43.79 120.84 2.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.2 24.29 17.18 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.871 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 188' ' ' ALA . 4.2 m -142.73 124.08 8.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.753 0.311 . . . . 0.0 111.075 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.606 ' C ' HD11 ' A' ' 209' ' ' ILE . 86.9 Cg_endo -86.43 90.53 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.87 2.38 . . . . 0.0 112.247 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.916 HD13 ' N ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -70.88 151.87 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 193' ' ' ILE . 2.0 t -115.26 122.77 69.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.543 ' CE2' HD12 ' A' ' 193' ' ' ILE . 75.3 m-85 -111.02 118.4 35.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.82 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.663 ' O ' HG12 ' A' ' 204' ' ' VAL . 2.3 t60 -77.78 98.0 5.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -94.74 160.09 14.77 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.558 0.694 . . . . 0.0 112.385 -178.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -75.73 -174.78 2.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.929 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -78.66 4.25 14.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.658 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -112.74 -12.23 13.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.463 ' O ' HD22 ' A' ' 174' ' ' LEU . . . 98.18 48.11 1.93 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.536 ' CA ' HD13 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -143.49 149.59 37.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.517 ' HA ' HD22 ' A' ' 197' ' ' LEU . 1.1 p90 -35.43 154.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -166.38 20.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.449 -176.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 196' ' ' HIS . 13.7 t 177.82 -117.97 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.443 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 205' ' ' SER . 2.6 mmtp -144.88 -175.28 4.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.986 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' A' ' 193' ' ' ILE . 5.1 pt-20 -103.32 166.58 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.143 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 209' ' ' ILE . 0.5 OUTLIER -168.59 146.49 4.05 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.303 0.573 . . . . 0.0 112.101 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.715 ' H ' HD23 ' A' ' 208' ' ' LEU . 0.5 OUTLIER -131.81 168.26 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.693 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -96.81 -39.79 9.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 48' ' ' ARG . 3.6 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.064 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' THR . 25.8 mtp . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.615 HG23 ' N ' ' A' ' 156' ' ' GLU . 7.2 p 37.24 -153.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.6 m -141.45 -59.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 8.7 pt-20 -137.78 22.1 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 4' ' ' GLU . . . 85.98 -53.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.312 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.951 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -52.29 -67.75 0.5 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.292 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.951 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 91.5 Cg_endo -79.48 89.82 1.32 Allowed 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.665 2.243 . . . . 0.0 112.528 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.14 143.11 39.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.729 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.986 HD12 ' OH ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -100.67 148.25 25.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.261 0.553 . . . . 0.0 111.4 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 9' ' ' LEU . 1.7 tp -149.11 124.73 10.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.231 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.994 ' C ' HD23 ' A' ' 12' ' ' LEU . 41.4 t -118.3 132.18 68.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.432 0.634 . . . . 0.0 111.001 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -117.42 134.7 54.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.557 -179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 HD11 ' A' ' 159' ' ' LEU . 14.9 t -127.55 151.18 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 190' ' ' GLY . 0.7 OUTLIER -118.62 122.6 42.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.721 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.748 ' HA ' HG21 ' A' ' 70' ' ' THR . 6.2 p80 -36.86 142.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.033 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 34' ' ' LEU . . . -71.28 128.26 15.75 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.659 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' OE1' HG21 ' A' ' 37' ' ' THR . 4.1 pt-20 -12.18 118.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.009 0.524 . . . . 0.0 112.24 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.535 ' HB3' ' NE1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -86.74 -155.23 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.978 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.26 -24.11 60.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.957 ' CZ3' HG23 ' A' ' 27' ' ' THR . 0.0 OUTLIER -71.92 -15.32 62.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.87 -33.83 51.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.07 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -83.91 -33.27 24.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.82 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -79.44 -40.79 29.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.298 179.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 23' ' ' LEU . 2.3 t30 84.88 73.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.81 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.6 170.31 22.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.105 0.478 . . . . 0.0 111.325 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.0 m-85 -71.19 170.38 13.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.526 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.957 HG23 ' CZ3' ' A' ' 20' ' ' TRP . 2.7 m -107.0 -86.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.378 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' HG22 ' A' ' 27' ' ' THR . . . 97.83 -118.81 6.22 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.715 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -119.54 -22.56 6.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.186 -179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -45.58 158.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.97 95.23 20.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.586 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.748 ' HG2' ' CH2' ' A' ' 20' ' ' TRP . 6.0 Cg_endo -85.83 -162.57 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.121 2.547 . . . . 0.0 112.05 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -132.06 128.93 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.798 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.893 HD23 ' CD1' ' A' ' 39' ' ' ILE . 4.4 tp -54.21 156.2 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.542 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 38' ' ' GLY . 81.9 p -114.7 156.93 23.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.265 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 35' ' ' SER . 1.3 tp10 -40.32 -55.46 2.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.505 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.533 HG21 ' OE1' ' A' ' 17' ' ' GLU . 38.9 m -48.94 -48.57 42.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 35' ' ' SER . . . -56.42 -55.72 28.19 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.893 ' CD1' HD23 ' A' ' 34' ' ' LEU . 1.4 mp -49.4 -56.43 2.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -52.87 -40.79 63.74 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.747 178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 37' ' ' THR . 4.4 mm-40 -62.63 -47.81 82.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.402 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.13 9.24 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.686 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.775 ' CD ' HG23 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.26 -53.67 16.34 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.474 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' O ' ' CG ' ' A' ' 48' ' ' ARG . 7.0 tp -59.04 -56.96 15.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.491 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 190' ' ' GLY . . . -45.86 -54.52 7.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.842 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 77' ' ' GLU . . . -62.92 -53.09 43.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.102 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -50.26 -38.28 40.1 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -73.76 -50.41 20.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.958 HD13 ' HG2' ' A' ' 192' ' ' PRO . 6.3 tp -50.68 -45.16 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -76.42 -53.23 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.383 179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 22.3 t -39.99 -57.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.052 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 13.5 mmp_? -49.69 -41.46 43.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.21 25.65 2.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.821 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.986 ' OH ' HD12 ' A' ' 9' ' ' LEU . 41.8 t80 -94.24 113.24 25.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 111.032 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -95.66 154.94 16.96 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.789 ' CE1' ' HB2' ' A' ' 159' ' ' LEU . 33.5 m-85 -123.29 150.2 43.84 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' HB2' ' CG ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -119.02 -26.61 5.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.983 177.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 158' ' ' VAL . 5.2 mm -132.49 131.5 60.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.996 0.427 . . . . 0.0 111.232 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.813 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -113.09 128.8 56.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.236 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CE2' HD11 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -119.53 104.95 10.76 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.698 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 4.8 p -113.92 159.62 19.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.179 0.514 . . . . 0.0 111.174 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.2 p -87.52 148.69 24.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.093 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -43.94 -26.17 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.002 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 64' ' ' LEU . 2.8 mt -68.32 126.87 30.93 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.939 0.4 . . . . 0.0 111.134 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 69' ' ' LYS . 2.0 pp0? -45.9 -47.36 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.534 HH22 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -30.06 -63.86 0.13 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.938 0.399 . . . . 0.0 111.222 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 161' ' ' ALA . . . -62.57 -39.59 94.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.481 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 3.7 mt-30 -65.27 -62.16 1.7 Allowed 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -47.94 -49.82 29.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.113 177.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.748 HG21 ' HA ' ' A' ' 15' ' ' HIS . 45.5 m -59.1 -50.45 74.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.491 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 74' ' ' ILE . 11.1 t -56.11 -48.46 76.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.497 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 69' ' ' LYS . 34.6 mt-30 -42.41 -47.79 5.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.688 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.775 HG23 ' CD ' ' A' ' 43' ' ' LYS . 63.4 mt -59.89 -71.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.086 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.828 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -45.17 -46.75 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.99 179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 81' ' ' PRO . 2.3 mm? -64.25 -47.79 78.25 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 72' ' ' GLN . 28.9 mt-10 -65.05 -39.28 93.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.646 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 74' ' ' ILE . 16.3 pt-20 -77.16 -46.16 24.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.693 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 74' ' ' ILE . 33.8 m -61.46 -18.0 17.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 121.2 0.524 . . . . 0.0 110.136 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 81' ' ' PRO . . . 72.61 24.31 76.39 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.026 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.768 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 77.3 mm-40 -114.24 23.66 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.768 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 34.5 Cg_exo -58.83 -38.31 89.22 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 121.288 1.326 . . . . 0.0 111.704 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -55.41 -20.02 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.292 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.852 ' C ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -59.58 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.322 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' CB ' HD13 ' A' ' 58' ' ' ILE . 8.1 mm-40 -87.08 97.57 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.637 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.813 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -83.11 105.2 13.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.481 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.848 HG21 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -113.93 136.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.066 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.752 ' HZ1' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -130.23 153.11 48.92 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.209 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 143' ' ' TYR . 9.3 t -145.81 143.95 29.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.268 0.556 . . . . 0.0 111.648 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 13.8 pt-20 -81.03 -25.64 37.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.61 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -76.38 -7.11 54.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -92.93 12.49 23.65 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.535 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 10.5 m-20 -78.68 154.86 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.273 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.0 tp10 -61.33 148.19 42.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HB2' HG21 ' A' ' 136' ' ' THR . 0.7 OUTLIER -47.49 147.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 111.456 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 29' ' ' TRP . 4.0 t80 -69.8 136.88 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 m-85 -118.92 51.55 1.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.601 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 96' ' ' TYR . . . -6.81 -84.72 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 O-C-N 123.787 0.68 . . . . 0.0 114.646 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -94.31 3.33 55.36 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -96.01 -28.4 14.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 96' ' ' TYR . 2.4 mt-30 -48.3 92.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.216 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 99' ' ' LEU . . . 115.19 -15.95 17.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.59 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 26' ' ' PHE . 10.5 tp -59.68 136.23 57.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.067 0.434 . . . . 0.0 111.098 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.7 m120 -74.46 124.2 26.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 2.9 mtmt -40.08 -40.3 1.04 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 6.7 t0 -62.36 -54.57 38.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.453 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -61.08 -45.13 96.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.728 179.032 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.87 81.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.167 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -74.7 -16.08 60.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.945 178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -87.6 -45.1 10.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.408 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.565 ' O ' ' CG ' ' A' ' 111' ' ' TRP . 11.1 tttt -105.55 67.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.03 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.567 ' CZ3' HD11 ' A' ' 99' ' ' LEU . 0.9 OUTLIER 157.27 -23.53 0.0 OUTLIER 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.661 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' VAL . . . 59.05 165.68 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.387 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 117' ' ' GLN . . . -51.05 -46.02 61.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.848 0.356 . . . . 0.0 110.652 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -43.79 -65.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.579 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.5 mt-30 -73.17 -42.42 62.78 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.248 0.546 . . . . 0.0 110.514 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.871 HG21 ' HA ' ' A' ' 108' ' ' ARG . 3.0 t -51.03 -50.89 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.994 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.568 ' CG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 pt20 -52.12 -57.62 9.03 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.8 -17.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.928 0.394 . . . . 0.0 110.073 178.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.8 m95 -91.35 -25.8 19.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.4 OUTLIER -105.52 -35.61 7.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.724 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.554 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 37.5 mmt-85 -91.41 -72.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.694 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.723 ' CB ' HG23 ' A' ' 125' ' ' ILE . 1.3 p 23.04 103.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.788 0.68 . . . . 0.0 112.038 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.552 ' CD2' ' HA3' ' A' ' 179' ' ' GLY . 17.2 t80 -77.71 -27.11 50.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.32 -33.16 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.47 150.77 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.875 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 125' ' ' ILE . . . -114.68 147.87 39.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 112.122 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 27.4 Cg_exo -58.51 -175.59 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.061 2.507 . . . . 0.0 111.214 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 127' ' ' PRO . 29.2 Cg_endo -63.22 89.2 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.883 1.722 . . . . 0.0 111.299 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 6.5 t30 91.72 -29.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.37 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 95' ' ' TYR . . . -57.06 -161.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.631 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.686 ' CD ' HG23 ' A' ' 136' ' ' THR . 0.0 OUTLIER -126.54 177.85 6.25 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.558 ' N ' ' CG ' ' A' ' 131' ' ' GLU . 56.8 p -119.45 175.76 5.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.669 0.271 . . . . 0.0 111.092 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.529 ' HA ' ' OG1' ' A' ' 136' ' ' THR . 2.9 tp -57.33 -49.53 75.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -49.43 -56.59 9.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.306 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -55.3 -59.22 5.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.296 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.808 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.7 p -46.44 -59.49 2.93 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.229 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.923 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -54.41 -56.74 15.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 142' ' ' PRO . 0.7 OUTLIER -51.85 -34.61 41.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.57 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -99.97 -15.98 18.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.816 0.341 . . . . 0.0 111.322 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 90' ' ' LYS . 50.1 t -88.99 -37.46 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.178 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 142' ' ' PRO . 0.1 OUTLIER -84.36 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.777 ' N ' HD23 ' A' ' 141' ' ' LEU . 32.4 Cg_exo -58.22 -55.9 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 120.391 1.175 . . . . 0.0 109.278 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.806 ' CE1' HG21 ' A' ' 147' ' ' THR . 2.9 t80 -49.92 -44.95 50.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.794 ' CE2' HD21 ' A' ' 174' ' ' LEU . 1.4 t80 -55.58 -59.16 5.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.426 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.525 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 18.4 pttp -65.94 -49.41 68.02 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.639 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 145' ' ' LYS . 5.9 t -73.37 -17.83 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 143' ' ' TYR . 2.0 m -131.4 -20.17 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.906 -0.718 . . . . 0.0 112.831 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 1.155 HG23 ' CE1' ' A' ' 151' ' ' HIS . 51.0 mt -105.03 -17.06 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -72.61 -28.05 0.98 Allowed Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.413 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.2 Cg_endo -82.76 -36.8 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.993 1.795 . . . . 0.0 113.357 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 1.155 ' CE1' HG23 ' A' ' 148' ' ' ILE . 0.9 OUTLIER -73.9 -34.64 64.49 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.548 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.593 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 1.2 pp -65.69 -27.79 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.944 0.402 . . . . 0.0 110.492 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 199' ' ' LYS . 19.8 mt -85.12 -10.79 56.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.677 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -27.02 29.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.218 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 112.84 47.61 0.66 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.555 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.615 ' N ' HG23 ' A' ' 2' ' ' THR . 0.0 OUTLIER -140.51 160.62 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HE3' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -111.06 158.57 18.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -178.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 58' ' ' ILE . 1.6 t -123.68 155.47 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . 2.9 tp -114.61 130.61 56.81 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.662 -1.608 . . . . 0.0 107.935 174.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.781 ' N ' HD12 ' A' ' 159' ' ' LEU . 92.9 mt -123.86 116.78 49.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.319 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' A' ' 67' ' ' ALA . . . -121.78 84.07 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.009 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HB2' HD23 ' A' ' 91' ' ' LEU . . . -120.76 -95.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.525 ' CG ' ' C ' ' A' ' 162' ' ' ALA . 3.0 m-70 -163.04 158.94 22.72 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.209 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.61 -48.89 5.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.297 -0.954 . . . . 0.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 2.4 m120 -60.76 -62.63 1.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.06 -52.9 11.15 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 163' ' ' HIS . 3.5 mt -56.59 -58.94 5.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.676 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 164' ' ' GLY . 48.4 mtm180 -46.08 -59.43 2.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.923 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -45.89 -51.99 12.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.54 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -64.53 -63.13 1.21 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.982 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.569 HG21 ' HD2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.19 -43.99 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.25 -179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.541 ' CB ' HG13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -53.49 -43.75 68.46 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.751 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.614 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.7 t70 -75.89 -47.11 26.7 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.794 HD21 ' CE2' ' A' ' 144' ' ' TYR . 91.2 mt -59.3 -40.5 86.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.509 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.57 ' HG2' ' CD1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -90.32 -27.47 19.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.809 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 172' ' ' MET . . . 83.83 13.37 75.28 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.386 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -51.03 -172.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.708 0.29 . . . . 0.0 110.347 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 181' ' ' GLN . 0.2 OUTLIER -120.9 -176.83 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.557 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.552 ' HA3' ' CD2' ' A' ' 123' ' ' TYR . . . -83.4 2.46 87.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.973 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -124.78 -5.09 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.785 0.292 . . . . 0.0 111.296 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 178' ' ' THR . 15.5 mm100 -125.45 1.15 7.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.045 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 172' ' ' MET . 0.0 OUTLIER -104.89 -38.42 4.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.242 0.544 . . . . 0.0 109.917 179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 121' ' ' ARG . 11.3 m -53.5 -19.96 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.28 -48.91 14.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.031 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.569 ' HD2' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -48.2 117.27 1.86 Allowed 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.055 0.455 . . . . 0.0 110.21 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -120.7 157.96 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.616 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.549 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -126.07 126.0 43.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.912 0.387 . . . . 0.0 111.092 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.892 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -71.6 122.0 19.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 40.6 p -55.66 112.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.955 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' ARG . . . 115.03 -44.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.153 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.892 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 14.4 m -80.74 115.5 55.96 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.38 . . . . 0.0 111.704 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.958 ' HG2' HD13 ' A' ' 49' ' ' LEU . 95.6 Cg_endo -77.15 120.87 5.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.967 2.445 . . . . 0.0 112.238 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.549 HG21 HD21 ' A' ' 187' ' ' LEU . 8.9 tp -91.91 142.33 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.393 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 9' ' ' LEU . 10.2 t -103.24 150.28 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.561 ' CE2' ' HG ' ' A' ' 12' ' ' LEU . 21.7 m-85 -139.15 124.73 19.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.434 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.875 ' O ' HG22 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -87.88 86.62 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.028 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.745 HD11 HD22 ' A' ' 10' ' ' LEU . 47.9 mt -82.91 160.1 22.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.007 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' LYS . 1.7 p-10 -85.89 -154.63 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.888 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.539 ' O ' HD21 ' A' ' 153' ' ' LEU . 1.2 pptp? -79.27 10.03 4.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.722 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -144.13 13.99 1.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.533 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 144' ' ' TYR . . . 83.29 18.39 64.66 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.209 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.573 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 ttpp -92.29 124.06 36.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.592 0.234 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.638 ' HA ' HD23 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -51.28 128.78 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 0.0 110.439 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 196' ' ' HIS . 35.6 m -128.39 12.79 2.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.969 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 1.4 t -156.51 -147.1 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.26 155.54 38.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.009 0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.521 ' HB2' ' CG1' ' A' ' 193' ' ' ILE . 6.4 pm0 -91.01 157.38 17.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 209' ' ' ILE . 8.1 tt -161.34 147.89 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.193 0.521 . . . . 0.0 111.754 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.672 ' O ' HD23 ' A' ' 208' ' ' LEU . 0.9 OUTLIER -98.91 145.03 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.163 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 0.0 OUTLIER -42.16 -56.57 2.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.089 179.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.489 ' ND2' ' NH1' ' A' ' 52' ' ' ARG . 11.9 p30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.913 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' HG3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.824 0.345 . . . . 0.0 111.256 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.574 HG23 ' HA2' ' A' ' 155' ' ' GLY . 6.1 t -48.84 177.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 14.1 t -92.54 21.26 5.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.503 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 155' ' ' GLY . 6.8 pm0 56.15 155.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.811 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 40.87 33.23 0.2 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.806 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -156.4 178.35 1.71 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.192 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.889 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 71.5 Cg_exo -48.82 93.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.622 2.214 . . . . 0.0 112.424 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.778 ' OD1' HD21 ' A' ' 197' ' ' LEU . 6.4 p30 -73.24 -175.35 1.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.403 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -134.52 133.17 40.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 160' ' ' ILE . 1.6 tp -126.13 126.44 44.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.343 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 194' ' ' VAL . 19.8 t -108.28 120.88 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.442 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 167' ' ' LEU . 11.2 mt -93.52 151.36 19.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.066 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.6 ' HB ' ' HB2' ' A' ' 161' ' ' ALA . 80.0 m -137.92 140.93 40.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -121.15 108.39 13.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.442 ' ND1' ' HD2' ' A' ' 66' ' ' ARG . 7.5 p80 -44.11 129.15 6.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.6 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -39.8 -96.01 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.398 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' OE2' HG22 ' A' ' 37' ' ' THR . 1.5 pm0 -152.45 139.46 19.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.37 170.07 9.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.2 -53.85 19.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.49 ' CZ3' ' HA2' ' A' ' 101' ' ' GLY . 2.0 m95 -61.94 -33.72 74.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.266 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' SER . 26.5 t-20 -57.36 -47.44 81.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.21 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.72 -45.5 70.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.072 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -63.27 -21.56 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.684 179.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER 74.13 35.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.724 HD23 HD22 ' A' ' 103' ' ' ASN . 0.2 OUTLIER -109.88 142.33 41.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 110.632 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CE1' ' CE1' ' A' ' 96' ' ' TYR . 15.6 m-85 -48.01 139.39 8.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.842 HG22 ' HE2' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -102.82 -79.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.848 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 -137.47 13.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -85.3 -24.02 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.842 ' HE2' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -49.5 161.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -114.06 101.42 53.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' ' CZ ' ' A' ' 66' ' ' ARG . 81.2 Cg_endo -77.85 -168.06 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.5 2.133 . . . . 0.0 112.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.92 117.66 26.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -48.43 160.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.94 176.61 6.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.109 0.481 . . . . 0.0 111.161 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 6.4 mt-10 -51.06 -39.49 56.09 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.365 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.549 HG22 ' OE2' ' A' ' 17' ' ' GLU . 1.9 m -64.7 -44.17 91.12 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 16' ' ' GLY . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 73' ' ' ILE . 23.9 mm -59.04 -53.68 44.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 36' ' ' GLU . 6.3 mtpm? -55.5 -38.19 68.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.281 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' THR . 3.5 mm-40 -65.55 -49.99 66.84 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.434 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.04 70.92 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.675 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -54.43 -52.76 60.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.517 178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 48' ' ' ARG . 2.6 mt -57.24 -42.94 82.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.338 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.79 -57.41 19.99 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.889 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 74' ' ' ILE . . . -57.51 -49.74 70.84 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.26 -0.972 . . . . 0.0 110.993 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' SER . 15.7 tm-20 -59.03 -30.22 67.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 1.9 mmt85 -78.26 -38.89 41.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.219 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 192' ' ' PRO . 13.0 mt -78.24 -23.74 47.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.849 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -92.52 -48.73 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.282 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 12.0 t -47.95 -37.65 14.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.264 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' ARG . 6.4 mmp_? -69.79 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.73 -17.3 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.706 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 38.6 t80 -53.66 109.68 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.694 0.283 . . . . 0.0 110.829 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 157' ' ' LYS . 0.4 OUTLIER -96.56 154.38 17.31 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.379 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.702 ' CZ ' HD12 ' A' ' 159' ' ' LEU . 31.7 m-85 -112.92 153.28 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -116.86 -35.79 4.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.513 177.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CG2' HG13 ' A' ' 158' ' ' VAL . 3.2 mm -131.31 147.57 32.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.957 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -128.93 116.22 19.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.944 ' CE2' HD12 ' A' ' 148' ' ' ILE . 13.9 m-85 -114.46 120.43 40.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.156 0.503 . . . . 0.0 111.632 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.8 OUTLIER -126.67 174.85 8.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.47 0.652 . . . . 0.0 111.792 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.7 p -92.49 148.27 22.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 89' ' ' GLU . . . -49.32 -25.19 2.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.252 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.911 HD12 ' CE1' ' A' ' 163' ' ' HIS . 21.1 mt -60.96 133.56 56.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.807 0.337 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 11.7 pt20 -50.98 -42.61 60.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.534 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' HG2' HD12 ' A' ' 34' ' ' LEU . 11.1 mtm180 -40.75 -62.89 0.73 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.94 79.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.176 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 65' ' ' GLN . 2.6 mt-30 -57.79 -46.91 83.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -67.57 -46.54 72.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.83 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 m -55.76 -31.34 62.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.826 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.767 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -76.36 -55.03 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.944 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -51.74 23.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.595 HD13 HG23 ' A' ' 39' ' ' ILE . 21.0 mt -60.42 -63.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.911 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.23 -47.41 25.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.702 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD13 ' OG1' ' A' ' 85' ' ' THR . 16.2 mt -63.99 -57.67 9.01 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 59.5 mt-10 -55.76 -23.05 27.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.196 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ILE . 21.2 tp10 -85.17 -40.92 16.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.959 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 74' ' ' ILE . 90.6 t -58.46 -34.04 49.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.571 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.95 18.69 24.07 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.692 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 12.2 mm-40 -139.88 55.74 7.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 52.3 Cg_exo -56.85 -38.51 95.68 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.278 1.985 . . . . 0.0 112.0 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -53.92 -23.94 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 56' ' ' PHE . 5.9 tt -47.69 156.05 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' C ' HD23 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -64.02 94.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.243 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.771 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.2 m -97.77 102.34 14.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.807 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.753 HD13 ' HE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -127.85 163.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.212 0.529 . . . . 0.0 110.601 -178.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -149.59 167.73 25.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.191 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.928 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.2 t -135.87 153.68 51.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.439 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -77.5 -32.07 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.47 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' CA ' ' HD2' ' A' ' 139' ' ' ARG . 5.7 mtmt -72.09 -10.89 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.692 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.928 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.3 OUTLIER -88.52 14.76 9.11 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.785 -0.188 . . . . 0.0 111.11 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 163' ' ' HIS . 8.7 m-20 -89.85 149.76 22.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 13.3 tp10 -53.31 147.38 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.082 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.68 176.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.075 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.517 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -100.3 140.04 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.554 ' CE1' ' CE1' ' A' ' 26' ' ' PHE . 10.4 m-85 -104.88 22.22 15.6 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 129' ' ' ASN . . . 40.52 -105.44 0.05 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.681 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -104.58 2.81 31.1 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 mp -78.69 -21.07 48.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 110.625 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.63 112.22 0.88 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA2' ' CZ3' ' A' ' 20' ' ' TRP . . . 111.57 8.43 22.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.151 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -111.93 125.79 54.43 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.868 0.365 . . . . 0.0 110.841 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.946 ' N ' HD12 ' A' ' 102' ' ' LEU . 5.8 t-20 -55.48 114.85 2.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.181 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -43.64 -49.47 7.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.004 0.43 . . . . 0.0 110.496 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -55.39 -61.37 2.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.855 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -48.83 -52.94 21.41 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.817 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . . . -55.3 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 115' ' ' GLN . 5.4 ptm180 -37.45 -32.04 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.743 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 105' ' ' ASP . 8.2 ttmm -73.03 -64.18 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.604 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 55.94 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.68 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.806 ' CD1' HG12 ' A' ' 116' ' ' VAL . 25.4 t-105 -139.5 0.25 1.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 45.53 -141.81 4.44 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 119.167 -1.492 . . . . 0.0 110.785 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 118' ' ' ILE . . . 53.74 44.01 30.23 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 118.344 1.072 . . . . 0.0 109.701 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 tt0 52.28 37.18 21.5 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER 57.4 50.55 11.18 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-O 124.048 1.88 . . . . 0.0 109.408 -173.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.806 HG12 ' CD1' ' A' ' 111' ' ' TRP . 1.4 m 49.29 18.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.99 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLU . 15.1 tt0 -68.38 -43.47 77.27 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -67.57 -14.97 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.671 176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.571 ' CD1' ' CB ' ' A' ' 113' ' ' ALA . 1.9 m95 -92.42 -43.29 9.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' NH1' ' CZ ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -112.03 -19.22 12.41 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.634 ' O ' HG23 ' A' ' 183' ' ' VAL . 4.6 mmt-85 -98.37 -27.43 14.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.812 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER -43.37 165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.621 0.248 . . . . 0.0 110.999 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.627 ' CE1' ' HE3' ' A' ' 172' ' ' MET . 32.0 t80 -104.92 -11.34 16.75 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -136.31 -36.81 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.059 HD13 HD11 ' A' ' 118' ' ' ILE . 13.5 tt -87.38 144.81 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.954 0.407 . . . . 0.0 111.316 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' ' CD ' ' A' ' 127' ' ' PRO . . . -125.73 170.14 10.05 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.046 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 6.6 Cg_exo -74.36 172.14 16.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.913 2.408 . . . . 0.0 112.474 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.26 103.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.359 2.039 . . . . 0.0 111.268 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.423 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 10.4 m-80 74.51 145.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.923 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 118.7 -148.57 18.39 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.733 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -143.19 172.85 12.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 110.574 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 41.2 t -120.92 -162.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -75.99 -53.36 8.5 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.756 0.312 . . . . 0.0 111.101 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -51.24 -44.68 61.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.515 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 131' ' ' GLU . 0.3 OUTLIER -58.79 -51.82 68.33 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 1.022 ' O ' HG12 ' A' ' 140' ' ' VAL . 48.0 m -55.26 -66.28 0.44 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.046 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.836 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -45.26 -47.1 12.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.588 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 0.9 OUTLIER -62.88 -39.69 95.22 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.977 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -80.44 -32.49 37.3 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.316 -179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 1.022 HG12 ' O ' ' A' ' 136' ' ' THR . 2.1 p -82.61 -35.59 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.931 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -49.56 -51.05 62.41 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.866 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 73.4 Cg_exo -47.8 -48.81 15.0 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.045 1.83 . . . . 0.0 111.014 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.53 ' CD1' ' CG2' ' A' ' 147' ' ' THR . 22.0 t80 -59.04 -42.62 90.68 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.631 ' CZ ' HD21 ' A' ' 174' ' ' LEU . 20.1 t80 -58.26 -69.1 0.19 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.045 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -53.95 -47.38 71.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 13.8 t -61.99 -61.27 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.774 ' O ' HD13 ' A' ' 148' ' ' ILE . 1.5 t -107.45 14.67 25.66 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.944 HD12 ' CE2' ' A' ' 60' ' ' PHE . 11.2 mm -129.2 -5.04 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.734 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.2 p -91.42 -16.28 0.21 Allowed Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.2 Cg_endo -76.28 -59.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.302 1.335 . . . . 0.0 113.624 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.64 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.5 p-80 -57.59 -46.15 84.38 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.518 ' N ' ' CD2' ' A' ' 151' ' ' HIS . 6.6 pt -49.59 -25.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 199' ' ' LYS . 65.9 mt -91.22 -15.73 28.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -77.99 -31.04 50.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.722 0.296 . . . . 0.0 111.122 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' HA2' HG23 ' A' ' 2' ' ' THR . . . 119.16 49.41 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.47 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -137.14 159.28 42.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.614 0.245 . . . . 0.0 110.832 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.535 ' CE ' ' CE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.23 160.59 15.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.772 HG13 ' CG2' ' A' ' 58' ' ' ILE . 14.3 t -140.38 157.14 24.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.702 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 1.9 tt -102.32 145.62 29.21 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.209 -1.359 . . . . 0.0 109.444 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 10' ' ' LEU . 11.2 mt -138.44 98.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.345 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.6 ' HB2' ' HB ' ' A' ' 13' ' ' THR . . . -113.18 101.16 9.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.809 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -132.34 -92.57 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.911 ' CE1' HD12 ' A' ' 64' ' ' LEU . 3.2 m-70 -159.98 164.54 33.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.939 0.4 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -48.06 -42.54 23.66 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.755 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 4.4 t-20 -65.48 -52.61 51.66 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -55.63 -45.18 77.63 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -62.28 -45.26 94.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.561 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.794 ' HB3' HD11 ' A' ' 133' ' ' LEU . 43.7 mtm180 -59.23 -57.66 12.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.836 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -50.31 -44.89 54.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.828 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.611 HD21 ' CE2' ' A' ' 144' ' ' TYR . 1.6 tp -72.93 -64.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.682 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -47.21 -45.55 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.61 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.627 ' HE3' ' CE1' ' A' ' 123' ' ' TYR . 1.5 ppp? -59.61 -41.96 91.55 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.541 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.931 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.4 t70 -77.64 -29.83 51.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.261 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 ' CZ ' ' A' ' 144' ' ' TYR . 98.5 mt -75.22 -37.36 61.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.284 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 203' ' ' TYR . 1.8 tt0 -91.85 -35.39 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.37 32.74 5.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.36 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 182' ' ' ILE . 1.4 mp -66.77 -174.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.925 ' O ' HG22 ' A' ' 182' ' ' ILE . 13.2 t -135.51 -167.89 2.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.969 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.491 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . -69.71 -39.61 77.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.761 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.418 ' H ' HG23 ' A' ' 178' ' ' THR . 2.2 m-20 -94.99 26.19 3.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 111.013 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.811 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.3 OUTLIER -133.77 -67.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.874 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.925 HG22 ' O ' ' A' ' 178' ' ' THR . 7.3 tp -50.46 -26.53 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ARG . 8.3 p -60.2 -16.59 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.443 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.416 ' CD ' ' O ' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -97.96 -30.19 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.384 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.561 HH22 HD12 ' A' ' 167' ' ' LEU . 1.3 tmt_? -48.11 127.16 12.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.76 0.314 . . . . 0.0 111.012 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.04 150.22 49.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.962 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 193' ' ' ILE . 0.2 OUTLIER -133.01 126.45 31.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -57.36 156.88 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.101 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 20.5 p -89.06 131.11 35.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.23 -45.59 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.423 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.857 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 20.8 m -85.49 109.88 25.14 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HG3' ' CD1' ' A' ' 49' ' ' LEU . 34.6 Cg_endo -64.44 -162.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.539 2.159 . . . . 0.0 111.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 187' ' ' LEU . 5.9 tp -163.5 133.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.295 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.654 HG22 HG22 ' A' ' 11' ' ' VAL . 3.0 t -92.11 137.22 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.428 ' CE2' ' CD ' ' A' ' 207' ' ' GLU . 26.5 m-85 -129.58 113.53 14.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.726 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.761 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -73.67 130.64 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.778 HD21 ' OD1' ' A' ' 8' ' ' ASN . 2.3 pt? -141.37 168.71 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 111.859 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -84.96 177.93 7.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.692 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.514 ' O ' HD21 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -65.26 -17.94 64.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.406 ' N ' ' HD2' ' A' ' 199' ' ' LYS . 4.4 m-20 -82.49 -26.44 32.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 113.62 15.15 8.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.812 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 174' ' ' LEU . 8.3 ttmt -106.85 137.86 44.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.812 0.339 . . . . 0.0 110.675 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.506 ' CD1' ' HA ' ' A' ' 175' ' ' GLU . 0.1 OUTLIER -49.97 137.55 16.82 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.483 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.702 HG22 ' CA ' ' A' ' 197' ' ' LEU . 14.5 m -128.98 17.84 2.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.689 0.28 . . . . 0.0 111.337 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.431 ' OG ' ' CB ' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -170.93 -158.63 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.326 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.429 ' N ' ' OG ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -103.38 161.63 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.451 . . . . 0.0 111.157 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.601 ' C ' HD12 ' A' ' 208' ' ' LEU . 19.7 pm0 -105.57 156.7 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.279 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 207' ' ' GLU . 3.5 mp -161.71 163.94 29.4 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.422 0.63 . . . . 0.0 111.351 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.69 HG23 ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -108.22 -163.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.899 -178.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.69 ' N ' HG23 ' A' ' 209' ' ' ILE . 38.9 m-20 -103.06 -47.58 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 209' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.073 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 157' ' ' LYS . 12.3 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.726 0.298 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 8' ' ' ASN . 3.0 p -44.86 157.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 7' ' ' PRO . 4.3 p -103.18 -81.4 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.1 -78.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.732 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.6 53.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.804 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -162.59 -69.5 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.241 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 57.2 Cg_endo -70.7 67.7 2.27 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.164 1.909 . . . . 0.0 112.366 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 2' ' ' THR . 0.3 OUTLIER -71.59 146.59 48.29 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.396 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 196' ' ' HIS . 4.2 mp -106.67 138.76 42.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 111.523 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' CD1' HG22 ' A' ' 158' ' ' VAL . 0.8 OUTLIER -112.54 114.33 26.94 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.435 -179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.753 HG22 ' HB ' ' A' ' 194' ' ' VAL . 87.8 t -93.09 141.35 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.706 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 160' ' ' ILE . 0.3 OUTLIER -128.96 127.53 41.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.648 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.727 HG22 HD11 ' A' ' 159' ' ' LEU . 8.7 t -123.99 75.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.699 ' HD2' HD12 ' A' ' 187' ' ' LEU . 37.4 ttt180 -59.46 129.0 39.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.948 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' HG21 ' A' ' 70' ' ' THR . 20.0 p80 -49.23 138.02 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.865 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.78 -97.98 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.252 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -143.84 135.32 25.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.998 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.85 174.24 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -54.93 41.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -57.64 -26.53 61.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -59.14 -42.17 90.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -71.19 -35.36 71.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.546 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 25' ' ' LEU . 5.5 mp -64.58 -13.86 55.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.234 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.9 t-20 73.83 45.49 0.23 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD11 HD23 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.13 147.22 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -59.27 155.17 14.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' NH1' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -99.22 -82.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.88 -123.46 7.84 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.465 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m0 -106.59 -20.83 13.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 111.074 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -47.39 155.14 0.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.839 0.352 . . . . 0.0 111.045 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -106.49 86.19 2.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HZ1' ' A' ' 30' ' ' LYS . 70.8 Cg_endo -74.55 -168.24 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.549 2.166 . . . . 0.0 112.231 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.23 125.42 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.195 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.623 HD23 HD13 ' A' ' 39' ' ' ILE . 15.9 tp -53.86 164.02 0.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.54 178.62 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.024 0.44 . . . . 0.0 111.478 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.85 -43.14 63.09 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.508 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.4 m -63.29 -37.57 87.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -68.04 -55.36 13.75 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG22 ' HD3' ' A' ' 43' ' ' LYS . 25.4 mm -56.38 -49.35 77.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -58.72 -39.47 80.92 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.745 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 41' ' ' GLU . 2.9 mm-40 -61.51 -48.09 82.62 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 70' ' ' THR . . . -59.85 -47.73 84.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.179 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD3' HG22 ' A' ' 39' ' ' ILE . 3.7 mptp? -54.91 -56.34 20.62 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.167 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' NH1' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -54.97 -45.78 75.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.268 178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 192' ' ' PRO . . . -55.71 -56.92 21.35 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -54.33 -48.39 64.45 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 51' ' ' SER . 2.4 mt-10 -56.19 -42.64 77.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.555 ' NH1' HD21 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -61.37 -57.68 11.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.799 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 192' ' ' PRO . 6.7 tp -53.89 -50.81 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.372 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' CE ' ' O ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -69.57 -21.53 63.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.585 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 4.7 m -82.56 -66.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' NH1' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -44.95 -27.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.589 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.41 22.6 9.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.769 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.605 ' CE1' HG21 ' A' ' 11' ' ' VAL . 2.5 t80 -95.54 132.26 40.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -111.65 169.65 8.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.305 0.574 . . . . 0.0 111.79 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.015 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 6.9 m-30 -119.28 156.47 29.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.644 -1.162 . . . . 0.0 113.405 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.633 ' C ' HD21 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -127.66 -43.83 1.54 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.922 177.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.684 ' HB ' HG12 ' A' ' 158' ' ' VAL . 11.5 mm -128.51 159.36 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.739 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -138.34 133.7 33.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.056 0.455 . . . . 0.0 111.217 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.755 ' CE2' HG21 ' A' ' 158' ' ' VAL . 23.0 m-85 -124.21 113.47 18.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.711 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.974 HG23 ' HB3' ' A' ' 161' ' ' ALA . 0.1 OUTLIER -119.15 167.79 11.48 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 122.034 0.921 . . . . 0.0 111.952 179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 2.1 p -92.33 148.06 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.2 -22.61 4.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.178 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.633 HD12 ' CE1' ' A' ' 163' ' ' HIS . 93.1 mt -68.93 138.04 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 111.466 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.3 pt20 -56.65 -31.17 64.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.096 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' NH1' HG21 ' A' ' 27' ' ' THR . 2.9 ttm180 -48.69 -57.38 6.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -81.11 -36.05 30.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.854 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.5 OUTLIER -60.71 -30.45 69.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 65' ' ' GLN . 2.1 ttpm? -87.63 -56.36 3.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.82 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 15' ' ' HIS . 58.9 m -49.68 -29.95 8.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.393 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.496 ' HB2' HG21 ' A' ' 61' ' ' THR . 34.7 t -67.01 -49.6 64.83 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -51.22 -46.18 62.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.37 179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 HG23 ' A' ' 39' ' ' ILE . 12.3 mt -56.83 -62.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.651 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -55.2 -45.82 77.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 109.92 179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.633 HD11 ' OG1' ' A' ' 85' ' ' THR . 9.4 mt -57.87 -66.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.185 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 73' ' ' ILE . 8.3 pt-20 -55.83 -26.39 46.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.119 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 73' ' ' ILE . 23.5 mm-40 -71.41 -52.91 16.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.465 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HD13 ' A' ' 74' ' ' ILE . 21.1 m -60.26 -18.05 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.13 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.3 23.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.133 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 10.7 mm-40 -143.12 44.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 85.2 Cg_exo -46.54 -42.51 23.31 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.063 1.842 . . . . 0.0 112.261 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -50.83 -24.64 3.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 84' ' ' GLU . 3.1 tm? -41.69 140.74 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.451 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.881 ' N ' HD13 ' A' ' 83' ' ' LEU . 34.0 mt-10 -66.86 97.86 0.51 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.916 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 30.3 m -107.3 130.07 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.999 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -134.58 163.58 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.708 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.891 ' CE ' HG22 ' A' ' 85' ' ' THR . 0.1 OUTLIER -143.52 176.94 8.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.848 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 t -159.97 156.16 26.65 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.662 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -77.05 -36.34 56.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.9 ' O ' HG22 ' A' ' 140' ' ' VAL . 12.7 mtmt -70.0 -12.41 61.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.224 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.696 HD23 ' CD2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -91.08 19.93 5.36 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 62' ' ' SER . 18.3 m-20 -88.59 -173.94 4.36 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.879 0.371 . . . . 0.0 111.054 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HB2' ' CG ' ' A' ' 163' ' ' HIS . 5.9 tp10 -80.2 151.93 29.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.757 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 165' ' ' ASN . 4.5 tmm_? -55.97 118.76 4.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.545 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 2.6 t80 -55.14 140.41 38.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.459 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 127' ' ' PRO . 6.5 m-85 -116.69 31.86 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 41.18 -110.31 0.2 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.597 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.37 -2.67 54.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.31 5.66 22.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.485 0.183 . . . . 0.0 111.322 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.466 ' OE1' ' CE1' ' A' ' 95' ' ' TYR . 33.5 mt-30 -69.01 100.34 1.21 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.738 0.304 . . . . 0.0 111.106 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.45 28.9 7.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.837 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.739 HD12 ' HB2' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -96.06 119.99 35.54 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.796 0.331 . . . . 0.0 110.295 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -50.69 118.43 3.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.514 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE3' ' ND2' ' A' ' 24' ' ' ASN . 4.3 mtmt -42.31 -39.72 2.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.7 t70 -63.97 -57.22 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.218 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.82 -47.35 85.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' HB2' HD12 ' A' ' 102' ' ' LEU . . . -58.91 -49.44 77.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.992 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.735 ' HA ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.04 -3.16 37.72 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.804 178.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.9 tttt -101.44 -37.78 8.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.886 0.374 . . . . 0.0 110.522 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -83.53 -24.25 31.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.97 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.703 ' HB2' HG13 ' A' ' 116' ' ' VAL . 6.0 m-90 -115.71 -11.38 11.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.415 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.966 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 60.25 149.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.783 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 116' ' ' VAL . . . -40.64 -52.78 2.86 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -43.56 -58.43 2.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' TRP . 0.6 OUTLIER -76.42 -54.66 6.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 112' ' ' GLY . 3.6 m -51.25 -40.24 22.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.416 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 121' ' ' ARG . 32.8 tt0 -55.82 -75.82 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -47.6 -27.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.546 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.498 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 3.5 m95 -70.62 -45.62 64.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.377 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -101.53 -7.77 22.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 117' ' ' GLN . 8.5 mmt-85 -104.31 -49.37 3.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.435 ' CB ' ' HB ' ' A' ' 125' ' ' ILE . 16.6 t -38.68 144.98 0.09 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.379 . . . . 0.0 111.615 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.808 ' HD2' HD23 ' A' ' 133' ' ' LEU . 1.6 t80 -87.22 -33.77 19.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.6 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 134' ' ' LYS . 8.2 p-10 -99.81 -43.24 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.699 0.285 . . . . 0.0 111.364 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 118' ' ' ILE . 6.5 mm -65.57 148.37 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.064 0.459 . . . . 0.0 110.824 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -136.92 139.35 28.5 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.686 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.498 ' HA ' ' CE3' ' A' ' 119' ' ' TRP . 50.9 Cg_exo -52.37 -179.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.426 2.084 . . . . 0.0 112.143 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.65 88.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.39 2.06 . . . . 0.0 111.59 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 127' ' ' PRO . 1.0 OUTLIER 73.27 155.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.439 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 95' ' ' TYR . . . 128.17 -126.38 5.39 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.501 -0.856 . . . . 0.0 112.848 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 132' ' ' SER . 26.7 tt0 -147.44 153.55 39.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.429 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -115.51 168.05 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.808 HD23 ' HD2' ' A' ' 123' ' ' TYR . 3.1 tp -53.6 -52.71 58.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.88 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -50.88 -47.47 60.53 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.346 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 6.2 t0 -62.58 -48.99 77.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 140' ' ' VAL . 98.1 m -54.02 -56.92 13.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.664 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.77 ' CA ' ' HB1' ' A' ' 169' ' ' ALA . . . -59.86 -45.0 93.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 142' ' ' PRO . 5.6 mm-40 -58.93 -38.19 78.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.614 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 136' ' ' THR . 0.0 OUTLIER -87.27 -29.87 21.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 90' ' ' LYS . 75.7 t -76.51 -49.31 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.425 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.919 HD21 ' CG ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.85 -51.33 30.93 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' LYS . 92.7 Cg_exo -41.7 -48.9 5.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.419 2.079 . . . . 0.0 111.345 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.728 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 0.2 OUTLIER -56.37 -52.96 62.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.605 ' HA ' HD12 ' A' ' 148' ' ' ILE . 2.0 t80 -53.21 -69.09 0.12 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.023 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.466 ' CG ' ' HA ' ' A' ' 142' ' ' PRO . 0.2 OUTLIER -50.8 -48.32 59.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.226 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 142' ' ' PRO . 25.1 t -56.47 -75.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.523 HG22 ' HD1' ' A' ' 143' ' ' TYR . 5.9 t -103.96 17.17 24.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.728 HD11 ' CZ ' ' A' ' 143' ' ' TYR . 9.5 mt -127.6 -5.25 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.399 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -86.71 -21.25 0.27 Allowed Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 57.3 Cg_endo -74.08 -55.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.223 1.282 . . . . 0.0 113.575 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 148' ' ' ILE . 18.6 p-80 -67.59 -46.18 73.36 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.547 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 152' ' ' ILE . 2.5 pp -53.38 -23.14 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 199' ' ' LYS . 2.7 mt -85.1 -25.45 27.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -75.98 -31.05 58.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.598 ' C ' HG21 ' A' ' 2' ' ' THR . . . 120.26 46.96 0.35 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.575 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.48 ' N ' HG21 ' A' ' 2' ' ' THR . 29.4 tt0 -115.71 155.54 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.749 0.309 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.778 ' HZ1' ' N ' ' A' ' 159' ' ' LEU . 3.3 tmtt? -106.23 139.96 39.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.755 HG21 ' CE2' ' A' ' 60' ' ' PHE . 1.3 m -128.45 142.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.015 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 12.5 tp -89.69 152.25 21.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.898 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 170' ' ' LEU . 95.8 mt -142.06 110.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.049 0.452 . . . . 0.0 111.426 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.974 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -107.94 83.78 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.498 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.632 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -126.16 -154.07 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.377 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.643 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 m-70 -114.12 170.66 8.12 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -49.98 -55.14 15.94 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.608 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 94' ' ' ARG . 79.9 m-20 -56.69 -53.0 62.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.407 ' HB3' ' HB1' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -52.52 -56.61 13.98 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 163' ' ' HIS . 1.7 mt -56.43 -34.65 67.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.312 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.645 ' HG3' HD11 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -62.58 -57.32 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 178.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.77 ' HB1' ' CA ' ' A' ' 137' ' ' ALA . . . -57.93 -37.17 73.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.701 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 160' ' ' ILE . 2.5 tp -72.69 -57.69 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -61.62 -44.27 98.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.484 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.437 ' CE ' ' CE2' ' A' ' 123' ' ' TYR . 2.8 ppp? -54.03 -41.36 67.98 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 110.033 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.919 ' CG ' HD21 ' A' ' 141' ' ' LEU . 7.3 t70 -81.47 -34.83 31.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.769 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 197' ' ' LEU . 6.7 tp -65.42 -31.43 72.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.22 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' CG ' ' CG ' ' A' ' 203' ' ' TYR . 2.5 tt0 -101.25 -41.44 6.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.712 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.84 20.95 8.46 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.405 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 181' ' ' GLN . 4.2 mm? -62.19 -176.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.0 110.978 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.966 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.2 t -129.2 160.88 31.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -54.07 -21.53 17.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.511 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -87.05 -25.15 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.344 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.701 ' CB ' HD12 ' A' ' 177' ' ' LEU . 91.9 mt-30 -99.1 -57.35 2.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.966 HG22 ' O ' ' A' ' 178' ' ' THR . 7.0 tp -49.23 -26.12 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 121' ' ' ARG . 9.8 p -56.03 -19.6 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.581 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 57.52 1.8 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.686 HH21 HD23 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -101.63 14.83 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.398 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 185' ' ' ARG . 1.2 tt0 10.04 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.657 1.183 . . . . 0.0 113.39 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 193' ' ' ILE . 2.8 tm? -108.51 129.72 55.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.156 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.609 ' O ' HD13 ' A' ' 187' ' ' LEU . . . -57.92 -167.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -147.78 112.12 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.078 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.13 54.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.804 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.506 ' HB ' HD12 ' A' ' 209' ' ' ILE . 21.3 m -90.17 122.6 67.4 Favored Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 122.843 -0.21 . . . . 0.0 111.173 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.674 ' HB2' HD13 ' A' ' 49' ' ' LEU . 40.0 Cg_endo -67.58 84.74 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.402 2.068 . . . . 0.0 112.075 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 207' ' ' GLU . 1.8 tp -82.34 128.89 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.033 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.753 ' HB ' HG22 ' A' ' 11' ' ' VAL . 7.4 p -112.37 147.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.72 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.98 123.5 41.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.473 ' CE1' HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -69.88 124.09 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.68 HD12 ' HA2' ' A' ' 201' ' ' GLY . 1.7 pt? -142.54 167.41 22.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 111.696 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -91.95 -178.56 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.547 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.543 ' HB2' HD23 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -64.65 -22.09 66.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.064 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.28 -14.71 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.68 ' HA2' HD12 ' A' ' 197' ' ' LEU . . . 99.6 13.57 37.55 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.45 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -101.17 139.62 36.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.761 0.315 . . . . 0.0 110.682 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.527 ' CG ' ' CG ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -63.56 130.61 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.33 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG22 ' CA ' ' A' ' 197' ' ' LEU . 11.2 m -123.18 25.31 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.275 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -179.3 -169.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -92.35 148.84 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.948 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.764 ' HB2' HD11 ' A' ' 193' ' ' ILE . 4.3 pt-20 -58.64 176.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.922 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.452 ' HB3' ' CG1' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -144.93 138.67 27.04 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 121.619 0.723 . . . . 0.0 112.825 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.673 HD11 ' N ' ' A' ' 193' ' ' ILE . 1.5 mm -154.84 163.8 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.33 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' HB2' ' NH1' ' A' ' 52' ' ' ARG . 34.0 t0 -73.71 -52.15 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.745 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.929 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HB3' ' A' ' 157' ' ' LYS . 1.6 tmt? . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.757 0.313 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -42.17 163.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.354 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -108.31 -34.5 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -127.33 -178.18 4.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.685 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.24 47.8 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -159.57 -68.4 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.212 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 61.1 Cg_endo -73.17 69.3 3.99 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.295 1.997 . . . . 0.0 112.339 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 197' ' ' LEU . 6.9 p-10 -52.19 174.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.737 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 9' ' ' LEU . 6.8 tp -130.59 125.32 33.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.335 0.588 . . . . 0.0 110.831 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 160' ' ' ILE . 0.4 OUTLIER -130.68 123.94 30.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.994 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 194' ' ' VAL . 47.1 t -100.06 135.99 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.328 0.585 . . . . 0.0 111.714 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.716 HD12 ' CE1' ' A' ' 195' ' ' TYR . 3.9 mt -112.01 119.92 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.824 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.458 ' CG2' ' HB2' ' A' ' 161' ' ' ALA . 11.9 t -122.34 132.65 54.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 111.026 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.741 ' HB2' HD13 ' A' ' 187' ' ' LEU . 1.6 ttt-85 -109.95 112.88 25.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.495 ' CE1' ' HD2' ' A' ' 66' ' ' ARG . 6.6 p80 -43.1 148.63 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.801 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 38' ' ' GLY . . . -62.09 -131.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.353 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.614 ' OE1' HG21 ' A' ' 37' ' ' THR . 1.8 pt-20 -113.65 133.96 55.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.893 0.378 . . . . 0.0 110.847 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -94.43 172.21 8.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.462 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.8 mt-10 -50.02 -25.69 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.036 0.446 . . . . 0.0 110.748 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.515 ' CZ3' ' HA ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -61.96 -22.82 65.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' N ' ' CD1' ' A' ' 20' ' ' TRP . 40.6 t30 -68.2 -40.0 82.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.346 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -63.99 -41.25 97.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.585 HD22 HD11 ' A' ' 25' ' ' LEU . 1.1 mp -70.68 -27.12 63.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 1.2 t30 73.2 36.29 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.9 171.04 8.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.136 0.493 . . . . 0.0 110.802 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' A' ' 101' ' ' GLY . 5.9 m-85 -83.61 -171.77 3.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.567 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.4 m -133.53 -60.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 100' ' ' GLN . . . 92.6 -104.9 3.24 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.47 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -113.46 -26.48 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.607 0.241 . . . . 0.0 111.302 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HG3' HG23 ' A' ' 27' ' ' THR . 7.8 pttt -51.3 -178.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -127.52 107.76 20.97 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.17 -179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.46 ' HG2' ' CD ' ' A' ' 66' ' ' ARG . 93.9 Cg_endo -79.59 -167.49 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.563 2.175 . . . . 0.0 112.194 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 119.13 27.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.255 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.659 HD23 HD13 ' A' ' 39' ' ' ILE . 13.7 tp -50.71 164.75 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.87 179.05 5.76 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.274 0.559 . . . . 0.0 111.605 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -50.93 -39.95 56.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -62.37 -41.65 98.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -63.69 -57.27 15.05 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HD23 ' A' ' 34' ' ' LEU . 7.3 mm -54.81 -48.06 74.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -59.87 -31.67 69.99 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.212 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' CG ' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.07 -52.73 25.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' N ' ' OE2' ' A' ' 41' ' ' GLU . . . -55.11 -51.34 66.7 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.644 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -52.04 -58.15 7.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.789 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 ' NE ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -55.39 -57.56 11.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.567 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -44.98 -59.26 4.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.659 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -57.93 -46.42 92.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.88 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 51' ' ' SER . 4.9 mm-40 -54.4 -42.87 70.93 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.795 0.331 . . . . 0.0 110.157 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -72.68 -56.93 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.907 HD13 ' HG2' ' A' ' 192' ' ' PRO . 4.4 tp -49.44 -47.07 48.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.761 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -74.17 -24.28 59.36 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.185 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 47' ' ' GLU . 40.2 t -101.33 18.8 19.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -114.22 -21.53 10.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.722 0.296 . . . . 0.0 111.077 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 22.97 8.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.282 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' HG11 ' A' ' 194' ' ' VAL . 27.3 t80 -113.24 124.92 53.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -107.04 151.85 24.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.687 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 159' ' ' LEU . 19.2 m-85 -115.52 140.04 49.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.63 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -52.43 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 158' ' ' VAL . 3.2 mm -109.6 146.81 14.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.964 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -132.56 129.49 39.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.126 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.613 ' CD2' HD11 ' A' ' 148' ' ' ILE . 4.9 m-85 -123.65 111.95 16.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.94 0.4 . . . . 0.0 111.654 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.002 HG22 ' HB3' ' A' ' 161' ' ' ALA . 16.7 p -118.31 159.63 23.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 6.9 p -76.94 150.45 35.94 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . . . -51.0 -22.86 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.103 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' CE1' ' A' ' 163' ' ' HIS . 18.7 mt -63.66 140.35 58.86 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.548 0.689 . . . . 0.0 112.056 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -58.07 -32.61 68.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.337 179.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 10.0 mtm180 -49.42 -57.06 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.157 0.504 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 70' ' ' THR . . . -82.08 -36.13 27.92 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.71 -26.67 68.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.293 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 29.7 ttpt -93.04 -49.95 5.77 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 28.9 m -50.36 -27.22 5.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.355 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 61' ' ' THR . 4.8 t -70.4 -53.49 16.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.957 0.408 . . . . 0.0 110.866 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.58 -46.94 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.832 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 39' ' ' ILE . 15.1 mt -61.25 -65.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.48 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -51.3 -44.9 31.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.674 179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 71' ' ' CYS . 43.5 mt -65.54 -46.2 80.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.124 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -68.06 -23.66 64.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.551 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.2 tm-20 -85.1 -50.51 7.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.002 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' CG2' HD13 ' A' ' 74' ' ' ILE . 53.6 t -59.46 -29.83 43.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.54 22.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.032 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.612 ' HG2' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -124.23 27.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 74.9 Cg_exo -47.82 -36.91 27.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.26 1.306 . . . . 0.0 112.247 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -45.65 -27.69 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.34 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD13 ' HG2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -61.1 -175.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.8 mt-10 -95.9 100.96 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.912 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 96.7 m -91.26 103.35 16.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.178 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -118.04 159.21 18.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.4 0.619 . . . . 0.0 111.256 -178.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.595 ' NZ ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -137.77 158.76 43.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.311 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.884 ' HB3' HD12 ' A' ' 91' ' ' LEU . 11.0 t -132.24 145.03 51.04 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 15.1 pt-20 -76.44 -31.93 58.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 140' ' ' VAL . 4.5 mttt -76.05 -10.05 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 88' ' ' SER . 1.9 mt -79.89 2.01 24.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.283 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -71.1 161.65 30.77 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.727 0.299 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 6.7 tp10 -63.24 140.45 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.466 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 0.5 OUTLIER -50.74 133.71 25.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.417 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CE2' ' HA2' ' A' ' 97' ' ' GLY . 7.3 t80 -53.55 149.1 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.121 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.454 ' HB3' ' N ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -116.49 13.95 15.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.75 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' HA2' ' A' ' 130' ' ' GLY . . . 47.56 -125.27 10.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.967 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -89.95 17.22 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.617 0.246 . . . . 0.0 111.342 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.633 HD11 ' CZ2' ' A' ' 111' ' ' TRP . 2.5 mp -106.69 -21.15 13.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.807 0.337 . . . . 0.0 111.024 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.454 ' N ' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -62.97 149.65 44.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.123 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 66.91 8.18 47.23 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.345 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -90.83 129.48 36.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.958 0.379 . . . . 0.0 110.521 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 24' ' ' ASN . 3.1 t-20 -50.54 118.83 3.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' A' ' 108' ' ' ARG . 6.7 mtmt -45.24 -39.35 6.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 109' ' ' LYS . 4.5 m-20 -66.61 -51.42 56.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.948 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 110' ' ' LYS . 4.9 t70 -58.23 -49.42 77.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.82 74.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HA ' HG11 ' A' ' 116' ' ' VAL . 56.5 mtt180 -65.96 -18.11 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.769 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 105' ' ' ASP . 9.9 mtpp -95.32 -27.23 15.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 mmmt -96.79 -19.74 18.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.261 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HD11 ' A' ' 99' ' ' LEU . 1.5 m-90 -121.15 -7.95 9.32 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.908 0.385 . . . . 0.0 111.594 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.902 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 55.34 160.88 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.707 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 117' ' ' GLN . . . -48.89 -41.43 33.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 118' ' ' ILE . 46.3 mp0 -56.76 -72.65 0.08 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.564 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.3 tp60 -56.22 -50.0 72.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.661 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 112' ' ' GLY . 33.1 m -56.78 -36.31 48.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.966 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 5.9 tt0 -63.19 -63.53 1.17 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.623 HD11 HG21 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.32 -23.74 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.323 178.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.497 ' CZ3' ' HA ' ' A' ' 127' ' ' PRO . 5.2 m95 -82.01 -47.9 12.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.848 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CD ' ' HG2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -88.92 -38.79 14.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 19.2 mmt-85 -90.69 -86.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.539 0.209 . . . . 0.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 125' ' ' ILE . 2.5 p 42.1 -103.22 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.432 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.512 ' CD2' ' HA2' ' A' ' 179' ' ' GLY . 0.9 OUTLIER 164.48 -53.43 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.554 0.342 . . . . 0.0 110.54 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 134' ' ' LYS . 9.5 p-10 -121.63 -23.89 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -84.36 121.35 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 111.008 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.716 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -110.1 157.61 37.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HA ' ' CZ3' ' A' ' 119' ' ' TRP . 24.4 Cg_exo -62.88 162.72 24.49 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 111.798 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 73.1 Cg_exo -48.28 107.86 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.22 1.947 . . . . 0.0 111.522 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 128' ' ' PRO . 7.0 m-20 89.93 -22.98 0.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.09 0.556 . . . . 0.0 111.212 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.478 ' HA2' ' N ' ' A' ' 97' ' ' GLY . . . -74.59 165.96 54.79 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.381 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' C ' ' HB2' ' A' ' 126' ' ' ALA . 33.3 tt0 -104.67 167.8 9.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.271 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 131' ' ' GLU . 22.9 t -118.83 -167.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 165' ' ' ASN . 11.9 tp -76.62 -47.96 20.64 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.464 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -48.95 -47.65 43.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.828 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' LYS . 1.5 m-20 -61.29 -48.23 82.32 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.682 ' O ' HG23 ' A' ' 140' ' ' VAL . 32.1 m -50.62 -49.95 55.45 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.473 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.36 -41.13 85.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -61.14 -20.47 62.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.298 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HD2' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -113.26 -19.23 11.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 90' ' ' LYS . 80.9 t -95.53 -41.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.856 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 137' ' ' ALA . 14.7 mt -54.98 -44.7 99.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.77 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 51.3 Cg_exo -52.4 -47.09 28.8 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 121.617 1.545 . . . . 0.0 110.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.499 ' HE1' HD11 ' A' ' 86' ' ' ILE . 2.4 t80 -59.35 -44.15 92.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.786 ' CE2' HD11 ' A' ' 174' ' ' LEU . 30.2 t80 -57.91 -67.38 0.35 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.455 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.561 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -52.39 -64.34 0.85 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.725 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.3 t -51.59 -59.0 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -96.19 3.74 52.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -176.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 60' ' ' PHE . 6.6 mt -130.17 -4.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.793 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.1 p -91.2 -5.57 0.11 Allowed Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 97.7 Cg_endo -87.68 -49.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.535 1.49 . . . . 0.0 113.127 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.563 ' NE2' HG21 ' A' ' 158' ' ' VAL . 15.2 p-80 -71.58 -44.1 65.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.626 0.251 . . . . 0.0 111.423 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 148' ' ' ILE . 19.0 pt -50.53 -25.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 0.0 111.0 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 199' ' ' LYS . 1.3 mm? -74.29 -32.03 62.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -77.15 -39.62 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.46 43.98 0.22 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.42 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' HG2' ' CG1' ' A' ' 58' ' ' ILE . 4.6 tp10 -107.11 152.75 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.608 ' HE3' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.14 145.98 34.86 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 58' ' ' ILE . 3.8 t -136.45 146.68 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 56' ' ' PHE . 42.0 tp -90.38 153.07 20.69 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.614 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mp -139.06 112.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.982 0.42 . . . . 0.0 110.04 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 1.002 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -124.18 106.36 10.25 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.843 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -144.87 -95.52 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.857 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.922 ' O ' HD12 ' A' ' 167' ' ' LEU . 3.5 m-70 -160.9 161.01 31.62 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -41.37 -50.01 4.63 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.033 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.531 ' O ' HD11 ' A' ' 133' ' ' LEU . 4.1 t30 -61.83 -50.85 70.62 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.791 0.329 . . . . 0.0 110.186 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.4 -61.18 2.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.036 0.446 . . . . 0.0 110.046 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 163' ' ' HIS . 0.9 OUTLIER -60.86 -33.45 73.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.842 179.155 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.554 HH12 HG12 ' A' ' 183' ' ' VAL . 21.3 mtp85 -56.94 -58.32 8.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -57.91 -45.8 85.94 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.759 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.533 HD11 ' CD2' ' A' ' 144' ' ' TYR . 6.0 tp -56.07 -66.26 0.46 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.48 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 1.024 HG21 ' CD ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -51.93 -32.11 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -56.42 -69.36 0.15 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' N ' ' CG ' ' A' ' 172' ' ' MET . 1.0 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.141 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.786 HD11 ' CE2' ' A' ' 144' ' ' TYR . 4.7 mt -77.81 -25.75 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.673 ' HB3' HD13 ' A' ' 171' ' ' ILE . 6.3 pt-20 -104.22 -49.92 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.087 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 175' ' ' GLU . . . 115.52 42.23 0.76 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.917 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.808 HD22 ' N ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -53.24 -169.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.129 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.808 ' N ' HD22 ' A' ' 177' ' ' LEU . 6.6 t -165.53 73.66 0.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' A' ' 123' ' ' TYR . . . 73.57 -57.72 2.07 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.669 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.94 -15.15 12.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.784 0.291 . . . . 0.0 111.784 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.674 ' HB2' HG22 ' A' ' 178' ' ' THR . 0.6 OUTLIER -71.24 -5.6 33.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.1 OUTLIER -103.5 -47.92 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.554 HG12 HH12 ' A' ' 168' ' ' ARG . 0.1 OUTLIER -58.68 -21.81 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -24.47 63.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.749 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 1.024 ' CD ' HG21 ' A' ' 171' ' ' ILE . 18.3 ttt85 -70.29 161.95 29.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.481 ' N ' ' HG2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -159.7 -172.47 3.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.418 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.806 HD21 HH22 ' A' ' 185' ' ' ARG . 28.5 mt -149.98 165.23 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 111.185 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 189' ' ' THR . . . -111.88 28.43 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.637 HG22 ' HD3' ' A' ' 14' ' ' ARG . 80.8 p 35.95 102.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.571 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 41' ' ' GLU . . . 99.1 25.81 9.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.83 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 191' ' ' VAL . 35.7 m -131.47 92.66 31.11 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.756 0.312 . . . . 0.0 110.837 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.907 ' HG2' HD13 ' A' ' 49' ' ' LEU . 22.4 Cg_endo -62.75 99.0 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.63 2.22 . . . . 0.0 112.211 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD13 HG12 ' A' ' 209' ' ' ILE . 6.5 tp -84.67 129.5 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 11' ' ' VAL . 9.3 t -88.9 138.91 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.809 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.716 ' CE1' HD12 ' A' ' 12' ' ' LEU . 9.7 m-85 -122.77 122.29 38.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.712 0.291 . . . . 0.0 110.862 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.759 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.5 t60 -78.95 86.9 4.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.286 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 202' ' ' LYS . 1.5 mt -91.55 162.98 14.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.835 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.5 OUTLIER -89.37 -176.07 4.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.75 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -73.79 -2.82 25.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.38 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.445 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 0.2 OUTLIER -99.82 -20.94 15.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.825 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.7 28.33 4.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.374 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.889 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -127.16 148.38 50.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.994 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.644 ' N ' HD23 ' A' ' 197' ' ' LEU . 2.0 p90 -57.09 142.54 41.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.243 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 198' ' ' ASP . 33.5 m -141.36 24.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 196' ' ' HIS . 0.1 OUTLIER -177.52 -157.55 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.034 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 143.84 41.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.437 . . . . 0.0 110.893 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.481 ' CG ' HD11 ' A' ' 193' ' ' ILE . 2.8 pm0 -78.72 168.16 20.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.838 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 209' ' ' ILE . 2.3 tt -156.14 136.92 13.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.511 0.672 . . . . 0.0 112.195 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.502 HD11 ' C ' ' A' ' 192' ' ' PRO . 1.2 mm -111.45 161.77 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.041 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 48' ' ' ARG . 0.9 OUTLIER -66.87 -47.48 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.716 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 209' ' ' ILE . 4.2 t30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HA ' ' CG ' ' A' ' 157' ' ' LYS . 1.2 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.653 0.263 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.743 HG23 ' N ' ' A' ' 156' ' ' GLU . 1.6 t -80.87 172.69 13.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.427 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -177.8 132.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.94 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 65.14 56.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.88 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -167.44 178.77 1.08 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.991 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.924 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 87.5 Cg_exo -43.49 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.729 2.286 . . . . 0.0 112.41 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.697 ' CG ' HG21 ' A' ' 2' ' ' THR . 2.1 m120 -65.08 142.51 58.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.611 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.565 HD11 HG22 ' A' ' 194' ' ' VAL . 7.7 tp -111.18 133.08 53.81 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 112.138 -179.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.789 ' CD2' HD11 ' A' ' 160' ' ' ILE . 1.3 tp -126.83 118.76 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.547 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' CG2' ' CZ ' ' A' ' 54' ' ' TYR . 2.7 t -105.42 131.16 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.212 0.529 . . . . 0.0 110.788 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.577 ' CD2' HD12 ' A' ' 160' ' ' ILE . 2.3 mt -104.1 145.83 29.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 13' ' ' THR . 9.4 t -149.59 90.26 1.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.899 ' HB2' HD11 ' A' ' 187' ' ' LEU . 72.5 ttt180 -68.23 138.54 55.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.418 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.53 ' HA ' HG21 ' A' ' 70' ' ' THR . 7.1 p80 -46.05 130.44 9.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 41' ' ' GLU . . . -40.69 -62.24 1.7 Allowed Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.529 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.64 163.98 1.02 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.862 0.363 . . . . 0.0 110.98 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -131.63 161.01 33.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -30.36 4.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.394 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 1.037 ' CE3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.2 -23.17 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.309 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -64.24 -40.45 96.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.544 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -70.33 -37.79 74.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -70.31 -28.7 65.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 t30 72.4 38.38 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.241 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.2 166.2 12.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.974 178.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 101' ' ' GLY . 0.5 OUTLIER -73.93 -179.25 3.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.886 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.037 HG23 ' CE3' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -118.02 -77.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.608 -179.494 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 100' ' ' GLN . . . 93.29 -137.14 13.47 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.001 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -90.69 -20.37 22.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.128 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HZ1' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -54.67 168.76 0.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.19 103.1 47.93 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HG2' ' NE ' ' A' ' 66' ' ' ARG . 87.4 Cg_endo -83.56 167.38 13.36 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.738 2.292 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.86 128.67 45.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 39' ' ' ILE . 4.3 tp -53.45 176.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.596 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 p -137.51 172.84 12.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.952 0.406 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -51.04 -46.04 61.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.9 m -63.1 -39.0 93.4 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.07 45.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 34' ' ' LEU . 28.8 mm -59.14 -54.17 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -54.68 -41.32 70.05 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.674 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 4.6 mm-40 -63.39 -48.29 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.714 178.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.91 -56.54 19.91 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.069 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -51.89 -54.5 28.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.844 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 44' ' ' LEU . 10.0 tp -57.95 -45.6 86.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.53 -59.39 10.6 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.043 178.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 74' ' ' ILE . . . -59.0 -48.74 84.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.098 178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 51' ' ' SER . 14.9 tt0 -54.25 -41.38 68.7 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' NE ' ' OD1' ' A' ' 211' ' ' ASN . 13.0 mmt180 -72.49 -36.64 68.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.638 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' HB3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -63.7 -48.36 77.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.252 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.14 -27.42 39.08 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.737 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 1.2 m -49.34 -66.83 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' CD ' ' HB3' ' A' ' 210' ' ' ASP . 0.0 OUTLIER -51.76 -25.46 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.696 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.53 21.35 6.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.64 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' CE ' ' A' ' 157' ' ' LYS . 40.1 t80 -81.28 109.67 16.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.769 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -95.81 159.51 14.94 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.456 179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 159' ' ' LEU . 34.7 m-85 -115.41 157.95 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' ' HG2' ' A' ' 156' ' ' GLU . 4.6 m-20 -121.45 -42.01 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.754 177.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.796 ' CG2' HG13 ' A' ' 158' ' ' VAL . 11.1 mm -125.29 149.53 29.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.63 178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -131.7 119.18 21.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.538 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.756 ' HE1' HD13 ' A' ' 86' ' ' ILE . 22.1 m-85 -118.97 114.76 23.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.939 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.936 HG21 ' HB2' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -121.4 165.09 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.942 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.0 p -79.59 173.36 12.66 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . . . -88.74 18.53 4.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.347 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.824 HD12 ' CE1' ' A' ' 163' ' ' HIS . 47.1 mt -101.13 146.83 26.96 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.041 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 68' ' ' GLN . 9.5 pt20 -52.8 -36.79 58.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.11 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HD2' ' CE1' ' A' ' 15' ' ' HIS . 16.4 mtm180 -52.52 -54.56 30.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 71' ' ' CYS . . . -81.69 -33.16 31.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.792 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -65.5 -29.31 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.056 179.022 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 65' ' ' GLN . 18.2 ttpt -90.69 -47.74 7.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.27 178.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 15' ' ' HIS . 28.1 m -58.25 -25.62 61.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.028 179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.936 ' HB2' HG21 ' A' ' 61' ' ' THR . 45.7 t -66.45 -62.33 1.52 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -45.52 -49.27 13.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.046 -179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 33.9 mt -59.47 -65.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.769 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.955 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -50.69 -46.03 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.626 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' SG ' ' A' ' 71' ' ' CYS . 8.0 mt -63.87 -62.77 1.43 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.11 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -53.52 -23.87 11.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.131 179.204 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ILE . 14.2 tp10 -82.49 -38.15 24.28 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.768 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 74' ' ' ILE . 71.4 t -62.06 -48.21 89.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.24 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.02 24.34 4.26 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.664 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 81' ' ' PRO . 44.7 mm-40 -148.21 58.59 3.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 80' ' ' GLU . 39.7 Cg_exo -61.79 -34.73 82.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.366 2.044 . . . . 0.0 112.121 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.93 -26.46 68.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.045 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 84' ' ' GLU . 3.7 tt -45.78 158.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.645 ' N ' HD23 ' A' ' 83' ' ' LEU . 6.4 mm-40 -58.47 86.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 110.836 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.935 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.6 m -95.49 95.15 8.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.141 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' OH ' ' A' ' 143' ' ' TYR . 0.8 OUTLIER -118.62 164.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.308 0.575 . . . . 0.0 110.706 -179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.18 176.54 9.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.183 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 91' ' ' LEU . 27.3 t -147.49 150.05 33.82 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.257 0.551 . . . . 0.0 111.876 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 77.9 tt0 -79.63 -30.79 41.49 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.661 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.813 ' O ' HG22 ' A' ' 140' ' ' VAL . 2.0 mttp -75.09 -10.74 59.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.346 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 88' ' ' SER . 0.5 OUTLIER -84.07 7.39 18.8 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.43 -178.44 4.05 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 165' ' ' ASN . 29.8 tp10 -82.47 144.32 30.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HB2' HG21 ' A' ' 136' ' ' THR . 2.7 tmm_? -49.8 123.91 8.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.285 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.47 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -50.63 116.94 2.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.126 178.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 3.9 m-85 -89.71 37.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 129' ' ' ASN . . . 38.41 -113.6 0.27 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.745 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -96.68 2.49 52.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -83.19 -24.24 32.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.801 179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' OE1' ' CD1' ' A' ' 95' ' ' TYR . 15.4 mt-30 -42.79 110.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 26' ' ' PHE . . . 88.45 7.0 73.03 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.79 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.784 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.3 tt -82.42 142.39 31.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.258 0.529 . . . . 0.0 110.086 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.06 122.3 17.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.268 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -34.91 20.81 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 109' ' ' LYS . 85.2 m-20 -59.83 -47.37 85.98 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -62.48 -50.34 71.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . . . -50.31 -52.91 32.63 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.414 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -74.93 -16.89 60.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 105' ' ' ASP . 8.4 mtpp -88.51 -21.6 24.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.629 0.252 . . . . 0.0 110.998 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -114.93 -28.15 7.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.817 0.341 . . . . 0.0 111.342 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.719 ' CH2' HD22 ' A' ' 99' ' ' LEU . 10.8 m0 -117.41 -15.54 10.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 116' ' ' VAL . . . 51.96 168.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.244 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CA ' HG22 ' A' ' 116' ' ' VAL . . . -47.95 -43.06 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.802 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.3 -75.84 0.05 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.446 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.479 ' O ' ' CD1' ' A' ' 119' ' ' TRP . 1.8 tt0 -54.16 -45.8 72.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.491 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 112' ' ' GLY . 5.8 m -59.55 -38.86 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.794 178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 20.5 tt0 -59.42 -55.81 29.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -65.63 -12.4 13.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 178.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' CE3' ' HA ' ' A' ' 127' ' ' PRO . 4.2 m95 -93.79 -38.3 11.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.589 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' NH1' ' NH2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -109.44 -34.81 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.648 ' O ' HG12 ' A' ' 183' ' ' VAL . 20.3 mmt-85 -87.32 -24.03 24.44 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.428 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.6 ' CB ' HG23 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -38.3 160.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.518 ' CG ' ' HA2' ' A' ' 179' ' ' GLY . 21.4 t80 -91.53 -53.97 4.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.445 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.0 -31.79 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 0.0 111.134 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.6 HG23 ' CB ' ' A' ' 122' ' ' SER . 3.7 tp -73.0 110.61 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -102.47 166.82 11.34 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.743 -179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.858 ' HB3' HD11 ' A' ' 99' ' ' LEU . 11.9 Cg_exo -70.54 172.84 12.64 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.107 2.538 . . . . 0.0 112.265 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.83 96.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.008 . . . . 0.0 111.53 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.408 ' O ' ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 73.86 162.14 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.431 -179.145 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 95' ' ' TYR . . . 113.47 -137.49 14.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.018 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -138.65 -174.96 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.032 0.444 . . . . 0.0 111.145 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.44 167.81 23.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.229 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 168' ' ' ARG . 2.5 tp -48.25 -58.59 4.34 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HE3' ' CA ' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -52.09 -45.44 64.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 -179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.451 ' CA ' ' HE3' ' A' ' 134' ' ' LYS . 4.4 t70 -61.78 -60.21 3.99 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 140' ' ' VAL . 70.4 p -48.26 -45.09 34.05 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.449 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -62.43 -50.35 71.85 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -55.74 -22.93 26.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.016 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -107.69 -12.09 15.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.676 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 136' ' ' THR . 78.9 t -98.25 -28.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 0.0 110.004 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 8.2 mt -67.88 -43.77 38.78 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.896 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 141' ' ' LEU . 50.7 Cg_exo -52.08 -47.82 24.75 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.782 1.655 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.81 ' OH ' HD11 ' A' ' 86' ' ' ILE . 10.9 t80 -58.42 -46.87 85.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.699 ' OH ' HD11 ' A' ' 174' ' ' LEU . 42.6 t80 -55.38 -67.17 0.3 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.405 178.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 149' ' ' VAL . 0.0 OUTLIER -53.21 -66.95 0.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.359 179.578 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 142' ' ' PRO . 4.5 t -45.12 -65.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.529 ' CG2' ' CD1' ' A' ' 143' ' ' TYR . 1.5 t -103.04 8.83 38.8 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 148' ' ' ILE . 6.5 mt -129.21 -1.35 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.34 178.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 150' ' ' PRO . 1.7 p -89.08 -19.09 0.24 Allowed Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 149' ' ' VAL . 56.9 Cg_endo -76.88 -60.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.394 1.396 . . . . 0.0 113.582 -179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 148' ' ' ILE . 15.9 p-80 -58.49 -42.83 88.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.569 0.223 . . . . 0.0 111.366 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.668 HG13 HD23 ' A' ' 153' ' ' LEU . 14.9 pt -54.79 -21.65 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.225 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 152' ' ' ILE . 3.3 mm? -103.1 9.8 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.355 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -101.42 -40.95 6.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 2' ' ' THR . . . 130.91 50.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.599 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -139.08 160.6 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 110.658 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -109.21 157.96 18.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.088 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.796 HG13 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -133.48 158.86 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.882 HD13 ' CZ ' ' A' ' 56' ' ' PHE . 5.3 tp -105.74 140.02 39.42 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.097 176.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 10' ' ' LEU . 67.3 mt -130.07 131.32 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.233 179.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.755 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -143.83 105.8 4.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.808 ' HB1' ' O ' ' A' ' 91' ' ' LEU . . . -144.75 -99.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.858 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.929 ' O ' HD12 ' A' ' 167' ' ' LEU . 5.5 m-70 -159.21 162.28 36.23 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 111.377 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' ARG . . . -45.49 -44.59 11.45 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.053 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.729 ' ND2' HG21 ' A' ' 136' ' ' THR . 4.0 t30 -66.13 -54.78 21.27 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 0.2 OUTLIER -50.65 -51.91 44.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 163' ' ' HIS . 1.8 mp -67.43 -33.53 75.35 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.339 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.574 ' HB3' HD11 ' A' ' 133' ' ' LEU . 10.8 mtm180 -59.84 -55.69 31.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 137' ' ' ALA . . . -61.93 -46.4 89.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.3 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 174' ' ' LEU . 1.8 tm? -54.3 -67.18 0.28 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -54.97 -39.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.737 179.191 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.46 ' HB2' HG12 ' A' ' 182' ' ' ILE . 4.6 tpt -48.83 -56.29 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.55 -34.59 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.07 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.919 ' HG ' HD21 ' A' ' 197' ' ' LEU . 9.9 tp -58.38 -35.39 71.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.168 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 171' ' ' ILE . 3.1 tt0 -96.76 -37.38 10.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.381 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.6 40.51 4.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.963 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.584 HD23 HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -82.97 -175.8 6.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.878 0.371 . . . . 0.0 110.999 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.745 HG22 ' CB ' ' A' ' 181' ' ' GLN . 12.2 t -113.73 -160.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.718 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.518 ' HA2' ' CG ' ' A' ' 123' ' ' TYR . . . -84.29 -44.7 6.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.554 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.99 24.87 4.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.744 0.306 . . . . 0.0 110.836 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.745 ' CB ' HG22 ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.74 16.95 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.328 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.584 HD13 HD23 ' A' ' 177' ' ' LEU . 1.2 tp -138.81 12.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.632 0.253 . . . . 0.0 111.625 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -92.44 18.65 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -117.19 -35.49 4.04 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.439 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.475 ' NH2' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -49.41 150.95 1.66 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.578 179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -171.77 -170.73 0.81 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 14' ' ' ARG . 2.4 pt? -163.47 169.97 18.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.889 ' HB3' ' CG2' ' A' ' 191' ' ' VAL . . . -104.17 136.27 44.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 14' ' ' ARG . 3.5 p -74.95 122.18 23.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.66 -25.5 20.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.373 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.889 ' CG2' ' HB3' ' A' ' 188' ' ' ALA . 34.4 m -99.9 126.81 35.5 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.602 0.239 . . . . 0.0 110.776 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.75 ' O ' HD13 ' A' ' 209' ' ' ILE . 91.5 Cg_endo -83.48 117.59 2.43 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.625 2.217 . . . . 0.0 113.033 -179.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.92 HD12 ' HB2' ' A' ' 207' ' ' GLU . 0.9 OUTLIER -88.99 157.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.379 179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 9' ' ' LEU . 7.2 p -130.27 117.53 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.43 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.593 ' O ' HD12 ' A' ' 197' ' ' LEU . 13.5 m-85 -106.88 112.88 26.05 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.837 ' O ' HG22 ' A' ' 204' ' ' VAL . 1.8 t60 -75.1 100.71 4.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.416 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.919 HD21 ' HG ' ' A' ' 174' ' ' LEU . 1.5 mp -98.06 158.56 15.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.28 0.562 . . . . 0.0 111.527 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.564 ' HB3' HG11 ' A' ' 204' ' ' VAL . 0.3 OUTLIER -90.79 -175.04 4.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.676 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER -67.2 -9.46 40.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.551 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 199' ' ' LYS . 6.5 t70 -108.07 23.2 14.84 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.724 0.297 . . . . 0.0 111.16 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.451 ' C ' HD23 ' A' ' 197' ' ' LEU . . . 58.51 50.25 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.453 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.554 ' N ' HD23 ' A' ' 197' ' ' LEU . 21.6 tttt -140.73 136.03 32.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.505 ' CE1' ' HG2' ' A' ' 175' ' ' GLU . 2.1 p90 -50.16 148.82 3.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 196' ' ' HIS . 20.1 m -141.82 11.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.746 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 m -154.17 -85.49 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.885 0.374 . . . . 0.0 110.959 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.51 179.91 0.08 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.998 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.92 ' HB2' HD12 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -95.0 150.22 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -155.52 157.64 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.236 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 192' ' ' PRO . 14.6 mm -114.14 161.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.521 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 209' ' ' ILE . 4.8 m-20 -91.63 -40.25 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.426 ' N ' HG22 ' A' ' 209' ' ' ILE . 1.1 t30 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 stop_ save_